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Emmanuelle Villedieu-Percheron, Véronique Ferreira, Joana Filomena Campos, 
Emilie Destandau, Chantal Pichon and Sabine Berteina-Raboin
Quantitative Determination of Andrographolide and Related Compounds in 
Andrographis paniculata Extracts and Biological Evaluation of Their Anti-Inflammatory Activity
Reprinted from: Foods 2019, 8, 683, doi:10.3390/foods8120683 . . . . . . . . . . . . . . . . . . . . . 129
Su-Jung Yeon, Ji-Han Kim, Won-Young Cho, Soo-Ki Kim, Han Geuk Seo and Chi-Ho Lee
In Vitro Studies of Fermented Korean Chung-Yang Hot Pepper Phenolics as Inhibitors of Key
Enzymes Relevant to Hypertension and Diabetes
Reprinted from: Foods 2019, 8, 498, doi:10.3390/foods8100498 . . . . . . . . . . . . . . . . . . . . . 141
Sotirios Kiokias, Charalampos Proestos and Vassiliki Oreopoulou
Phenolic Acids of Plant Origin—A Review on Their Antioxidant Activity In Vitro (O/W
Emulsion Systems) Along with Their In Vivo Health Biochemical Properties
Reprinted from: Foods 2020, 9, 534, doi:10.3390/foods9040534 . . . . . . . . . . . . . . . . . . . . . 149
Bahare Salehi, Zeliha Selamoglu, Bilge Sener, Mehtap Kilic, Arun Kumar Jugran, 
Nunziatina de Tommasi, Chiara Sinisgalli, Luigi Milella, Jovana Rajkovic, 
Maria Flaviana B. Morais-Braga, Camila F. Bezerra, Janaı́na E. Rocha, Henrique D.M. 
Coutinho, Adedayo Oluwaseun Ademiluyi, Zabta Khan Shinwari, Sohail Ahmad Jan, 
Ebru Erol, Zulfiqar Ali, Elise Adrian Ostrander, Javad Sharifi-Rad, Marı́a de la Luz Cádiz-
Gurrea, Yasaman Taheri, Miquel Martorell, Antonio Segura-Carretero and William C. Cho
Berberis Plants—Drifting from Farm to Food Applications, Phytotherapy, 
and Phytopharmacology
Reprinted from: Foods 2019, 8, 522, doi:10.3390/foods8100522 . . . . . . . . . . . . . . . . . . . . 171
Bang-Yan Li, Xiao-Yu Xu, Ren-You Gan, Quan-Cai Sun, Jin-Ming Meng, Ao Shang,
Qian-Qian Mao and Hua-Bin Li
Targeting Gut Microbiota for the Prevention and Management of Diabetes Mellitus by Dietary
Natural Products
Reprinted from: Foods 2019, 8, 440, doi:10.3390/foods8100440 . . . . . . . . . . . . . . . . . . . . . 199
vi
About the Editor
Charalampos Proestos (Associate Professor in Food Chemistry) Charalampos Proestos has a BSc 
in Chemistry, University of Ioannina, Greece, and an MSc in Food Science at Reading University, 
U.K. He obtained his Ph.D. in Food Chemistry at the Agricultural University of Athens (AUA), 
Greece, where he continued his post-doc working on natural antioxidants on programs funded by 
the EU and Greece. After further training at Wageningen University (the Netherlands), he worked 
as a Research Associate at AUA. He worked as a Chemist for the Hellenic Food Authority (EFET 
as a food industry auditor and supervisor of the Chemical Laboratory in Athens accredited with 
ISO 17025. He is currently Associate Professor at the Department of Chemistry, National and 
Kapodistrian University of Athens, and director of the laboratory of Food Chemistry. He has 
published more than 70 papers in reputed journals and has been serving as an editorial board 
member of more than 10 reputed journals. He is Member of the European Committee of the Division 
of Food Chemistry, European Association of Chemical and Molecular Sciences (EuChemS). His 






The Benefits of Plant Extracts for Human Health
Charalampos Proestos
Laboratory of Food Chemistry, Department of Chemistry, National and Kapodistrian University of Athens,
15771 Athens, Greece; harpro@chem.uoa.gr; Tel.: +30-210-727-4160
Received: 5 November 2020; Accepted: 10 November 2020; Published: 12 November 2020
Nature has always been, and still is, a source of foods and ingredients that are beneficial to
human health. Nowadays, plant extracts are increasingly becoming important additives in the food
industry due to their content in bioactive compounds such as polyphenols [1] and carotenoids [2],
which have antimicrobial and antioxidant activity, especially against low-density lipoprotein (LDL) and
deoxyribonucleic acid (DNA) oxidative changes [3]. The aforementioned compounds also delay the
development of off-flavors and improve the shelf life and color stability of food products. Due to their
natural origin, they are excellent candidates to replace synthetic compounds, which are generally
considered to have toxicological and carcinogenic effects. The efficient extraction of these compounds
from their natural sources and the determination of their activity in commercialized products have been
great challenges for researchers and food chain contributors to develop products with positive effects
on human health. The objective of this Special Issue is to highlight the existing evidence regarding the
various potential benefits of the consumption of plant extracts and plant extract-based products,
along with essential oils that are derived from plants also and emphasize in vivo works and
epidemiological studies, application of plant extracts to improve shelf-life, the nutritional and
health-related properties of foods, and the extraction techniques that can be used to obtain bioactive
compounds from plant extracts.
In this context, Concha-Meyer et al. [4] studied the bioactive compounds of tomato pomace
obtained by ultrasound assisted extraction. In this review, it was presented that the functional
extract obtained by ultrasounds had antithrombotic properties, such as platelet anti-aggregant activity
compared with commercial cardioprotective products. Turrini et al. [5] introduced bud-derivatives
from eight different plant species as a new category of botanicals containing polyphenols and studied
how different extraction processes can affect their composition. Woody vine plants from Kadsura spp.
belonging to the Schisandraceae family produce edible red fruits that are rich in nutrients and antioxidant
compounds such as flavonoids. Extracts from these plants had antioxidant properties and had shown
also key enzyme inhibitions [6]. Hence, fruit parts other than the edible mesocarp could be utilized
for future food applications using Kadsura spp. rather than these being wasted. Saji et al. [7]
studied the possible use of rice bran, a by-product generated during the rice milling process, normally
used in animal feed or discarded due to its rancidity, for its phenolic content. It was proved
that rice bran phenolic extracts via their metal chelating properties and free radical scavenging
activity, target pathways of oxidative stress and inflammation resulting in the alleviation of vascular
inflammatory mediators. Villedieu-Percheron et al. [8] evaluated three natural diterpenes compounds
extracted and isolated from Andrographis paniculata medicinal herb as possible inhibitors of NFκB
(nuclear factor kappa-light-chain-enhancer of activated B cells) transcriptional activity of pure analogues.
Yeon et al. [9] evaluated the antioxidant activity, the angiotensin I-converting enzyme (ACE)
inhibition effect, and the α-amylase and α-glucosidase inhibition activities of hot pepper water
extracts both before and after their fermentation. These water extracts were proved to have potentially
inhibitory effects against both hyperglycemia and hypertension. The hydrolyzed extracts of Ziziphus
jujube fruit, commonly called jujube, were examined for their protective effect against lung inflammation
in mice [10]. They contained significant amounts of flavonoids which inhibited cytokine release from
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macrophages and promoted antioxidant defenses in vivo. Tran at al. [11] examined the antidiabetic
activity of spray-dried Euphorbia hirta L. herb extracts containing high concentrations of bioactive
compounds such as phenolics and flavonoids. Li et al. [12] reported that intestinal microbiota is closely
associated with the initiation and progression of diabetes mellitus and reviewed bioactive components
which exhibited anti-diabetic activity by modulating these intestinal microbiotas. Essential oils have
promising activity against antibiotic-resistant bacteria and chemotherapeutic-resistant tumors. This was
supported by the study of Viktorová et al. [13] where lemongrass essential oil and especially citral,
the dominant component, proved to have potential antimicrobial and anticancer activity. Additionally,
Mitropoulou et al. [14] investigated the antimicrobial potential of Sideritis raeseri subps. raeseri essential
oil against common food spoilage and pathogenic microorganisms and evaluated its antioxidant and
antiproliferative activity. Salehi et al. [15] reviewed the Berberis plants, which contain alkaloids, tannins,
phenolic compounds and essential oils, and their possible use in the food and pharmaceutical industry.
Last but not least, Kiokias et al. [16] reviewed the naturally occurring phenolic acids from plants and
their antioxidant activities in o/w emulsions and in vitro lipid-based model systems.
Still more research is needed to explore more and in depth the health beneficial effects of plant
extracts, since nature certainly has more to give to humans.
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Abstract: Tomato paste production generates a residue known as tomato pomace, which corresponds
to peels and seeds separated during tomato processing. Currently, there is an opportunity to use tomato
pomace to obtain a functional extract with antithrombotic properties, such as platelet anti-aggregant
activity. The aim of this study was to evaluate the yield and inhibitory activity of different
extracts of tomato pomace on in vitro platelet aggregation, comparing this activity with commercial
cardioprotective products, and quantify bioactive compounds. Aqueous or ethanolic/water (1:1)
extracts of whole tomato pomace, seedless tomato pomace, tomato pomace supplemented with seeds
(50% and 20%), and only seeds were obtained with different ultrasound-assisted extraction times.
The inhibition of platelet aggregation was evaluated using a lumi-aggregometer. The quantification of
bioactive compounds was determined by HPLC-MS. From 5 g of each type of tomato pomace sample,
0.023–0.22 g of a dry extract was obtained for the platelet aggregation assay. The time of sonication
and extraction solvent had a significant role in platelet anti-aggregant activity of some extracts
respect the control. Thus, the most active extracts decreased adenosine diphosphate (ADP)-induced
platelet aggregation from 87 ± 6% (control) to values between 26 ± 6% and 34 ± 2% (p < 0.05).
Furthermore, different ultrasound-assisted extraction conditions of tomato pomace fractions had
varied concentration of flavonoids and nucleosides, and had an effect on extract yield.
Keywords: tomato pomace; extraction; platelet; ultrasound; functional ingredient
1. Introduction
Cardiovascular disease (CVD) is the number one cause of death worldwide since more people
die annually (≈17 million) from CVD than from any other cause [1]. In Chile, CVD causes 27% of
deaths [2]. In this context, the adherence to a diet rich in fruit and vegetables was associated with a
decrease of all-cause mortality among individuals with CVD [3–5]. Furthermore, tomato (Lycopersicon
esculentum) has been one of the most powerful vegetables associated with the reduction of this type of
disease [6–10]. Emerging epidemiological and interventional data support the connection between
higher tomato consumption and a lower risk of CVD. Additionally, tomato has the lowest uric acid
Foods 2020, 9, 1564; doi:10.3390/foods9111564 www.mdpi.com/journal/foods5
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content of any fruit and vegetable [11,12]. The latter is important because a high uric acid level in the
body can cause various health issues like arthritis [13].
Tomato is an important vegetable grown in many countries across the world for fresh markets and
multiple processed forms. The worldwide production of processed tomato in 2017 was 38 million tons [14].
During the season 2017–2018, Chile produced 918,000 metric tons of industrial tomato and the Maule
region represented about 66% of this total [15]. This crop is industrially processed to produce concentrated
tomato paste, which is used to formulate products such as ketchup, sauce, puree, and juice. This processing
generates a byproduct named tomato pomace, corresponding mostly to peels and seeds that account for 3–5%
(wet basis (w.b.)) of fresh tomato [16]. Currently, the tomato pomace has different uses, such as a protein
supplement for growing lambs [17], ruminant feeding [18], chemical and nutritional supplementation
of crackers [19], and sustainable fabrication of packaging films [20]. Furthermore, if the latter is not
possible, this residue is disposed of on agricultural lands causing environmental contamination [21,22].
The results of the proximate composition of tomato pomace, on a dry weight basis, showed a relevant
nutritional content of total protein (19.40%, N × 6.25), total fat (12.33%), available carbohydrates (17.15%),
total dietary fiber (47.80%), ash (3.32%), sodium (13.20 mg/100 g), and sugars (9.54%) [23]. Meanwhile,
tomato seed oil contains high levels of linoleic (54%) and oleic (22%) acids [24]. On the other hand, the main
polysaccharides identified in tomato pomace correspond to glucose (40.5 ± 1.2%) and fructose (22.6 ± 2.1%)
from total carbohydrates of 382.9 ± 10.3 mg/g dry weight [25]. Tomato pomace is also known as a source of
bioactive compounds, such as carotenoids, phenolic compounds, and dietary fiber [26]. Considering the
above, there is an opportunity to use tomato pomace to obtain a functional product with antithrombotic
properties, such as platelet anti-aggregant activity, that could be useful as an ingredient in healthy foods for
CVD prevention [5].
Different extraction procedures have been evaluated to increase the efficiency of tomato pomace
compound extraction for pectin, dietary fiber, and carotenoids such as lycopene, including varied
solvent extraction by mixing and heating, microwave-assisted extraction, enzymatic extraction,
ultrasound-assisted extraction, and ultrasound-assisted treatment combined with subcritical
water [27–30]. Ultrasound is a non-thermal technology that has shown to be particularly effective for
improving the extraction of heat-labile compounds [31]. Ultrasound equipment is also commonly
available in most analytic laboratories and is used to improve the efficiency of any extraction solvent,
thus reducing the extraction times [32]. Furthermore, there is a need to improve the extraction of
bioactive compounds, such as flavonoids and nucleosides (adenosine and guanosine), that are present
in tomato (Solanum lycopersicum) and tomato pomace, which have significant platelet anti-aggregant
activity [5,6,33,34]. This work aimed to evaluate the chemical profile and platelet anti-aggregant
activity of ultrasound-assisted extracts of different tomato pomace fractions obtained using water or
ethanol/water (1:1) as the solvent.
2. Materials and Methods
2.1. Chemicals
The solvents used were ethanol (Sigma-Aldrich, St. Louis, MO, USA) and type I ultrapure water
(18.2 MΩ-cm), which was supplied by the Purelab Classic Elga water system (Labwater/VWS Ltd.,
London, UK). Adenosine diphosphate (ADP) was used as an agonist in the platelet aggregation assay
(Chrono-log, Havertown, PA, USA).
2.2. Plant Material
Tomato pomace (mainly peels and seeds), which is a byproduct of the industrial production
of tomato paste, was obtained from the company Sugal Chile (Talca, Chile) during the 2016 season.
Given the production line of the plant, it was not possible to define specific fruit hybrids that
corresponded to the tomato pomace; and it was only possible to identify middle (Sun6366, AB3,
and HMX7883) and late (H9665, H7709, and H9997) hybrid tomatoes [35]. Tomato pomace was placed
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in trays and dried for 48 h at 60 ◦C in a convection oven (VHC-1A, Ventus Corp., Santiago, Chile);
after this, a portion of tomato pomace (22% of seeds) was manually separated into seeds and peels for
the preparation of the different extracts; and finally, all parts from tomato pomace were milled and
sieved through a 425 μm mesh (No. 40) (TRF 300, TRAPP, Jaraguá do Sul, Brazil).
2.3. Preparation of Extracts
Aqueous or ethanolic/water (1:1) extracts of whole tomato pomace, seedless tomato pomace,
tomato pomace supplemented with seeds (50% and 20%), and only seeds were obtained. Briefly, 5 g of
each fraction was mixed with 50 mL of water for aqueous extract, and with 25 mL of water and 25 mL
of ethanol for ethanolic extracts. An ultrasonic bath of 2.8 L, 220 V, amplitude 100%, and power 90 W
(VWR 97043-962, Leicestershire, UK), was used with different sonication time cycles were applied as
the extraction process: cycle 1 with one cycle of 20 min, cycle 3 with three cycles of 20 min each with a
10-min pause in between, and cycle 6 with six cycles of 20 min each with a 10-min pause in between.
All cycles were controlled each 1 min at a frequency of 35 kHz and a temperature of 45 ◦C. Then,
the extracts were centrifuged at 725× g (International Equipment Company IEC, Centra MP4R, Boston,
MA, USA) for 5 min to obtain the supernatant, which was frozen at −86 ◦C for 48 h, then freeze-dried
(Operon, FDU 7024, Gimpo, Korea) for 20 h with a cold trap (−70 ◦C), and stored at 20 ◦C in vacuum
airtight packaging in a dark environment. Freeze-dried extracts were resuspended in physiological
saline solution at a concentration of 1 mg/mL and filtered (pore filter 0.22 μm) for analysis and platelet
aggregation assay.
2.4. Platelet Aggregation Assay
The inhibition of platelet aggregation was evaluated in a lumi-aggregometer (Chrono-Log) [5].
Thus, 480 μL of plasma rich in human platelets (2 × 105 platelets/μL) was added to the reaction cuvette
that was pre-incubated with 20 μL of extract (all extracts at a concentration of 1 mg/mL) or control for
maximum platelet aggregation (0.9% saline). After 5 min of incubation, 20 μL of agonist (ADP, 4 μM)
was added to initiate platelet aggregation, which was measured for 6 min. The results were expressed
as a percentage of platelet aggregation. Platelets were obtained from 20 different donors and were used
during a period of 2 h after blood extraction. All volunteers signed informed consent. The maximum
platelet aggregation of the controls (without extracts) was 87 ± 6%. This study was conducted
following the Declaration of Helsinki and informed consent was obtained for experimentation with
human subjects.
2.5. Identification and Quantification of Bioactive Compounds by HPLC-MS
2.5.1. Phenolic Compounds
Phenolic compounds were analyzed following the method of Torres et al., [36] with modifications.
Briefly, 350 mg samples of each freeze-dried extract were weighed, ground, and mixed with 5 mL of
75% methanol and 100 μL of internal standard (naringenin, Sigma-Aldrich). Samples were centrifuged
at 11,180× g at 10 ◦C for 10 min (International Equipment Company IEC, Centra MP4R, Boston, MA,
USA). The supernatant was removed and diluted with 20 mL HPLC-grade water (Merck, Darmstadt,
Germany). Simultaneously, extraction column C18 (No. 12102052, Agilent Technologies, Palo Alto,
CA, USA) was activated with 1 mL of 75% methanol. Briefly, 5 mL HPLC-grade water was added to
the C18 column and allowed to drain until dry to remove solvent residues. Samples were eluted using
a vacuum pump (Welch 2545C/02, Mount Prospect, IL, USA) and a vacuum trap (20–40 kPa). Then,
samples inside C18 were allowed to elute until completely drained using 2 mL of pure propanol to
remove concentrated sample-specific phenolic compounds and collected in 4 mL test tubes. N2 gas was
used to dry samples that were reconstituted in 200 μL of pure methanol, mixed, and sonicated (Bandelin
Sonorex TK52H, Berlin, Germany) for 1 min. Samples were analyzed using the ultra-high performance
liquid chromatography (UHPLC) Dionex UltiMate 3000 chromatography system (Thermo Scientific,
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Waltham, MA, USA) equipped with a refrigerated autosampler. The samples were injected into the
Hypersil Gold C18 column (Thermo Fisher Scientific, Bremen, Germany) using 1 μL of samples and a
gradient sample with 75% (v/v) acetonitrile, 24.5% (v/v) water, and 0.5% (v/v) formic acid (solution A)
and 5% (v/v) acetonitrile, 94.5% (v/v) water, and 0.5% (v/v) formic acid (solution B) with a flow rate of
300 μL/min. Gradient elution conditions were set as follows: initial 0–1 min (10% B), 1–5 min (10% B),
5–10 min (30% B), 10–18 min (100% B), and 18–24 min (0% B), with final cleaning and reconditioning
of the column. Mass quantification was carried out with an Exactive Plus Orbitrap spectrometer
(Thermo Scientific) equipped with an electrospray interface operating with negative ionization mode,
and data were processed using the Xcalibur 2.1 software (Thermo Scientific). Mass spectrometry
conditions were 2500 spray volts, vaporization temperature of 350 ◦C, sheath gas pressure of 40
arbitrary units (a.u.), auxiliary gas pressure of 10 a.u., and capillary temperature of 35 ◦C. N2 was used
as the collision gas and all values were normalized to 350 mg/dry weight. Phenolic compounds were
identified and quantified using suitable standards (Extrasynthese, Lyon, France), which were prepared
as 1 mg/mL stock solutions in methanol and stored at −80 ◦C for up to 1 month in dark conditions.
All results were expressed in mg/100 g dry weight.
2.5.2. Carotenoids Compounds
Fuentes et al. (2013) procedures were followed with modifications [37]. Briefly, 0.71 mL of 2:1
solution (pure acetone and 0.2 M HEPES buffer (pH 7.7)) was mixed with 500 mg of the freeze-dried
extract sample and then agitated and centrifuged at 11,180× g for 5 min. The supernatant was separated;
and the pellet was mixed with 0.71 mL of 2:1 solution (pure acetone and 0.2 M HEPES buffer (pH 7.7)),
then stirred, and centrifuged to obtain the supernatant, which was then deposited together with
the previous one. After that, 1 mL of pure acetone was added again to the pellet and centrifuged,
the supernatant was deposited in the same tube, 1 mL of pure acetone was added to the pellet and it
was stirred and centrifuged, the supernatant was deposited in the same tube, and 0.75 mL of pure
hexane was added to the pellet, which was stirred and centrifuged. The supernatant was transferred
to the same tube and 0.75 mL of hexane was added and centrifuged. The sample was recovered and
evaporated with N2 gas; and the obtained sample was reconstituted, microfiltered, and stored in
vials. UHPLC-MS was used for quantification with lycopene and β-carotene standards. Results were
expressed in mg/100 g dry weight.
2.5.3. Nucleosides Compounds
The method used was performed considering Dudley and Bond recommendations [38]. Briefly,
1 g of the freeze-dried extract was mixed with 20 mL of ultra-pure water and then homogenized in a
mortar. The extract was sonicated with ultrasound (VWR 97043-962, Leicestershire, UK) at 35 kHz
for 30 min, then centrifuged at 11,180× g for 10 min at 10 ◦C, and filtered at 0.22 μL with a microfilter
disc (Millex-GN PTFE, Merck Millipore, Darmstadt, Germany). Quantification was performed by
UHPLC-MS. An ESI injector with a positive charge at 35 kV, a capillary temperature of 350 ◦C, a flow of
250 μL were used. Mobile phase A was a solution of 10 mM ammonium acetate with 0.8% acetic acid
and mobile phase B was a solution of acetonitrile with 0.1% acetic acid. A gradient of 10% at the first
6 min, then 6 min at 50% A, and then return in 6 min at 10% A was used. For quantification, adenosine,
guanosine, and inosine standards were used in a curve of 0.05–1.5 μg/μL. Results were expressed in
μg/100 g dry weight.
3. Competitive Study
The platelet anti-aggregant activity was compared with commercial cardioprotective products
sold in the Chilean market (M1: CardioSmile, Nutrartis S.A., Providencia, Chile; M2: UltraPure Omega
3, Unicaps, Brea. CA, USA; M3: Eykosacol, Procaps S.A., Barranquilla, Colombia; M4: Benexia,
Functional Products Trading S.A., Vitacura, Chile; and M5: Maqui Berry, Nativ for Life, Santiago,
Chile). Liquid products (M2, M3, and M4) were evaluated directly on platelet aggregation at 1 mg/mL,
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while the solid product (M5) was dissolved in physiological serum in a final study concentration of
1 mg/mL. For the M1 product (given its milky consistency that affects the turbidity of the plasma in the
platelet aggregation test), an aqueous extract was obtained. Thus, the product was mixed with water
in a 1/8 ratio and centrifuged at 11,180× g for 5 min to obtain the supernatant that was freeze-dried and
kept at −20 ◦C until use. Before the platelet aggregation assay, the aqueous extract of product M1 was
resuspended in physiological saline solution at a concentration of 1 mg/mL.
4. Statistical Analysis
Data were expressed as mean ± standard deviations and analyzed by the Prism 6.0 software
(GraphPad Inc., La Jolla, CA, USA). All measurements were made from six different donors.
Before performing the statistical analysis, it was necessary to know if the results met with a
normal distribution or not. Thus, using a significance level of 5% and according to Kolmogorov
statistic with a p-value of 0.003, the results of platelet aggregation showed a non-normal distribution.
The results of percentage of platelet aggregation were analyzed using non-parametric Kruskal–Wallis
test, and subsequently analyzed by Dunn’s test, used as a post-test, to establish significant differences
between each extract with respect to control (p-value < 0.05).
5. Results and Discussion
5.1. Extraction Yield
Table 1 shows the extraction yield of different types of tomato pomace extracts. From 5 g of each type
of tomato pomace sample, 0.023–0.22 g of a dry extract was obtained. Freeze drying allowed obtaining
extracts (e.g., AWTPE3) that are considered microbiologically safe [5,23]. The process of ultrasound
extraction produces a phenomenon called cavitation which generates physical, chemical, and mechanical
effects responsible for the cellular wall disruption of the vegetal matrix [39,40]. According to many authors
(Al-Dhabi et al., 2017; Chemat et al., 2017; Contamine et al., 1995; Delgado-Povedano and de Castro,
2017; Mason et al., 1996; Rastogi, 2011), the association of different ultrasound extraction conditions
(e.g., power, temperature, time, and solvent) may change the polarity and viscosity of the system, as well
as the interaction between the solute and solvent. Thus, in this study, aqueous extracts (2.8 ± 1.1% m/m)
showed higher extraction yields in comparison with ethanolic extractions (1.0 ± 0.5% m/m), and this was
due to the polarity and viscosity of these solvents. According to Chemat et al. (2017) and other studies,
variations in viscosity, although small, may induce resistance to ultrasound waves and it may affect the
extraction efficiency of the solvent system [39,41,42].
The cavitation phenomena also cause a temperature rise with the extraction time, increasing the
extraction yield of phenolic and nucleosides compounds by their higher solubility and diffusion.
However, when a higher extraction time exposes these compounds at high temperatures for a long
time, it may promote its degradation by oxidation mechanisms, consequently decreasing the extraction
yield [41–43]. Therefore, in this study, cycle 3 showed promising potential to obtain high extraction
yields, since AWTPE3 preliminarily presented 3.45% (m/m). This could be explained by the higher
value of soluble solids observed for AWTPE3 (6.00 ◦Brix) compared with whole ground dried tomato
pomace (1.67 ◦Brix, performed in 1 g of sample powder dissolved in 10 mL ultrapure water). The latter
can be explained due to mechanical effects of ultrasound that triggered the release of water-soluble
compounds such as polysaccharides, polyphenols, and nucleosides from their matrices by disrupting
them from cellular tissues [5,6,23,33,34,44,45]. Ultrasound is also an effective method to improve
fractioning of water-soluble compounds from tomato pomace fiber, since the latter was separated as a
precipitate after centrifugation [5,23].
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Table 1. Extraction yield and platelet anti-aggregant activity of different types of tomato pomace extracts.
Type of Extracts Code Yield (%) Platelet Aggregation (%)
Aqueous whole tomato pomace extract cycle 1 AWTPE1 3.57 46 ± 12
Aqueous whole tomato pomace extract cycle 3 AWTPE3 3.45 32 ± 9 **
Aqueous whole tomato pomace extract cycle 6 AWTPE6 2.13 48 ± 3
Ethanolic whole tomato pomace extract cycle 1 EWTPEC1 0.82 52 ± 8
Ethanolic whole tomato pomace extract cycle 3 EWTPEC3 0.68 32 ± 9 **
Ethanolic whole tomato pomace extract cycle 6 EWTPEC6 0.57 51 ± 9
Aqueous seedless tomato pomace extract cycle 1 ASTPEC1 1.31 61 ± 7
Aqueous seedless tomato pomace extract cycle 3 ASTPEC3 1.87 46 ± 9
Aqueous seedless tomato pomace extract cycle 6 ASTPEC6 0.80 26 ± 6 ***
Ethanolic seedless tomato pomace extract cycle 1 ESTPEC1 ND ND
Ethanolic seedless tomato pomace extract cycle 3 ESTPEC3 0.59 45 ± 9
Ethanolic seedless tomato pomace extract cycle 6 ESTPEC6 0.46 29 ± 7 **
Aqueous seed extract cycle 1 ASEC1 2.51 29 ± 8 **
Aqueous seed extract cycle 3 ASEC3 1.60 34 ± 2 *
Aqueous seed extract cycle 6 ASEC6 3.45 40 ± 7
Ethanolic seed extract cycle 1 ESEC1 0.48 38 ± 4
Ethanolic seed extract cycle 3 ESEC3 1.44 47 ± 8
Ethanolic seed extract cycle 6 ESEC6 1.27 52 ± 12
Aqueous extract, 50% tomato pomace/50% seed cycle 1 AE5TPSC1 2.96 27 ± 12 ***
Aqueous extract, 50% tomato pomace/50% seed cycle 3 AE5TPSC3 4.43 36 ± 8
Aqueous extract, 50% tomato pomace/50% seed cycle 6 AE5TPSC6 2.61 54 ± 9
Ethanolic extract, 50% tomato pomace/50% seed cycle 1 EE5TPSC1 1.11 29 ± 12 **
Ethanolic extract, 50% tomato pomace/50% seed cycle 3 EE5TPSC3 ND ND
Ethanolic extract, 50% tomato pomace/50% seed cycle 6 EE5TPSC6 ND ND
Aqueous extract, 80% tomato pomace/20% seed cycle 1 AE8TPSC1 2.94 41 ± 7
Aqueous extract, 80% tomato pomace/20% seed cycle 3 AE8TPSC3 4.25 40 ± 11
Aqueous extract, 80% tomato pomace/20% seed cycle 6 AE8TPSC6 4.08 38 ± 11
Ethanolic extract, 80% tomato pomace/20% seed cycle 1 EE8TPSC1 2.29 39 ± 15
Ethanolic extract, 80% tomato pomace/20% seed cycle 3 EE8TPSC3 1.07 52 ± 16
Ethanolic extract, 80% tomato pomace/20% seed cycle 6 EE8TPSC6 1.28 39 ± 12
Non-ultrasound-assisted aqueous whole tomato pomace extract 64 ± 11
Control (maximum platelet aggregation) 87 ± 6
Platelet aggregation data were expressed as mean ± standard deviations (SD). Statistically significant difference in
platelet aggregation (%) is considered with * p < 0.05, ** p < 0.01, and *** p < 0.001, analyzed with Dunn’s test with
respect to control. ND: not determined. Not determined (ND) extracts correspond to extracts that were generated,
but obtained at a very low yield, preventing them to be weighed and evaluated. Cycle 1: 20 min, cycle 3: three cycles
of 20 min each; and cycle 6: six cycles of 20 min each.
5.2. Platelet Anti-Aggregant Activity
We observed that the non-ultrasound-assisted aqueous extraction of whole tomato pomace
affected the platelet anti-aggregant activity of the extract (64 ± 11% vs. control 87 ± 6%, not significant).
The time of sonication and solvent used in the extraction had a significant role in platelet anti-aggregant
activity [46]. As is shown in the Table 1, the extracts with significant antiplatelet activity, with respect
to control (87 ± 6%), were AWTPE3 (32 ± 9%, p < 0.01), EWTPEC3 (32 ± 9%, p < 0.01), ASTPEC6
(26 ± 6%, p < 0.001), ESTPEC6 (29 ± 7%, p < 0.01), ASEC1 (29 ± 8%, p < 0.01), ASEC3 (34 ± 2%,
p < 0.05), AE5TPSC1 (27 ± 12%, p < 0.001), and EE5TPSC1 (29 ± 12%, p < 0.01). These levels of
inhibition of platelet aggregation induced by ADP were different, depending on ultrasound cycle times,
tomato pomace composition, and solvent used. Thus, the sonication cycles only improved the platelet
anti-aggregant activity in the seedless extracts. Six cycles of sonication of 20 min each significantly
improved the platelet anti-aggregant activity of aqueous (ASTPEC6 26 ± 6%, p < 0.001) and ethanolic
(ESTPEC6, 29 ± 7%, p < 0.01) seedless tomato pomace extracts. Tomato seeds are composed with
proteins (35.5%), fiber (13.2%), fatty acids (30%), ash (3%), and also essential amino acids (except
tryptophan), so they could be used in several applications, for example, as an enrichment for cereal
products and foods low in lysine [22,47].
For aqueous seed extracts and aqueous 50% tomato pomace/50% seed extracts, the best activity
was achieved using one ultrasound cycle (ASEC1, 29 ± 8%, p < 0.01 and AE5TPSC1, 27 ± 12%, p < 0.001),
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while antiplatelet activity decreased with an increase to six sonication cycles (ASEC6, 40 ± 7% and
AE5TPSC6, 54 ± 9%, not significant). On the other hand, three-cycle sonication allowed the best
significant activity of the extracts obtained from aqueous whole tomato pomace (AWTPE3, 32 ± 9%,
p < 0.01) and ethanolic whole tomato pomace (EWTPEC3, 32 ± 9%, p < 0.05). Although, in a previous
study, the ultrasound extraction time used by the authors was 5 min [10], in this study ultrasound
cycle was increased to 20 min to achieve a better extraction of compounds responsible for platelet
anti-aggregant activity. Furthermore, 5 min of ultrasound extraction achieved an aggregation of 55%
in aqueous tomato pomace extract [10], while the 20-min cycle improved the activity of the aqueous
tomato pomace extract by lowering maximum aggregation to 46 ± 12% (AWTPE1).
Based on the results of yield and platelet anti-aggregant activity, it seemed that the most suitable
extract was AWTPE3 (yield, 3.45% and platelet aggregation, 32 ± 9%, p < 0.01). Meanwhile, ASTPEC6
(platelet aggregation, 26 ± 6%, p < 0.001) had a poor yield of 0.80% and showed no statistically
significant differences in platelet anti-aggregant activity when compared to AWTPE3.
5.3. Identification of Bioactive Compounds
Table 2 shows the amounts of bioactive compounds by HPLC-MS on aqueous extracts (whole tomato
pomace, seed, and seedless) obtained from the same original matrix. Since tomato pomace is mainly
composed of peels and seeds, we compared the bioactive compounds of AWTPE3 (aqueous whole tomato
pomace), previously reported [5], with two other aqueous extracts obtained with the same sonication
cycles—ASTPEC3 (aqueous seedless tomato pomace) and ASEC3 (aqueous seeds).
Table 2. Identification and quantification of bioactive compounds by HPLC-MS.
Samples
Compounds ** AWTPE3 * ASEC3 ASTPEC3
Flavonoids (mg/100 g Dry Weight)
Gallic acid 0.83 6.94 0.53
Ferulic acid 2.44 9.08 3.68
Coumaric acid 88.56 2.58 <0.001
Phloridzin 4.71 1.35 2.62
Phloretin 97.31 26.72 1.71
Procyanidin B2 1868.49 76.62 27.95
Apigenin-7-O-glucoside <0.001 0.196 <0.001
Kaempferol-3-O-glucoside 2032.58 415.39 <0.001
Luteolin-7-O-glucoside 63.34 55.77 57.63
Genistein <0.001 0.196 <0.001
Kaempferol 77.09 <0.001 <0.001
Daidzein <0.001 0.02 <0.001
Quercetin 408.23 <0.001 7.74
Quercitrin 1.96 0.003 <0.001
Rutin 0.262 0.065 0.012
Epicatechin 0.131 0.026 <0.001
Nucleosides (μg/100 g Dry Weight)
Adenosine 42.90 <0.001 <0.001
Inosine 57.20 42.21 <0.001
Guanosine 20.97 7.44 7.26
Carotenoids (mg/100 g Dry Weight)
Lycopene <0.001 <0.001 7.74
β-Carotene 55.5 4.3 3.4
* Data reported in Palomo et al., (2019) [5]. p < 0.001 indicates concentrations close to the limit of detection. AWTPE3:
aqueous whole tomato pomace extract cycle 3, ASEC3: aqueous seed extract cycle 3, and ASTPEC3: aqueous
seedless tomato pomace extract cycle 3. ** Twenty-one flavonoid molecules were analyzed and sixteen molecules
were detected by chromatography. Three nucleoside molecules were analyzed and detected by chromatography.
Two carotenoid molecules were analyzed and detected by chromatography.
Several studies have observed that ultrasound is effective in assisting the extraction of bioactive
compounds such as nucleosides, polyphenols, and carotenoids from different plant byproducts,
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including tomato pomace [5,27,48,49]. In comparison with unprocessed tomatoes and on a dry weight
basis, tomato pomace contained significantly lower amounts of lycopene and increased amounts of
β-carotene, tocopherols, sterols, terpenes, and flavonoids (e.g., naringenin) [50]. Thus, in this study
higher concentrations of flavonoids (procyanidin B2, kaempferol-3-O-glucoside, and kaempferol) were
observed for AWTPE3 in comparison with whole dried ground tomato pomace [5]. These results
demonstrated that the ultrasound-assisted extraction and concentration using freeze drying resulted
in a greater concentration of flavonoids in AWTPE3 [5]. A similar result was obtained by
Navarro-González et al., where the best extraction of phenolic compounds (e.g., rutin, naringenin,
and chlorogenic acid derivatives) was with ultrasonic assistance [51]. This concentration of compounds
(e.g., kaempferol-3-O-glucoside) in AWTPE3 may be due to the fact that tomato pomace is composed
of pulp residues, in addition to peels and seeds [52].
ASEC3 and ASTPEC3 had different levels of polyphenols because they were lost simply by
removing their peels or seeds. Thus, the removal of the peels represented a loss of lycopene (80%),
β-carotene (57%), and phenolic compounds (63%). Meanwhile, the elimination of seeds had a
greater impact on polyphenols with a loss of 63% [53]. ASEC3 showed higher concentrations of
flavonoid compounds than ASTPEC3, except for quercetin, which was detected in tomato peels
in higher concentrations than seeds, according to literature [44]. In this context, it has been
described that seed aqueous lyophilized extract from tomato contains 20,657 mg/100 g phenolic
compounds, with the highest amounts of quercetin-3-O-sophoroside, kaempferol-3-O-sophoroside,
and isorhamnetin-3-O-sophoroside [54]. However, ASEC3 did not present concentrations of kaempferol
and quercetin, suggesting differences due to an extraction procedure effect. ASTPEC3 did not
show concentrations of coumaric acid, apigenin-7-O-glucoside, kaempferol-3-O-glucoside, genistein,
kaempferol, daidzein, quercitrin, and epicatechin, suggesting that these compounds were not effectively
recovered from tomato peels by ultrasound-assisted extraction (Table 2). Chlorogenic acid, which is
usually predominant in tomato byproducts, was not detected or quantified by chromatography in any
of the samples. The latter could be explained due to low stability of this molecule during storage of
dehydrated tomato byproducts [55].
The data available in the literature suggest a potential therapeutic effect of several flavonoids
against CVD through the inhibition of platelet aggregation, such as coumaric acid [56], phloretin [57],
procyanidin B2 [58], kaempferol-3-O- glucoside [59], and epicatechin [60]. The presence of these
compounds in greater amounts in AWTPE3 and ASEC3 than in ASTPEC3 correlated with a better
capacity to inhibit platelet aggregation. Several mechanisms of antiplatelet action of polyphenols
have been reported, including inhibition of the arachidonic acid pathway, suppression of cytoplasmic
increase in Ca2+, degradation blockage, αIIbβ3 integrin-mediated signaling, inhibition of secretion of
platelet granules, and inhibition of thromboxane formation [61,62]. The ultrasound was able to increase
the extraction of adenosine in AWTPE3 when compared with whole dried ground tomato pomace
from 6.32 μg/100 g to 42.90 μg/100 g, almost 6 times more [5]. However, the extraction of inosine and
guanosine was not affected by ultrasound. The results obtained from the quantification of nucleosides
(adenosine, inosine, and guanosine) demonstrated that AWTPE3 presented greater amounts of these
compounds compared with ASEC3 and ASTPEC3 [5]. Authors involved in this present work have
previously observed that adenosine is concentrated in higher amounts in the aqueous extract from ripe
tomato pulp than whole tomato pomace and peels extracts [9]. The presence of inosine in significant
concentrations in ASEC3, but not in ASTPEC3, suggests that this compound is available only in tomato
seeds [6,63]. In part, this could explain why ASEC3 had better platelet anti-aggregant activity than
ASTPEC3, since inosine has been reported to inhibit platelet aggregation, significantly preventing
in vivo thrombus formation [34]. Both extracts (ASEC3 and ASTPEC3) presented close concentrations
of guanosine and adenosine, the latter had no significant amount detected. The present research group
isolated and identified adenosine and guanosine as bioactive compounds in tomato with a potent
platelet anti-aggregant activity [9,33,34].
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The results showed that ultrasound was not efficient to extract carotenoids in the conditions
established. Lycopene was solely quantified in ASTPEC3. Lycopene is found mainly in the peels
and acts as a red pigment and, although resistant to thermal processing, it is very susceptible to
light degradation [64]. To determine this compound, a prior extraction process must be carried out,
which requires conditions of absence of light to avoid degradation, which makes its quantification
very complicated and delicate. In the case of β-carotene, a higher concentration was found in whole
dried ground tomato pomace powder in comparison with the other samples. According to literature,
most non-polar solvents have higher extraction yield of carotenoids than aqueous extracts, since they
are lipophilic compounds that are soluble in organic solvents, such as acetone, alcohol, ethyl ether,
chloroform, and ethyl acetate. Therefore, large concentrations of carotenoids in the aqueous extract of
tomato pomace were not expected.
5.4. Competitive Study
In the current market, there are cardioprotective products like phytosterols, polyphenols,
and omega-3 [65]. Platelet anti-aggregant activity of commercial products was compared with
that of AWTPE3 (Figure 1). In the presence of M2 (platelet aggregation, 57 ± 5%), M3 (platelet
aggregation, 56 ± 5%), and M4 (platelet aggregation, 54 ± 7%), platelets showed a significant decrease
in aggregation compared with the control of maximum platelet aggregation (79 ± 8%). Products M1
and M5 did not show inhibition of platelet aggregation. AWTPE3 presented a significant difference
compared with the control and the commercial products M2, M3, and M4.
Figure 1. Platelet anti-aggregant activity of commercial products. Different letters indicate a significant
difference with a p value< 0.05. AWTPE: aqueous whole tomato pomace extract cycle 3; M1: CardioSmile,
Nutrartis S.A., Chile; M2: UltraPure Omega 3, Unicaps CA, USA; M3: Eykosacol, Laboratorio Procaps
S.A., Colombia; M4: Benexia, Functional Products Trading S.A., Chile; and M5: Maqui Berry, Nativ for
Life, Chile.
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6. Conclusions
Currently, tomato pomace is considered as waste by the food industry; however, in this study,
we showed that ultrasound-assisted extracts from this byproduct had significant platelet anti-aggregant
activity. The levels of inhibition of platelet aggregation were different, depending on ultrasound cycle
times, tomato pomace composition (whole, seedless, and seed), the solvent used, and the flavonoid and
nucleoside content (Figure 2). In this context, the ultrasound-assisted extraction improved extraction
yields, showing significant recovery of bioactive compounds from tomato pomace and increased
platelet aggregation inhibition.
Figure 2. Platelet anti-aggregant activity and bioactive compounds of ultrasound-assisted extracts from
whole and seedless tomato pomace. AE5TPSC1: aqueous extract 50% tomato pomace/50% seed cycle 1,
ASEC1: aqueous seed extract cycle 1, ASEC3: aqueous seed extract cycle 3, ASTPEC3: aqueous seedless
tomato pomace extract cycle 3, ASTPEC6: aqueous seedless tomato pomace extract cycle 6, AWTPE3:
aqueous whole tomato pomace extract cycle 3, EE5TPSC1: ethanolic extract 50% tomato pomace/50%
seed cycle 1, ESTPEC6: ethanolic seedless tomato pomace extract cycle 6, EWTPEC3: ethanolic whole
tomato pomace extract cycle 3, CA: coumaric acid, G: guanosine, I: inosine, K-3-O-G: kaempferol-3-O-
glucoside, L: lycopene, L7OG: luteolin-7-O- glucoside, P: phloretin, PB2: procyanidin B2, Q: quercetin.
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Abstract: The use of herbal food supplements, as a concentrate form of vegetable extracts, increased so
much over the past years to count them among the relevant sources of dietetic polyphenols.
Bud-derivatives are a category of botanicals perceived as a “new entry” in this sector since they are
still poorly studied. Due to the lack of a manufacturing process specification, very different products
can be found on the market in terms of their polyphenolic profile depending on the experimental
conditions of manufacturing. In this research two different manufacturing processes, using two
different protocols, and eight species (Carpinus betulus L., Cornus mas L., Ficus carica L., Fraxinus excelsior
L., Larix decidua Mill., Pinus montana Mill., Quercus petraea (Matt.) Liebl., Tilia tomentosa Moench),
commonly used to produce bud-derivatives, have been considered as a case study. An untargeted
spectroscopic fingerprint of the extracts, coupled to chemometrics, provide to be a useful tool to
identify these botanicals. The targeted phytochemical fingerprint by HPLC provided a screening of
the main bud-derivatives polyphenolic classes highlighting a high variability depending on both
method and protocol used. Nevertheless, ultrasonic extraction proved to be less sensitive to the
different extraction protocols than conventional maceration regarding the extract polyphenolic profile.
Keywords: bud-derivatives; botanicals; polyphenols; UV-Visible spectroscopic fingerprint; chemometrics;
targeted chromatographic fingerprint
1. Introduction
In recent decades, food supplements have an important impact on the consumers showing a
significant expectation for their health and well-being [1]. They are concentrated sources of nutrients
or bioactive compounds endowed with nutritional or physiological effects and, due to their presumed
health benefits, they can supplement the common diet [2,3].
In particular, the interest in herbal food supplements (botanicals) is exponentially grown and
consequently the relative market has increased in all the world [4]. Botanicals are become among the
most popular into the food supplements category, due to the general belief which “natural” is better,
healthier and safer than synthetic drugs, although this is not always true [4]. In Italy, more than 20%
of the Italian population is considered “regular” consumer of these herbal products, as highlighted
from the recent European PlantLibra (Plant Food Supplements: Levels of Intake, Benefit and Risk
Assessment) consumer survey [5]. The wide range of herbal food supplements on the market and the
non-attendance of effective legislation to guarantee the safety and quality aspects make these products
vulnerable for fraud, falsification and adulteration [6,7].
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Bud-derivatives (BDs) are a relatively new category of herbal food supplements and they
represent one of the supply chains investigated in the FINNOVER project (Innovative strategies for
the development of cross-border green supply chains), an European Interreg Alcotra Italy/France
project (2017–2020) whose aim is the green innovation of several agro-industrial chains [8]. BDs are
conventionally produced, according to the European Pharmacopoeia VIII edition [9], by cold maceration
of the fresh meristematic tissues of trees and herbaceous plants (i.e., buds and young sprouts) using as
extraction solvent mixtures of water, ethanol and glycerol [10,11]. These natural products are already
marketed, and a long history of use as dietary supplements for human well-being and health is reported
in traditional medicine. No health claims are yet approved by the European Food Safety Authority
(EFSA) and just for some of these botanicals pharmacognostic findings supported their use as adjuvants
in several diseases. In fact, some in-vitro/in-vivo biological studies for human and veterinary use
have been already reported in the literature. For examples, Allio et al. (2015) investigated whether
Tilia tomentosa bud extracts affect hippocampal Gamma-aminobutyric acid (GABA) ergic synapses [12].
In other studies, bud extracts from Salix caprea L. have been demonstrated to inhibit voltage gated calcium
channels and catecholamines secretion in mouse chromaffin cells [13]. Moreover, different patents have
also been registered on the veterinary use of bud-extracts (e.g., Composition of Salix caprea bud-extract
and its use in the treatment of animal endometritis, patent n. TO2015A000193) [14] and several studies
are carried out on several bud-derivative biological effects [15–17].
Although gemmotherapy has been used since ancient times because of the peculiar content of
buds in bio-active compounds, especially polyphenols, nowadays BDs are still a little studied “niche”
production [18,19]. The lack of detailed scientific information and a clear and unique regulation, as well
as for the category of herbal food supplements in overall [6,7,20], it makes these products high risk
and there is an increase request for efficient quality control to ensure the proper identification of the
botanical source and their content [21].
With regards to BDs, a first problem it is accidentally confusing the raw material: fresh buds must
be collected, generally from spontaneous grown, in a very limited period in the late winter and/or
in the early spring, corresponding to the annual germination of the plant [18]. During this period,
plants may not show their distinctive characteristics and sometimes the attribution of the botanical
species may be difficult for the collector. A second problem concerns the manufacturing process and
the extraction protocols whose parameters are not strictly defined, and production rules are often loose
and deficient [22–24].
Polyphenols play key roles in plant development processes and their synthesis increases when
plants are under conditions of abiotic stress, thus helping the plant to cope with environmental
constraints [25]. They form an integral part of the human diet and they are very abundant in
plant-based foods, such as fruits and vegetables, tea, wine, and coffee [26]. Their chemical structure is
based on at least one aromatic ring with one or more hydroxyl groups, which explains their known
antioxidant and anti-inflammatory properties [27].
In recent years, many health benefits of dietetic polyphenol supplementation have been
described in humans i.e., against aging and cardiovascular disease [28,29], to prevent obesity
and diabetes [30,31], to modulate human gut microbiota [32] and to improve the brain cognition
skills [33,34]. This knowledge guides the choice of consumers not only towards plant foods but also
towards herbal food supplements, whose polyphenol content is often even more concentrated and
responsible for their bioactivity [12,13]. Nevertheless, polyphenols content is strongly influenced by
the manufacturing methods whose parameters are often not strictly defined (e.g., solvent ratios in the
extraction mixtures, raw material/extraction mixture ratios, extraction time) and thus they could affect
the final compositions [35].
In previous articles, the polyphenolic pattern of some BDs prepared starting from different
botanical species have been studied [10,11,21,36].
In this research, eight species spontaneously grown and commonly used to produce BDs, i.e.,
Carpinus betulus L., Cornus mas L., Ficus carica L., Fraxinus excelsior L., Larix decidua Mill., Pinus montana
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Mill., Quercus petraea (Matt.) Liebl., Tilia tomentosa Moench, have been taken into account as case
study. Two different manufacturing methods, one conventional (maceration) and one innovative
(direct sonication), as well as two different extraction protocols have been taken into account and the
corresponding polyphenolic extracts’ profiles have been investigated.
Pulsed Ultrasound-Assisted Extraction (PUAE), according to the six principles of the green
extraction [37] and the twelve principles of green chemistry [38], has been employed as an innovative
technique to quickly produce BDs comparing to the long conventional maceration [39]. Even if,
the positive impacts of the ultrasound-assisted extraction, i.e., reduction of the extraction time,
diminution of solvent and energy used, improvement in yield and selectivity, high reproducibility,
intensification of diffusion and eliminating wastes, are known in the scientific literature [40–42],
this technique is still underused in this sector.
Moreover, two different BDs manufacturing protocols, which used different extraction mixture of
solvents and different solid/liquid ratio, have also been studied to evaluate both the proper identification
of the botanical species and the traceability of these vegetal products regardless of extraction method
and experimental conditions.
A strategy based on the untargeted UV-Visible fingerprinting coupled to chemometrics
(Principal Component Analysis—PCA) has been proposed for the screening of the polyphenolic BDs
profile in order to obtain a rapid control tool [43]. Finally, HPLC methods were used to obtain a targeted
chromatographic profile [7,44] of the main polyphenol classes (i.e., flavonols, benzoic acids, catechins,
cinnamic acids). Polyphenols are correlated with their potential health-promoting activity [45], even if
they are strongly influenced both by the methods and protocols used [35].
2. Materials and Methods
2.1. Raw Samples
Buds, belonging to eight different vegetable species (Carpinus betulus L., Cornus mas L., Ficus carica L.,
Fraxinus excelsior L., Larix decidua Mill., Pinus montana Mill., Quercus petraea (Matt.) Liebl., Tilia tomentosa
Moench) were collected from plants spontaneously grown in the Turin Province (Italy) and were
immediately authenticated by an agronomist. Sampling has been performed in two years (2018–2019),
from February to April, during the bud break (“balsamic period”).
Table 1 reports the geo-localization coordinates of the different collection sites and the scientific
naturalistic illustrations (specifically achieved during the Finnover project) of all the eight vegetable
species investigated.
2.2. Chemicals
MilliQ ultrapure water, obtained by means of a Millipore equipment (Bedford, MA, USA) was
used throughout. All chemicals employed for the extract preparations and for the subsequent analysis
were HPLC-grade. They were supplied by VWR International S.r.l (Milan, Italy) and Sigma-Aldrich
(St. Louis, MO, USA). Purity of all the used standards for HPLC analysis of BDs has been reported in
the Supplementary Materials (Table S1).
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Table 1. The collection sites, the corresponding geo-localization coordinates, and the scientific
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2.3. Bud-Derivatives Manufacturing Applying Two Different Methods
Fresh buds, after their collection, were immediately processed to prepare the corresponding BDs
in order to minimize any degradation preserving the peculiar phytocomplex as much undamaged as
22
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possible. The manufacturing was performed both in an Italian company (Geal Pharma Turin, Italy)
and by the Authors in the analytical laboratory of the University of Genoa (Department of Pharmacy).
The following two different preparation methods of BDs were investigated: the conventional cold
Maceration (M) [9], and a more rapid and innovative procedure by Ultrasounds (US) recently described
by the Authors [11]. Moreover, for both preparation methods two different extraction solvents and
different sample/solvent ratios were investigated too (“Protocol A” and “Protocol B”, see Figure 1),
in order to evaluate both the proper identification of the botanical species and the traceability of
the BDs independently from their manufacturing process (Table 2). Each extraction was performed
in duplicate.
Figure 1. The global scheme of the experimental manufacturing of BDs: two methods (cold maceration,
namely M, and ultrasounds, namely US) have been used. Each method has been applied following two
different protocols (A and B).
2.3.1. Conventional Cold Maceration (M) as Traditional Method
BDs were prepared using a cold maceration by an Italian Company of botanicals (Geal Pharma,
Bricherasio, Turin) following two different experimental manufacturing protocols, reported in Table 2:
(A) A 21 days maceration of buds in glycerol/ethanol 96% (1/1 w/w) with a 1:20 bud/solvent ratio
(considering the dry weight) has been performed, according to the official method of glyceric
macerates reported in the European Pharmacopoeia VIII edition [9] (“M_A”).
(B) A 3 months maceration of buds in a mixture of water/glycerol/ethanol 96% (50/20/30 w/w/w) as
extraction solvent with a bud/solvent ratio variable (considering the fresh weight) depending on
the botanical species (see Table 2) has been used, according to the method optimized and used by
the Company to produce glyceric macerates (“M_B”).
In both methods, after the maceration step, the extracts, namely BDs, have been obtained by a
preliminary filtration, a manual pressing and a second filtration after two days of decanting. The so
obtained BDs were stored at 4 ◦C in the dark until their further analysis.
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Table 2. BDs obtained starting from the eight vegetable species (raw materials). Two different methods
(cold maceration-M and Pulsed Ultrasound-Assisted Extraction US) and two different experimental











1 Cb_M_A Carpinusbetulus M Protocol A 1/20 DW
2 Cb_US_A Carpinusbetulus US Protocol A 1/20 DW
3 Cb_M_B Carpinusbetulus M Protocol B 1/15 FW
4 Cb_US_B Carpinusbetulus US Protocol B 1/15 FW
5 Cm_M_A Cornus mas M Protocol A 1/20 DW
6 Cm_US_A Cornus mas US Protocol A 1/20 DW
7 Cm_M_B Cornus mas M Protocol B 1/20 FW
8 Cm_US_B Cornus mas US Protocol B 1/20 FW
9 Fc_M_A Ficus carica M Protocol A 1/20 DW
10 Fc _US_A Ficus carica US Protocol A 1/20 DW
11 Fc _M_B Ficus carica M Protocol B 1/10 FW
12 Fc_US_B Ficus carica US Protocol B 1/10 FW
13 Fe_M_A Fraxinusexcelsior M Protocol A 1/20 DW
14 Fe_US_A Fraxinusexcelsior US Protocol A 1/20 DW
15 Fe_M_B Fraxinusexcelsior M Protocol B 1/10 FW
16 Fe_US_B Fraxinusexcelsior US Protocol B 1/10 FW
17 Ld_M_A Larix decidua M Protocol A 1/20 DW
18 Ld_US_A Larix decidua US Protocol A 1/20 DW
19 Ld_M_B Larix decidua M Protocol B 1/20 FW
20 Ld_US_B Larix decidua US Protocol B 1/20 FW
21 Pm_M_A Pinus montana M Protocol A 1/20 DW
22 Pm_US_A Pinus montana US Protocol A 1/20 DW
23 Pm_M_B Pinus montana M Protocol B 1/10 FW
24 Pm_US_B Pinus montana US Protocol B 1/10 FW
25 Qp_M_A Quercuspetraea M Protocol A 1/20 DW
26 Qp_US_B Quercuspetraea US Protocol A 1/20 DW
27 Qp_M_B Quercuspetraea M Protocol B 1/15 FW
28 Qp_US_B Quercuspetraea US Protocol B 1/15 FW
29 Tt_M_A Tilia tomentosa M Protocol A 1/20 DW
30 Tt_US_A Tilia tomentosa US Protocol A 1/20 DW
31 Tt_M_B Tilia tomentosa M Protocol B 1/15 FW
32 Tt_US_B Tilia tomentosa US Protocol B 1/15 FW
DW: dry weight; FW: fresh weight.
2.3.2. Green Extraction: Pulsed Ultrasound-Assisted Extraction (US) as Alternative Method
Fresh buds were finely ground by a Grindomix 200 M (Retsch, Haan, Germany) for 20 s at 5000 rpm,
and then sieved by a 150 μm sieve, in order to improve the efficiency of the following extraction step [46].
PUAE was performed directly by an Hielscher UP200St sonicator (Teltow, Germany) equipped with an
ultrasonic titanium sonotrode (7 mm of diameter), at a constant frequency of 26 kHz. The pulsed mode,
referring to an alternation of “on” time and “off” time of the sonicator, guarantees a lowering increase
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in temperature, which better preserve the phytocomplex, and greater energy savings compared to
continuous treatments [47]. The experimental sonication conditions (amplitude 30%, duty cycle 65%,
extraction time 20 min) were previously optimized by the Authors on the same raw materials [11].
The same two experimental extraction conditions described in the paragraph 2.3.1 (“Protocol
A” and “Protocol B”, see Figure 1) were employed (“US_A” and “US_B”, see Table 2). The extracts
obtained were filtered for Buchner (Whatman n. 1 paper), centrifuged at 3000 rpm for 10 min and then
stored at 4 ◦C in the dark until analysis.
2.4. Spectroscopic Analysis: UV-Visible Fingerprint
UV–Visible absorption spectra (200 nm–900 nm) were recorded by a spectrophotometer Agilent
Cary 100 (Varian Co., Santa Clara, CO, USA) with 0.5 nm resolution, using rectangular quartz cuvettes
with 1 cm path length. BDs, before the spectroscopic analysis, were suitably diluted in the corresponding
extraction solvent (glycerol/ethanol 1/1 w/w or water/glycerol/ethanol 50/20/30 w/w/w) depending
on the followed experimental protocol (“Protocol A” and “Protocol B”, respectively). Dilution was
necessary to avoid signal saturation but was subsequently considered in order to make a comparison
between the different spectra achieved. BDs spectra were acquired in duplicate and then averaged.
The collection was performed at room temperature (25 ± 1 ◦C), against a blank solution represented by
the corresponding extraction solvent.
2.5. HPLC Analysis
In this study, effective HPLC–DAD methods were used for fingerprint analysis and phytochemical
identification of samples. Four polyphenolic classes were considered: benzoic acids (ellagic and gallic
acids), catechins ((+)catechin and (-)epicatechin), cinnamic acids (caffeic, chlorogenic, coumaric,
and ferulic acids), and flavonols (hyperoside, isoquercitrin, quercetin, quercitrin, and rutin).
Total bioactive compound content (TBCC) was determined as the sum of the most important bioactive
compounds with positive effects on human organism (“multimarker approach”) [48].
The external standard method was used for quantitative determination of bioactive compounds.
Stock solutions of cinnamic acids and flavonols with a concentration of 1.0 mg·mL−1 were prepared
in methanol: five calibration standards were prepared by dilution with methanol; stock solutions of
benzoic acids and catechins with a concentration of 1.0 mg·mL−1 were prepared in 95% methanol and
5% water. In this case, five calibration standards were prepared by dilution with 50% methanol–water.
An Agilent 1200 High-Performance Liquid Chromatograph coupled to an Agilent UV-Vis diode
array detector (Agilent Technologies, Santa Clara, CA, USA) was used for the chromatographic analysis.
Four chromatographic methods were used to separate the bioactive molecules on a Kinetex C18 column
(4.6 × 150 mm, 5 μm, Phenomenex, Torrance, CA, USA). Several mobile phases were used for bioactive
compound identification and UV spectra were recorded at different wavelengths, based on HPLC
methods, previously tested and validated [10,40], with some modifications: (i) a solution of 10 mM
KH2PO4/H3PO4 (A) and acetonitrile (B) with a flow rate of 1.5 mL·min−1 (method A—analysis of
cinnamic acids and flavonols, gradient analysis: 5% B to 21% B in 17 min + 21% B in 3 min + 2 min of
conditioning time); (ii) a solution (A) of methanol/water/formic acid (5:95:0.1 v/v/v) and a mix (B) of
methanol/formic acid (100:0.1 v/v) with a flow rate of 0.6 mL·min−1 (method B—analysis of benzoic
acids and catechins, gradient analysis: 3% B to 85% B in 22 min + 85% B in 1 min + 2 min of conditioning
time). UV spectra were recorded at 330 nm (A); 280 nm (B).
Biomarkers were selected for their demonstrated positive healthy properties and antioxidant
capacity by literature in relation to the use of this plant-derived products. All single compounds were
identified in samples by comparison and combination of their retention times and UV spectra with
those of authentic standards in the same chromatographic conditions. Each sample was analyzed in
triplicate and results were reported as mean value ± standard deviation to assess the repeatability of
the employed methods.
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2.6. Data Analysis
2.6.1. Chemometric Analysis
Multivariate data analysis has been performed by CAT (Chemometric Agile Tool) software,
one advanced chemometric multivariate analysis tool based on R, developed by the Chemistry
Group of the Italian Chemical Society [49].
PCA was applied as common multivariate statistical method of unsupervised pattern recognition.
Its aim is extracting important information from the data and decreasing the high-dimensional dataset
volume by maintaining the important information [50,51].
2.6.2. Data Matrices Organization
A data matrix A32,601 consisting of 32 rows (corresponding to the BDs analyzed, 4 samples for
each of the eight botanical species investigated) and 601 columns (the absorbance values in the range of
200–500 nm of the UV-Visible spectra, with 0.5 nm of resolution) was prepared and further analyzed by
PCA. Standard normal variate (SNV) transform and column autoscaling were previously performed on
the spectral data to remove multiplicative effects of scattering and to scale the data, respectively [52].
Available sample were divided in two different subsets: a calibration (or training) set and a
test (or evaluation) set in order to build and validate the statistical model, respectively [53]. For a
reliable validation strategy, it is important that data used as test set were not used to build the
model in order to avoid the overestimations of the prediction ability [53]. 32 samples, previously
reported in Table 2, were selected for the construction and identification of the model (Calibration
set). The representative calibration data set consisted of 4 extracts (M_A, M_B, US_A, US_B) for each
botanical species investigated (Carpinus betulus L., Cornus mas L., Ficus carica L., Fraxinus excelsior
L., Larix decidua Mill., Pinus montana Mill., Quercus petraea (Matt.) Liebl., Tilia tomentosa Moench).
Furthermore 16 BDs, obtained both by conventional maceration and ultrasound extraction respectively
from the same eight vegetal species, were randomly selected and used as an independent set to test the
model and assess its validity (Test set, Table 3).
Table 3. External test set. 16 BDs obtained starting from the eight vegetable species using two
different methods (cold maceration M and Pulsed Ultrasound-Assisted Extraction US) and two








1 Cb_TS Carpinus betulus US Protocol A
2 Cb_TS2 Carpinus betulus US Protocol B
3 Cm_TS Cornus mas US Protocol A
4 Cm_TS2 Cornus mas US Protocol B
5 Fc_TS Ficus carica US Protocol A
6 Fc _TS2 Ficus carica US Protocol B
7 Fe_TS Fraxinus excelsior M Protocol A
8 Fe_TS2 Fraxinus excelsior US Protocol A
9 Ld_TS Larix decidua US Protocol A
10 Ld_TS2 Larix decidua US Protocol B
11 Pm_TS Pinus montana M Protocol A
12 Pm_TS2 Pinus montana US Protocol A
13 Qp_TS Quercus petraea M Protocol A
14 Qp_TS2 Quercus petraea US Protocol A
15 Tt_TS Tilia tomentosa US Protocol A
16 Tt_TS2 Tilia tomentosa US Protocol B
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All the pre-treated UV-Visible absorption spectra, in the range 200–500 nm, are reported in Figure 2.
For each species, the four averaged spectral profiles corresponding to the Calibration set (Table 2) are
highlighted in grey while in red have been reported the Test set samples (TS/TS2) belonging to the
same class.
Figure 2. Averaged UV-Visible spectra of the 8 botanical species after SNV pre-treatment of data. For
each species, the four averaged spectral profiles of the Calibration set (Table 2) are highlighted in grey
while in red are reported the External Test set samples (Table 3).
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Then, a data matrix B32,620 consisting of 32 rows and 620 columns was prepared and analogously
analyzed by PCA. B32,620 rows correspond to the 32 BDs analyzed (Calibration set), and columns
are the absorbance values of the UV-Visible spectra after SNV in the range 200–500 nm coupled to
the chromatographic quantifications by HPLC (4 polyphenolic classes and 13 bioactive compounds).
The data set was previously scaled by using a block scaling procedure [54], with the aim to give to
the spectroscopic and chromatographic variables a comparable influence in the data analysis. In fact,
this pretreatment allows to divide variables in different blocks whose values will be scaled to attain
the same block-variance after pretreatment. Moreover, the variables belonging to the same block are
equally weighted.
3. Results and Discussion
The quality control of vegetal material is critical both if the botanical product is to be used as a
drug or as an herbal food supplement. For consumer safety and the protection of who operate in this
industrial field, quality control should be applied throughout the different processing steps, from the
raw material to the final product. Scientific-naturalistic illustrations of the most common buds used in
BDs production (Table 1) have been realized within the Finnover project by an expert botanical graphic
designer, in order to provide a useful first tool for the operators in the BDs manufacturing. In fact,
this peculiar raw material is generally spontaneously collected and mistakes in the attribution of some
botanical species may be possible. For this, bud illustrations could represent a preliminary control of
these vegetable materials after their collection in the point of view of a controlled manufacturing chain
of BDs.
Moreover, a strategy based on the untargeted UV-Visible fingerprinting coupled to chemometrics
allows rapid screening of the polyphenolic BDs profile to obtain a preliminary control tool to identify
the botanical species.
3.1. Bud-Derivatives Identification: UV-Visible Fingerprint
Figure 2 show the UV–Visible spectral profiles, after SNV pretreatment of the data, recorded
for the eight vegetable species investigated: Carpinus betulus L., Cornus mas L., Ficus carica L.,
Fraxinus excelsior L., Larix decidua Mill., Pinus montana Mill., Quercus petraea (Matt.) Liebl., Tilia tomentosa
Moench. The extracts were obtained by the conventional maceration and the innovative green
extraction (M or US) respectively, using the two experimental protocols (A or B) as described in detail
in Table 2. Ultrasounds represent one of the innovative processing techniques of officinal plants [39].
In fact, several companies already exploit innovative applications of ultrasound to obtain liquid foods,
beverages, and alcoholic drinks [55,56]. Previously, the Authors described PUAE as an alternative
time-saving method to the conventional maceration for the extraction of the polyphenolic fraction from
buds [11]. Particularly, PUAE on a lab pilot reactor demonstrated to be an excellent approach for a
rapid (20 min vs. 21 days or 3 months of maceration, depending on the Protocol applied) and efficient
extraction of phenolic compounds.
Looking at Figure 2, the spectra of the different vegetable species are quite different, highlighting
as the pattern of absorbances in the UV–Visible region is strictly connected with the botanical origin of
the plants. On the contrary, for each botanical species the spectral differences due to the extraction
method (M or US) and to the extraction solvent (Protocol A or B), are minimal. The 501–900 nm interval
has been preliminarily removed because there were none interesting absorptions in this spectral region
at the assayed concentrations.
PCA, an unsupervised pattern recognition technique [50,51], was applied in order to explore and
to analyze the data set using a multivariate approach since the analytical information contained in each
spectrum was considered as a multivariate fingerprint. Particularly, the data matrix A32,601, whose rows
are the extracts (Calibration set) and the columns are the absorbances recorded in the spectral range
200–500 nm, was considered. PCA was performed on the pretreated and autoscaled data matrix.
The first two principal components (PCs) of the data set (A32,601), which together explained the 77.9% of
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the total information of the data set since they visualize almost the 80% of the total variance, were firstly
taken into account. Figure 3a,b shows the PCA score plots on the 1st–2nd principal components
(PC1-PC2) obtained from the above-mentioned data matrix. In Figure 3a the extracts are categorized
according to the vegetable species and each one is visualized with a different color (Carpinus betulus L.:
black, Cornus mas L.: red, Ficus carica L: green., Fraxinus excelsior L.: blue, Larix decidua Mill.: brown,
Pinus montana Mill.: light blue, Quercus petraea (Matt.) Liebl.: orange, Tilia tomentosa Moench: pink).
In Figure 3b, for each vegetable class all the extracts belonging to the calibration set were indicated with
their identification code (see Table 2). PC1, the direction of maximum variance which explains almost
the 60% of the total information, allows good discrimination between the botanical class regardless
of the extraction method (M or US) and the experimental preparation protocol (A or B). Particularly,
the Fraxinus class (blue, lowest scores on PC1) separates from Ficus (green) and Pinus (light blue)
which have higher scores on PC1. PC2, which explains the 21.1% of the remaining variance, allows to
mainly separate Larix class (brown, highest scores on PC2) from Quercus (orange) and Carpinus (black,
lowest scores on PC2).
Figure 3c,d show the PCA score plots on the PC1-PC3, which explain together the 69.3% of the total
variance of the data set. A good separation among the above cited botanical classes is also highlighted
except for Larix and Carpinus ones. In fact, these latter separate on PC2 (Figure 3a,b) and since PCs are
orthogonal, they are uncorrelated and no duplicate information are shown in their plots [50].
In Figure 3e,f, the projections of the external test set (red samples) were reported on the PC1-PC2
and PC1-PC3 score plots respectively, showing a good correspondence with the calibration set for each
botanical species.
The spectral variables having greater importance (loading values) on the first three PCs are
represented by spectral areas near the following absorbances (in ascending order): 200 nm, 212 nm,
240 nm, 275 nm, 310 nm, 360 nm, 420 nm, as highlighted in the Loading plot on PC1-PC2-PC3 (Figure 4).
Several of them could be related to some secondary metabolites largely distributed in plant
material (even in buds) such as tannins, whose structural variability depends on the vegetal species and
even among organs of the same plant species [57]. The chemotaxonomic values of tannins have been
recognized in the literature for several botanical species [58,59] and, the distribution of hydrolysable
tannins has been used as chemotaxonomic markers by several authors [60].
It is well known that the different classes of tannins present characteristic absorption bands
in the UV spectral region. Particularly as far as hydrolysable tannins are concerned, gallotannins
show two characteristic absorption maximums, λ max around 212 nm and λ max around 275 nm,
with an inflection point (λ min) around 242 nm; ellagitannins present strong absorption near 200 nm
and a shoulder around 277 nm and another absorption near 360 nm. Instead condensed tannins
(or proanthocyanidins), chemically defined as flavonoid polymers in which the phenolic hydroxyls are
partially or totally esterified with gallic acid, present an absorption around 200 nm, a λ min between
258–259 nm and λ max between 279–281 nm [57]. Nevertheless, also other polyphenols, such as
hydroxycinnamic acids and flavonoids, could contribute to the UV-Visible fingerprints, even if some of
them are more ubiquitarians and lesser species-specific [61,62]. Furthermore, as far as flavonoids are
concerned, it is important to underline that their absorptions in the Visible are almost negligible at the
measured concentrations, which are instead useful to avoid saturation of the UV region.
The fingerprint UV-Visible, at least in a preliminary screening step, seems to discriminate the
peculiar polyphenols composition of BDs and could be a simple and quick method to confirm the
proper identification of the botanical source after the botanic check by a professional botanist.
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Figure 3. The scores plots of the UV–Visible absorbances data matrix A32,601. Each vegetable species
is reported with a different color (Carpinus betulus L.: black, Cornus mas L.: red, Ficus carica L: green.,
Fraxinus excelsior L.: blue, Larix decidua Mill.: brown, Pinus montana Mill.: light blue, Quercus petraea
(Matt.) Liebl.: orange, Tilia tomentosa Moench: pink). (a) PC1-PC2 score plot with BDs categorized
according to the vegetable species; (b) PC1-PC2 score plot with BDs categorized according to their
identification code (Table 2); (c) PC1-PC3 score plot with BDs categorized according to the vegetable
species; (d) PC1-PC3 score plot with BDs categorized according to their identification code (Table 2);
(e) PC1-PC2 score plot obtained projecting the external test set samples (highlighted in red); (f) PC1-PC3
score plot obtained projecting the external test set samples (highlighted in red).
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Figure 4. Loading plot on PC1, PC2, PC3.
3.2. Bud-Derivatives Identification: UV-Visible and HPLC Fingerprints
Figure 5 shows the PCA plots of the data matrix B32,620 on PC1-PC2, which together explained the
76.2% of the total variance.
Figure 5. The PC1–PC2 plots of the UV–Visible absorbances coupled to the HPLC data (data matrix
B32,620): (a) Score plot; (b) Biplot.
PCA was performed on the pretreated and autoscaled data matrix, after the block scaling treatment
in order to consider in the data analysis the same importance for the spectroscopic and chromatographic
variables [63]. The PC1-PC2 score plot (Figure 5a) highlights a good separation between the vegetal
species. Particularly PC1, which represents the direction of maximum variance explaining the 55.4% of
the total information, allows good discrimination between Fraxinus class (blue, highest scores on PC1),
Ficus (green) and Pinus (light blue) classes, which have lowest scores on this PC. As highlighted in
the Biplot (Figure 5b) the variables having greater importance (loading value) on this separation are
represented by total cinnamic acids, caffeic acid, coumaric acid and hyperoside content which are high
in Fraxinus species and very low in Pinus one (as reported in Table 4). Instead PC2, which explains the
20.7% of the remaining information, allows mainly to separate Carpinus (black) and Cornus (red) classes
from all the other ones. These species result particularly rich in tannins (catechins and benzoic acids).
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Table 4. Bioactive classes and total phenolics in the analyzed samples.
Cinnamic Acids Flavonols Benzoic Acids Catechins Total Phenolics
Sample ID Mean Value SD Mean Value SD Mean Value SD Mean Value SD Mean Value SD
(mg/100 gFW **) (mg/100 gFW **) (mg/100 gFW **) (mg/100 gFW **) (mg/100 gFW **)
Tt_M_A 5.30 0.73 51.64 2.66 22.98 0.79 52.17 1.46 132.09 5.64
Tt_M_B 23.87 1.06 90.79 5.02 6.62 1.04 50.68 1.03 171.97 8.16
Tt_US_A 5.33 1.39 71.26 5.92 132.56 1.68 156.46 1.78 365.61 10.77
Tt_US_B 12.43 5.20 100.23 14.84 96.28 8.41 81.15 10.16 290.10 38.61
Pm_M_A n.d. / 31.13 1.45 n.d. / 171.38 1.65 202.51 3.10
Pm_M_B n.d. / n.d. / n.d. / 49.36 2.29 49.36 2.29
Pm_US_A n.d. / 31.36 3.86 3.67 1.56 378.90 2.54 413.93 7.96
Pm_US_B n.d. / 38.74 4.35 n.d. / 325.88 4.77 364.62 9.12
Ld_M_A n.d. / 275.15 0.91 97.07 0.31 112.09 0.67 484.31 1.88
Ld_M_B n.d. / 151.57 2.23 137.23 0.88 70.90 2.62 359.70 5.72
Ld_US_A 2.40 1.02 810.86 3.32 190.25 0.95 152.12 2.12 1155.63 7.42
Ld_US_B n.d. / 941.62 13.22 219.28 3.66 127.08 7.33 1287.98 24.21
Fe_M_A 829.03 2.26 499.08 2.52 214.49 0.69 328.25 1.68 1870.85 7.15
Fe_M_B 119.44 0.98 223.61 3.43 40.81 1.25 98.75 2.52 482.61 8.18
Fe_US_A 151.00 2.32 378.93 4.62 115.82 0.93 225.26 2.21 871.01 10.07
Fe_US_B 113.53 6.70 551.07 10.06 77.40 2.30 215.96 5.28 957.96 24.34
Cm_M_A 23.97 0.40 1055.03 1.87 577.48 0.37 104.70 0.53 1761.19 3.18
Cm_M_B 24.59 1.55 310.99 2.06 541.34 2.35 1161.65 2.48 2038.58 8.45
Cm_US_A 14.87 1.04 672.04 3.57 276.38 1.33 98.83 1.21 1062.12 7.15
Cm_US_B n.d. / 784.79 12.98 329.55 2.85 167.03 4.67 1281.37 20.50
Cb_M_A 47.04 0.83 442.45 2.04 286.40 1.25 523.93 1.14 1299.83 5.26
Cb_M_B n.d. / 203.20 1.18 418.85 2.56 248.73 2.73 870.78 6.47
Cb_US_A n.d. / 230.16 2.82 80.56 1.04 297.57 1.07 608.29 4.92
Cb_US_B n.d. / 198.98 5.89 206.42 4.05 227.60 3.00 633.00 12.95
Fc_M_A 62.21 0.84 287.89 4.35 67.29 0.89 267.35 2.16 684.74 8.25
Fc_M_B n.d. / 123.28 3.65 45.86 1.08 68.42 2.11 237.57 6.83
Fc_US_A 6.49 2.62 116.68 4.31 26.33 1.18 138.27 2.64 287.77 10.76
Fc_US_B 10.77 5.54 155.02 11.39 52.18 3.49 183.91 7.34 401.88 27.76
Qp_M_A 5.08 0.65 223.63 1.97 283.59 1.28 294.75 0.85 807.06 4.75
Qp_M_B n.d. / 59.40 2.75 84.02 2.16 109.81 2.18 253.23 7.09
Qp_US_A 1.76 1.29 55.98 4.96 223.32 2.35 253.81 2.23 534.87 10.83
Qp_US_B n.d. / 72.09 8.50 58.43 5.70 161.81 4.89 292.32 19.08
SD: standard deviation; ** FW: fresh weight
In the Supplementary materials an example (Larix decidua) of chromatographic pattern was
reported. As shown in Figure 5, the addition of chromatographic variables does not greatly improve
the taxonomic separation previously obtained by the only UV-Visible fingerprint (Figure 3). However,
these results show that the main polyphenols evaluated could be useful markers for identifying the
botanical species regardless of the extraction method and the experimental preparation protocol.
3.3. Phenolic Composition of BDs
In this study, the health-promoting compounds were grouped into four different polyphenolic
classes in order to assess the contribution of each class to the phytocomplex composition of buds
belonging to the eight different species: cinnamic acids (as sum of caffeic acid, chlorogenic acid,
coumaric acid, ferulic acid), flavonols (as sum of hyperoside, isoquercitrin, quercetin, quercitrin
and rutin), benzoic acids (ellagic and gallic acids) and catechins ((+)catechin and (-)epicatechin).
The identification and quantification of each single bioactive compound, expressed in mg/100 g FW,
is reported in the Supplementary Materials (Table S2). For a better data visualization, Figure 6 shows the
radar plot, made considering for each botanical species the mean values obtained from the 4 different
extracts (M_A, M_B, US_A, US_B) for each marker compound quantified.
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Figure 6. The mean content of each phenolic marker (caffeic acid, chlorogenic acid, coumaric acid, ferulic
acid, hyperoside, isoquercitrin, quercetin, quercitrin and rutin, ellagic acid, gallic acid, (+)catechin and
(-)epicatechin) for the eight botanical species investigated.
Several markers of cinnamic acids were considered but not detected in all the extracts.
Fraxinus excelsior BDs showed the highest content in cinnamic acids (ranged from 113.53 ± 6.70
to 829.03 ± 2.26 mg/100 g FW), and as shown in Table S2, ferulic and chlorogenic acids were the
most abundant. Cornus mas and Tilia tomentosa species showed very low amounts of ferulic acid
(respectively 12.14 and 11.73 mg/100 g FW), while in the other species it was not detected. In recent
years, several physiological functions of ferulic acid have been demonstrated [64]. Particularly,
its free radical scavenging activity and its cholesterol-lowering activity, together with the low toxicity,
suggested its chemo preventive effects on heart diseases [65]. Chlorogenic acid is also involved
in beneficial effects on human health due to its anti-inflammatory, antioxidative, anti-aging and
anticancer activities [66]. Chlorogenic acid was detected only in Fraxinus excelsior BDs (ranges from
43.88 to 489.94 mg/100 gFW), in all the other species it was not detectable. Li et al. 2013 reported
that chlorogenic acid and flavonols may be considered the main phenolic compounds responsible
for in vitro anti-cancer property (i.e., against breast, colon, liver and lung cancer) [66]. As regards
the total flavonol content, it was highly variable among species. The highest content was quantified
in Cornus mas species (mean value: 705.71 mg/100 g FW) while the lowest value in Pinus montana
(mean value: 25.31 mg/100 g FW). As highlighted in Figure 6, quercetin represented the phenolic
marker of BDs belonged to Larix decidua species (in orange), while hyperoside was more abundant in
Fraxinus excelsior ones (in light blue).
Benzoic acids are known to be very important in the human diet because of their relation
to many biological and functional activities including antioxidative, anti-inflammatory, anticancer
and antihepatotoxic properties [67]. Gallic acid, due to its antioxidant activity, has been shown
to be effective against oxidative stress (OS), and many other properties have been reported
(i.e., anti-mutagenic, anti-carcinogenic, antiviral, antibacterial, anti-inflammatory, antithrombotic
and anti-atherosclerotic activities) [68]. A multi-target activity of ellagic acid, mainly ascribed to
its antioxidant property and free radical trapping ability, has been reported too. In particular
anti-angiogenic, anti-atherogenic, anti-carcinogenic, anti-obesity, anti-inflammatory, antioxidant,
anti-thrombotic and anti-neurodegenerative properties have been demonstrated [69]. Ellagic acid was
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very abundant in almost all the described species (Table S2) while gallic acid was not detectable in
Ficus carica, Fraxinus excelsior, Larix decidua and Pinus montana species. The highest content in ellagic
acid was identified in Cornus mas extracts, followed by Larix decidua and Quercus petraea BDs (Figure 6,
in red).
Catechins have important effects on human health thanks to its antioxidant, anti-inflammatory,
antidiabetic, and antimicrobial properties [67]. The intake of foods and dietary supplements rich
in catechins could have an important role in the prevention of various diseases (i.e., cardiovascular
diseases), inhibition of lipid peroxidation, improvement of blood flow, elimination of several toxins
and inhibition of human cancer cell line proliferation and cyclooxygenase enzymes [70]. All the vegetal
species considered in this research were a good source of catechins (catechin and epicatechin) as shown
in Table 3 and Table S2. Particularly, as highlighted in Figure 6, catechin represented the phenolic
marker of Pinus montana BDs (in violet), while epicatechin was more abundant in Carpinu betulus and
Quercus petraea extracts (in light green).
All BDs analyzed showed a good content of phenolics although there was a high variability both
between the different vegetal species and between the extracts obtained by the different manufacturing
method and experimental conditions starting from the same botanical species. Figure 7 showed the
radar plots of each botanical species in order to better highlight the phenolic composition of the 4
different extracts (M_A, M_B, US_A, US_B).
As showed in Figure 7, the manufacturing methods (conventional maceration or sonication) and
the experimental conditions used for the preparation of BDs (i.e., extraction solvent, extraction time,
solid/ solvent ratio, extraction time) strongly influenced the phenolic extraction yield despite having
removed the variability of the raw material (same batch of buds for each vegetal species). Generally
US_A (green line) and US_B (red line) appears more similar in terms of phenolic composition respect
to M extracts (M_A and M_B), except for some species, such as Pinus montana and Larix decidua,
in which there is a greater homogeneity in the polyphenolic profile of the final products. In almost
all species, the M_B extract (yellow line) is the most different from the others. In example, the M_B
extract of Cornus mas was rich in catechin which was not detected in extracts obtained by different
extraction conditions (M_A, US_A, US_B). Analogously, rutin represents a phenolic marker of the
M_B extract of Fraxinus excelsior, while it was poorly detectable in the other extracts of the same
species. Surely Protocol A, according to the European Pharmacopoeia, provided a higher alcoholic
concentration of the extraction solvent than protocol B and it is known that a higher solvent polarity
allows a higher phenolic extraction from plant materials [71]. Moreover, Protocol A used an higher
solid/solvent ratio because it is evaluated on the dry weight of the raw material while following
the industrial Protocol (B), the fresh weight of buds was taken into account. Regarding the effect
of ultrasounds, the implosion of cavitation bubbles on the material surface results in micro-jetting
which generates several effects such as surface peeling, detexturation, erosion and cell breakdown [40].
Probably, the destruction of vegetal cells allowed to increase the extraction yield making up for the
lower alcohol content of protocol B.
Due to the lack of a single regulation and an unique preparation protocol for these botanicals,
very different products can be found on the market in terms of their polyphenolic fraction depending
on both the raw materials (i.e., taking into account their specific agro-environmental and biological
traits) and on the experimental conditions of manufacturing (method of preparation, extraction solvent,
solid/solvent ratio, extraction time).
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Figure 7. For each botanical species the phenolic composition (caffeic acid, chlorogenic acid, coumaric
acid, ferulic acid, hyperoside, isoquercitrin, quercetin, quercitrin and rutin, ellagic acid, gallic acid,
(+)catechin and (-)epicatechin) of the 4 different extracts (M_A: blue line, M_B: yellow line, US_A:
green line, US_B: red line) was reported.
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4. Conclusions
Although BDs have been widely used in traditional medicine because of the peculiar content of
buds in phenolic compounds, nowadays they are a category of botanicals still poorly studied. The lack
of detailed scientific information and a clear and unique regulation, it makes these products high risk
and vulnerable for accidental mistakes in the attribution of the botanical species, but also frauds and
adulterations. Moreover, the polyphenols content of BDs is strongly influenced by the manufacturing
processes whose parameters are often not strictly defined (e.g., solvent ratios in the extraction mixtures,
raw material/extraction mixture ratios, extraction time) and thus they affect their final compositions.
This research, within the Finnover project, aims to answer to the growing demand for efficient
quality control in the BDs field to guarantee the proper attribution of the botanical source and
their content. Moreover, a manufacturing process specification should be advisable to monitor the
bioactive contents.
UV-Visible spectroscopy and HPLC-DAD analysis have been employed to obtain an untargeted
and a targeted phytochemical fingerprint of BDs, respectively. UV-Visible coupled with an appropriate
chemometric data processing is a simple, rapid and low-cost technique proved to be very useful to
identify the botanical source regardless the manufacturing method and the experimental conditions
used. Moreover, the targeted phytochemical fingerprint by HPLC-DAD allowed to obtain a detailed
screening of the BDs polyphenolic profile which highlighted an high variability due to the different
vegetal species and to the manufacturing method and protocol. The ultrasonic extraction of buds
compared to conventional maceration proved less sensitive to the different extraction protocols.
The proposed strategy offers to those operating in this industrial sector an untargeted method
for the identification of the bud’s botanical species and a green extraction strategy (PUAE) which is
more robust with respect to the different extractive protocols that can be used. The same approach,
described for BDs, could be analogously applied to other botanical productions.
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Abstract: Kadsura spp. in the Schisandraceae family are woody vine plants, which produce edible
red fruits that are rich in nutrients and antioxidant activities. Despite their valuable food applications,
Kadsura spp. are only able to grow naturally in the forest, and reproduction handled by botanists is
still in progress with a very low growth rate. Subsequently, Kadsura spp. were listed as endangered
species by the International Union for Conservation of Nature and Natural Resources (IUCN) in 2011.
Two different Kadsura spp., including Kadsura coccinea (Lem.) A.C. Sm. and Kadsura heteroclita (Roxb.)
Craib, are mostly found in northern Thailand. These rare, wild fruits are unrecognizable to outsiders,
and there have only been limited investigations into its biological properties. This study, therefore,
aimed to comparatively investigate the phenolic profiles, antioxidant activities, and inhibitory activities
against the key enzymes involved in diabetes (α-glucosidase and α-amylase) and Alzheimer’s disease
(acetylcholinesterase (AChE), butyrylcholinesterase (BChE), and beta-secretase 1 (BACE-1)) in different
fruit parts (exocarp, mesocarp (edible part), seed, and core) of Kadsura coccinea (Lem.) A.C. Sm. and
Kadsura heteroclita (Roxb.) Craib. The results suggested that Kadsura spp. extracts were rich in flavonol
(quercetin), flavanone (naringenin), anthocyanidins (cyanidin and delphinidin), and anthocyanins
(cyanidin 3-O-glucoside (kuromanin), cyanidin 3-O-galactoside (ideain), cyanidin 3-O-rutinoside
(keracyanin), and cyanidin 3,5-di-O-glucoside (cyanin)). These flavonoids were found to be
responsible for the high antioxidant activities and key enzyme inhibitions detected in Kadsura spp.
extracts. The findings of the present study can support further development of Kadsura spp. as a
potential source of phenolics and anti-oxidative agents with health benefits against diabetes and
Alzheimer’s disease. Besides, exocarp and the core of Kadsura spp. exhibited higher phenolic contents,
antioxidant activities, and key enzyme inhibitory activities compared to the mesocarp and seeds,
respectively. This information can promote the use of fruit parts other than the edible mesocarp for
future food applications using Kadsura spp. rather than these being wasted.
Keywords: Kadsura spp.; fruit parts; phenolics; antioxidant capacity; in vitro health properties
1. Introduction
For thousands of years, humans have consumed naturally indigenous plants as green medicines
to treat illnesses, including vegetables, herbs, and fruits. However, the development of effective,
advanced scientific technology and synthetic drugs has significantly lowered the popularity of the
natural medicine approach. Besides several advantages, including ready-to-use therapeutic applications
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and the commercial availability of synthetic drugs, severe side effects and economic impacts are other
factors of concern. These issues have brought indigenous plants back into focus. Natural products have
been considered as better functional food sources for alternative approaches in the prevention of certain
non-communicable diseases (NCDs), and have even been used as green medicine to treat particular
diseases. Subsequently, the study of medicinal applications and functional food development from
beneficial plants are currently in focus.
Kadsura spp. in the Schisandraceae family produce ovate-elliptical shaped leaves and solitarily
unisexual flowers [1]. The globose fruit is between 14 and 20 cm in diameter and forms a hexagonal
structured skin developed by each carpel [1]. The fruit shape is similar to that of sugar-apples, but with
a sourer and astringent taste. While the ripened fruit is edible [2], other plant parts can also be used as
traditional medicine [1]. The stem and root of Kadsura coccinea are used to reduce rheumatic pain in the
bones, chronic enteritis, acute gastritis, and the immunologic hepatic fibrosis effect [3], while those of
Kadsura longipedunculata are used in the treatment of rheumatic arthritis, traumatic injury, dysmenorrhea,
abdominal pain, irregular menstruation, canker sores, and gastrointestinal inflammation [3]. Moreover,
the Kadsura heteroclita stem can prevent and treat rheumatic and arthritic diseases with anti-nociceptive
and anti-inflammatory effects [4,5]. Phenolics detected in Kadsura spp. appear to be responsible
for these health properties. Flavonoids identified in Kadsura oblongifolia, including quercetin and
kaempferol, possess potent antioxidant activities [6]. Additionally, K. coccinea has been previously
reported to contain gallic acid as a major phenolic acid, which has strongly demonstrated DPPH-radical
scavenging activity (the half maximal inhibitory concentration (IC50) = 23.64 μg/mL) compared to
commercial antioxidants, ascorbic acid, and 2,6-ditertbuty l-4-methylphenol (BHT) (the IC50 of 48.46
and 975.96 μg/mL, respectively) [7]. However, stressful conditions i.e., aphid feeding [8], light and
drought intensity [9,10], or even the processing of biological material [11] can significantly affect the
antioxidant properties or the phenolic profile.
The local Thai name for Kadsura spp. is noi-na-kreau and was first discovered in northern Thailand
in 1972 [12]. Kadsura spp. were listed as an endangered species by the International Union for
Conservation of Nature and Natural Resources (IUCN) in 2011, and since then only 11 trees have been
found in the Thai provinces of Chiang Rai, Chiang Mai, and Mae Hong Son. Due to how rare they are,
Kadsura spp. were listed by the Plant Genetic Conservation Project under the initiative of Her Royal
Highness Princess Maha Chakri Sirindhorn (RSPG) in the same year of 2011, aiming to sustainably
conserve and allocate plant resources to optimize beneficial utilizations [13]. Unlike more ubiquitous
fruits in Thailand, Kadsura spp. are not well known, and due to largely being unrecognized, they are at
high risk of extinction. In order to obtain the main goal of RSPG to sustainably conserve Kadsura spp.
by expanding the knowledge on their biological properties, eventually leading to proper management
of the plant, the objective of the present study is, therefore, to examine the phenolic profiles, antioxidant
activities, and in vitro key enzyme inhibitory properties of K. coccinea (Lem.) A.C. Sm. and K. heteroclita
(Roxb.) Craib, the two most abundant Kadsura spp. found in northern Thailand. These enzyme
inhibitory properties are related to medicinal abilities against diabetes and Alzheimer’s disease (AD)
by inhibiting key enzymes, which control these diseases. Targeting the inhibition of the carbohydrate
degrading enzymes, including α-glucosidase and α-amylase, is a key approach for drugs designed to
control diabetes. Based on enzyme–inhibitor structural interactions, several phenolics have been proven
as effective α-glucosidase and α-amylase inhibitors [5,14]. In addition, neurotransmitter degrading
enzymes, acetylcholinesterase (AChE) and butyrylcholinesterase (BChE), and amyloid precursor
protein (APP) degrading enzyme, beta-secretase (BACE-1), are the key enzymes, which control the
occurrence of AD. It has been previously suggested that the extreme loss of cholinergic markers found
in the cerebral cortex is associated with AD, while BACE-1 causes the formation of beta-amyloid
peptides or senile plaques, a hallmark of AD [15]. The findings of the present study provide valuable
information for the sustainable conservation of the nearly extinct Kadsura spp. by describing their
advantageous biological properties and potential applications, which can help to establish proper
management and prolong the existence of the plants.
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2. Materials and Methods
2.1. Sample Collection, Preparation, and Extraction
Kadsura coccinea (Lem.) A.C. Sm. and Kadsura heteroclita (Roxb.) Craib were collected from forests
near Hui-Nam-Guen village, Mae-Jedi-Mai sub-district, Weing-Pa-Pao district, Chiang Rai Province,
Thailand (19◦11′58.3” N and 99◦31′00.7” E). The fruits of both species could be harvested only once a
year at different time periods. The fruits of Kadsura coccinea (Lem.) A.C. Sm. were collected in October
2017, while those of Kadsura heteroclita (Roxb.) Craib were collected in January 2018. Both samples were
identified and authenticated by Assist. Prof. Dr. Chunthana Suwanthada and Assoc. Prof. Dr. Chusri
Trisonthi of the Plant Genetic Conservation Project under the royal initiative of Her Royal Highness
Princess Maha Chakri Sirindhorn. The voucher specimens, including BK No. 071406 (Kadsura coccinea
(Lem.) A.C. Sm.) and BK No. 071407 (Kadsura heteroclita (Roxb.) Craib), were deposited at the Bangkok
Herbarium (BK), Bangkok, Thailand.
All fresh samples were cleaned with deionized water and prepared as exocarp, mesocarp (edible part),
seed, and core (Supplementary Table S1). All the samples were cut (approximately 0.3 cm thick) before
freeze drying by a Heto Powerdry PL9000 freeze dryer (Heto Lab Equipment, Allerod, Denmark) for
3 days. Dry samples were then ground using a grinder (Philips 600 W series from Philips Electronic
Co., Ltd., Jakarta, Indonesia) into a fine powder before packing in a vacuum aluminum foil bag and
storing in a freezer at −20 ◦C for further analysis.
A spectrophotometer (ColorFlex EZ, Hunter Associates Laboratory, Reston, VA, USA) was used
to analyze the colors of the fresh and dry samples, which were expressed as CIELAB units, where L*
represents dark (0) to white (100) colors, a* represents green (−) to red (+) colors, and b* represents
blue (−) to yellow (+) colors. The moisture content of the powdered samples was analyzed using a
Halogen moisture analyzer (HE53 series, Mettler-Toledo AG, Greifensee, Switzerland). The color data
and moisture content data are presented in Supplementary Table S2.
The extraction of Kadsura spp. was optimized as described by a previous study [16].
Briefly, the powered samples (100 mg) were dissolved in distilled water (10 mL) and incubated
in a 90 ◦C temperature-controlled water bath shaker (WNE45 series from Memmert GmBh, Eagle,
WI, USA) for 1 h. The supernatant was then collected by centrifugation at 3800× g using a Hettich®
ROTINA 38R refrigerated centrifuge (Andreas Hettich GmbH, Tuttlingen, Germany) for 15 min and
filtered through a 0.45 μM PES membrane syringe filter. All the extracted samples were stored at
−20 ◦C for further analysis.
2.2. Determination of Antioxidant Activity
The antioxidant activities, including 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging,
ferric ion reducing antioxidant power (FRAP), and oxygen radical absorbance capacity (ORAC)
assays of the Kadsura spp. extracts, naringenin, and quercetin were determined using existing,
well-established protocols [17–20].
The DPPH radical scavenging assay was performed using DPPH in 95% (v/v) aqueous ethanol as
previously described [17,20]. Trolox solution (0.01–0.64 mM) was used as a standard, and the results
were reported as μmol TE/g dried weight (DW).
The FRAP assay was determined using FRAP reagent as previously described [18,20].
Trolox solution (7.81–250.00 μM) was used as a standard, and the results were reported as μmol
TE/g DW.
The ORAC assay was examined using fluorescein reagent as previously described [19,20].
Trolox solution (3.12–100.00 μM) was used as a standard, and the results were reported as μmol
TE/g DW.
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2.3. Determination of Total Phenolic Contents, Total Flavonoid Contents (TFCs), Total Anthocyanin Contents
(TACs), and Phenolic Profiles
The total phenolic contents (TPCs) of the Kadsura spp. extracts were determined using
Folin-Ciocalteu reagent as previously described [21,22]. Gallic acid (10–200 μg/mL) was used as
a standard, and the TPCs were reported as the mg gallic acid equivalent (GAE)/g DW.
Total flavonoid contents (TFCs) of the Kadsura spp. extracts were determined using aluminum
trichloride as previously described [23]. Quercetin (0–100 μg/mL) was used as a standard, and the
TFCs were reported as the mg quercetin equivalent (QE)/g DW.
Total anthocyanidin contents (TACs) of the Kadsura spp. extracts were determined using the pH
differential method as previously described [24]. Cyanidin 3-O-glucoside (2–63 μg/mL) was used as a
standard, and the TACs were reported as the mg cyanidin 3-O-glucoside equivalent (C3GE)/g DW.
Phenolic profiles were analyzed using high performance liquid chromatography (HPLC) as
described previously [25]. The powdered samples (0.5 g) were mixed with 62.5% (v/v) aqueous
methanol containing 0.5 g/L tBHQ (40 mL) and 6 N HCl (10 mL) before incubating in a 80 ◦C
temperature-controlled water bath shaker (WNE45 series from Memmert GmBh, Eagle, WI, USA) for
2 h in dark. The mixture was then cooled in ice for 5 min before sonicating in an ultrasonic cleansing
bath (Branson Ultrasonics™M series, Branson Ultrasonics Corp., Danbury, CT, USA) for a further 5 min.
The mixture was filtered through a 0.22 μM PTFE membrane syringe filter. Phenolic acids in the filtrate
were analyzed by HPLC utilizing a 5 μm Zorbax Eclipse XDB-C18 column (150 × 4.6 mm from Agilent
Technologies, Santa Clara, CA, USA) on an Agilent 1100 HPLC system with a photodiode array detector
from Agilent Technologies (Santa Clara, CA, USA). The gradient mobile phases comprised Milli-Q
water (18.2 MΩ.cm resistivity at 25 ◦C) containing 0.05% (v/v) TFA (solvent A), methanol containing
0.05% (v/v) TFA (solvent B), and acetonitrile containing 0.05% (v/v) TFA (solvent C) with a constant
flow rate of 0.6 mL/min, as shown in Table 1. The existence of the phenolic acids were visualized at
280 and 325 nm using the ChemStation software (Agilent Technologies, Santa Clara, CA, USA) by
comparing retention time (tR) and spectral fingerprint with standards including 4-hydroxybenzoic
acid (>99.0% GC, T), caffeic acid (>98.0% HPLC, T), chlorogenic acid (>98.0% HPLC, T), ferulic acid
(>98.0% GC, T), p-coumaric acid (>98.0% GC, T), sinapic acid (>99.0% GC, T), syringic acid (>97.0% T)
from Tokyo Chemical Industry (Tokyo, Japan), and gallic acid (97.5–102.5% T) from Sigma-Aldrich
(St. Louis, MO, USA).
Table 1. Solvent system of the phenolic acids and flavonoids using high performance liquid
chromatography (HPLC) analysis.
Time (min) Flow Rate (mL/min) Solvent A (%) Solvent B (%) Solvent C (%)
0 0.6 90 6 4
5 0.6 85 9 6
30 0.6 71 17.4 11.6
60 0.6 0 85 15
61 0.6 90 6 4
66 0.6 90 6 4
Solvent A = Milli-Q water containing 0.05% (v/v) TFA; solvent B = methanol containing 0.05% (v/v) TFA;
solvent C = acetonitrile containing 0.05% (v/v) TFA.
Flavonoid identification was performed similar to that of phenolic acids. However, the existence
of flavonoids was visualized at 338 and 368 nm and evaluated by comparing tR and spectral fingerprint
with standards including apigenin (>98.0% HPLC), genistein (>98.0% HPLC), hesperidin (>90.0% HPLC,
T), kaempferol (>97.0% HPLC), luteolin (>98.0% HPLC), myricetin (>97.0% HPLC), naringenin (>93.0%
HPLC, T), quercetin (>98.0% HPLC, E) from Tokyo Chemical Industry (Tokyo, Japan), and isorhamnetin
(≥99.0% HPLC) from Extrasynthese (Genay, France).
Anthocyanidin and anthocyanin identification was performed as previously described [26,27].
Anthocyanidins were extracted using the powdered sample (500 mg) that was dispersed in 50% (v/v)
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aqueous methanol containing 2 N HCl (5 mL). The mixture was incubated in a 100 ± 2 ◦C water bath
(TW20 series from Julabo GmbH, Seelbach, Germany) for 1 h before filtering through a 0.22 μM PTFE
membrane syringe filter. Anthocyanidins were identified by the HPLC system (an Ultimate 3000 with
diode array and multiple-wavelength detectors) from Thermo Fisher Scientific (Dreieich, Germany) and
a 5 μm ReproSil-Pur® ODS-3 column (250 × 4.6 mm) from Dr. Maisch GmbH (Ammerbuch, Germany).
Milli-Q water (18.2 MΩ.cm resistivity) containing 0.4% (v/v) TFA (solvent A) and acetonitrile containing
0.4% v/v TFA (solvent B) were used as an isocratic mobile phase at a ratio of 82% solvent A and 18%
solvent B, with a constant flow rate of 1.0 mL/min. The existence of anthocyanidins was visualized at
530 nm using a Chromeleon™ chromatography Data System (CDS) software (Thermo Fisher Scientific,
Dreieich, Germany) by comparing tR and spectral fingerprint with the standards including cyanidin
(≥96.0% HPLC), delphinidin (≥97.0% HPLC), pelargonidin (≥97.0% HPLC), peonidin (≥97.0% HPLC),
and petunidin (≥95.0% HPLC) from Extrasynthese (Genay, France).
Anthocyanin identification was performed similarly to the anthocyanidin identification.
Anthocyanins were extracted using the powdered sample (500 mg) that was dispersed in 50%
(v/v) aqueous methanol containing 2% (v/v) HCl (5 mL). The extract was then sonicated using an
ultrasonic cleansing bath (Branson Ultrasonics™M series, Branson Ultrasonics Corp., Danbury, CT,
USA) for 20 min and filtered through a 0.22 μM PTFE membrane syringe filter. Anthocyanins were
identified utilizing the same HPLC system as anthocyanidins. Milli-Q water containing 0.4% (v/v)
TFA (solvent A) and acetonitrile containing 0.4% (v/v) TFA (solvent B) were used as gradient mobile
phases with a constant flow rate 1.0 mL/min, as shown in Table 2. The existence of anthocyanins was
visualized at 525 nm and compared tR and spectral fingerprint with the standards including cyanidin
3-O-sophoroside (≥95.0% HPLC), cyanidin 3,5-di-O-glucoside (≥97.0% HPLC), cyanidin 3-O-galactoside
(≥97.0% HPLC), cyanidin 3-O-rutinoside (≥96.0% HPLC), cyanidin 3-O-glucoside (≥96.0% HPLC),
and delphinidin 3,5-di-O-glucoside (≥97.0% HPLC) from Extrasynthese (Genay, France).
Table 2. Solvent system of the anthocyanins using HPLC analysis.







Solvent A =Milli-Q water containing 0.4% (v/v) TFA; solvent B = acetonitrile containing 0.4% (v/v) TFA.
2.4. Determination of Enzyme Inhibitory Activities
Theα-glucosidase inhibitory activity was determined as previously described [28]. Briefly, the assay
comprising 2 mM p-nitrophenyl-α-D-glucopyranoside (50 μL) in a 50 mM phosphate buffer (pH 7.0),
0.1 U/mL Saccharomyces cerevisiae α-glucosidase (type 1, ≥10 U/mg protein, 100 μL), and sample extract
(50 μL) was visualized at a wavelength of 405 nm using a microplate reader (Synergy™HT 96-well
UV-visible spectrophotometer using the Gen5 data analysis software from BioTek Instruments, Inc.,







where A is the initial velocity of the reaction with the enzyme, a is the initial velocity of the reaction
without the enzyme, B is the initial velocity of the enzyme reaction with the extract, and b is the
initial velocity of the reaction with the extract but without the enzyme. The efficiency of flavonoids
against α-glucosidase was also determined using the half maximal inhibitory concentration (IC50),
and analyzed by a dose-response plot of flavonoids versus the inhibition percentage.
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The α-amylase inhibitory activity was determined as previously described [29]. Briefly, the assay
comprising of 30 mM p-nitrophenyl-α-D-maltohexaoside (50 μL) in a 50 mM phosphate buffer (pH 7.0)
containing 200 mM KCl, 30 mg/mL of porcine pancreatic α-amylase (type VII, ≥10 unit/mg, 100 μL),
and the sample extract (50 μL) was visualized at a wavelength of 405 nm using the microplate reader.
The inhibition percentage was then calculated as above.
Acetylcholinesterases (AChE) inhibitory activities were determined as previously described [25].
The enzyme assay consisting of 20 ng of Electrophorus electricus AChE (1000 units/mg, 100 μL) in 50 mM
KPB (pH 7.0), 16 mM 5,5-dithio-bis-(2-nitrobenzoic acid) (DTNB, 10 μL), 0.8 mM acetylthiocholine
(40 μL) in 50 mM KPB (pH 7.0), and the extract (50 μL) was detected at a wavelength of 412 nm using
the microplate reader. Butyrylcholinesterases (BChE) inhibitory activities were determined similarly to
AChE. However, 100 ng equine serum BChE (≥10 units/mg protein, 100 μL) in 50 mM KPB (pH 7.0)
containing 1 mM MgCl2 and 0.1 mM butyrylthiocholine (40 μL) in 50 mM KPB (pH 7.0) were used as
the enzyme and substrate, respectively. The results were expressed as the inhibition percentage and
the IC50 value, as mentioned above.
The beta-secretase (BACE-1) inhibitory activity was determined utilizing a BACE-1 activity
detection kit (Sigma-Aldrich, St. Louis, MO, USA). The manufacturer’s instructions were followed,
and the results expressed as a percentage of BACE-1 inhibition, as above.
All the enzymes, chemicals, and reagents in the enzyme inhibitory assays were purchased from
Sigma-Aldrich (St. Louis, MO, USA).
2.5. Statistical Analysis
All experiments were carried out in triplicate (n = 3) and expressed as mean ± standard deviation
(SD). One-way analysis of variance (ANOVA) followed by Duncan’s multiple comparison test and
unpaired t-test were performed to determine the significant differences between values with p < 0.05.
3. Results
3.1. Total Phenolic Contents (TPCs), Total Flavonoid Contents (TFCs), Total Anthocyanin Contents (TACs),
and Phenolic Profiles
The total phenolic contents (TPCs) of K. coccinea (Lem.) A.C. Sm. extracts (KCE) ranged between
0.83 and 43.61 mg gallic acid equivalent (GAE)/g dry weight (DW), while K. heteroclita (Roxb.) Craib
extract (KHE) exhibited the TPCs ranging from 1.13 to 103.72 mg GAE/g DW (Table 3). Among the
different fruit parts, the exocarp of KCE exhibited the significantly highest TPCs, followed by the core,
mesocarp, and seed, respectively. However, for KHE, its core exhibited significantly higher TPCs than
exocarp, mesocarp, and seed, respectively. Furthermore, significantly higher TPCs were observed in
all the fruit parts of KHE compared to KCE.
Similarly, the total flavonoid contents (TFCs) in KCE ranged between 1.45 and 60.52 mg quercetin
equivalent (QE)/g DW, with the exocarp providing the highest TFCs, followed by the core, while
mesocarp and seed exhibited the lowest TFCs (Table 3). The core of KHE exhibited the highest TFCs,
followed by the exocarp, mesocarp, and seed, respectively. In line with the TPC results, higher TFCs
were detected in all the fruit parts of KHE (ranging from 1.40 to 206.92 mg QE/g DW) compared to
KCE, in exception of seed.
Interestingly, the total anthocyanin contents (TACs) of KCE were only detected in the exocarp
and mesocarp (0.02–0.27 mg cyanidin 3-O-glucoside equivalent (C3GE)/g DW), while TACs in KHE
were found in the exocarp, mesocarp, and core (0.14–0.28 mg C3GE/g DW) (Table 3). The mesocarp of
KCE exhibited higher TACs than its exocarp. Meanwhile, the exocarp and mesocarp of KHE exhibited
insignificantly different TACs, but were significantly higher than that of the core.
Among all the phenolic acids and flavonoids investigated utilizing high performance liquid
chromatography (HPLC), quercetin and naringenin were the only flavonoids identified in Kadsura spp.
extracts (Table 4, Supplementary Figures S1 and S2). The most abundant flavonoid, naringenin,
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was detected in all fruit parts of KCE (ranging from 1395.22 to 1972.65 mg/100 g DW) and KHE
(ranging from 1739.91 to 1835.46 mg/100 g DW). Meanwhile, quercetin was only found in the exocarp
of KCE (17.94 mg/100 g DW), and in the exocarp and mesocarp of KHE (51.19 and 12.59 mg/100 g
DW, respectively). Among all the fruit parts, the exocarp and seed of KCE exhibited significantly
higher naringenin content than the core and mesocarp, respectively. However, insignificant naringenin
content differences were detected in all the fruit parts of KHE.
Table 3. Quantification of the total phenolic contents (TPCs), total flavonoid contents (TFCs), and total
anthocyanin contents (TACs) in different fruit parts of Kadsura coccinea (Lem.) A.C. Sm. extract (KCE)









Exocarp 43.61 ± 0.65 a,* 60.52 ± 5.51 a,* 0.02 ± 0.00 b,*
Mesocarp 6.20 ± 0.15 c,* 1.45 ± 0.52 c,* 0.27 ± 0.02 a
Seed 0.83 ± 0.08 d,* 3.48 ± 1.06 c,* ND
Core 17.71 ± 0.07 b,* 43.23 ± 1.18 b,* ND
KHE
Exocarp 54.00 ± 2.11 B 113.36 ± 4.87 B 0.28 ± 0.02 A
Mesocarp 21.20 ± 0.54 C 33.02 ± 1.55 C 0.26 ± 0.01 A
Seed 1.13 ± 0.14 D 1.40 ± 0.10 D ND
Core 103.72 ± 1.14 A 206.92 ± 4.08 A 0.14 ± 0.01 B
All data are expressed as mean ± standard deviation (SD) of triplicate experiments (n = 3). GAE: gallic acid
equivalent; QE: quercetin equivalent; C3GE: cyanidin 3-O-glucoside equivalent; DW: dry weight; ND: not detected.
Lower case and upper case letters indicate significant differences (p < 0.05) in different fruit parts of KCE and
KHE, respectively, using one-way analysis of variance (ANOVA) and Duncan’s multiple comparison test; * showed
significant difference (p < 0.05) in the same fruit part when comparing between KCE and KHE using the unpaired
t-test.
Anthocyanidins detected in Kadsura spp. extracts were identified as cyanidin and delphinidin
(Table 4 and Supplementary Figure S3). Only the exocarp, mesocarp, and core of both Kadsura spp.
extracts were found to contain these anthocyanidins, while none was detected in the seed. KCE exhibited
cyanidin contents in the range of 0.34–1.03 μg/100 g DW, with its exocarp and mesocarp containing
higher cyanidin content compared to its core. Similar results were observed in KHE (cyanidin content
ranging from 0.03 to 1.00 μg/100 g DW), in which its exocarp and mesocarp provided higher cyanidin
contents than its core. Delphinidin in KCE ranged between 0.42 and 4.02 μg/100 g DW, while KHE
exhibited delphinidin contents in the range of 0.31–0.50 μg/100 g DW. The exocarp in both Kadsura spp.
extracts provided higher delphinidin content than the mesocarp and core, respectively.
Anthocyanins (or glycosylated anthocyanidins) detected in Kadsura spp. extracts were identified
as cyanidin 3,5-di-O-glucoside (cyanin), cyanidin 3-O-galactoside (ideain), cyanidin 3-O-glucoside
(kuromanin), and cyanidin 3-O-rutinoside (keracyanin) (Table 4 and Supplementary Figure S4).
Only the mesocarp of KCE contained cyanin (9.94 μg/100 g DW) and ideain (10.16 μg/100 g DW),
while none was detected in the other fruit parts. Meanwhile, KHE exhibited ideain (2.11–53.36 μg/100 g
DW), kuromanin (0.27–26.06 μg/100 g DW), and keracyanin (4.16–112.54 μg/100 g DW) in the exocarp,
mesocarp, and core, while none was detected in the seed. The exocarp contained higher content for
all three anthocyanins compared to the mesocarp and core, respectively. Besides, kuromanin and
keracyanin were only detected in KHE, while none was found in KCE. On the other hand, cyanin was
only found in KCE, while none was detected in KHE.
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3.2. Antioxidant Activities
Antioxidant activities of Kadsura spp. extracts were determined using 2,2-diphenyl-1-picrylhydrazyl
(DPPH) radical scavenging activity, ferric ion reducing antioxidant power (FRAP), and oxygen radical
absorbance capacity (ORAC) assays (Table 5). KCE exhibited DPPH radical scavenging activities in the
range of 0.04–2.73 μmol trolox equivalent (TE)/g DW, FRAP activities in the range of 3.14–300.44 μmol
TE/g DW, and ORAC activities in the range of 41.93–957.80 μmol TE/g DW. Among all fruit parts,
the exocarp provided significantly higher antioxidant activities than the core, mesocarp, and seed,
respectively. This data corresponds with the TPCs, in which the highest TPCs were detected in the
exocarp of KCE and the lowest in the seed. Similarly, KHE exhibited DPPH radical scavenging activities
in the range of 0.04–6.48 μmol TE/g DW, FRAP activities in the range of 2.91–900.60 μmol TE/g DW,
and ORAC activities in the range of 15.84–1330.23 μmol TE/g DW. Among all fruit parts, the core
exhibited significantly higher antioxidant activities, followed by the exocarp, mesocarp, and seed,
respectively. This data corresponds to the TPCs and TFCs, in which the highest TPCs and TFCs
were detected in the core of KHE and the lowest in the seed. Interestingly, considering the abundant
flavonoids detected in Kadsura spp., naringenin and quercetin, the results suggested that quercetin is a
stronger antioxidant with higher DPPH radical scavenging activity of 8.07 μmol TE/g DW, FRAP activity
of 13,519.54 μmol TE/g DW, and ORAC activity of 30,112.47 μmol TE/g DW than naringenin with
lower DPPH radical scavenging activity of 0.02 μmol TE/g DW, FRAP activity of 30.98 μmol TE/g DW,
and ORAC activity of 25,592.45 μmol TE/g DW.
Table 5. Antioxidant activities in the different fruit parts of Kadsura coccinea (Lem.) A.C. Sm.
extract (KCE) and Kadsura heteroclita (Roxb.) Craib extract (KHE) and their detected flavonoids,
naringenin and quercetin.
Kadsura spp.
Antioxidant Activities (μmol TE/g DW)
DPPH Radical Scavenging Assay FRAP Assay ORAC Assay
KCE
Exocarp 2.73 ± 0.08 a 300.44 ± 12.09 a,* 957.80 ± 77.76 a,*
Mesocarp 0.23 ± 0.00 c,* 25.80 ± 1.04 c,* 120.20 ± 10.88 c,*
Seed 0.04 ± 0.00 d 3.14 ± 0.18 d,* 41.93 ± 4.17 d,*
Core 1.00 ± 0.03 b,* 100.19 ± 1.69 b,* 440.35 ± 33.60 b,*
KHE
Exocarp 2.75 ± 0.10 B 351.48 ± 18.79 B 812.66 ± 77.67 B
Mesocarp 1.02 ± 0.03 C 143.23 ± 12.29 C 260.91 ± 23.48 C
Seed 0.04 ± 0.00 D 2.91 ± 0.24 D 15.84 ± 1.41 D
Core 6.48 ± 0.22 A 900.60 ± 6.22 A 1330.23 ± 49.67 A
Flavonoids
Naringenin 0.02 ± 0.00 30.98 ± 0.69 25,592.45 ± 495.92
Quercetin 8.07 ± 0.25 13,519.54 ± 242.20 30,112.47 ± 1631.24
All data are expressed as mean ± standard deviation (SD) of triplicate experiments (n = 3). TE: trolox equivalent;
DW: dry weight. Lower case and upper case letters indicate significant differences (p < 0.05) in different fruit parts
of KCE and KHE, respectively, using one-way analysis of variance (ANOVA) and Duncan’s multiple comparison
test; * showed significant difference (p < 0.05) in the same fruit part when comparing between KCE and KHE using
unpaired t-test.
3.3. In Vitro Enzyme Inhibitory Activities
Kadsura spp. extracts inhibited the key enzymes relevant to diabetes, including α-glucosidase
and α-amylase, with different degrees of inhibition (Table 6). The α-glucosidase inhibitory activities
in both Kadsura spp. extracts were detected in all fruit parts except for the seed. KCE exhibited
α-glucosidase inhibitory activities in the range of 60.04–98.23% inhibitions using an extract concentration
of 0.5 mg/mL, while those in KHE ranged between 89.72% and 91.84% inhibitions with the same
extract concentration. It is also found that the exocarp and core of both Kadsura spp. extracts exhibited
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significantly higher α-glucosidase inhibitory activities than mesocarp, as indicated by the half maximal
inhibitory concentration (IC50) (Table 6). Lower IC50 values indicated greater effectiveness of enzyme
inhibitions. The exocarp and core of KCE exhibited significantly lower IC50 values (0.13 and 0.45 mg/mL,
respectively) than mesocarp (0.56 mg/mL). Similar results were observed with KHE, in which its
exocarp and core exhibited significantly lower IC50 values (0.06 mg/mL) than its mesocarp (the IC50
value of 0.64 mg/mL). Interestingly, the exocarp and core of KHE exhibited significantly lower IC50
values compared to those of KCE, while insignificantly different IC50 values were observed in the
mesocarp of both Kadsura spp. extracts.
Likewise, KCE exhibited α-amylase inhibitory activities in the range of 12.18–51.85% inhibitions
using an extract concentration of 2.5 mg/mL, while those in KHE ranged between 33.93% and 44.75%
inhibitions when using the same extract concentration. When comparing the different fruit parts of
KCE, its exocarp exhibited significantly higher inhibitory activities than its core, mesocarp, and seed,
respectively. Similar results were observed in KHE, in which its exocarp and core possessed significantly
higher inhibitory activities than its mesocarp, but no inhibitory activity was observed in its seed. Due to
low inhibitory activities, the IC50 value against α–amylase of Kadsura spp. extracts is unavailable.
Kadsura spp. extracts were able to inhibit acetylcholinesterase (AChE), butyrylcholinesterase
(BChE), and beta-secretase (BACE-1), the key enzymes relevant to AD with different degrees of
inhibition. The AChE inhibitory activities in KCE ranged between 20.40% and 87.44% inhibitions,
while those of KHE ranged between 29.98% and 91.74% inhibitions using the extract concentration of
2.0 mg/mL. The exocarp and core of both Kadsura spp. extracts possessed significantly higher AChE
inhibitory activities than mesocarp, while no inhibitory activities were detected in the seed. Due to the
low inhibitory activities in the mesocarp, the IC50 values against AChE were only detected in exocarp
and core. KCE exhibited the IC50 values of 0.88 mg/mL in the exocarp and 1.54 mg/mL in the core,
while KHE exhibited the IC50 values of 0.52 mg/mL in the exocarp and 0.41 mg/mL in the core (Table 6).
It is also suggested that the KHE exocarp and core exhibited significantly lower IC50 values than those
of KCE.
Similar results were observed with BChE inhibition, in which only the exocarp, mesocarp, and core
of both Kadsura spp. extracts possessed inhibitory activities, while none was detected in the seed. KCE
exhibited BChE inhibitory activities in the range of 41.27–96.81% inhibitions, while those of KHE ranged
between 63.67% and 99.15% inhibitions using the same extract concentration of 2.0 mg/mL. The exocarp
and core of KHE exhibited significantly lower IC50 values (0.20 and 0.16 mg/mL, respectively) than
its mesocarp (1.32 mg/mL) (Table 6). However, KCE exhibited significantly lower IC50 values in its
exocarp (0.49 mg/mL) than its core (0.67 mg/mL). Interestingly, the exocarp and core of KHE exhibited
significantly lower IC50 values than those of KCE.
Additionally, KCE exhibited BACE-1 inhibitory activity in the range of 4.72–56.34% inhibitions,
while those of KHE ranged between 12.70% and 35.26% inhibitions using the same extract concentration
of 2.0 mg/mL. In KCE, the mesocarp exhibited a significantly higher BACE-1 inhibitory activity than
the exocarp, core, and seed, respectively. Similar results were observed in KHE, in which the mesocarp
exhibited the significantly higher BACE-1 inhibitory activity, followed by the exocarp and seed,
respectively. No inhibitory activity was observed in the core of KHE.
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4. Discussion
Two species of Kadsura spp., K. coccinea (Lem.) A.C. Sm. and K. heteroclita (Roxb.) Craib, are found
abundantly in Thailand. Kadsura spp. has been reportedly used as a folk medicine for several decades.
Despite their valuable medicinal applications, Kadsura spp. can only be naturally populated in
the forest, which makes them unrecognizable for outsiders, while knowledge of their biological
properties is also limited. The present research is the first comparative and comprehensive study of two
Kadsura spp. in terms of their phytochemicals (total phenolic contents (TPCs), total flavonoid contents
(TFCs), total anthocyanin contents (TACs), and phenolic profiles), and their health properties (in vitro
antioxidant, anti-diabetic, and anti-Alzheimer’s properties). The researchers found that (i) Kadsura spp.
extracts were rich in flavonol (quercetin), flavanone (naringenin), anthocyanidins (cyanidin and
delphinidin), and anthocyanins (cyanidin 3-O-glucoside (kuromanin), cyanidin 3-O-galactoside (ideain),
cyanidin 3-O-rutinoside (keracyanin), and cyanidin 3,5-di-O-glucoside (cyanin)); (ii) the antioxidant
activities of Kadsura spp. extracts were related to their phenolic contents; (iii) Kadsura spp. extracts
exhibited strong inhibitory activities against key diabetic enzymes, including α-glucosidase and
α-amylase; (iv) Kadsura spp. extracts provided effective in vitro anti-Alzheimer properties through
acetylcholinesterase (AChE), butyrylcholinesterase (BChE), and beta-secretase (BACE-1) inhibitions.
This information supports the further development of Kadsura spp. as a potential source of phenolics
with health benefits against the occurrence of diabetes and AD.
Flavonoids are diphenylpropanes-structured phytochemicals, which are mostly found in
plant-based diets. The HPLC outcomes reveal that the identified flavonol and flavanone in Kadsura spp.
extracts were quercetin (12.59–51.19 mg/100 g DW) and naringenin (1395.22–1972.65 mg/100 g DW),
respectively. Naringenin is the most abundant flavonoid in Kadsura spp. extracts and is also widely
distributed in citrus fruits such as kumquats, grapefruits, yuzu, and pomelo [30]. Quercetin is the most
common flavonol and is found ubiquitously in mulberry, apricot, apple, and onion [31]. The amounts of
quercetin and naringenin in the Kadsura spp. extracts corresponded with the TPCs and TFCs, in which
the exocarp appeared to exhibit higher TPCs and TFCs than mesocarp. Similar results were observed
in K. coccinea collected in China, which suggested that the TPCs of exocarp was double those detected
in mesocarp [7]. Besides, anthocyanidins, the pigmented water-soluble compounds widely found
in red to purplish-blue colored plants, were also identified in Kadsura spp. extracts as cyanidin and
delphinidin. This data corresponds to the anthocyanins found in most vegetables and fruits, in which
cyanidin (50%) is the most abundant anthocyanidin, followed by delphinidin (12%), peonidin (12%),
pelargonidin (12%), malvidin (7%), and petunidin (7%) [32]. Furthermore, glycosylated anthocyanidins,
namely anthocyanins, were identified in Kadsura spp. extracts as kuromanin, ideain, keracyanin,
and cyanin. These findings correspond to a previous study, suggesting that since cyanidin is the most
abundant anthocyanidin found in plants, its glycosylated form, kuromanin, is also the most common
form of glycoside derivatives in colored plants [32]. Besides Kadsura spp., these anthocyanins are also
abundantly detected in most berries. Cyanin is mostly found in mulberries, pomegranate, and wild
blackberry [26,27,33,34], while ideain is found in blueberries and cranberries [35,36]. Keracyanin is
detected in mulberries, raspberries, blackcurrants, and redcurrants [26,27,35]. In addition, kuromanin is
abundantly found in strawberries, mulberries, blackcurrants, and raspberries [26,27,35,37].
These flavonoids appear to be responsible for the high antioxidant activities detected in
Kadsura spp. extracts. The results on antioxidant activities of individual flavonoid suggested that
quercetin is a stronger antioxidant than naringenin. However, due to high content of detected
naringenin, this flavonoid might be responsible for high antioxidant activities in Kadsura spp. extracts.
When comparing fruit parts, the exocarp and core of Kadsura spp. extracts exhibited higher antioxidant
activities than the mesocarp and seed, respectively. These results correspond with the previous study,
finding that antioxidants detected in exocarp of K. coccinea collected in China were two times higher
than its mesocarp [38]. Comparably, the ORAC values of our Kadsura spp. extracts (675–2943 μmol
TE/100 g FW) are similar to those of high antioxidant containing fruits, including fuji apple (2589 μmol
TE/100 g FW), gala apple (2828 μmol TE/100 g FW), apricot (1110 μmol TE/100 g FW), hass avocado
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(1922 μmol TE/100 g FW), grapefruits (1640 μmol TE/100 g FW), grapes (red, black, white, and green as
1018–1837 μmol TE/100 g FW), white-flesh guava (2550 μmol TE/100 g FW), lemon (1346 μmol TE/100 g
FW), mangosteen (2510 μmol TE/100 g FW), oranges (2103 μmol TE/100 g FW), peach (1922 μmol
TE/100 g FW), and green-cultivar pear (2201 μmol TE/100 g FW) [39]. Additionally, the antioxidant
activities are related to the TPCs and TFCs. The phenolics are proven to be the strong anti-oxidative
agents [40,41]. Naringenin, the most abundant flavonoid detected in Kadsura spp. extracts, can strongly
inhibit oxidative stress [42] and induce endogenous antioxidants [43]. Besides, it can suppress lipid
peroxidation in rat liver tissue induced by hydroxyl and peroxyl radicals [44]. Many previous studies
report that the effectiveness of anti-oxidative agents is related to their structures. The antioxidant
properties activated by flavonoids are due to the existence of functional hydroxyl moieties, for instance,
an active 4′ hydroxyl moiety of naringenin is responsible for its antioxidant activity [45]. Since these
phenolics are responsible for the antioxidant activities in Kadsura spp. extracts, the exocarp and core
with higher TPCs and TFCs than the mesocarp and seed also exhibited higher antioxidant activities.
This data suggests that Kadsura spp. extracts have a strong antioxidant potential, leading to health
promoting biological effects.
Besides being rich sources of anti-oxidative agents, Kadsura spp. extracts also exhibit strong
inhibitory activities against α-glucosidase and α-amylase, the key enzymes in controlling diabetes.
These enzymes play a significant role in hydrolyzing carbohydrates (polysaccharides) into glucose
subunits (monosaccharide) before being absorbed into the small intestine. Various plant extracts have
been examined previously and reported to possess α-amylase and α-glucosidase inhibitions [46].
Moreover, epidemiological studies support that phenolics, mainly flavonoids and phenolic acids,
contribute to the prevention of DM through theα-amylase andα-glucosidase inhibitory effects. The most
abundant phenolic detected in Kadsura spp., naringenin, can act as a mixed, close to non-competitive
inhibitor with the IC50 value of 75 μM against α-glucosidase [28,47]. Additionally, naringenin inhibited
α-glucosidase activity in diabetic rats, resulting in delayed carbohydrate absorption and decreased
postprandial blood glucose level [48]. However, its action against α-amylase is much lower than that of
α-glucosidase, in which its IC50 value on α-amylase inhibition was found to be greater than 500 μM [47].
Since KHE contained higher quantities of phenolics than KCE, it also had higher α-amylase and
α-glucosidase inhibitory activities than the latter. Besides, these phenolics were more effective against
α-glucosidase than α-amylase, while Kadsura spp. extracts exhibited potentially higher α-glucosidase
inhibitions than α-amylase inhibitions.
Kadsura spp. extracts also provide effective in vitro anti-AD properties through AChE, BChE, and
BACE-1 inhibitions. Under normal conditions, acetylcholine (ACh), a neurotransmitter working as a
molecular messenger between neurons, is hydrolyzed mainly by AChE and co-regulated by BChE.
In the AD hypothesis, these neurotransmitters decrease as a result of overexpression of AChE and
BChE, leading to cognitive impairment [16]. Recent AD treatments are based on increasing cerebral
acetylcholine levels by cholinesterase inhibitors [49]. Synthetic drugs used widely to treat AD symptoms,
such as tacrine and donepezil, and can introduce both effective outcomes and cause side effects such as
hepatotoxicity and gastrointestinal complaints [20]. Thus, natural therapeutics such as plant extracts
are of interest, since some plant phenolics have been proven to provide a strong contribution in the
prevention of neurodegenerative diseases [50]. The major flavonoid contained in Kadsura spp. extract,
naringenin, has been previously reported to exhibit AChE inhibitory activity with the IC50 value of
42.66μM and BChE inhibitory activity with the IC50 value of over 100μM [51]. It has also been suggested
that naringenin could introduce neuroprotective effects in an in vivo study, in which naringenin was
found to suppress the activity of AChE, resulting in elevated synaptic cholinergic neurotransmitter
level, improved cognitive functions, and prevented memory extinction [52]. Another pathogenesis
of AD is amyloids cascade formation. Amyloid beta-peptides (Aβ) are overproduced and gradually
accumulated in the brain. This aggregation leads to amyloid plaques, which cause oxidative stress
and neurotoxicity. Aβ is derived from proteolytic cleavage by endogenous BACE-1, an enzyme
that is increasingly found in AD patients [53]. BACE-1 is, therefore, another key enzyme for AD
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progression. Naringenin was previously reported to inhibit BACE-1 activity with the IC50 value of
30.31 μM [51]. Additionally, an oral administration of naringenin could also improve memory deficits
in an Aβ-induced mouse model of AD [54]. Thus, AChE, BChE, and BACE-1 inhibitory activities
detected in Kadsura spp. extracts may be the result of the biological function of this flavonoid, which acts
as effective enzyme inhibitor.
In conclusion, Kadsura spp., including Kadsura coccinea (Lem.) A.C. Sm. and Kadsura heteroclita
(Roxb.) Craib, contained high phenolic and flavonoid contents with naringenin being the most
abundant compound. This flavonoid was responsible for the antioxidant activities and inhibitory
activities against the key enzymes controlling diabetes (α-glucosidase and α-amylase) and AD
(AChE, BChE, and BACE-1). This supports their future application as potential sources of phenolics
with health benefits against the occurrence of diabetes and AD. Interestingly, by comparing different
fruit parts within the same Kadsura spp., some fruit parts (exocarp of KCE, and exocarp and core
of KHE) appeared to exhibit higher TPCs, TFCs, and antioxidant activities than its edible mesocarp.
Besides, the exocarp and core of both Kadsura spp. also exhibited greater enzyme inhibitory activities
than mesocarp, suggesting the potential food application of other fruit parts rather than these being
wasted. Most importantly, this information can also lead to the sustainable conservation and establish
proper agricultural management of the nearly extinct Kadsura spp. by providing knowledge of their
advantageous biological properties and potential applications.
Supplementary Materials: The following are available online at http://www.mdpi.com/2304-8158/9/9/1222/s1,
Table S1: Images of whole fruit, sectioned fruit, exocarp, mesocarp (edible part), seed, and core of Kadsura coccinea
(Lem.) A.C. Sm. and Kadsura heteroclita (Roxb.) Craib; Table S2: Color (where L* describes darkness (−) to
lightness (+), a* describes green (−) to red (+) colors, and b* describes indigo (−) to yellow (+)) and the percentage
(%) of moisture content of fresh and freeze-dried Kadsura spp. Samples; Figure S1: High-performance liquid
chromatograms of (A.) naringenin and Kadsura spp. samples including (B.) exocarp, (C.) mesocarp, (D.) seed, and
(E.) core of Kadsura coccinea (Lem.) A.C. Sm. and (F.) exocarp, (G.) mesocarp, (H.) seed, and (I.) core of Kadsura
heteroclita (Roxb.) Craib. Retention times (Rt) of phenolics in Kadsura spp. extracts are indicated at a wavelength of
280 nm; Figure S2: High-performance liquid chromatograms of (A.) quercetin and Kadsura spp. samples including
(B.) exocarp, (C.) mesocarp, (D.) seed, and (E.) core of Kadsura coccinea (Lem.) A.C. Sm. and (F.) exocarp, (G.)
mesocarp, (H.) seed, and (I.) core of Kadsura heteroclita (Roxb.) Craib. Retention times (Rt) of phenolics in Kadsura
spp. extracts are indicated at a wavelength of 368 nm; Figure S3: High-performance liquid chromatograms of (A.)
cyanidin, (B.) delphinidin, and Kadsura spp. samples including (C.) exocarp, (D.) mesocarp, (E.) seed, and (F.) core
of Kadsura coccinea (Lem.) A.C. Sm. and (G.) exocarp, (H.) mesocarp, (I.) seed, and (J.) core of Kadsura heteroclita
(Roxb.) Craib. Retention times (Rt) of phenolics in Kadsura spp. extracts are indicated at a wavelength of 530 nm;
Figure S4: High-performance liquid chromatograms of (A.) cyanidin 3,5-di-O-glucoside (cyanin), (B.) cyanidin
3-O-glucoside (kuromanin), (C.) cyanidin 3-O-galactoside (ideain), (D.) cyanidin 3-O-rutinoside (keracyanin), and
Kadsura spp. samples including (E.) exocarp, (F.) mesocarp, (G.) seed, and (H.) core of Kadsura coccinea (Lem.) A.C.
Sm. and (I.) exocarp, (J.) mesocarp, (K.) seed, and (L.) core of Kadsura heteroclita (Roxb.) Craib. Retention times (Rt)
of phenolics in Kadsura spp. are indicated at a wavelength of 525 nm.
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Abstract: The fruit of Ziziphus jujuba, commonly called jujube, has long been consumed for its health
benefits. The aim of this study was to examine the protective effect of dietary supplementation
of enzymatically hydrolyzed jujube against lung inflammation in mice. The macerated flesh
of jujube was extracted with aqueous ethanol before and after Viscozyme treatment. The extract
of enzyme-treated jujube, called herein hydrolyzed jujube extract (HJE), contained higher levels
of quercetin, total phenolics, and flavonoids, and exhibited more effective radical-scavenging abilities
in comparison to non-hydrolyzed jujube extract (NHJE). HJE treatment decreased production
of inflammation-associated molecules, including nitric oxide and pro-inflammatory cytokines
from activated Raw 264.7 or differentiated THP-1 cells. HJE treatment also reduced expression
of nuclear factor-κB and its downstream proteins in A549 human lung epithelial cells. Moreover,
oral supplementation of 1.5 g of HJE per kg of body weight (BW) attenuated histological lung damage,
decreased plasma cytokines, and inhibited expression of inflammatory proteins and oxidative
stress mediators in the lungs of mice exposed to benzo(a)pyrene at 50 mg/kg BW. Expression levels
of antioxidant and cytoprotective factors, such as nuclear factor erythroid-derived 2-related factor 2 and
heme oxygenase-1, were increased in lung and liver tissues from mice treated with HJE, compared to
mice fed NHJE. These findings indicate that dietary HJE can reduce benzo(a)pyrene-induced lung
inflammation by inhibiting cytokine release from macrophages and promoting antioxidant defenses
in vivo.
Keywords: Jujube; hydrolysis; anti-inflammation; lung; NF-κB; Nrf2; HO-1
1. Introduction
Lung inflammation can be triggered by pathogens, toxins, and pollutants [1–3]. In response to
exogenous inflammatory factors, the innate immune defense system is acutely activated to rehabilitate
affected tissue and minimize systemic inflammation [4]. If the inflammatory response is not sufficient
to restore tissue homeostasis, lung damage progresses and causes pulmonary dysfunction and
respiratory failure [5].
Inflammation in the lungs is regulated by a variety of molecular mediators, including pro-
and anti-inflammatory chemokines and cytokines, which are produced by damaged pulmonary
epithelial cells, as well as various types of activated leukocytes [6,7]. Mediators related to lung
inflammation include tumor necrosis factor α (TNFα), interleukin-6 (IL-6), and interleukin-1β (IL-1β),
which regulate maturation of dendritic cells and induce recruitment of neutrophils at inflammatory
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sites [7,8]. Cyclooxygenase (COX) is an enzyme that metabolizes arachidonic acid into endoperoxides
and is closely associated with inflammation [9]. Of the two isoforms, COX-2 is expressed in most
cells in an inducible manner at the local inflammation site, whereas COX-1 is constitutively expressed.
COX-2 expression is controlled by nuclear factor κB (NF-κB) which is a ubiquitous transcription factor
that regulates expression of multiple proteins involved in inflammatory and immune responses [10].
Nuclear factor erythroid-derived 2-related factor 2 (Nrf2) is a key regulator of a set of phase-2
defense and antioxidant enzymes, including heme oxygenase-1 (HO-1) [11]. Nrf2 and its downstream
enzymes play a protective role against pro-inflammatory and detrimental oxidizing effects [12].
Several studies have demonstrated that antioxidative phytochemicals in fruits and vegetables can
upregulate the Nrf2 signaling pathway, downregulate the NF-κB pathway, and consequently modulate
inflammation-associated gene expression in macrophages and lung epithelial cells [13,14].
The fruit of Ziziphus jujuba var. inermis Rehder (commonly called jujube) is used widely
as a dietary ingredient and traditional remedy for digestive and respiratory dysfunctions [15–18].
Jujube contains not only antioxidative phytochemicals, including phenolics and flavonoids, but also
polysaccharides with immunomodulatory potential [19–21]. These compounds were found to exert
protective effects against gastrointestinal, hepatic, and pulmonary damage [19–21]. A couple of
studies have demonstrated that crude mixtures containing jujube extract can alleviate symptoms of
nasal or gastrointestinal inflammation in mice [22,23]. Some polysaccharides obtained from jujube
by ultrasonic-assisted extraction reportedly suppressed pro-inflammatory cytokine production in
activated Raw 264.7 cells [24,25]. In addition, a research group has shown that jujuboside B, a saponin
found in jujube ethanolic extract, lowered the number of immune cells in bronchoalveolar lavage
fluid, and decreased levels of allergic phenotype-regulating cytokines in lung homogenate from
an ovalbumin-induced allergic asthma mouse model [26]. These findings suggest that jujube ethanolic
extract contains a variety of bioactive substances and may relieve lung disease caused by exogenous
inflammatory stimuli.
In an attempt to liberate the bioactive components existing in inactive glycoside forms,
jujube fruit was preheated and enzymatically treated using Viscozyme, which possesses primarily
endo-1,3(4)-β-glucanase and collaterally cellulase and hemicellulase activities, to break any constraining
linkage and thereby enhance the bioavailability of the compounds. The fruit was then subjected to
extraction with aqueous ethanol. The hydrolyzed jujube fruit extract was evaluated for its biologically
beneficial effects in an acute lung inflammation mouse model using benzo(a)pyrene (B(a)P).
2. Materials and Methods
2.1. Preparation of Hydrolyzed Jujube Extracts
The commercially available fresh jujube fruits that were harvested from Gyeongsan region, S. Korea
in October 2019 [16,27] were obtained from a local market. The seeds were removed and the flesh was
cut into 100 g samples. The samples were homogenized with 10 volumes of distilled water, pretreated
at 95 ◦C for 10 min, followed by enzymatic hydrolysis using five units of Viscozyme (Novozyme,
Bagsvaerd, Denmark) in 1 M acetate buffer at a pH of 5.0 and a temperature of 55 ◦C, shaken at 250 rpm
for 1 h. Non-hydrolyzed jujube flesh homogenate was subjected to the same procedure as HJE but
without enzyme treatment. Both samples were then mixed with the same volume of absolute ethanol
to make the final concentration of 50% (v/v) ethanol in solution, and extracted in a shaking incubator
at 55 ◦C and 250 rpm for 1 h. Both extracts prepared in the absence and presence of Viscozyme were
referred to as non-hydrolyzed jujube extract (NHJE) and hydrolyzed jujube extract (HJE), respectively.
They were filtered using 8-μm filter papers (Whatman, Little Chalfont, UK), vacuum-evaporated
(EYELA N-1000, Tokyo, Japan), and freeze-dried. The NHJE and HJE powders were dissolved in
dimethyl sulfoxide (DMSO) at the concentration of 500 mg/mL for further experiments.
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2.2. Quantification of Total Phenolics and Flavonoids
Total phenolic and flavonoid contents in the jujube extracts were determined as reported
previously [28–30]. For quantification of the total phenolic content, briefly, each sample was mixed with
Folin reagent and 10% sodium carbonate. After incubation at room temperature for 1 h, the absorbance
was measured at 725 nm using a microplate reader. For measurement of the total flavonoid content,
samples were mixed with aluminum nitrate, potassium acetate, and ethanol. After incubation at room
temperature for 40 min, the absorbance was acquired at 415 nm. Total phenolic compound content and
total flavonoid content were estimated from a standard curve prepared using gallic acid and quercetin
(both from Sigma-Aldrich, St. Louis, MO, USA), respectively.
2.3. High-Performance Liquid Chromatography Analysis
Quantitative determination of rutin and quercetin in NHJE and HJE was performed using
high-performance liquid chromatography (Shimadzu Corporation, Tokyo, Japan) equipped with
a photodiode array (PDA) detector and an M1 column (SunFire, C18, 4.6 × 250 mm, 5-μm particle size)
with the mobile phase consisting of a mixture of 40% (v/v) methanol and 15% (v/v) acetonitrile in water
containing 1% (v/v) acetic acid. The flow rate was 1 mL/min. The column temperature was maintained
at 40 ◦C for 30 min during the analysis and the injection volume was 10 μL. Detection was made with
a PDA detector at 280 nm. The quantities of those compounds were determined by extrapolating the
corresponding peak areas from the calibration curves of standards, rutin, and quercetin (both from
Sigma-Aldrich).
2.4. Cell Culture and Treatment
Raw 264.7 murine macrophages, THP-1 human monocytes, and A549 human lung epithelial
cells were obtained from the Korean Cell Line Bank (Seoul, Korea). All cell lines were grown
in Dulbecco’s modified Eagle medium (DMEM, Invitrogen) containing 10% heat-inactivated fetal
bovine serum (FBS) and 1% penicillin-streptomycin (Welgene, Gyeongsan, Gyeongbuk) and placed in
a humidified incubator that provided 5% CO2 at 37 ◦C.
For cell viability assays, cells were dispensed into a 96-well plate at a density of 5 × 103 cells/well,
treated with jujube extract at the concentrations of 0, 62.5, 125, 250, and 500 μg/mL for 24 h, and
assayed using the Cell Counting Kit (CCK-8; Dojindo Laboratories, Kumamoto, Japan) as previously
described [31].
For measurement of nitric oxide (NO) levels in culture medium, Raw 264.7 cells were seeded at
a density of 2 × 103 cells per well of a 96-well plate and activated by treatment with lipopolysaccharide
(LPS) at 1 μg/mL for 24 h. The culture medium was collected and reacted with the Griess reagent
(Promega, Madison, WI, USA).
THP-1 cells were passaged at a density of 4 × 106 cells/mL in a 100-mm plate and maintained
in DMEM containing 10% FBS. The cells were activated and differentiated by applying 200 nM
of 12-O-tetradecanoylphorbol-13-acetate (TPA). For indirect co-culture of THP-1 and A549 cells,
the cultured medium (herein called ‘conditioned medium’) from THP-1 cells was collected and
transferred to A549 cells.
2.5. Antioxidant Response Element–Luciferase Reporter Assay
To determine the transcriptional activity of the antioxidant response element (ARE), a luciferase
reporter gene assay was conducted on a HepG2 cell line carrying the ARE-luciferase construct using
a luciferase assay system (Promega, Madison, WI, USA) [32]. Sulforaphane (Sigma-Aldrich, St. Louis,
MO, USA) was used as a positive control.
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2.6. Animal Treatment
The animal study was approved by, and conducted according to the guidelines of, the Institutional
Animal Care and Use Committee of the Kyungpook National University (approval number: KNU
2019-0157). A total of 48 adult C57BL/6J mice (six weeks old males, 20−25 g BW) were purchased
from Hyochang Science (Daegu, Korea). After one week of adaptation in a controlled laboratory
environment (temperature, 22 ± 2 ◦C; humidity, 50 ± 5%; 12-h light-dark cycle) with free access to water
and AIN-76A chow (Hyochang Science, Daegu, Korea), the mice were randomly assigned to six groups
(eight mice per group). The experimental groups were as follows: (1) control, a group treated only
with vehicle, (2) a group treated with B(a)P alone, (3) a group treated with NHJE at 0.75 g/kg BW and
B(a)P, (4) a group treated with NHJE at 1.5 g/kg BW and B(a)P, (5) a group treated with HJE at 0.75 g/kg
BW and B(a)P, and (6) a group treated with HJE at 1.5 g/kg BW and B(a)P. The NHJE and HJE samples
were dissolved in a vehicle composed of 5% (v/v) Tween-80, 5% ethanol, and 90% sterilized drinking
water. The freshly dissolved samples were administered by oral gavage in a volume of 0.2 mL/mouse
on a daily basis for two weeks. Lung inflammation was induced by intraperitoneal injection with
50 mg/kg BW of B(a)P dissolved in corn oil (Sigma-Aldrich, St. Louis, MO, USA) 24 h prior to sacrifice.
The blood, lung, and liver tissues were dissected and used for further biochemical analyses.
2.7. Histopathological Analysis
The entire lungs were dissected from the sacrificed. All lobes were fixed in a 10% (v/v) formalin
solution and embedded in paraffin [33]. Tissue blocks were then coronally sectioned into 5-μm-thick
slices using a microtome (RM-2125 Rt; Leica, Nussloch, Germany), and stained with hematoxylin and
eosin (H&E, Sigma-Aldrich, St. Louis, MO, USA). Histological damage in the tissue sections was
observed under a microscope (Eclipse 80i; Nikon, Tokyo, Japan).
2.8. Enzyme-Linked Immunosorbent Assay
An enzyme-linked immunosorbent assay (ELISA) was performed using commercially available
kits for the quantitation of inflammatory cytokines (TNFα, IL-1β, and IL-6) in plasma (mouse ELISA
sets for each cytokine, BD Biosciences, San Jose, CA, USA). Lung and liver tissues were collected
from the mice and homogenized in phosphate buffered saline including protease inhibitor cocktail
(Roche, Mannheim, Germany). After centrifugation at 15,000× g for 10 min, the supernatants were used
for the following analyses. Lung tissue homogenate was subjected to measurement of IL-10 (ELISA
MAX standard set, Biolegend, San Diego, CA, USA) and prostaglandin E2 (PGE2) (Cayman Chemical,
Ann Arbor, MI, USA) as per the manufacturer’s instructions. Liver tissue homogenate was used
to determine the levels of 8-hydroxy-2′-deoxyguanosine (8-OHdG) (Cat # ADI-EKS-350; Enzo Life
Sciences, Farmingdale, NY, USA) and malondialdehyde (MDA) (Cat # ALX-850-287; Enzo Life Sciences,
Inc., Farmingdale, NY, USA) as previously described [34]. The obtained values were normalized to the
total amount of proteins.
2.9. Western Blot Analysis
Cytoplasmic and nuclear fractions of cultured cells and mouse tissues were prepared using the
NE-PER Nuclear and Cytoplasmic Extraction Reagents (Thermo Fisher Scientific, Rockford, IL, USA).
The proteins in each fraction were blotted and their relative expression levels were determined as
previously described [34,35]. Briefly, the primary antibodies used in this study were immunoglobulins
against COX-2 (Cell Signaling Technology, Danvers, MA, USA), NF-κB (Bioworld Technology, St. Luis.
MN, USA), iNOS (Enzo Life Sciences, Farmingdale, NY, USA), HO-1 (Abcam, Cambridge, UK), Nrf2
(Abcam, Cambridge, UK), β-actin, and Lamin B1 (Santa Cruz Biotechnology, Dallas, TX, USA). They
were used at a dilution ratio of 1:1000 in 1% bovine serum albumin (Bio Basic Inc., Markham, ON,
Canada) in tris-buffered saline (TBS). After allowing the appropriate secondary antibody (horse radish
peroxidase–conjugated) at 1:2000 in TBS to interact with the primary antibody, protein bands were
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visualized using SuperSignal West Pico Chemiluminescent Substrate (Pierce, Cheshire, United Kingdom)
and LAS4000 Mini (GE Healhcare Life Sciences, Little Chalfont, UK). The digitalized blot images were
then densitometrically analyzed using Image-Studio Lite version 5.2 (LI-COR Biotechnology, Lincoln,
NE, USA).
2.10. Statistical Analysis
All statistical analyses were performed using SPSS version 23.0 (SPSS Inc., Chicago, IL, USA).
Statistical differences among means were tested by paired t-tests or one-way analysis of variance
followed by Duncan’s multiple range test. The p values less than 0.05 or 0.1 were considered significant.
Different alphabetical letters indicate statistically significant difference between values.
3. Results
3.1. Enzyme Hydrolysis of Jujube Fruit Increased Total Phenolic Content in Ethanolic Extract
For the preparation of HJE, the concentration of ethanol in the extraction solvent was determined
to be 50% (v/v) in water, based on the contents of total phenolics and flavonoids that were potent
bioactive compounds (Supplementary Table S1). For hydrolysis of jujube fruit, Viscozyme was chosen
among multiple food industrial enzymes as the highest total phenolic content was acquired in a 50%
ethanol extract after enzymatic reaction (Supplementary Table S2). HJE exhibited higher antioxidant
capacities assessed by a 2,2-diphenyl-1-picrylhydrazyl radical-scavenging assay and ferric reducing
antioxidant power values (Supplementary Figure S1), and also contained approximately 1.9-fold higher
total phenolic content and 10.9-fold higher quercetin content than its non-hydrolyzed counterpart,
NHJE (Table 1).
Table 1. Total phenolics, rutin, and quercetin contents in jujube extracts 1.
NHJE HJE
Total phenolics
(mg GAE 2/g dry weight) 6.73 ± 0.83
a 12.50 ± 1.69 b
Rutin
(mg/g dry weight) 12.68 ± 6.06
a 11.94 ± 4.99 a
Quercetin
(mg/g dry weight) 0.34 ± 0.59
a 3.72 ± 2.54 b
1 Values are expressed as means ± standard error of the mean (SEM) from three independent experimental sessions
(N = 3). Different alphabetical letters by the values (a–b) indicate statistically significant difference from each other
(p < 0.05). 2 GAE, gallic acid equivalent.
3.2. HJE Decreased NO Production and Increased ARE Transcription Activity in Cultured Cells
The anti-inflammatory and antioxidant effects of HJE and NHJE were compared in both Raw
264.7 cells and HepG2-ARE cells at concentrations of ≤500 μg/mL, which were non-toxic to both cell
lines (Supplementary Figure S2). HJE decreased production of NO in a dose-dependent manner in
LPS-stimulated Raw 264.7 cells (Figure 1A) and significantly increased ARE transcription activity in
HepG2-ARE cells (Figure 1B), whereas treatment with NHJE had no significant effect on NO levels and
ARE-transcriptional activity of these cells.
3.3. HJE Inhibited Secretions of Pro-Inflammatory Cytokines from TPA-Challenged THP-1 Cells and
Expressions of Inflammation-Related Proteins in A549 Cells
To investigate the role of HJE in interactions between macrophages and lung epithelial cells,
human monocyte THP-1 cells were differentiated by TPA treatment and incubated in the absence or
presence of either HJE or NHJE, and the resulting cultured media were added to lung epithelial A549
cell culture, followed by measurements of the expression of pro-inflammatory proteins, such as iNOS,
COX-2, and NF-κB.
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Figure 1. HJE decreased nitric oxide (NO) production and increased antioxidant response element
(ARE) transcription activity in cultured cells. (A) Raw 264.7 cells were stimulated by LPS and treated
with NHJE and HJE for 24 h. The culture media were collected and measured for the levels of NO
produced from the cells. (B) HepG2-ARE cells carrying the luciferase reporter gene linked to the ARE
sequence were treated with NHJE and HJE for 24 h. ARE transcription activity was assessed by the
activity of luciferase. SFN, sulforaphane. N = 3; error bars, mean ± SEM. Different alphabetical letters
on the bars (a–c) indicate statistically significant difference from each other (p < 0.05).
Quantification of pro-inflammatory cytokines in the THP-1-cultured medium (the conditioned
medium) revealed that HJE considerably reduced production of TNFα and IL-6 from THP-1 cells,
while NHJE had no effect (Figure 2A−C). A549 cells maintained in the conditioned media from
HJE-treated THP-1 cells expressed relatively lower levels of NF-κB, cytoplasmic iNOS and COX-2
proteins compared with the cells kept in NHJE-treated conditioned media (Figure 2D–G).
Figure 2. HJE decreased secretions of pro-inflammatory cytokines from differentiated THP-1 cells
and expression of inflammation-related proteins in A549 cells. (A–C) THP-1 human monocytes were
differentiated with tetradecanoylphorbol-13-acetate (TPA) (200 nM) and treated with either NHJE or
HJE at a concentration of 500 μg/mL for 24 h. The pro-inflammatory cytokines, including TNFα (A),
IL-1β (B), and IL-6 (C), in the culture media were quantified by enzyme-linked immunosorbent assay
(ELISA). (D–G) A549 human lung epithelial cells were cultured in conditioned media collected from
TPA-differentiated THP-1 cells treated with either NHJE or HJE. After 24 h, A549 cells were collected
and subjected to western blot analysis (D). The relative expression levels of inflammation-related
proteins, including COX-2 (E), iNOS (F), and NF-κB (G), were densitometrically determined. N = 3;
error bars, mean ± SEM. Different alphabetical letters (a–c) presented on the bars indicate statistically
significant difference from each other (p < 0.05).
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3.4. Oral Supplementation of HJE Alleviated B(a)P-Induced Lung Injury in Mice
To further evaluate the anti-inflammatory effect of HJE in vivo, acute lung inflammation in mice
was induced by a single intraperitoneal injection of B(a)P 24 h prior to sacrifice after 14 days of oral
administration of either NHJE or HJE (Figure 3A). The changes in the average BW of mice were
insignificant among the groups during the experimental period (Figure 3B). Histological observation
of lungs indicated that supplementation with HJE or NHJE at a high dose (1.5 g/kg BW) attenuated
B(a)P-induced lung injury (Figure 3C). In addition, H&E-stained lung tissue sections displayed that
B(a)P treatment caused disruption of lung architecture [36–38], including poor arrangement of epithelial
cells lining bronchiole and abnormal morphology of alveolar structure (inflated alveolar sacs and
thickened or ruptured interalveolar septa). However, the severity of B(a)P-induced histological damage
in the lungs was reduced in mice supplemented with HJE or NHJE-H (Figure 3D).
 
 
Figure 3. Oral administration of HJE alleviated B(a)P-induced lung injury in mice. C57BL/6J mice
were fed either NHJE or HJE at two different doses, 0.75 g/kg BW or 1.5 g/kg BW, every day for
14 days. One day prior to sacrifice, B(a)P was given by intraperitoneal injection. (A) Experimental
scheme. (B) Changes in average body weight during the experimental period. Values are means
± standard deviation (SD) (n= 8 mice per group). (C) Representative photographs of the dissected lungs.
(D) Representative tissue sections stained with H&E (magnification, 40×). A, alveolar sac; AD, alveolar
duct; B, respiratory bronchiole; TB, terminal bronchiole; bv, blood vessel. NHJE, non-hydrolyzed jujube
extract; NHJE-L, NHJE at a low dose (0.75 g/kg BW); NHJE-H, NHJE at a high dose (1.5 g/kg BW); HJE,
hydrolyzed jujube extract; HJE-L, HJE at a low dose (0.75 g/kg BW); HJE-H, HJE at a high dose (1.5 g/kg BW).
3.5. Oral Supplementation of HJE Lowered Plasma Pro-Inflammatory Cytokine Levels in B(a)P-Injected Mice
After supplementation with the extract for 14 days and then intraperitoneal injection with B(a)P,
blood samples were collected from mice and subjected to ELISA for quantification of TNFα, IL-1β,
and IL-6 (Figure 4). The group fed HJE at a high dose (1.5 g/kg BW) showed significantly lower
levels of TNFα and IL-1β in plasma, compared with the group injected with B(a)P without jujube
extract supplementation.
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Figure 4. Oral administration of HJE lowered plasma levels of pro-inflammatory cytokines in
B(a)P-injected mice. (A–C) Levels of pro-inflammatory cytokines, TNFα (A), IL-1β (B), and IL-6 (C),
in the mouse blood samples were measured by ELISA. Values are means ± SD (n = 8). Different
alphabetical letters presented on the bars (a–d) indicate statistically significant difference from each
other (p < 0.05). NS, not significant.
3.6. Oral Supplementation of HJE Suppressed the Expression of Inflammation-Related Proteins and Increased
the Expression of Antioxidant Proteins in Lung Tissue
Lung tissue homogenates were analyzed for the expression levels of inflammatory proteins,
such as NF-κB, cytoplasmic iNOS, and COX-2 (Figure 5A−D). Treatment with HJE (0.75 and 1.5 g/kg
BW) or NHJE (1.5 g/kg BW) significantly suppressed protein expression of NF-κB, cytoplasmic iNOS,
and COX-2, which were increased by B(a)P injection. Moreover, the tissue level of PGE2, which limits
inflammation and promotes lung tissue repair [39], was reduced in lungs of mice treated with B(a)P
alone but restored by co-treatment with 0.75 g HJE/kg BW or 1.5 g NHJE/kg BW, indicating that HJE is
more effective than NHJE (Figure 5E).
Figure 5. Oral administration of HJE suppressed expression of inflammation-related proteins in
lung tissue. Expression levels of inflammation marker proteins in the lung tissues were examined.
(A) Representative western blot images. (B–D) Quantitative data for cytosolic COX-2 (B), cytosolic
iNOS (C), and nuclear NF-κB (D). (E) PGE2 protein levels in dissected lung tissues were quantified
using ELISA. Values are mean ± SD (n = 5). Different alphabetical letters on the bars (a–c) indicate
statistically significant difference from each other (p < 0.05).
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A key transcription factor of antioxidant and defense response, Nrf2, and one of its downstream
proteins, HO-1, were highly expressed in B(a)P-treated lung tissues (Figure 6). Their expressions
were increased by HJE more effectively than by NHJE. In addition, oral administration of HJE but not
NHJE in mice increased the ratio of reduced to oxidized glutathione (GSH/GSSG) in lung homogenates
(Supplementary Figure S3).
Figure 6. Oral administration of HJE increased Nrf2 and HO-1 expressions in lungs. Expression levels
of a key antioxidant/defense transcription factor Nrf2 and its downstream protein HO-1 in the lung
tissues were examined. (A) Representative western blot images. (B–C) Quantitative data for cytosolic
HO-1 (B) and nuclear Nrf2 (C). Values are mean ± SD (n = 5). Different alphabetical letters on the bars
(a–c) indicate statistically significant difference from each other (p < 0.05).
3.7. Oral Administration of HJE to Mice Increased Nrf2 and HO-1 Expression and Reduced Oxidative Stress in
Liver Tissue
The relative quantities of nuclear Nrf2 and cytoplasmic HO-1 proteins were significantly higher
in liver tissue from HJE-H-fed mice than from NHJE-fed or control mice (Figure 7A−C). In addition,
oral administration of HJE reduced levels of oxidative stress markers, such as malondialdehyde (MDA)
and 8-OHdG, in liver homogenates (Figure 7D−E).
4. Discussion
Enzymatically hydrolyzed jujube extract was evaluated for its anti-inflammatory effect in
a B(a)P-induced lung inflammation mouse model. Our findings demonstrated that (1) Viscozyme-mediated
hydrolysis increased total phenolic content in an ethanolic extract of jujube fruit, (2) HJE inhibited
TNFα production in TPA-differentiated THP-1 cells and inflammatory protein expression in A549 cells
exposed to THP-1-conditioned media more effectively than did NHJE, and (3) oral supplementation
with HJE for two weeks protected the lungs from B(a)P-induced morphological and histological
damage, with decreased levels of inflammation-associated proteins in the lungs and increased levels of
antioxidant/defense proteins in the lungs and liver. A graphical summary of the findings is presented
in Figure 8.
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Figure 7. Oral administration of HJE increased Nrf2 and HO-1 expression and reduced oxidative stress
in hepatic tissue. Liver tissue homogenates were used for analyses of expression levels of antioxidant
proteins and oxidative stress markers. (A) Representative western blot images. (B,C) Quantitative data
for cytosolic HO-1 (B) and nuclear Nrf2 (C). (D,E) Oxidative stress markers including MDA (D) and
8-OHdG (E) were quantified by ELISA. MDA, malondialdehyde. 8-OHdG, 8-hydoxydeoxyguanosine.
Values are mean ± SD (n = 8). Different alphabetical letters presented on the bars (a–c) indicate
statistically significant difference from each other (p < 0.05).
Figure 8. Schematic illustration of a potential mechanism for the anti-inflammatory activity of HJE.
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Regardless of hydrolysis, jujube extracts used in this study were found to contain considerable amounts
of total phenolics and flavonoids and demonstrate radical-scavenging abilities, which is consistent with
previous reports [17,19,21]. HJE significantly promoted the transcription activity of the ARE-luciferase
reporter gene and decreased production of NO, a signaling molecule regulating inflammatory processes,
as shown by cell-based assays. In addition, HJE, but not NHJE, effectively inhibited TNFα secretion
from TPA-differentiated THP-1 cells and suppressed inflammatory protein expression in A549 cells
kept in THP-1-conditioned media. This suggests that the pre-treatment of jujube fruit with Viscozyme
improved biological activity by increasing the bioavailability of bioactive compounds in jujube, an effect
that may also be applicable to in vivo conditions.
To examine the in vivo anti-inflammatory effect of HJE compared with NHJE, a B(a)P-induced
acute lung inflammation mouse model was employed [2,36,40]. B(a)P is the most common and toxic
polycyclic aromatic hydrocarbon, an environmental pollutant, and reportedly the cause of health
problems, such as redox imbalance, respiratory diseases, and cancer [41]. Benzo[a]pyrenediol-epoxide,
which is metabolized from B(a)P by cytochrome P450 enzymes, provokes pulmonary inflammation by
stimulating the NF-κB-mediated pathway in human lung fibroblasts [42]. Thus, B(a)P is widely used to
generate a lung inflammation in mice [43–45]. Consistently, observations from this study demonstrated
that a single administration of B(a)P to mice resulted in lung injury at morphological and histological
levels. The elevation of pro-inflammatory cytokine levels in the blood samples was consistent with
previous reports that showed B(a)P-induced deleterious consequences in multiple organs [41,45].
Moreover, oral supplementation of jujube extracts, both HJE and NHJE, reduced levels of NF-κB and
its downstream cytoplasmic proteins, iNOS and COX-2, in the lungs while increasing expressions of
Nrf2 and cytoplasmic HO-1 in lung and liver tissues. This suggests that dietary jujube extract exerts
dual protective effects on both hepatic and pulmonary tissues from B(a)P-induced damage.
Intriguingly, our unpublished data demonstrated that Nrf2 and HO-1 protein expressions in
A549 cells kept in THP-1-conditioned media were marginally altered by treatment with either HJE or
NHJE. It implies that the stimulation of Nrf2-mediated antioxidant response in the lungs of the mice
supplemented with jujube extract may be indirectly induced possibly through intestinal or hepatic
metabolites. Specification and identification of biologically active metabolites produced from jujube
extract in vivo will require additional study.
One of the critical findings of this study was that the biological effect of jujube extract was further
enhanced when HJE was given to the mice compared with NHJE. It indicates that Viscozyme-mediated
hydrolysis improved the beneficial potential of jujube fruits, likely by converting bioactive compounds
in glycoside forms to aglycones and thereby increasing their bioavailability. A line of evidence
has demonstrated that jujube contains a variety of bioactive substances [19,20]. Some sugars,
terpenes, and phenolic acids have been reported as biologically functional components [21,24,26].
Rutin (quercetin-3-O-rutinoside), one of the major phenolics in jujube, has been demonstrated to
possess antioxidative and anti-inflammatory activities [46–48].
Viscozyme includes a broad range of carbohydrase activities including β-glucanase, arabanase,
and polygalacturonase, as described in previous reports [49,50]. Its cellulase and hemicellulase
activities can degrade the polysaccharide components of plant cell walls [51,52]. HJE undergone
Viscozyme-mediated hydrolysis was found to contain quercetin at levels 10.9-fold higher and total
phenolic content at levels 1.9-fold higher than those of NHJE. These results are not surprising because
rutin with β (1→6) glycosidic linkage can be broken by the enzyme and converted to quercetin.
Furthermore, it is presumed that the β-glucanase and polygalaturonase activities have degraded cell
walls and facilitated the extraction of phenolic compounds bound to cell-wall components. Considering
the activity of gut microbiota and the protective effects of quercetin and rutin in the liver [53,54] and
lungs against exogenous inflammatory agents [55–60], it is reasonable to assume that the hepatic and
pulmonary protective effects of HJE from B(a)P insult are at least partially attributable to aglycones,
including quercetin, released from glycosides during enzymatic treatment. However, further study is
needed to identify the component(s) responsible for the anti-inflammatory activity of HJE. Whether the
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anti-inflammatory effect of HJE or its active components is mediated by the Nrf2/ARE signaling
pathway or the NF-kB signaling pathway, or through crosstalk between both signaling pathways,
is a fascinating question to address in the future.
5. Conclusions
This study demonstrated that dietary HJE can significantly ameliorate B(a)P-mediated lung
inflammation and injury, possibly by inhibiting macrophage activity, suppressing NF-κB-mediated
inflammatory protein expression in lung tissue, and stimulating Nrf2-mediated antioxidant/defense
responses in the lung and liver. The findings would have implications for development of jujube-based
functional foods beneficial to lung health, especially in situations where the respiratory system can
be affected.
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Abstract: The present study was performed to spray-dry the high concentration of bioactive
compounds from Euphorbia hirta L. extracts that have antidiabetic activity. The total phenolic content
(TPC) and total flavonoid content (TFC) of four different extracts (crude extract, petroleum ether
extract, chloroform extract and ethyl acetate extract) from the dried powder of Euphorbia hirta L.
were determined using a spectrophotometer. After that, the fragment containing a high number
of bioactive compounds underwent spray-dried microencapsulation to produce powder which
had antidiabetic potential. The total phenolic content values of the crude extract, petroleum ether
extract, chloroform extract and ethyl acetate extract were 194.55 ± 0.82, 51.85 ± 3.12, 81.56 ± 1.72
and 214.21 ± 2.53 mg/g extract, expressed as gallic acid equivalents. Crude extract, petroleum
ether extract, chloroform extract and ethyl acetate extracts showed total flavonoids 40.56 ± 7.27,
29.49 ± 1.66, 64.99 ± 2.60 and 91.69 ± 1.67 mg/g extract, as rutin equivalents. Ethyl acetate extract
was mixed with 20% maltodextrin in a ratio of 1:10 to spray-dry microencapsulation. The results
revealed that the moisture content, bulk density, color characteristic, solubility and hygroscopicity
of the samples were 4.9567 ± 0.00577%, 0.3715 ± 0.01286 g/mL, 3.7367 ± 0.1424 Hue, 95.83 ± 1.44%
and 9.9890 ± 1.4538 g H2O/100 g, respectively. The spray powder was inhibited 51.19% α-amylase
at 10 mg/mL and reduced 51% in fast blood glucose (FBG) after 4 h treatment. Furthermore,
the administration of spray powder for 15 days significantly lowered the fast blood glucose level
in streptozotocin-diabetic mice by 23.32%, whereas, acarbose—a standard antidiabetic drug—and
distilled water reduced the fast blood glucose level by 30.87% and 16.89%. Our results show that
obtained Euphorbia hirta L. powder has potential antidiabetic activity.
Keywords: Euphorbia hirta L.; bioactive compounds; in vitro α-amylase inhibition; streptozotocin-
induced diabetic mice; diabetes mellitus
1. Introduction
Diabetes mellitus is a chronic disease and the result of metabolic disorders in pancreas β-cells
that have hyperglycemia [1,2]. Hyperglycemia is caused by a deficiency of insulin production by
pancreatic (Type 1 diabetes mellitus) or the insufficiency of insulin production in the face of insulin
resistance (Type 2 diabetes mellitus) [2,3]. Hyperglycemia causes damage to eyes, kidneys, nerves,
heart and blood vessels [4]. According to the ninth edition, in 2019, of the IDF Diabetes Atlas released
by the International Diabetes Federation (IDF), as of 2019, the total adult population living with
diabetes in the age group of 20–79 years stands at 463 million, which is set to increase to 578 million
by 2030 [5]. The present treatment of diabetes mellitus is focused on controlling and lowering the
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blood glucose levels in the vessel to a normal level [6]. Currently, there are six main classes of modern
medicines used across the world for controlling blood glucose levels and two classes of injections [7].
The tablets are known as biguanides (metformin), sulfonylureas, thiazolidinediones (glitazones),
meglitinides (glinides), alpha-glucosidase inhibitors and DPP-4 inhibitors. The classes of medications
given by injection are incretin mimetics and insulin. However, most modern drugs have many side
effects causing some serious medical problems during the period of treating. For instance, the main
side effects of metformin are gastrointestinal on the initial state, including dyspepsia, nausea and
diarrhea. The most common adverse effects with thiazolidinediones are weight gain and fluid retention,
leading to peripheral edema and a twofold increased risk for congestive heart failure. Besides modern
therapies, traditional medicines have been used for a long time and play an important role as alternative
medicines [8]. According to the WHO, a plant-based traditional system of medicine is still the chief
support of about 75–80% of the world’s population, mainly in developing countries having a diversity
of plants [9]. Several patients in type 2 diabetes mellitus have used functional foods to reduce their
blood glucose levels, such as olive leaf extract, turmeric and fenugreek.
Euphorbia hirta L. (E. hirta) is a common herb that belongs to the Euphorbia genus of the
Euphorbiaceae family. Euphorbia hirta L. is found in pan-tropic, partly sub-tropic areas and worldwide
including Australia, Western Australia, Northern Australia, Queensland, New South Wales, Central
America, Africa, Indonesia, Malaysia, Philippines, China and India [10]. In Vietnam, Euphorbia hirta
L. is commonly distributed in many provinces of the southern area. Euphorbia hirta L. was used as
a traditional medicine in the treatment of diabetes a long time ago [10,11]. Furthermore, this plant
contains a large number of phytochemicals including flavonoids, terpenoids, phenols, essential oil and
other compounds containing antidiabetic potential [12]. Therefore, producing an ingredient containing
E. hirta extract is necessary. However, phytochemicals such as flavonoids, terpenoids, and phenols are
very sensitive to environmental conditions such as temperature or oxygen, thence, microencapsulation
was supposed to protect these components [10,13].
The inhibition of the enzyme involved in the hydrolyzing carbohydrates such as α-amylase
is important to approach for reducing hyperglycemia [14,15]. Alpha-amylase (E.C.3.2.1.1) is a
potential protein tending to be a possibly applied inhibitor for anti-diabetic treatment. In human
beings, alpha-amylase is a prominent enzyme which hydrolyses the alpha bonds of large, alpha-linked
polysaccharides, such as starch and glycogen, yielding glucose and maltose [16–18]. The inhibition
of α-amylase has minimized the absorption of glucose into the blood by delaying the digestion of
carbohydrates. In recent years, several investigations have demonstrated the efficiency of α-amylase
inhibitors in the treatment of diabetes mellitus such as Acarbose, Miglitol and Voglibose [17,18].
The spray-drying process has been one of the popular techniques for decades to encapsulate food
ingredients because of its low operational cost and available equipment [19,20]. It has been used to
produce powder from a liquid form by using carrier agent materials. Nowadays, maltodextrin is a
popular carrier agent material to produce powder because it has many functionalities, such as wall
materials, flavor carrier, bulking agents, reducing stickiness and improving product stability [21].
Therefore, this study was carried out to determine fragments containing bioactive compounds from
various extracts (crude extract, petroleum ether extract, chloroform extracts and ethyl acetate extract)
for spray-drying microencapsulation and evaluate the antidiabetic ability of spray-dried powder on
in vitro α-amylase inhibitory activity test and the streptozotocin-induced diabetic mice model.
2. Materials and Methods
2.1. Chemicals and Reagents
The chemicals used including absolute ethanol, petroleum ether, chloroform, ethyl acetate,
methanol, purchased from Chemsol Company, Vietnam. Aluminum chloride (AlCl3), and sodium
carbonate (Na2CO3), Folin–Ciocalteu reagent, dimethyl sulfoxide, starch, and 5-dinitro salicylic acid
(DNS), were purchased from Merck, Germany. Gallic acid, streptozotocin (STZ), nicotinamide (NAD),
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enzyme α-amylase, acarbose, p-nitrophenyl glucopyranoside (pNPG) were products of Sigma-Aldrich
(St. Louis, MO, USA). The mouse was purchased from The Institute of Drug Quality Control–Ho Chi
Minh City (IDQC–HCMC).
2.2. Plant Material
E. hirta was identified by the Institute of Tropical Biology under the Vietnam Academy of Science
and Technology. The fresh E. hirta plant was harvested in Thu Duc District, Ho Chi Minh City, Vietnam,
in October 2015. The whole plant without root was washed with tap water to remove all contamination
and soaked in ethanol 70◦ to prevent the presence microorganisms. Then, the samples were dried in an
oven at 60 ◦C for 8 h to remove the water content. After that, the sample was ground into powder and
stored in a plastic bag for further uses.
2.3. Preparation of E. hirta Extracts
The plant powder (1.5 kg) was macerated with a methanol solvent by the ratio of 1:2 (w/w) in
2 weeks [22]. Then, the aqueous phase was filtered through Whatman No.1 filter paper, and the residue
was added by fresh methanol. This process was repeated seven times until a clear colorless solution was
obtained. Then, the extract solution was concentrated by a rotary evaporator at 60 ◦C to give 184.56 g
of crude extract. Subsequently, the crude extract was mixed with distilled water by ratio 1:1 (w/w) and
soaked with petroleum ether, chloroform, and ethyl acetate, respectively, to produce the fractional
extract. The rotary evaporator was used to evaporate all the solvents to take the concentrated extracts.
The percentage of the yield of the extract was calculated as
% Yield (%Y) =
weight of dried extract (g)
weight of sample (g)
× 100 (1)
2.4. Determination of Bioactive Compounds
2.4.1. Determination of Total Phenolic Content (TPC)
The determination of the total phenolic content was based on the Folin–Ciocalteu assay method
with some modification [23]. The reaction mixture consists of 0.2 mL of extract samples dissolving in
methanol at 1 mg/mL. One milliliter of 10% Folin–Ciocalteu reagent was treated into the mixture and
shaken well. After 5 min, 1.5 mL of 5% Na2CO3 solution was added into the mixture. Gallic acid was
used as the standard solutions (20, 40, 40, 60, 80 and 100 μg/mL). The absorbance was measured at
750 nm by a spectrophotometer. The total phenol content was expressed as mg of gallic acid equivalent
(GAE)/g of the extract [24].
2.4.2. Determination of Total Flavonoid Content (TFC)
The total flavonoid content was determined by the spectrophotometric method [25]. The reaction
mixture consists of 5 mL of extract samples dissolving in methanol at 0.4 mg/mL. Then, 5 mL of
2% AlCl3 solution was treated into the mixture. Rutin was used as a standard solution at different
concentrations (20, 40, 40, 60, 80 and 100 μg/mL). The absorbance was measured at 415 nm by a
spectrophotometer. The content of flavonoids in extracts was expressed in terms of rutin equivalent
(mg of RU/g of extract) [24].
2.5. Spray-Drying Microencapsulation
Spray drying has been used to protect the ingredients that are sensitive to light, heat or oxygen.
In this technique, a wall material protects the bioactive compounds [26,27]. The extracted sample
was mixed with 20% maltodextrin at a ratio of 1:10, and the resulting mixtures were homogenized
before spray dryer. The powder was obtained using LabPlant SD-06A spray dryer, serial number
485. The inlet temperatures were 180 ◦C, the outlet temperatures varied according to the inlet
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temperatures [28], the feed flow rate of the extracts was 10 rpm. Then, the E. hirta powder was used to
determine the physical properties as the moisture content, color characteristic, buck density, solubility
and hygroscopicity.
2.5.1. Determination of Moisture Content
The moisture content was determined by moisture balance, type MOC-120H, No. D207302059.
Triplicate samples of E. hirta powder (5 mg) were weighed and dried in the oven at 105 ◦C until its
weight was constant [21].
2.5.2. Color Characteristic
Color characteristic was measured by the Hue method. Distilled water-diluted triplicate samples
of E. hirta powder to ratio 10:1 (w/w). The absorbance of this solution was measured at 510 nm and
610 nm and calculated the Hue:






The Hue Index usually ranges from 3 (a greenish-yellow or olive hue) to 7.5 (amber red-brown)
for caramel colors.
2.5.3. Solubility
The solubility of the samples was determined according to the reported procedures with some
modification [29]. One gram of samples was added to 100 mL of distilled water, then the mixture was
stirred at 600 rpm for 5 min. After that, 20 mL of the supernatant was transferred into petri-dishes
and dried in an oven at 70 ◦C until the weight was constant. The solubility was calculated by weight
difference and expressed in dry basis, considering the moisture content of each sample.
2.5.4. Hygroscopicity
The hygroscopicity of the E. hirta powder was determined according to [28] with some
modifications. The E. hirta powder was stored at room temperature in desiccators containing saturated
sodium chloride solutions. The samples were weighed after one week, and the hygroscopicity was
expressed in grams of the absorbed moisture per 100 g of dry solids.
2.6. In Vitro α-Amylase Inhibitory Activity
Theα-amylase inhibitory activity was measured by the dinitrosalicylic acid method [16]. The 0.5 mL
of the extract samples dissolving in dimethyl sulfoxide at different concentrations were pre-incubated
with α-amylase 2 U/mL for 15 min. Then, 0.5 mL of the 1% w/v starch solution was added to the
mixture, which was further incubated at 37 ◦C for 10 min. Then, the reaction was stopped by adding
1 mL DNS reagent and heated in a boiling water bath for 5 min. Acarbose was used as a positive





The α-amylase inhibitory activity was expressed as the IC50 according to the percentage
inhibition [30,31].
2.7. Acute Toxicity Testing
Spray powder safety evaluation was conducted by pyramiding single-dose (acute) toxicity
testing [32]. A group of two mice (25–30 g) was fed with E. hirta powder with an increasing dosage on
alternate days as 10, 30, 100, 300, 1000, 3000 and 5000 mg kg−1, with the dosing continuing until death.
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The toxicity test was found to be safe up to the dose 5000 mg/kg body weight; hence 1/10 of the dose
was taken as an effective dose (500 mg/kg body weight).
2.8. Preliminary Anti-Hyperglycemic Test on STZ/NAD-Induced Mice
2.8.1. Induction of STZ/NAD-Diabetes Mice
The model of the STZ/NAD-induced mice followed the guideline of Masiello et al. [33] with
modification. Male mice weighing 22c25 received an intraperitoneally administered dose of 200 mg/kg
bw of NAD, and after 15 min received another intraperitoneally administered dose of 100 mg/kg bw
of STZ. After the intraperitoneal administration of STZ/NAD, the mice were observed for 30 min to
examine for any abnormal signals. STZ/NAD-induced mice were fed with a daily special diet with fat
milk and lard to make them obese. The blood glucose levels of mice were measured and recorded to
check for the change in blood glucose. After 21 days, a model of diabetic mice was completed.
2.8.2. Anti-Hyperglycemic Test
Diabetic mice (glucose level > 200 mg/dL) were divided into three groups of 6 mice each and
orally administered as below:
Group 1: negative control—orally administered with distilled water;
Group 2: positive control—orally administered with acarbose (100 mg/kg bw);
Group 3: sample group—orally administered with E. hirta powder (500 mg/kg bw).
The administration was continued for 15 days, once daily. Then, the blood glucose level was
measured and recorded after 0, 1, 2 and 4 h on the first day and on days 1, 2, 6, 10 and 15 of administration.
2.9. Statistical Analysis
Statistical analysis was performed using SPSS 22.0. One-way variance analysis (one-way ANOVA)
was applied to determine the significant difference between the samples at p-value < 0.05.
3. Results
3.1. Euphorbia hirta L. Extraction Yield
Nine and a half kilograms of fresh E. hirta produced around 1.5 kg of dried powder, 184.56 g of
crude extract, 61.25 g of petroleum ether extract, 2.1 g of chloroform extract and 32.95 g of ethyl acetate
extract. The results are shown in Figure 1. Different extracts were obtained from the E. hirta from the
different solvents (petroleum ether, chloroform, and ethyl acetate) employed.
3.2. Phytochemical Analysis
According to the previous investigations, Euphorbia hirta L. contain a large amount of phenolic
and flavonoid components [10]. In the present study, the total phenolic and flavonoid contents were
shown in Table 1. The total phenolic content in the examined extracts was expressed in terms of gallic
acid equivalent (mg of GAE/g extract) by the standard curve equation: y = 8.659x − 0.0153, R2 = 0.998.
The value of the phenolic content was 194.55 ± 0.82, 51.85 ± 3.12, 81.56 ± 1.72 and 214.21 ± 2.53 mg of
GAE/g extract for the crude extract, petroleum ether extract, chloroform extract and the ethyl acetate
extract, respectively. The concentration of flavonoids was expressed as rutin (mg of RU/g extract) by
the standard curve equation: y = 12.905x − 0.0515, R2 = 0.9888. The concentration of flavonoids in
various plant extracts were 40.56 ± 7.27, 29.49 ± 1.66, 64.99 ± 2.60 and 91.69 ± 1.67 mg of RU/g extract.
The highest phenolic and flavonoid concentrations were measured in ethyl acetate extract, and the
lowest phenolic and flavonoid concentrations were measured in petroleum ether extract. The phenolic
and flavonoid concentrations in the plant extracts depend on the solvent polarity which used in the
extract preparation [24]. These data suggested that the total phenolic and flavonoid compounds were
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best extracted via ethyl acetate solvent from E. hirta. Therefore, the ethyl acetate extract was suggested
to further investigate and determine the bioactive compounds and identify their antidiabetic activity.
Figure 1. Percentage of extracts from Euphorbia hirta L.
Table 1. Total phenolic and flavonoid contents in the E. hirta extracts.
Extract Total Phenolic Content (mg of GAE/g Extract) Total Flavonoid Content (mg of RU/g Extract)
Crude extract 194.55 ± 0.82 1 40.56 ± 7.27
Petroleum ether extract 51.85 ± 3.12 29.49 ± 1.66
Chloroform extract 81.56 ± 1.72 64.99 ± 2.60
Ethyl acetate extract 214.21 ± 2.53 91.69 ± 1.67
1 Each value is the average of three analyses ± standard deviation (n = 3).
3.3. Spray-Drying Microencapsulation
The physical properties of spray powder were shown to clarify the quality of the E. hirta powder
(Table 2). The moisture content effects on the shelf-life of dried materials, and the shelf-life of powder
can extend in moisture under than 10% [34]. The moisture content in the E. hirta powder is around
4.9567 ± 0.00577%, which is less than 5% so that it is suitable for storage for a long time. Bulk density is
a property of food powder, the bulk density of E. hirta powder ranges from 0.36 to 0.48 g/mL, and the
high bulk density increases its sticky or less free-flowing nature. In this research, the E. hirta powder
had a bulk density of 0.3715 ± 0.01286 g/mL, as it adapted the requirement. Solubility shows the ability
of the powder to be dissolved in water, and the solubility of the E. hirta powder is around 95.83 ± 1.44%.
Color is a major quality parameter in a dried food product; color was presented in the Hue Index value.
Table 2 shows that the Hue index value around 3.7367 ± 0.1424 means that the color of spray sample is
yellow. Hygroscopicity is the ability of food powder to absorb moisture from a high relative humidity
environment. The result from Table 2 showed that E. hirta powder could absorb 9.9890 ± 1.4538 g H2O
in a 100 g sample.
Table 2. Physical properties of the spray power.







21.034 4.9567 ± 0.00577 1 0.3715 ±0.01286 95.83 ± 1.44 9.9890 ± 1.4538 3.7367 ± 0.1424
1 Each value is the average of three analyses ± standard deviation (n = 3).
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3.4. In Vitro α-Amylase Inhibitory Activity Essay
The inhibition of α-amylase minimized the absorption of glucose into blood by the delay of the
digestion of carbohydrates. The in vitro α-amylase inhibitory activities of the E. hirta powder were
assayed. The result of this study showed that spray powder has a good α-amylase inhibitory activity
(Figure 2) with the IC50 value as evidence (Table 3). The E. hirta powder and acarbose—a standard drug
in diabetes management (at concentration 10 mg/mL) showed a 51.19% and 94.69% inhibitory effect on
α-amylase, respectively. The IC50 value of the E. hirta powder was 5.725 mg/L, meanwhile for acarbose
it was 2.511 mg/mL. Although the α-amylase inhibitory activity of E. hirta powder is not strong enough
as that of acarbose is, it also proved that E. hirta can inhibit the carbohydrate-hydrolyzing enzyme and
has potential antidiabetic activity.
 
Figure 2. The inhibitory potency of the E. hirta powder against α-amylase activity. Each value is the
average of three analyses ± standard deviation (n = 3).
Table 3. The IC50 of the E. hirta powder on α-amylase inhibition.
Sample
α-Amylase Equation
(y = ax + b)
α-Amylase IC50
(mg/mL)
Acarbose y = 29.246x − 23.446 2.511
Spray powder y = 14.355x − 32.175 5.725
3.5. Acute Toxicity
The mice orally administered 10, 30, 100, 300, 1000, 3000, 5000 mg kg−1 doses of E. hirta powder
were kept under observation for two weeks. After two weeks, all the mice were alive and did not show
any toxic symptoms such as body weight loss. Therefore, it was found that 5000 mg kg−1 dose of the
powder showed a confidence dose and was considered as safe. Therefore, it was concluded that the
median lethal dose (LD50) was more than 5000 mg kg−1 when administered orally (Table 4). Therefore,
the extracts used in this study are safe for long administration.
Table 4. Pyramiding dose.
Dosage Mortality
10 mg kg−1 0/2
30 mg kg−1 0/2
100 mg kg−1 0/2
300 mg kg−1 0/2
1000 mg kg−1 0/2
3000 mg kg−1 0/2
5000 mg kg−1 0/2
Both minimal lethal dosage and LD50 > 5000 mg kg−1
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3.6. Anti-Hyperglycemic Test
This experiment was undertaken to evaluate the hypoglycemic activity of the spray powder
containing Euphorbia hirta L. in the STZ-induced diabetic mice. Diabetic mice usually have fast
blood glucose levels above 200 mg/dL. Acarbose is commonly used as a standard antidiabetic
drug in STZ-induced diabetes to compare the anti-hyperglycemic extent of bioactive compounds.
In normoglycemic rats, the test showed a significant reduction of blood glucose level till the end of 4 h.
The fast blood glucose levels in 4 h showed that after 4 h of treatment with the E. hirta powder
(Figure 3), there was a 51% reduction in the fast blood glucose level, whereas the treatment with
acarbose and distilled water at the same time produced a 44% and 35% reduction. In a short time,
the E. hirta powder reduced fast blood glucose levels better than distilled water and acarbose.
 
Figure 3. Effect of the E. hirta powder on the streptozotocin-induced diabetic mice in 4 h. Values are
presented as the means ± standard deviation (n = 6).
A significant reduction of 23.32% in fast blood glucose was observed after 15 days of treatment
with the E. hirta powder, compared to the 30.87% and 16.89% reduction when treated with acarbose
and distilled water, respectively (Figure 4). In the longer time treatment, acarbose was the competitive
inhibitor in the reduction of fast blood glucose levels, however, the reduction of the fast blood glucose
levels of the E. hirta powder was close to acarbose and better than distilled water. Therefore, the result of
this test showed that the E. hirta powder exhibited a significant reduction in the fast blood glucose levels.
 
Figure 4. Effect of the E. hirta powder on the streptozotocin (STZ)-induced diabetic mice in 15 days.
Values are presented as the means ± standard deviation (n = 6).
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4. Discussion
Plants are a rich resource of natural bioactive compounds, such as phenolics, flavonoids and their
derivatives. These compounds have received attention because of their bioactivities and physiological
functions, including antioxidant, anti-allergic, anti-inflammatory, antimicrobial, and antidiabetic
activities [35]. From the crude extract of Euphorbia hirta L. containing multiple different groups of
bioactive compounds, liquid–liquid extractions can be employed to separate many different fractions.
During this procedure, the chemical constituents of the extract are separated based on their polarity by
specific solvents including petroleum ether, chloroform, and ethyl acetate. This procedure typically
results in a total of four extracts. The qualitative phytochemical analysis in E. hirta was obtained from
these extracts. In relation to the solvent used, high concentrations of the total phenolic content and total
flavonoid content were found in the chloroform and ethyl acetate extracts. The value of the phenolic
contents was 81.56 ± 1.72 and 214.21 ± 2.53 mg of GAE/g extract for the chloroform extract and the ethyl
acetate extract, respectively. The concentration of flavonoids was 64.99 ± 2.60 and 91.69 ± 1.67 mg of
RU/g extract for the chloroform extract and the ethyl acetate extract, respectively.
In the previous studies, the point of focus has been on elucidating the mechanism of action and the
phytochemicals of plant extracts for traditional diabetes treatment. The study of the inhibitory activity of
phytochemicals against α-amylase and α-glucosidase has been widely popular. Several phytochemicals
including flavonoids and phenolics have been detected. The presence of these compounds, especially in
chloroform and ethyl acetate extracts, demonstrated ability in the treatment of diabetes. The inhibition
of the enzymes involved in the metabolism of saccharides such as α-amylase is an important therapeutic
strategy for reducing hyperglycemia [14]. Polyphenolic compounds have popularly reported the
inhibitory activity against α-amylase in both in vitro and in vivo experiments [11,12,36]. Phenolics
and flavonoids found in E. hirta such as quercetin, quercitrin, and rutin were proved to be effective
inhibitors of mammalian α-amylase. The E. hirta powder and acarbose (at concentration 10 mg/mL)
showed 51.19% and 94.69% inhibitory effects on α-amylase, respectively. The IC50 value of the E. hirta
powder was 5.725 mg/L, meanwhile acarbose was 2.511 mg/mL. Although the α-amylase inhibitory
activity of E. hirta powder was not strong enough as acarbose, it also proved that E. hirta had a mild
α-amylase inhibition and has potential antidiabetic activity. This result is consistent with the reported
investigation [37,38].
The control of postprandial plasma glucose concentrations is the key to the the treatment of
diabetes mellitus and its related complications. The results of this study showed that Euphorbia hirta L.
powder from the highest number of bioactive compounds possessed antidiabetic activities. Phenolics
and flavonoids are commonly distributed in plants and have been demonstrated to possess potential
effects in the treatment of diabetes disease. The possible mechanism of antidiabetic action of E. hirta
is the inhibition of α-amylase and the reduction of the fast blood glucose level on diabetic mice [39].
Therefore, this study supports the drug/functional food development from the E. hirta extract in the
management of diabetes.
5. Conclusions
This study provided significant evidence for the antidiabetic activity of Euphorbia hirta L. One of
the possible mechanisms of antidiabetic activity of this plant is related to the inhibitory action of the
key enzymes involving the hydrolysis of carbohydrates, to control the blood glucose concentration in
the body. Recent investigations have proved that phenolics and flavonoids from natural resources
containing bioactive components have hypoglycemia in action. Therefore, in further studies, we will
continue to investigate the stabilities in functional food application. Besides, the fragments of E.
hirta extracts having antidiabetic activities will be carried out to isolate and identify the bioactive
compounds for the in vitro and in vivo studies of their antidiabetic activity. Furthermore, it is necessary
to elucidate the mechanisms of action of the extracts and phytochemicals of this plant at the cellular
and molecular levels.
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Abstract: The aim of the present study was to investigate the antimicrobial potential of Sideritis
raeseri subps. raeseri essential oil (EO) against common food spoilage and pathogenic microorganisms
and evaluate its antioxidant and antiproliferative activity. The EO was isolated by steam
distillation and analyzed by GC/MS. The main constituents identified were geranyl-p-cymene
(25.08%), geranyl-γ-terpinene (15.17%), and geranyl-linalool (14.04%). Initially, its activity against
Staphylococcus aureus, Staphylococcus epidermidis, Escherichia coli, Listeria monocytogenes, Salmonella
Enteritidis, Salmonella Typhimurium, Pseudomonas fragi, Saccharomyces cerevisiae, and Aspergillus niger
was screened by the disk diffusion method. Subsequently, minimum inhibitory concentration (MIC),
non-inhibitory concentration (NIC), and minimum lethal concentration (MLC) values were determined.
Growth inhibition of all microorganisms tested was documented, although it was significantly lower
compared to gentamycin, ciproxin, and voriconazole, which were used as positive controls. In a next
step, its direct antioxidant properties were examined using 2,2-diphenyl-1-picrylhydrazyl (DPPH)
and 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) assays, and the IC50 values were
determined. The potential cytoprotective activity of the oil against H2O2–induced oxidative stress
and DNA damage was studied in human immortalized keratinocyte (HaCaT) cells using the comet
assay. Finally, the antiproliferative activity of the oil was evaluated against a panel of cancer cell
lines including A375, Caco2, PC3, and DU145 and the non-cancerous HaCaT cell line using the
sulforhodamine B (SRB) assay, and the EC50 values were determined. The oil demonstrated weak
radical scavenging activity, noteworthy cytoprotective activity against H2O2–induced oxidative stress
and DNA damage in HaCaT cells, and antiproliferative activity against all cell lines tested, being
more sensitive against the in vitro model of skin melanoma.
Keywords: Sideritis raeseri subsp. raeseri; essential oil; antimicrobial; antioxidant; antiproliferative
activity
1. Introduction
The use of natural compounds isolated by plant origins with biological activity (antimicrobial,
antioxidant, and antiproliferative) has always been a topic of great interest [1–5]. The rising trend for
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bioactive substances witnessed today can be mainly attributed to the growing number and severity
of food poisoning outbreaks worldwide along with the recent negative consumer perception against
artificial food preservatives and the demand for novel functional foods with a health potential.
Among the various herbs, Sideritis, known as the “mountain” tea, is a controversial botanic genus
with a complex taxonomical classification due to the high number of hybridizations that occur between
species. It comprises more than 150 perennial and annual vegetal species and several subspecies [6].
It belongs to the Lamiaceae family and is well known for its use as herbal medicine, commonly as
an herbal tea. Sideritis is abundant in Mediterranean regions, the Balkans, the Iberian Peninsula,
and Macaronesia, but it can also be found in Central Europe and in Asia. In Greece, the most commonly
cultivated species is Sideritis raeseri, distinguished in three main subspecies, Sideritis raeseri subsp.
raeseri, Sideritis raeseri subsp. attica, and Sideritis raeseri subsp. florida [7].
Essential oils (EOs) are naturally occurring volatile compound mixtures isolated by plant material
by different methods, including solvent extraction, supercritical fluid extraction, hydro distillation,
and steam distillation. Selection of the extraction method is crucial, since extraction yield and
volatile composition depend greatly on the conditions applied. Distillation-based processes are
considered advantageous due to flexibility, versatility, avoidance of volatile compounds decomposition,
and ability for wide volume range operations, but the extraction yields may vary highly upon time,
pressure, and temperature [8], as previously recorded for Sideritis raeseri subsp. raeseri EOs [9,10].
Likewise, remarkable differences on its chemical composition have been reported [7,9,10], which could
be attributed to variations on extraction/isolation methods, plant chemotypes, harvesting periods,
environment and climate, as well as improper taxonomical classification [11].
Despite the fact that a series of pharmacological activities such as antimicrobial, antioxidant,
anti-inflammatory, and antiproliferative action of various extracts and oils isolated by several Sideritis
spp. have been previously published [9,11–13], the biological activity of S. raeseri subsp. raeseri EO has
been scarcely studied. In particular, no inhibitory action of S. raeseri subsp. raeseri EO against common
food spoilage microorganisms, such as Staphylococcus epidermidis, Pseudomonas fragi, Saccharomyces
cerevisiae, Aspergillus niger, etc. [14–16], and pathogens associated with food poisoning outbreaks
worldwide, such as Staphylococcus aureus, Escherichia coli, Listeria monocytogenes, Salmonella spp., etc. [17],
has been reported, although the antimicrobial activity of wide range of Sideritis spp. EOs and extracts
has been tested [11]. There are also few reports on the antioxidant or other biological activities of various
extracts or isolated compounds of plant preparations of S. raeseri species [13], but no information on
EO preparations from S. raeseri subsp. raeseri exists.
Hence, the aim of the present study was to investigate the antimicrobial potential of S. raeseri
subsp. raeseri EO against common food spoilage and pathogenic microorganisms and evaluate its
antioxidant and antiproliferative activity, in order to assess potential commercial applications in food
and pharmaceutical industries.
2. Materials and Methods
2.1. Standard Compounds
Standard compounds used for identification in GC/MS analysis were kindly provided by Professor
L. Skaltsounis, Department of Pharmacy, National and Kapodistrian University of Athens, Athens,
Greece. n-Pentane (Merck, Darmstadt, Germany) for spectroscopy (Uvasol®) was used for the dilution
of EOs analyzed by GC–MS. The alkane C10–C40 analytical standard mixture was obtained from
Sigma-Aldrich (Sigma-Aldrich, Darmstadt, Germany).
2.2. Plant Material
S. raeseri subsp. raeseri plant was cultivated in 2014 at Vrinena region of the Othrys mountain in
Greece. The aerial parts of the plants were collected and air-dried naturally at temperature ranging
25–27 ◦C during the daytime and 16–22 ◦C during the night for 7–8 days.
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2.3. Extraction of EO
EO was produced by steam distillation for 75 min using dried herb of S. raeseri subsp. raeseri
(20 kg dry weight). The obtained EO (5 mL) was dried over anhydrous sodium sulfate and kept in a
sealed vial at 4 ◦C. The yield (w/w) was 0.025% (on a dry weight basis).
2.4. Microbial Strains
Staphylococcus aureus ATCC 25923, Staphylocccus epidermidis FMCC B-202 C5M6 (kindly provided
by Dr. A. Nisiotou, Athens Wine Institute, ELGO-DEMETER, Greece), Escherichia coli ATCC 25922,
Listeria monocytogenes NCTC 10527 serotype 4b, Salmonella enterica subsp. enterica ser. Enteritidis FMCC
B56 PT4 (kindly provided by Professor G.J.E. Nychas, Agricultural University of Athens, Greece),
and Salmonella enterica subsp. enterica ser. Typhimurium DSMZ 554 were grown in Brain Heart Infusion
(BHI) broth (LABM, Heywood, UK) at 37 ◦C for 24 h. Pseudomonas fragi 211 (kindly provided by
Professor G.J.E. Nychas) was grown in BHI broth (LABM) at 25 ◦C for 24 h. Saccharomyces cerevisiae
uvaferm NEM (Lallemand, Montreal, QC, Canada) was grown in YPD broth (yeast extract 10 g/L,
peptone 20 g/L, and dextrose20 g/L) at 28 ◦C for 3 days. Aspergillus niger 19111 (kindly provided by
Professor G.J.E. Nychas) was grown on Malt extract agar (LABM) for 7 days at 37 ◦C.
2.5. Analytical Procedures
2.5.1. GC/MS
EO was diluted with n-pentane at a concentration of 2 mg/mL, and 1 μL was injected to the
GC/MS (in splitless mode). The analysis was performed in triplicate using Finnigan Trace GC Ultra
2000/Finnigan Trace DSQ MSD (Thermo Electron Corporation, Waltham, MA, USA) operating in EI
mode. The separation was performed on a Trace TR-5MS (Thermo Scientific, Waltham, MA, USA)
(30 m × 0.25 mm, 0.25 μm film thickness) capillary column. He at a flow rate of 0.8 mL/min was used
as carrier gas. The initial temperature of the column was set at 60 ◦C, and then it was heated to 240 ◦C
at a rate of 3 ◦C/min for 10 min. The injector temperature was kept at 200 ◦C. The detector voltage was
70 eV, and the temperature was 250 ◦C. Identification of the compounds was carried out by comparing
the retention times and the mass spectra of volatiles to ADAMS, Wiley275, NIST, and in-house created
libraries and by determining Kovats’ retention indexes (KI) using n-alkanes (C10–C40) and comparing
them with those reported in the literature.
2.5.2. Antimicrobial Assays
Screening of S. raeseri subp. raeseri EO Antimicrobial Activity by the Disc Diffusion Assay
The antimicrobial activity of the Sideritis raeseri subsp. raeseri EO was initially tested using the
disk diffusion assay, as described previously by Mitropoulou et al. [18], using gentamycin (10 mg)
(Oxoid Ltd., Basingstoke, UK) as positive control and sterile water as negative.
A similar procedure was also followed for screening the activity against yeasts and molds, using
S. cerevisiae and A. niger as model microorganisms [18]. Voriconazole (1 mg) (BioRad Laboratories Inc.,
Hercules, CA, USA) was used as positive control and sterile water as negative.
Determination of Minimum Inhibitory), Non-Inhibitory, and Minimum Bactericidal Concentrations
Determination of minimum inhibitory concentration (MIC) and non-inhibitory concentrations
(NIC) was carried out, as recently described by Mitropoulou et al. [18], by monitoring changes in
optical density of bacterial suspensions in BHI broths containing multiple concentrations (ranging
from 41–8786 mg/L) of the EO at 610 nm using a microplate reader (Molecular Devices, VERSAmax,
San Jose, California, USA, Softmaxprov.5.0 software) during incubation at 37 ◦C for 24 h for all bacteria
species, except P. fragi, which was incubated at 25 ◦C. Ciproxin and gentamycin were used as positive
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controls, and BHI broths with no inoculum and inoculated BHI broths with no essential oil were used
as negative controls.
The calculation of MIC and NIC values was based on the Lambert–Pearson model (LPM) [19,20].
As the LPM model was not applicable to S. cerevisiae and A. niger due to yeast cell sedimentation
and conidia flotation, the standard protocols described by The European Committee on Antimicrobial
Susceptibility Testing (EUCAST) were applied for MIC determination [21,22], using voriconazole as
positive control [23,24].
Minimum lethal concentration (MLC) was determined, as previously described by
Mitropoulou et al. [18].
All experiments were carried out at least in four replicates.
2.6. Assessment of Cell-Free Antioxidant Activity by DPPH and ABTS Assays
The radical scavenging activity of S. raeseri subsp. raeseri EO was determined by the colorimetric
2,2-diphenyl-1-picrylhydrazyl (DPPH) and 2,2′-Azino-bis(3-ethylbenzothiazoline-6-sulfonic acid)
(ABTS) assays [25,26], as previously described. Serial dimethylsulfoxide (DMSO) solutions of EO
concentration ranging from 0.0042 to 42 mg/mL were prepared. Samples (10 μL) were mixed with
DPPH or ABTS solution (200 μL total volume) in a 96-well plate and then incubated for 30 min in the
dark (RT). Inhibition of formation of the radicals was monitored by measuring absorbance at 492 nm
(DPPH assay) or 734 nm (ABTS assay) using a microplate reader (EnSpire Multimode Plate Reader,
PerkinElmer, Waltham, MA, USA). The inhibition percentage of the radicals for each dilution was
calculated as described previously [27]. Ascorbic acid was used as positive control. Based on the
values derived from the inhibition percentage of each radical, reference curves were made for S. raeseri
subsp. raeseri EO, from which the IC50 values (mg/mL) were calculated (EO concentration–inhibition
percentage) by regression analysis using Sigma Plot Software v.10 (Systat Software Inc., San Jose, CA,
USA). All determinations were performed in triplicates.
2.7. Sulforhodamine B Assay (SRB)
The antiproliferative effect of S. raeseri subsp. raeseri EO was evaluated by the SRB assay as
previously described by Fitsiou et al. [27]. For this assay, 3 × 103 human immortalized keratinocyte
(HaCaT) and A375 cells and 4 × 103 PC3, DU145, and Caco2 were cultured in 96-well microplates for
24 h and then treated with various concentrations of S. raeseri subsp. raeseri EO (0–0.84 mg/mL) for 72
h. Cell viability curves were plotted, and the EC50 values corresponding to efficient concentrations
of S. raeseri subsp. raeseri EO required to cause 50% decrease in cell viability were determined by
regression analysis using Sigma Plot Software v.10.
2.8. Single Cell Gel Electrophoresis (comet) Assay
Single cell gel electrophoresis (comet) assay was performed as described previously [28,29]. Briefly,
HaCaT cells (2 × 104) were treated with S. raeseri subsp. raeseri EO (0.05 mg/mL and 0.5 mg/mL) for 20
min followed by incubation with H2O2 (50 μM) for 20 min in phosphate buffered saline (PBS) or left
untreated or treated with EO/H2O2 alone for 20 min. Then, cells were embedded in low-melting agarose
on microscope slides and processed for monitoring DNA damage levels by applying the alkaline
version of the comet assay, which detects both single- and double-strand DNA breaks. Slides were
observed by fluorescence microscopy (Zeiss Axio Scope.A1, Oberkochen, Germany). Image analysis
and scoring of DNA damage in arbitrary units (AU) was performed as previously described by
Panayiotidis et al. [30]. Results were expressed as fold-change relative to control.
2.9. Statistical Analysis
The mean values are presented, and standard deviation in MIC and NIC values determined by the
Lambert–Pearson model (LPM) was calculated by Figure P.2.1 software (Fig.P Software Incorporated,
Hamilton, ON, Canada).
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The results were analyzed with analysis of variance (ANOVA) using Duncan’s multiple range test to
determine significant differences (p < 0.05) among results (coefficients, ANOVA tables, and significance
(p < 0.05) were computed using Statistica software (v.10.0, StatSoft, Tulsa, USA).
3. Results and Discussion
3.1. GC/MS Analysis
A significantly low oil extraction yield (0.025%) compared to a previous study was recorded [9],
probably due to the lower time allowed for steam distillation (75 min in contrast to 3 h usually
applied) [8,9]. A short distillation process was decided to avoid decomposition and chemical changes
of the major constituents, as time is a crucial factor affecting the quality of the distilled EO [8].
However, similar or even lower extraction yields have been previously reported for various Sideritis
species [8,31,32].
The main constituents of S. raeseri subsp. raeseri EO were determined by GC/MS. The results are
presented in Table 1, and a typical chromatogram is shown in Figure 1. In total, 19 compounds were
identified. Geranyl-p-cymene (25.08%), geranyl-γ-terpinene (15.17%), and geranyl-linalool (14.04%)
were the main compounds detected, accounting for approximately 54% of the total area. Of note,
GC/MS analysis provided data about the content percentage of the volatile compounds and not their
actual concentration.
Table 1. GC/MS analysis of Sideritis raeseri subsp. raeseri essential oil.
RT (min) Component Name MS Fragments Area (%)
6.11 α-Pinene 136 (MW), 121, 105, 93, 92, 91, 77, 41,39, 27 2.13
7.53 β-Pinene 136 (MW), 121, 93, 91, 79, 77, 69, 41,39, 27 2.31
9.20 1,3,8-p-Menthatriene 134 (MW), 119, 91 2.67
18.78 1,1,6-Trimethyl-tetralin 174 (MW), 159, 131, 115 0.43
21.20 Carvacrol 150 (MW), 135, 91 0.93
23.91 β-Copaene 204 (MW), 161, 119, 105, 93 0.72
25.81 caryophyllene 204 (MW), 189, 175, 161, 147, 133, 120,105, 93, 91, 79, 69, 41 2.88
28.96 γ-Elemene 204(MW), 161, 121, 107, 93 5.73
29.36 α-Bisabolene 204 (MW), 121, 119, 109, 93 1.56
29.80 (+)-δ-Cadinene 204 (MW), 189, 161, 134, 119, 105, 81, 41 0.60
30.03 Cadina-1,3,5-triene 202 (MW), 187, 159, 144, 129, 115, 105 3.25
32.31 (-)-Spathulenol 220 (MW), 205, 187, 159, 105, 91 2.82
32.49 Caryophyllene oxide 220 (MW), 205, 177, 161, 149, 135, 121,109, 93, 79, 43, 41 1.24
36.32 α-Bisabolol 204 (MW), 189, 161, 139, 119, 109, 93, 69,43, 41 2.90
41.58 (2E,6E)-Farnesyl acetate 264 (MW), 204, 161, 138, 123, 107, 93, 69,43, 41 3.59
44.03 Geranyl-linalool 290 (MW), 272, 203, 161, 147, 135, 119,107, 93, 81, 69, 41 14.04
44.32 (6E,10E)-7,11,15-Trimethyl-3-methylene-1,6,10,14-hexadecatetrene 272 (MW), 148, 132, 109, 93, 69, 41 1.54
45.37 Geranyl-p-cymene 242 (MW), 134, 119, 91 25.08
45.71 Geranyl-γ-terpinene 272 (MW), 136, 121, 93, 91, 77 15.17
MW: Molecular Weight.
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Figure 1. A typical GC/MS chromatogram of Sideritis raeseri subsp. raeseri essential oil.
Our results are in contradiction with previous studies [7,9,10]. Specifically, the Sideritis raeseri
subsp. raeseri oil isolated by Alligiannis et al. [9] was characterized by the presence of β-pinene
(9.06%), AR-curcumene (6.14%), β-phellandrene/limonene (6.06%), δ-cadinene (4.83%), β-caryophyllene
(4.17%), and α-copaene (3.80%), while Koedam et al. [10] reported that the major constituents of the
S. raeseri subsp. raeseri oil isolated by circulatory distillation were β-pinene (20.61%), α-pinene (16.50%),
α-humulene (9.91%), limonene (6.73%), β-caryophyllene (6.52%), and D-germacrene (5.52%). However,
compounds with similar structure to compounds identified in our study, such as 9-geranyl-α-terpinene
and 9-geranyl-p-cymene, were found in Sideritis dichotoma oil [32]. Of note, 9-geranyl-p-cymene was
also identified as a major constituent in Sideritis trojana oil [31]. These differences might be due to
difficulties in proper taxonomical classification, as well as in differentiations in isolation/extraction
methods, plant and location origin, climate and environmental conditions, time of harvesting, etc, that
affect significantly the chemical composition [6,11,33]. In addition, the existence of more than one
chemotype or ecotype of S. raeseri ssp. raeseri should not be excluded.
3.2. Antimicrobial Assays
The antimicrobial activity of S. raeseri subsp. raeseri EO was evaluated against a list of common food
spoilage and pathogenic microorganisms [4,14–17], consisting of Staphylococcus aureus, Staphylococcus
epidermidis, Escherichia coli, Listeria monocytogenes, Salmonella Enteritidis, Salmonella Typhimurium,
Pseudomonas fragi, Saccharomyces cerevisiae, and Aspergillus niger. The presence of Escherichia coli, Listeria,
and Salmonella spp. in foods is a primary concern due to their implication in a number of food poisoning
outbreaks worldwide [17]. Similarly, food quality and safety is directly related to staphylococci counts,
as its presence in high numbers constitutes a health hazard and results in spoilage [14]. Likewise,
Pseudomonas fragi is a psychrotrophic bacteria associated mainly with food spoilage during storage at
low temperatures [15]. Saccharomyces cerevisiae and Aspergillus niger are the usual cause of soft drinks
and both alcoholic and non-alcoholic beverages [16] and served as model systems [34,35].
The effectiveness of the oil was initially confirmed using the disk diffusion method (data not
shown). Subsequently, MIC and NIC values against were assessed, because their precise determination
is crucial for food and pharmaceutical industries in order to regulate the optimum amount of the
antimicrobial agent to secure microbial safety. MIC and NIC for bacteria were determined using a
previously published model [19], combining the absorbance measurements with the common dilution
method and non-linear regression analysis to fit the data, while the corresponding MIC values for
S. cerevisiae and A. niger were estimated by standard protocols [21,22]. The effective growth inhibition
of S. raeseri subsp. raeseri EO against all microorganisms tested (Table 2) was documented, although
MIC, NIC, and MLC values were significantly (p < 0.05) higher compared to ciproxin, gentamycin,
and voriconazole [18,27], which were used as positive controls.
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Although similar results reporting remarkable antimicrobial activity of EOs or methanol and
aqueous extracts isolated by various Sideritis spp. were previously reported [9,11,12], EO derived
from S. raeseri subsp. raeseri had no inhibitory effect when tested against a series of spoilage and
pathogenic microorganisms, such as S. aureus, S. epidermidis, P. aeruginosa, E. cloacae, K. pneumonia,
E. coli, C. albicans, C. tropicalis, or T. glabrata [9], in contrast to our results. These findings highlight that
chemical composition of the EOs and thus their biological activity may vary greatly depending on a
high number of factors [11]. Hence, to the best of our knowledge, this is the first report estimating
MIC and NIC values for S. raeseri subsp. raeseri EO, applying a reliable, rapid, and efficient method
based on the LPM model [19,20]. Despite the fact that no antimicrobial action has been correlated to
the main components of the S. raeseri subsp. raeseri EO separately, its activity could be attributed to all
constituents, and possible synergistic effects should not be excluded.
3.3. Determination of Radical Scavenging Activity
To investigate the potential anti-oxidant potential of S. raeseri subsp. raeseri EO, we studied the
in vitro radical scavenging activity by utilizing the DPPH• and the ABTS•+ radical scavenging assays.
The IC50 value of the S. raeseri subsp. raeseri EO, corresponding to the sample concentration required
to scavenge radicals by 50%, was estimated to be 24.77 ± 4.21 and 1.27 ± 0.59 mg/mL in the cases of
DPPH• and ABTS•+ assays, respectively (Table 3). Ascorbic acid (potent antioxidant agent) was used
as a positive control. Low IC50 values indicate strong antioxidant activities. Compared to ascorbic
acid, the S. raeseri subsp. raeseri EO possesses weak in vitro antioxidant capacity. This is the first time
reporting on the direct in vitro antioxidant activity of the S. raeseri subsp. raeseri EO preparation. To
our best knowledge, there is no available information about the antioxidant potential of its major
compounds (geranyl-p-cymene, geranyl-γ-terpinene, and geranyl-linalool).
Table 3. Antioxidant activity of S. raeseri subsp. raeseri essential oil in vitro.
IC50 (mg/mL) *
DPPH Assay ABTS Assay
S. raesaeri 24.77 ± 4.21 1.27 ± 0.59
Ascorbic acid ** 0.012 ± 0.004 0.0045 ± 0.0002
* Results are shown as mean ± SD. ** Ascorbic acid was used as positive control.
Additionally, limited literature information exists on the antioxidant activity of EO preparations
of other Sideritis spp. Antioxidant, anticholinesterase, and anti-tyrosinase activities of the EOs of
Sideritis albiflora and Sideritis leptoclada have been reported, and those preparations characterized by
high concentrations of phenolic and flavonoid contents indicated the highest antioxidant and enzyme
inhibitory activities [36]. In a follow-up study, the acetone extracts showed the highest activity in terms
of antioxidant activity of both Sideritis species, while the hexane extracts exhibited superior urease
inhibitory activity. Both species were found to be rich in rosmarinic and caffeic acids [37].
Previous studies on different parts of plant extracts of Sideritis spp. demonstrated antioxidant
activity for methanolic/etnanolic or aqueous extracts measured similarly by DPPH• or ABTS•+ assays,
which was the weakest amongst 24 extracts from Greek domestic Lamiaceae species. Moderate
antioxidant activity was reported for a methanolic extract of the aerial parts of the plant Sideritis
raeseri subsp. raeseri estimated by Co(II) ethylenediaminetetraacetic acid (EDTA)-induced luminol
chemiluminescence and DPPH• scavenging assay. The extract comprised nine 7-o-allosyl glucosides of
5,8-dihydroxy substituted flavones [38]. In most cases, the anti-oxidant effects reported for the samples
studied were related to the total phenolic or flavonoid content of the extract preparations.
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3.4. S. raeseri subsp. raeseri EO Protects Human Epidermal Keratinocytes (HaCaT) Cells from H2O2-Induced
DNA Damage
Our previous results indicated that the S. raeseri subsp. raeseri EO possesses weak antioxidant
activity using direct in vitro radical scavenging assays. However, the application of in vitro cell-based
assays offers various advantages towards more accurately, accessing the antioxidant effects of tested
compounds at a subcellular level. Cell-based assays can be more advantageous in the way that
they may reveal more information about the antioxidant capacity of compounds that may trigger
cell antioxidant mechanisms without direct radical scavenging action [39]. For this reason, we next
explored the potential cytoprotective effect of S. raeseri subsp. raeseri EO against H2O2-induced DNA
damage. Hydrogen peroxide is a non-radical derivative of oxygen with physiological significance as an
oxidative agent; it is soluble, present in all biological systems, and capable of cell death induction [39].
Human keratinocytes (HaCaT) were pre-incubated in the presence or the absence of EO (0.05 and 0.5
mg/mL for 20 min, RT) and treated with H2O2 (100 μM) for 20 min to induce cellular oxidative DNA
damage. DNA damage was monitored as single- and double-strand breaks in DNA by employing
the alkaline version of single cell gel electrophoresis (comet) assay. The results are represented in
Figure 2. Incubation of the HaCaT cells with the S. raeseri subsp. raeseri EO alone slightly caused a
significant increase in DNA damage levels only in the case of the highest concentration of the EO used
(0.5 mg/mL) (approximately 1.2-fold compared to untreated cells). Treatment of HaCaT cells with
H2O2, significantly induced DNA damage levels (> 2.5-fold) compared to control. In the case of cell
pretreatment with the two different concentrations of S. raeseri subsp. raeseri EO, the DNA damage
observed was significantly lower and dose-dependent. More particularly, pre-treatment of HaCaT
cells with 0.05 mg/mL or 0.5 mg/mL S. raeseri subsp. raeseri EO caused 34% and 44% decrease in the
H2O2-induced DNA damage levels, respectively.
Figure 2. Cytoprotective activity of S. raeseri subsp. raeseri essential oil against H2O2-induced DNA
damage on human immortalized keratinocyte (HaCaT) cells. HaCaT cells were incubated with S. raeseri
subsp. raeseri essential oil (0.05 mg/mL and 0.5 mg/mL) for 20 min and then 20 min with H2O2 both
in presence and in absence of the oil. Comet assay was performed to assess the H2O2-induced DNA
damage. The data presented are the mean ± SD of three independent experiments performed in
triplicates. * p < 0.05, *** p < 0.001 vs. untreated.
Previously, González-Burgos et al. [40] demonstrated the cytoprotective role of other species of
Sideritis spp. on PC12 and U373-MG cells. They indicated that pre-treatment with isolated diterpenoids
from Sideritis spp. prevented the H2O2-induced mitochondrial membrane disorder. Further studies
95
Foods 2020, 9, 860
are required to investigate the potential protective role of the EO against oxidative stress and the
underlying mechanism(s) of action.
3.5. Determination of Antiproliferative Activity
Next, we evaluated the antiproliferative effect of the EO in various cancer cell lines. For this
purpose, we utilized human melananoma A375, human colon adenosarcoma Caco2, and human
prostate carcinoma cell lines PC3 and DU145. Moreover, a non-cancerous human cell line, the human
keratinocytes HaCaT, was also employed in the study to discrete for preferential cancer-specific
antiproliferative activity amongst the cell lines. Overall, cells were treated with increasing
concentrations of S. raeseri subsp. raeseri EO for 72 h, and then cell viability was assessed as
percent of control, and the corresponding EC50 value was also determined. As shown in Table 4,
the observed patterns of antiproliferative activity were very similar between all the cell lines, and the
EC50 value ranged approximately from 0.114–0.216 mg/mL. To our best knowledge, there is no available
information about the antiproliferative/anticancer potential of its major compounds (geranyl-p-cymene,
geranyl-γ-terpinene, and geranyl-linalool).
Table 4. Antiproliferative activity of S. raeseri subsp. raeseri essential oil against different cell lines.
Cell Line EC50 (mg/mL) *
A375 0.151 ± 0.008
HaCaT 0.114 ± 0.015
Caco2 0.175 ± 0.080
PC3 0.216 ± 0.090
DU145 0.188 ± 0.060
* Results are shown as mean ± SD.
Few studies have investigated the antiproliferative potential of Sideritis spp. Tóth et al. [41]
examined the antiproliferative effects of isolated diterpenoids derived from Sideritis montana on human
cancer cell lines (HeLa, SiHa, and C33A) by using MTT assay. Moreover, Tadić et al. [42] investigated
the cytotoxic effect of Sideritis scardica on PBMC, B16, and HL-60 cells, demonstrating also the potential
anti-inflammatory effects of that extract.
4. Conclusions
The use of EOs as natural antimicrobial, antioxidant, and antiproliferative agents is less explored
compared to their utilization as food flavorings and, thus, their application in food and pharmaceutical
industries is limited. Our results revealed the growth inhibitory action of S. raeseri subsp. raeseri EO
against food spoilage and pathogenic microoganisms, although its activity was significantly lower
than gentamycin, ciproxin, and voriconazole that were used as positive controls, indicating that it
represents a source of natural antimicrobial agent, which may be incorporated in food products to
prevent spoilage and assure microbial safety. Furthermore, the oil exhibited low antioxidant activity
by directly scavenging radicals. However, it indicated promising cytoprotective activity against
H2O2-induced oxidative stress and DNA damage in HaCaT cells, suggesting the exertion of non-direct
antioxidant mechanisms that require further exploration. Finally, the antiproliferative activity of the
EO was evaluated against a panel of cell lines. It showed similar activity against all cell lines tested
being more sensitive against the in vitro model of skin melanoma. However, similar activity was also
observed against the non-carcinoma cell line HaCaT, indicating that it may not possess cancer-specific
antiproliferative activity, although further studies are required. Although main components of the EO
have been reported as main constituents in other plant extracts with similar biological activities [43–45],
there are no available studies on the biological activities of the individual compounds, which is a
valid area of further investigation. Overall, the results of our study indicated that EO form S. raeseri
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subsp. raeseri has favorable biological properties that may have potential applications in food and
pharmaceutical industries.
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Abstract: With strong antimicrobial properties, citral has been repeatedly reported to be the dominant
component of lemongrass essential oil. Here, we report on a comparison of the antimicrobial and
anticancer activity of citral and lemongrass essential oil. The lemongrass essential oil was prepared
by the vacuum distillation of fresh Cymbopogon leaves, with a yield of 0.5% (w/w). Citral content was
measured by gas chromatography/high-resolution mass spectrometry (GC-HRMS) and determined
to be 63%. Antimicrobial activity was tested by the broth dilution method, showing strong
activity against all tested bacteria and fungi. Citral was up to 100 times more active than the
lemongrass essential oil. Similarly, both citral and essential oils inhibited bacterial communication
and adhesion during P. aeruginosa and S. aureus biofilm formation; however, the biofilm prevention
activity of citral was significantly higher. Both the essential oil and citral disrupted the maturated
P. aeruginosa biofilm with the IC50 7.3 ± 0.4 and 0.1 ± 0.01 mL/L, respectively. Although it may
seem that the citral is the main biologically active compound of lemongrass essential oil and the
accompanying components have instead antagonistic effects, we determined that the lemongrass
essential oil-sensitized methicillin-resistant S. aureus (MRSA) and doxorubicin-resistant ovarian
carcinoma cells and that this activity was not caused by citral. A 1 mL/L dose of oil-sensitized MRSA
to methicillin up to 9.6 times and a dose of 10 μL/L-sensitized ovarian carcinoma to doxorubicin up
to 1.8 times. The mode of multidrug resistance modulation could be due to P-glycoprotein efflux
pump inhibition. Therefore, the natural mixture of compounds present in the lemongrass essential oil
provides beneficial effects and its direct use may be preferred to its use as a template for citral isolation.
Keywords: multidrug resistance; doxorubicin; MRSA; quorum sensing; biofilm
1. Introduction
Cymbopogon citratus (monocotyledonous plant belonging to Poaceae family), known as lemongrass,
is widely used for its characteristic lemon odor and flavor in the culinary industry [1] as a component of
spices. Moreover, it is used for its curative effects in traditional and alternative medicine in Asia, Africa
and Latin America. Lemongrass is usually used in the form of a concoction of the aboveground parts
of the plant or as an essential oil. In addition to vitamins (esp. A, C, folate, niacin, β-carotene, source:
Foods 2020, 9, 585; doi:10.3390/foods9050585 www.mdpi.com/journal/foods101
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USDA National Nutrient data base), C. citratus contains flavonoids, alkaloids, tannins, phenols and
saponins as beneficial compounds [2]. The chemical composition of the essential oil varies depending
on the geographical origin of the plant. However, the main component is always citral (65%–85%),
a mixture of isomers of geranial (citral a) and neral (citral b). It also contains citronellol, citronellal,
limonene, linalool, nerol, etc. [3]. Lemongrass in traditional medicine is used for the treatment of colds,
influenza, cough, diabetes, malaria [4], high blood pressure, high cholesterol, fever, inflammation,
hypertension [5,6], dental hygiene [7], colorectal cancer [8], nervousness, toothache and sore throat [9].
The main demonstrated bioactivities are antimicrobial, anti-inflammatory, anticancer,
antimutagenic and antidiabetic activities [2]. The antimicrobial activity is the most explained.
Lemongrass essential oil has a nonselective activity against both Gram-negative (Escherichia coli, Klebsiella
pneumoniae, Pseudomonas aeruginosa, Proteus vulgaris) and Gram-positive bacteria (Bacillus subtilis,
Staphylococcus aureus), yeasts and fungi [2]. The oil was active against Cronobacter sakazakii, a food-borne
pathogen associated with neonatal necrotizing enterocolitis. Its action is ascribed to decreasing quorum
sensing, biofilm formation and endotoxin production [10]. The inhibition of sulfate-reducing bacteria,
causing several issues in the petroleum industry, was demonstrated as well [11,12]. Recently, the
inhibition of Candida albicans and Cryptococcus sp. biofilm formation and its disruption by the essential
oil were published [13–15]. The activity of lemongrass oil against Aspergillus flavus was even higher than
that of some synthetic fungicides, e.g., benzimidazole and diphenylamine [16]. Besides antimicrobial
activity, an effect was also demonstrated against protozoa (Plasmodium sp., Leishmania sp.) [17,18]
and insects (Anopheles sp., Musca domestica, Aedes aegypti) [19–21]. In addition, the essential oil of
lemongrass is an effective repellent [22].
Despite showing strong antimicrobial activity and potency to treat diseases of human civilization,
neither the ability of lemongrass essential oil nor citral to modulate drug resistance has ever been tested.
Drug resistance is a major challenge for contemporary medicine. Antibiotic resistance is currently a
frequent and typical complication of the treatment of diseases or injury. The first antibiotic, penicillin,
was only introduced a few years before bacteria resistant to it were isolated. Similarly, antineoplastic
resistance is a major challenge for treatment and for patient survival overall. Numerous generations of
compounds overcoming drug resistance in therapy have been described; however, the usage of natural
compounds still looks to be the most promising [23].
Although the effects of C. citratus extracts and especially its essential oil are studied relatively
often, there are many areas that are controversial or deserve deeper exploration. In this paper, we
report on the large spectrum of antimicrobial activities resulting from the chemical composition of
lemongrass essential oil. Some of the activities have been already previously identified, however, we
seek to provide deeper understanding and report some new explanations and context especially in the
field of drug resistance modulation.
2. Materials and Methods
2.1. Chemicals
Mueller Hinton Broth 2 (MH broth, Sigma-Aldrich, St. Louis, MO, USA), Malt extract broth
(ME broth, Oxoid, Hampshire, UK), Brain Heart Infusion Broth (BHI, Sigma-Aldrich), resazurin
(Sigma-Aldrich), methicillin (Sigma-Aldrich), vancomycin (Sigma-Aldrich), citral (Sigma-Aldrich),
casamino acids (Sigma-Aldrich), L-arginine (Sigma-Aldrich), Pgp-Glo Assay System (Promega,
Madison, WI, USA), Na3VO4 (Promega), Dulbecco’s Modified Eagle’s Medium (DMEM, Sigma-Aldrich),
doxorubicin (Sigma-Aldrich).
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2.2. Plant Material and Essential Oil Extraction
Cymbopogon citratus (DC.) Stapf (family: Poaceae) was identified by the Viet Nam Institute of
Medicinal Plants under the Ministry of Health (3 Quang Trung Str., Hoan Kiem Distr, Ha Noi, Viet Nam).
The planting location was the Phu Thanh, Hung Thi and An Binh Communes, Lac Thuy District,
Hoa Binh province, Mountainous North of Viet Nam. The plants were harvested during October and
November 2018. The water content of the material before oil extraction was 50%. The water content
was determined by weighing before and after drying.
The essential oil was distilled from the above-ground part of the plant by steam distillation under
vacuum (0.5 atm, Shanghai EVP Vacuum Technology, China) at a temperature of 80–90 ◦C for two
hours. By this procedure, which was modified according to [24], 1 kg of essential oil was obtained
from 200 kg of fresh leaves. The yield of oil extraction was calculated as the percentage of obtained oil
weight to fresh leaves weight. Density was determined gravimetrically.
2.3. Essential Oil Composition Screening
For the analysis of volatile and semi–volatile compounds in the lemongrass essential oil, gas
chromatography coupled to high-resolution mass spectrometry (GC–HRMS) was employed as
previously described by [25].
2.3.1. Sample Preparation
Fifty grams of the lemongrass essential oil was weighted into a 15 mL polypropylene centrifuge
tube and 10 mL of ethyl acetate was added. One milliliter of ethyl acetate extract was diluted in 9 mL
of isooctane. Finally, 2 μl of the isooctane extract was injected into the GC-HRMS instrumentation
(Agilent Technologies, Santa Clara, CA, USA).
2.3.2. GC-HRMS
An Agilent 7200b system consisting of an Agilent 7890B gas chromatograph equipped with a
quadrupole–time of flight mass spectrometer (Q–TOF) (Agilent Technologies, Santa Clara, CA, USA)
was used for the instrumental analysis.
Sample components were separated in a 30 m HP-5MS capillary column (0.25 mm id, film
thickness: 0.25 μm; Agilent Technologies, Santa Clara, CA, USA). The sample was injected in split
mode (1:5) at 250 ◦C and the oven temperature was as follows: 40 ◦C (1 min), 10 ◦C/min to 150 ◦C,
5 ◦C/min to 190 ◦C, 20 ◦C/min to 310 ◦C (hold 5 min).
The mass spectrometric detector was operated in electron ionization mode and the temperature of
the ion source was 230 ◦C. The mass range was 40–550 m/z and the resolution of the mass analyzer was
set to >12 500 (FWHM).
Volatile and semi–volatile compounds were identified and verified by NIST library 2017, isotopic
pattern, exact mass (mass error <5 ppm) and Kovats retention index.
2.4. Antimicrobial Activity
The inhibitory activity of the essential oil and citral was determined against both Gram-positive and
Gram-negative bacterial strains, yeasts and micromycetes. Unless otherwise stated, microorganisms
were obtained from the Collection of the Department of Biochemistry and Microbiology (DBM, UCT
Prague, Prague, Czech Republic) as follows: Salmonella enterica (CCM, 4420), Proteus vulgaris (DBM,
3022), Mycobacterium smegmatis (ATCC, 70084), Pseudomonas aeruginosa (CCM, 3955), Staphylococcus
aureus (ATCC, 25923), Candida famata (DBM, 23), Candida albicans (DBM, 2186), Cryptococcus albidus
(DBM, 4), methicillin-resistant Staphylococcus aureus (DBM, 12). The resistant strain was obtained
from the Collection of the Laboratory of Medical Microbiology (Czech Laboratory, lnc., NEM 449)
and was previously characterized for its multidrug resistance properties. Unless otherwise stated, all
strains are sensitive to commercial drug strains according to EUCAST (The European Committee on
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Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters.
Version 10.0, 2020).
Antibacterial and anti-yeast activity was evaluated by the standard broth-dilution method using
96-well plates and MH broth or ME broth. Overnight microbial culture was diluted to a turbidity equal
to 0.5 McFarland. After that, the standard broth microdilution method recommended by EUCAST (The
European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of
MICs and zone diameters. Version 10.0, 2020) was used. The essential oil and citral were diluted with
the prepared microbial culture. Subsequent binary dilution provided the range of tested concentrations
from 5 to 10,000 μL/L. The positive control was the suspension of microorganisms without essential oil.
Plates were incubated for 24 h at 37 or 28 ◦C after that, absorbance (500 nm) was recorded using a
SpectraMax i3x Multi-Mode Detection Platform (Molecular Devices, San Jose, CA, USA). The turbidity
of each strain was measured in eight replicates. The turbidity of the methicillin-resistant S. aureus was
measured in eight replicates, both with and without chloramphenicol (0.2–200 mg/L), and both with
and without lemongrass essential oil.
2.5. Anti-Biofilm Activity
The effect of lemongrass essential oil and citral on the bacterial biofilm was tested on
Staphylococcus aureus (ATCC, 25923) and Pseudomonas aeruginosa (CCM, 3955). A static anti-biofilm assay
was performed in 96-well polystyrene plates, as described previously with some modifications [26].
Both samples were evaluated for their activity in two main stages (i) planktonic cell adhesion and
(ii) mature biofilm disruption. The overnight culture of the tested organism was diluted with BHI
broth to obtain a turbidity equal to 0.5 McFarland, and 100 μl of the suspension was pipetted into
each well. In the cell adhesion assay, the viability of adhered cells was evaluated by resazurin assay
immediately after 24 h of incubation in the presence of the tested compounds at 37 ◦C and triple
washing with PBS (pH 7.4). In the disruption of mature biofilm assay, fresh BHI medium containing
various concentrations of lemongrass or citral was added to wells with a pre-formed biofilm. After
24 h of incubation, the medium was removed, the wells were washed three times with PBS and 100 μL
of resazurin in PBS (0.03 mg/L) was added. The viability was evaluated by measuring fluorescence
(560/590 nm, ex./em.) using a SpectraMax i3x Multi-Mode Detection Platform (Molecular Devices,
USA). Each experiment was done in 16 repetitions.
2.6. Anti-Quorum Sensing Activity
For the evaluation of anti- quorum sensing activity, two commercial (ATCC) strains of Vibrio
campbellii were used - BAA1118 and BAA1119 [27]. The bacteria were cultivated in Autoinducer
Bioassay (AB-A) medium as described previously by [28]. The overnight culture was diluted with
AB-A medium to a cell density of approximately 1 × 104 CFU/mL. The binary dilution of citral and
lemongrass oil (0.1 μL/L—6 mL/L) was tested using Vibrio campbellii in a 96-well plate and after 24 h,
the cell viability was determined by resazurin assay. IC10 was chosen for the subsequent experiment.
The lemongrass essential oil or citral were applied at the IC10 concentration and further binary diluted
with diluted cell culture. After that, the luminescence was recorded for 24 h with a measurement step
of 20 min using a microplate reader (SpectraMax i3 Multi-Mode Detection Platform, Molecular Devices,
San Jose, CA, USA) set to 30 ◦C; integration time of 10,000 ms; shaking for 60 s prior to measurement.
The sum of luminescence was calculated and used for the determination of EC50.
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2.7. Inhibition of Transmembrane Efflux Pump
The inhibition of P-glycoprotein (P-gp) was tested using the in vitro Pgp-Glo Assay System
according to the standard procedure [29] with only slight modification of time incubation. The
incubation was prolonged in our case to 60 min. The luminescence (ΔRLU samples) was calculated as
the difference between the relative luminescence of Na3VO4 and that of the samples. Orthovanadate
was used as a known inhibitor of P-gp, Verapamil was used as a known activator of P-gp.
2.8. Sensitization of Doxorubicin-Resistant Human Ovarian Carcinoma
A human ovarian carcinoma cell line (HOC, A2780) and its doxorubicin-resistant sub-line
(HOC/DOX, A2780/ADR) were purchased from Sigma-Aldrich (USA). Both cell lines were cultivated
as described previously [29]. For the experiment, 1 × 105 cells/mL were seeded into the 96-well plates.
After 24 h, the cells were washed 3× with PBS and fresh DMEM supplemented with lemongrass
essential oil (10 μL/L) was added. Doxorubicin in the concentration range of 0.3–80 μM was then
applied. The cell viability was evaluated after 72 h by resazurin assay as described previously [30].
The fold change was calculated as the ratio of IC50 for doxorubicin and IC50 for the doxorubicin
co-treated with the lemongrass essential oil.
2.9. Data Processing and Statistical Analysis
The experiment was done with the appropriate number (n) of repetitions. The relative activity
was evaluated as a percentage according to the formula: 100*(slope of sample fluorescence—average
slope of PC)/(average slope of NC—average slope of PC). As the positive control (PC), non-treated
reaction was used. As the negative control (NC), the blank reaction was used. IC50 values were
determined using the software GraphPad Prism 7 and its function of nonlinear regression (Y = Bottom
+ (Top-Bottom)/(1 + 10ˆ((LogIC-X)*HillSlope)). MIC was determined as IC90 using an online tool freely
provided by AAT BioQuest. The data are presented as the averages of the repetitions with the standard
error of the mean (SEM). Statistical significance was checked with the Excel t-test function (two-tailed
distribution, heteroscedastic type). One-way analysis of variance (ANOVA) was used followed by
Duncan’s post hoc test (P < 0.05) to show the differences between the groups. For ANOVA, the software
Statistica version 12 was used (Tibco Software Inc., Palo Alto, CA, USA).
3. Results
The Cymbopogon citratus essential oil was obtained by vacuum steam distillation at 80–90 ◦C. The
procedure yielded 0.5% (w/w) of the oil with the density 0.891 + 0.004 g/mL.
3.1. Essential Oil Composition Screening
The composition of the essential oil (volatile and semi–volatile compounds) was characterized by
GC–HRMS. To characterize the relative abundance of volatile components in the sample, deconvolution
of all compounds was performed, and the detected compounds were normalized by percent of total
peaks area (Figure 1). The compounds occurring at a level higher than 1% were identified. The
most dominant components in the sample were as follows: two stereoisomers of citral (geranial and
neral) >> geraniol–myrcene > γ-selinene > terpineol-1–geranyl acetate > β-caryophyllene > linalool >
α-humulene > nerol > eucalyptol. The repeatability of the method, expressed as a relative standard
deviation (RSD), was determined by the analysis of the oil sample in six repetitions, and ranged from
1.5% to 5.5% in all analyses.
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Figure 1. Chemical composition (%) of essential oil determined by GC–HRMS. Data are presented as
an average of six repetitions (n) ± relative standard deviation (RSD).
3.2. Antimicrobial Activity
The antimicrobial activity of lemongrass essential oil was previously published with a special
focus on its strong antifungal activity. In this paper, we summarize the spectrum of its antimicrobial
activity, taking into account both Gram-positive and Gram-negative bacteria and yeasts (Table 1).
In agreement with previous papers, its antifungal activity was higher than its antibacterial activity. The
essential oil was the most active against C. albidus, which could cause ocular and systematic diseases in
immunosuppressed patients and against other human/animal (C. famata, C. albicans) fungal pathogens,
with an IC50 in the concentration range of 180–570 μL/L. This antibacterial activity was shown against
both Gram-positive and Gram-negative bacteria. The essential oil was also active against M. smegmatis,
the model organism for studies of M. tuberculosis and other mycobacterial pathogens. Among the
tested organisms, the lowest activity was determined against the Gram-negative bacteria P. aeruginosa
and S. enterica with an IC50 equal to 2.4–2.6 mL/L and an MIC of almost double that. In comparison
to lemongrass essential oil, citral—the dominant oil component, exhibited an IC50 that was several
times lower with no antimicrobial specificity. In contrast to the oil, it effectively inhibited the growth of
both types of bacteria and yeast in the same concentration range. Similar to the oil, citral was the most
active against C. albidus; however, its IC50 was 100 × lower than the IC50 of the oil. Similar results were
observed for the other tested microorganisms, showing that citral is the main antimicrobial agent of oil
and that its activity is antagonistically modulated by the accompanying components.
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Table 1. Antimicrobial activity of lemongrass essential oil.
Lemongrass Essential Oil Citral
species Classification IC50 [μL/L] MIC [μL/L] IC50 [μL/L] MIC [μL/L]
Candida famata Fungi, Ascomycota 177 ± 19 a 3684 ± 271 c,d 37 ± 7 b 142 ± 19 b,c
Cryptococcus albidus Fungi, Basidiomycota 199 ± 25 a 265 ± 31 a 2 ± 0 a 20 ± 6 a
Candida albicans Fungi, Ascomycota 571 ± 109 a,b 2734 ± 250 b,c 83 ± 8 d,e 110 ± 15 b,c
Mycobacterium smegmatis Bacteria, Gram positive 860 ± 89 b 3409 ± 775 c,d 109 ± 12 e 137 ± 19 b,c
Proteus vulgaris Bacteria, Gram negative 992 ± 37 b 1453 ± 40 a,b 97 ± 12 e 163 ± 34 c
Staphylococcus aureus Bacteria, Gram positive 1841 ± 199 c 5830 ± 198 e 77 ± 2 e 92 ± 2 b,c
Pseudomonas aeruginosa Bacteria, Gram negative 2385 ± 162 d 5308 ± 339 e 41 ± 2 b 93 ± 8 b
Salmonella enterica Bacteria, Gram negative 2626 ± 301 d 4693 ± 634 d,e 66 ± 8 c,d 97 ± 3 b,c
The data are presented as an average of eight repetitions (n) ± standard error of the mean (SEM). The data were
analyzed by one-way ANOVA with Duncan’s post hoc test (P > 0.05) as indicated by the superscript letters. The
letters indicate the differences between the groups within one assay. Statistically significant levels are denoted
with different letters. The data are presented as the concentration (μM) that (i) halved the cell viability (IC50) or (ii)
reduced 90% of cell viability (MIC).
The antimicrobial activity of the essential oil was also tested against antibiotic-resistant bacteria.
The clinical isolate of methicillin-resistant S. aureus (MRSA) used in this study was characterized
as multidrug-resistant to a broad spectrum of antibiotics (data not shown). The IC50 concentration
of chloramphenicol for MRSA was 142 mg/L. To evaluate the MDR-modulating activity, MRSA
was cultivated in the presence of lemongrass essential oil (1000 μL/L) or citral (400 μL/L) and
chloramphenicol. Even though the citral content in the oil is 63%, this concentration (630 μL/L) was
not applied because of the high toxicity of pure citral to the cells, as shown above for drug-sensitive
S. aureus (IC50 77 μL/L). Therefore, we chose concentrations of lemongrass essential oil or citral equal
to IC10, which were applied simultaneously with chloramphenicol to determine the IC50 of the mixture
(Table 2). The addition of lemongrass oil reduced the IC50 of MRSA almost tenfold (to 15 mg/L). The
effect of citral on MRSA was almost three times lower, the sensitization of MRSA was only 3-fold.






Essential Oil [1000 μL/L]
Chloramphenicol IC50 [mg/L]
Affected by Citral [400 μL/L]
MRSA 142 ± 10 15 ± 2 42 ± 1
Fold 9.6 ± 1.9 3.4 ± 0.3
The data are presented as an average of eight repetitions (n) ± standard error of the mean (SEM).
3.3. Anti-Biofilm Activity
Biofilm formation plays a crucial role in many medical and industrial applications. Typically,
the effect of anti-biofilm compounds can be seen in two main stages: a) adhesion of the planktonic
cells to the surface and b) disruption of a maturated biofilm. Both citral and lemongrass essential oil
inhibited the adhesion of Gram-positive (S. aureus) and Gram-negative (P. aeruginosa) bacteria in a
dose-dependent manner. In contrast to direct antimicrobial activity, a higher effect was observed for
the adhesion of P. aeruginosa than for S. aureus (Figure 2). In the eradication of mature biofilms, just only
citral disrupted bacterial biofilms in concentration-dependent manner with significantly higher effect
on gram negative bacteria (P. aeruginosa) while lemon grass essential oil was not considered significant
(Figure 3). Both citral and lemongrass essential oil disrupted the biofilm in a concentration-dependent
manner with a significantly higher effect on Gram-negative bacteria (P. aeruginosa).
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Figure 2. Inhibition of adhesion of bacteria forming a biofilm by lemongrass essential oil (A) and citral
(B). The data are presented as an average of 16 repetitions with SEM.
Figure 3. Disruption of maturated biofilm by lemongrass essential oil (A) and citral (B). The data are
presented as an average of 16 repetitions with SEM.
As can be seen from Table 3, which compares the concentrations of citral and lemongrass
essential oil that halve the respective activity, citral was more active against both phases of biofilm
formation—adhering and maturated cells. As the IC50 values of citral were 7–70 × lower than the IC50
of lemongrass essential oil, it could be concluded that citral is responsible for the main activity of the
essential oil against a biofilm. However, this activity is negated by the antagonistic effect of some
other compounds that are also in the oil. Citral is up to 5 ×more active against the adhesion phase of
P. aeruginosa biofilm than against an S. aureus biofilm.
Table 3. Concentration of citral and lemongrass essential oil that halves the respective activity: (i)
adhesion of bacteria forming biofilm and (ii) mature biofilm.
Anti-adhesion IC50 [mL/L] Anti-biofilm IC50 [mL/L]
S. aureus P. aeruginosa S. aureus P. aeruginosa
Citral 0.32 ± 0.03 0.06 ± 0.01 >1.5 0.11 ± 0.01
Lemongrass essential oil 2.16 ± 0.11 1.90 ± 0.20 >10 7.34 ± 0.40
Data are presented as an average of 16 repetitions with SEM.
3.4. Inhibition of Bacterial Cell-To-Cell Communication
The inhibition of bacterial quorum sensing was measured by using the sensor system of V. campbellii.
First, the direct toxicity of the oil and citral was determined in order to avoid false-positive results.
Table 4 shows the concentrations of citral and lemongrass essential oil that halved the bacterial quorum
sensing and viability of mutant sensor strains of V. campbellii, which responds either only to (i) AI-1
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autoinducer (BAA1118) or (ii) AI-2 autoinducer (BAA1119). As can be seen from the table, the
concentrations that halve viability [mL/L] and those that halved communication [μL/L] differ by a
factor of 1000. The decrease in luminescence was therefore caused by an inhibition of communication
rather than inhibition of cell growth (Figure 4). The lemongrass essential oil inhibited communication
based on both autoinducer 1 (AI-1) and autoinducer 2 (AI-2) systems similarly to citral. However,
in comparison to the oil, citral effectively inhibited both systems, with a slightly higher activity for
the first one. Although the oil inhibited the AI-2-mediated communication, which is based on boron
compounds and used by many Gram-negative and Gram-positive bacteria, its activity was significantly
higher against AI-1, which is based on homoserine lactones used by Gram-negative bacteria.
Table 4. The effect of citral and lemongrass essential oil on the quorum sensing and viability of
Vibrio campbellii.





IC50 IC10 IC50 IC10
citral 0.24 ± 0.11 0.09 ± 0.05 0.26 ± 0.03 0.99 ± 0.04 0.68 ± 0.08 1.7 ± 0.8
lemongrass essential oil 0.17 ± 0.01 0.05 ± 0.01 1.4 ± 0.03 5.42 ± 0.09 4.07 ± 0.16 259 ± 88
The data are presented as an average of 3 repetitions with SEM.
Figure 4. Dose-dependent effect of lemongrass essential oil (blue circle) and citral (black triangle) on
V. campbellii BAA1118: (A) quorum sensing inhibition, (B) cell viability. The data are presented as an
average of 3 repetitions with SEM.
3.5. Modulation of MDR in Cancer Cells
As was shown with the bacteria, lemongrass essential oil affected the multidrug resistance
phenotype of MRSA. One of the main mechanisms involved in both bacteria and cancer drug-resistance
is the overexpression of transmembrane efflux pumps, which transport the drug outside the cells and
thus decrease its intracellular concentration [23]. Therefore, the activity of both citral and lemongrass
essential oil was tested on a fraction of isolated membranes containing human P-glycoprotein (P-gp)—a
transmembrane efflux pump responsible for most multidrug resistance phenotypes in tumors. As can
be seen from Figure 5, lemongrass essential oil inhibited this pump. The function of P-gp is connected
to the ATP consumption; therefore, the better the inhibitor, the lower the amount of consumed
ATP. Compared with lemongrass essential oil, citral was unable to inhibit this pump even at higher
concentration levels. Rather than being an inhibitor, citral was potentially the substrate of this pump,
showing the typical trend, i.e., the higher the concentration, the higher the amount of consumed ATP.
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Figure 5. P-glycoprotein activity modulation. Orthovanadate was used as a known inhibitor of P-gp,
Verapamil was used as a known activator of P-gp.
P-glycoprotein activity inhibition was determined as the amount of ATP which was not consumed
during the efflux pump activation in comparison to the control. Orthovanadate (white columns), a
known inhibitor of P-gp, was used as a positive control, verapamil (dotted columns) was used as
known activator and lemongrass essential oil (black columns) and citral (gray columns) were tested in
the concentration range 2.5–50 mL/L. Data are presented as an average of 3 repetitions (n) with SEM.
Data were analyzed by one-way ANOVA with Duncan’s post hoc test (P > 0.05) as indicated by the
superscript letters. Statistically significant levels were denoted with different letters.
The activity of both the oil and citral were tested on an ovarian cancer cell line resistant to
doxorubicin. As predicted based on the P-gp inhibition results, citral exhibited no potential to modulate
the resistant phenotype of this cell line. In contrast, the co-administration of doxorubicin with the oil at
a concentration far below the IC50 significantly decreased the cell viability (Figure 6).
Figure 6. Inhibition of human ovarian carcinoma viability by doxorubicin (red line) and doxorubicin
with lemongrass essential oil (10 μL/L, black line) after 72 h.
The sensitization of doxorubicin-resistant ovarian carcinoma was determined as the ratio of
doxorubicin concentration needed to halve the cell viability with and without lemongrass essential oil
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(Table 5). The resistant cell line treated with lemongrass essential oil was almost twice as sensitive as
without oil, with the p value of the t-test being 0.022. As can be seen from the table, the resistant cell line
is more than 100×more resistant than the sensitive line. The chosen dose of lemongrass was non-toxic
even for the sensitive cancer cell line (note: viability 86% ± 4%); therefore, the sensitization effect was
not caused by a direct cytotoxicity of the oil. Citral at the same concentration level (10 μL/L) did not
modulate the resistant phenotype and its presence did not affect the values of doxorubicin’s IC50.
Table 5. Modulation of resistance to doxorubicin by lemongrass essential oil. The table shows the
concentrations of doxorubicin that halved the viability of human ovarian carcinoma (HOC) cell lines in
the presence of lemongrass essential oil and doxorubicin with a single-dose addition of lemongrass
essential oil (10 μL/L). Both HOC and the same line resistant to doxorubicin (HOC/DOX) were tested.
HOC HOC/DOX
Doxorubicin, IC50 [μM] 0.022 ± 0.001 2.86 ± 0.18
Lemongrass, IC50 [μL/L] 55.2 ± 8.1 197.8 ± 5.7
Doxorubicin, IC50 [μM] with lemongrass essential oil [10 μL/L] 1.60 ± 0.14
Sensitization FOLD 1.78 ± 0.27
The sensitization factor was calculated as the ratio of IC50 [doxorubicin, μM] and IC50 [doxorubicin in the presence
of lemongrass essential oil, μM]. The data are presented as an average of 3 repetitions with SE.
4. Discussion
Although the promising biologic activities of both lemongrass essential oil and citral have been
known for decades, their modulation of the drug-resistant phenotype has never been tested in as much
depth as by this paper. Here we report on the modulation of both bacterial and cancer drug resistance by
lemongrass essential oil; however, based on our results, this activity is not caused by citral. The activity
of Cymbopogon flexuosus essential oil against multi-drug resistant bacteria was previously studied using
Acinetobacter baumannii strains [25]. The mean value of MIC was about 0.65% (v/v). Our IC50 value for
MRSA (0.4%, v/v) agrees with published data. The sensitization factor of methicillin-resistant S. aureus
(MRSA) by lemongrass essential oil was several times higher than the factor for citral. Therefore, the oil
is more promising for modulating a bacterial drug-resistance phenotype. In addition, Berdejo et al. [31]
reported on an enhanced resistance in S. aureus after sub-inhibitory doses of citral exposure. This was
in agreement with the study of Chueca et al. [32], who published that the exposure of a hyper-resistant
strain of E. coli to a sub-inhibitory concentration of citral did not increase the direct resistance globally;
however, it led to the emergence of several mutants displaying an increased minimum inhibitory
concentration of citral. Therefore, the application of oil as a natural component mixture is in agreement
with the current trend of drug resistance treatment based on a combination of biologically active
compounds with different targets.
Both lemongrass essential oil and citral possess strong antimicrobial activity, even against
antibiotic-resistant strains; therefore, their activity against a biofilm was evaluated within this paper as
well. The disruption of a matured biofilm was only observed for Gram-negative bacteria treated with
either citral or with the oil. The application of 0.06 mL/L of citral eliminated half of the P. aeruginosa cells
adhesion, which is in agreement with the results of Espina et al., who demonstrated that the biofilm
formation of resistant S. aureus was significantly inhibited by 0.2 mL/L of citral [33]. Lemongrass
essential oil was previously used for an oral spray preparation intended to inhibit Streptococcus sp.
biofilm formation [34]. Similarly, both oil and citral prevented the biofilm formation of sulfate-reducing
bacteria [12]. Both papers are in agreement with our results, which show that relatively low citral
doses of 61 and 323 ppm inhibit the adhesion of both Gram-negative and positive bacteria by 50%,
respectively. Lemongrass essential oil inhibited the adhesion of both cell types as well, however at
several times higher concentrations. In another study, 0.2 μg/mL of citral significantly inhibited mixed
biofilm (S. aureus and S. enterica) formation, which could be caused by decreasing AI-2-mediated
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quorum sensing communication [35]. The inhibition of AI-2 production by citral treatment was
demonstrated by [36]. Our results also proved that citral significantly inhibited both biofilm formation
and bacterial communication via AI-2; however, the inhibition of quorum sensing based on AI-1 was
more effective and to our knowledge, this is the first report on such activity.
The potential of citral to interact with transmembrane efflux pumps has not been satisfactorily
explained yet. It was previously shown that citral acts neither as a P-gp inhibitor (ABCB1) nor as a
multidrug resistance protein 1 and 2 (MRP1, ABCC1; MRP2, ABCC2) inhibitor [37–39]. Moreover, citral
should not affect ATPase activity in any of these pumps [38]. On the other hand, Queiroz et al. [40]
observed that citral downmodulated the activity and inhibited the expression of multidrug resistance
associated protein 1 (MRP1). In contrast to lemongrass essential oil, citral up to a concentration of
50 mL/L was unable to inhibit pure P-gp in the in vitro system and did not affect the DOX sensitivity of
doxorubicin-resistant ovarian carcinoma over 72 h of incubation. The resistance of the cell line is caused
by P-gp overexpression [29]. Therefore, the 10-μL/L dose of citral should not affect the expression level
of P-gp, as the cells preserved the drug-resistant phenotype. As in bacteria, the lemongrass essential
oil, being a natural mixture of biologically active compounds, is more promising in overcoming drug
resistance in eukaryotic cells.
The antimicrobial activity of both lemongrass essential oil and citral have been reported many times
before, but here we compared the activity of the same essential oil and pure citral against prokaryotic
and eukaryotic organisms, i.e., Gram-positive, Gram-negative bacteria and yeasts, respectively. Despite
the similarity of some of our results with published data, we found some differences, e.g., in the
minimal oil concentration inhibiting C. albicans (MIC), which was published as 288 mg of oil per
liter [41]. Our determination of the MIC for C. albicans gave 2734 μL/L, which corresponds to an MIC
of 2435 mg of oil per liter (recalculated based on the gravimetrically defined density of our oil as 0.891
± 0.004 g/mL). The difference could be explained by the different sensitivity of yeast strains. The same
reasons may apply for differences between our MIC of C. albicans, which about 14 times higher than
that obtained by Sacchetti et al. [42].
The antimicrobial activity of citral was previously measured for E. coli. The determined value
(≥0.01%) [43] corresponds to our observation for Gram-negative bacteria (41–97 μL/L). Similar to our
results, Gupta et al. also demonstrated that citral has a stronger antimicrobial activity than lemongrass
essential oil [44]. Citral was up to 10 times more active against some Acinetobacter baumannii strains
than lemongrass essential oil in the study of Adukwu et al. [25].
The quality of the oil is generally assessed by its content of citral, high oxygenated monoterpenes,
low monoterpene and sesquiterpene hydrocarbons, and finally low oxygenated sesquiterpenes. Our
lemongrass essential oil had a standard composition comparable to previously published data. The
yield of essential oil obtained by our distillation of fresh leaves was 0.5% (w/w), which corresponds to
the data of other authors, who published yields of 0.6% [45] or 0.7% [46–48]. As expected, the dominant
group of terpenes present in essential oil was comprised of oxygenated monoterpenes with the main
components being neral (citral b, 33.7%) and geranial (citral a, 29.3%). The amounts of citral isomers
differ in the literature, typically with a higher content of neral. The common contents are 36.2% [41],
39.5% [48], 41.3% [42], 41.8% [47], 42.2% [45], 50.5% [25], 52.9% [34], up to 56.8% [49] for citral a and
26.5% [41], 30.4% [47], 32.3% [42], 32.5% [45], 33.1 [49], 35.5% [48], 38.1% [34], up to 38.5% [25] for
neral. The presence of 1.5% linalool is comparable with the data published by other authors—0.4% [49],
1.3% [42], 2.8% [25]. The level of geraniol was also similar, which we quantified as 4.9% and other
research groups as 2.2%–8.2% [25,48].
5. Conclusions
Although the antimicrobial activity of citral is to some extent negated by the accompanying
components of lemongrass essential oil, these components have promising activity against
antibiotic-resistant bacteria and chemotherapeutic-resistant tumors. Citral preserves its strong
antimicrobial activity, resulting in direct bacterial cytotoxicity, the inhibition of quorum sensing
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and influence on cell adhesion during biofilm formation as well as disruption of a matured biofilm.
Further fractionation searching for bioactive compounds modulating the drug-resistance phenotype is
a promising therapeutic approach.
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Abstract: Oxidative stress and inflammation are known to be linked to the development of chronic
inflammatory conditions, such as type 2 diabetes and cardiovascular disease. Dietary polyphenols
have been demonstrated to contain potent bioactivity against specific inflammatory pathways.
Rice bran (RB), a by-product generated during the rice milling process, is normally used in animal
feed or discarded due to its rancidity. However, RB is known to be abundant in bioactive polyphenols
including phenolic acids. This study investigates the antioxidant and anti-inflammatory effects of RB
phenolic extracts (25, 50, 100, and 250 μg/mL) on RAW264.7 mouse macrophage cells stimulated with
hydrogen peroxide and lipopolysaccharide. Biomarkers of oxidative stress and inflammation such as
malondialdehyde (MDA), intracellular reactive oxygen species, nitric oxide and pro-inflammatory
cytokines such as interleukin-6 (IL-6), monocyte chemoattractant protein 1 (MCP-1), interleukin-10
(IL-10), tumor necrosis factor-α (TNF-α), interleukin-12, p70 (IL-12p70), and interferon-γ (IFN-γ)
were measured in vitro. Treatment with RB extracts significantly decreased the production of MDA,
intracellular reactive oxygen species, nitric oxide and pro-inflammatory cytokines (IL-6, IL-12p70,
and IFN-γ) when compared to the control. It is proposed that RB phenolic extracts, via their metal
chelating properties and free radical scavenging activity, target pathways of oxidative stress and
inflammation resulting in the alleviation of vascular inflammatory mediators.
Keywords: rice bran; polyphenols; oxidative stress; antioxidant; inflammation; anti-inflammatory
1. Introduction
Oxidative stress is generated due to an imbalance between the endogenous antioxidant systems
in our body and free radicals such as reactive oxygen species [1]. This consequently results in chronic
inflammation leading to cardiovascular complications [2]. The key role of macrophages in the innate
immune system is to engulf foreign agents, eliminate apoptotic cells and resolve inflammation via
inflammatory cytokines and other mediators [3]. During an oxidative stress environment or a chronic
inflammatory state, malondialdehyde (MDA), intracellular reactive oxygen species, nitric oxide,
pro-inflammatory cytokines such as interleukin-6 (IL-6), monocyte chemoattractant protein 1 (MCP-1),
interleukin-10 (IL-10), tumor necrosis factor-α (TNF-α), interleukin-12, p70 (IL-12p70), and interferon-γ
(IFN-γ) are known to be secreted by activated macrophages [4,5].
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MDA is generated as a result of the peroxidation between polyunsaturated fatty acids [6], as lipids
are susceptible to oxidation due to their molecular structure which is abundant in reactive double
bonds [7]. MDA is known to interlink with proteins (e.g., lysine to generate lysine–lysine cross-links)
and subsequently result in interactions between oxidized low-density lipoprotein and macrophages,
to promote the pathogenesis of cardiovascular disease [8]. Generally, cellular antioxidants such as
catalase, superoxide dismutase and glutathione peroxidase are known to maintain the homeostatic
levels of reactive oxygen species in the vasculature. However, the excess production of reactive oxygen
species as a result of oxidative stress is recognized to result in the impairment of cell membrane, proteins,
and nucleic acids leading to a series of vascular restructures resulting in atherosclerosis [1]. Nitric oxide,
a gaseous lipophilic free radical cellular messenger, is generally known to protect against cardiovascular
diseases by regulating blood pressure, impeding platelet aggregation and inhibiting smooth muscle
cell proliferation. However, under oxidative stress conditions, nitric oxide is recognized to change from
being a protective agent to being an infectious agent [9]. Moreover, during inflammation, activated
macrophages are recognized to secrete several pro-inflammatory cytokines to further up-regulate the
inflammatory responses. For example, IL-6 is a key cytokine involved in the synthesis and secretion of
C-reactive protein which is one of the risk factors for the development of cardiovascular disease [10].
MCP-1 is involved in atherosclerotic plaque formation as it allows monocytes to pass from the lumen
to the sub-endothelial space where they become foam cells, initiating fatty streak formation [11]. IL-10
is known to have a cardioprotective role as it is recognized to inhibit the adhesion of monocytes to
endothelial cells and result in the destabilization of atherosclerotic plaque [12]. Similarly, TNF is
normally recognized as a modulator of both cardiac contractility and peripheral resistance, but increased
levels of TNF are known to result in cardiovascular complications [13]. In stimulated mouse
macrophages, the increased production of IL-12p70 has been previously observed as a result of protein
kinase C activation, which is known to control multiple physiological processes in the heart [14,15].
IFN-γ is a macrophage-activating factor, vital for both innate and adaptive immunity. It is produced by
T cells and is known to initiate the generation of reactive oxygen species, and is therefore expressed at
high levels during cardiovascular events such as atherosclerosis [16]. Therefore, the regulation of these
inflammatory responses, by modulating the production of pro-inflammatory and oxidant markers has
been the key metabolic target towards the treatment of vascular disorders.
Several synthetic drugs are currently available in the treatment of acute inflammatory
states, however, their long-term use has been associated with gastrointestinal, cardiac and renal
complications [17]. Moreover, a rise in health-conscious consumers has resulted in the search for
functional foods with nutritional and disease-preventive properties [18]. Natural plant-derived
phytochemicals, such as polyphenols and phenolic acids, have been demonstrated to target pathways
of inflammation and oxidative stress [18]. Furthermore, it is believed that polyphenols, via their free
radical scavenging, metal-chelating properties and blunting cellular signalling pathways, modulate
the risk factors associated with chronic ailments including cardiovascular disease and cancer [19].
Phenolic compounds are known to exert anti-inflammatory activity through the regulation of cellular
activities in inflammatory cells, modulating enzymes associated with the arachidonic acid metabolism
and by blunting the release of pro-inflammatory molecules [19].
Rice is the seed of the grass species Oryza sativa, and has been cultivated around the globe for
centuries and is considered a staple food. During rice milling, the rice bran (RB) layer is removed
due to its rancidity associated with storage and is primarily used as animal feed. However, RB is
known to be abundant in macronutrients and bioactive compounds such as p-coumaric acid, ferulic
acid, and caffeic acid [20]. Although studies have demonstrated that RB phenolic compounds have
the potential to exhibit antioxidant and/or anti-inflammatory properties [2], their impact on specific
pathways of inflammation in an oxidative stress-induced/inflammatory environment has not been
studied. The current study aimed to determine the antioxidant and anti-inflammatory effect of RB
phenolic extracts on RAW264.7 mouse macrophage cells stimulated with hydrogen peroxide (H2O2)
and lipopolysaccharide (LPS). Biomarkers of oxidative stress such as MDA, intracellular reactive
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oxygen species, nitric oxide and pro-inflammatory cytokines such as IL-6, MCP-1, IL-10, TNF-α,
IL-12p70, and IFN-γ were measured in vitro.
2. Materials and Methods
2.1. Chemicals and Reagents
Unless otherwise stated, all the chemicals and reagents used in this study were acquired from
Sigma-Aldrich (St Louis, MI, USA) and BD Biosciences (Franklin Lakes, NJ, USA).
2.2. Rice Bran Extract Preparation
Stabilization of RB was previously conducted by SunRice, Leeton, Australia using a drum-drying
method. Extraction of the RB phenolic compounds was performed using an acetone/water/acetic acid
(70:29.5:0.5, v/v) mixture, and characterized using ultra-high-performance liquid chromatography
coupled to an 2,2’-Azino-bis 3-ethylbenzothiazoline-6-sulfonic acid-online system and mass
spectrometry (Agilent Technologies) [20]. Prior to the cell culture studies, the extract was reconstituted
in 50% dimethyl sulfoxide (DMSO).
2.3. Cell Culture Conditions
Experiments were conducted on RAW264.7 cells purchased from Sigma-Aldrich (St Louis,
MO, USA). RAW264.7 cells were cultured in high-glucose Dulbecco’s modified Eagle’s medium
(DMEM) (Sigma-Aldrich: D6429) supplemented with 10% fetal bovine serum and 1% 10,000 U/mL
penicillin–10 mg/mL streptomycin at 37 ◦C in 5% CO2. Cultured RAW264.7 cells were used before
reaching the 8th passage.
2.4. Cytotoxicity Assessment
A resazurin red cytotoxicity assay, as described by Saji, Francis [21], was utilized to examine
the effect of RB phenolic extracts on RAW264.7 cells. Briefly, RAW264.7 cells were seeded into
96-well plates at a density of 50,000 cells/well and incubated overnight in the DMEM complete media.
The cell count for the experimental seeding was achieved with a Muse® Cell Analyzer from Luminex
Corporation (Austin, TX, USA). RAW264.7 cells were then treated with 200 μL of DMEM complete
media containing RB phenolic extract (25 μg/mL, 50 μg/mL, 100 μg/mL, 250 μg/mL, 500 μg/mL,
750 μg/mL and 1000 μg/mL) for 6 h. For the positive control, 5 mM concentration of H2O2 was used,
and 0.5% DMSO served as the negative control. Subsequently, all the treatment wells were emptied
before incubation with 200 μL of resazurin red solution for an additional 4 h. The absorbance at 570
and 600 nm was measured on a microplate reader (FLUOstar Omega microplate reader, BMG Labtech,
Offenburg, Germany) against a resazurin red blank. The percentage of cell viability was calculated.
Each treatment was measured in quintuplicate.
2.5. Antioxidant Effect of RB Phenolic Extract
2.5.1. Malondialdehyde Determination
RAW264.7 cells (500,000 cells/well) were seeded into 6-well plates and incubated for 24 h.
RB phenolic extracts at varying concentrations (25 μg/mL, 50 μg/mL, 100 μg/mL, 250 μg/mL) were
then incubated with the cells for 6 h. To induce oxidative stress, RAW264.7 cells were subjected to
12 h incubation with a 500 μM concentration of H2O2. For MDA determination, a Lipid Peroxidation
(MDA) Assay Kit (Sigma-Aldrich: MAK085) was used according to the manufacturer’s instructions.
Briefly, the cell lysate was centrifuged for 10 min at 13,000× g to remove any insoluble material.
Subsequently, 600 μL of freshly prepared thiobarbituric acid (TBA) solution was combined with 200 μL
of the sample supernatant and the previously prepared MDA standards (0 nmol, 4 nmol, 8 nmol,
12 nmol, 16 nmol, and 20 nmol) to form the MDA–TBA adduct. All the samples were incubated at
119
Foods 2020, 9, 829
95 ◦C for 1 h and subsequently placed in an ice bath for 10 min. The sensitivity of each sample was
enhanced by adding 300 μL of 1-butanol, followed by centrifugation for 3 min at 16,000× g to separate
the layers. The 1-butanol layer (the top layer) was then transferred to another tube and evaporated at
55 ◦C. The remaining residue was dissolved in 200 μL of water and transferred to a 96-well plate for
analysis. Absorbance was measured at 532 nm using a microplate reader (FLUOstar Omega microplate
reader, BMG Labtech, Offenburg, Germany). Each treatment was measured in quintuplicate.
2.5.2. Intracellular Reactive Oxygen Species Generation
RAW264.7 cells were seeded at a density of 50,000 cells/well into a black, clear-bottom 96-well
plate and incubated for 24 h. The cells were then incubated with RB extracts (25 μg/mL, 50 μg/mL,
100 μg/mL, 250 μg/mL) for 6 h. The DMSO-treated cells served as the control. Oxidative stress was
induced by treatment with 500 μM concentration of H2O2 for 12 h. Formation of reactive oxygen species
was determined by removing the old media and replenishing with 50 μM 2,7-dichlorofluorescein
diacetate (Sigma-Aldrich: 35845) and incubating for an additional 30 min in the dark at 37 ◦C.
The assessment of intracellular reactive oxygen species levels was conducted by measuring the
fluorescence using a fluorescence microplate reader (FLUOstar Omega microplate reader, BMG
Labtech, Offenburg, Germany) at 480 nm excitation and 530 nm emission at 37 ◦C. Each treatment was
measured in octuplicate.
2.6. Anti-Inflammatory Effect of RB Phenolic Extract
2.6.1. Nitric Oxide Determination
RAW264.7 cells at a density of 500,000 cells/well were seeded into a 6-well plate and incubated for
24 h, followed by treatment with 25 μg/mL, 50 μg/mL, 100 μg/mL, 250 μg/mL RB phenolic extracts for
6 h. DMSO-treated cells served as the control. To induce inflammation, RAW264.7 cells were further
subjected to 24 h incubation with 1 μg/mL of LPS. The supernatant was collected by centrifugation
(3000× g, 10 min, 4 ◦C). To assess the nitric oxide levels, the cell supernatants and standards (400 μL)
were combined with 400 μL of Griess reagent (Sigma-Aldrich: G4410) and incubated for 15 min
in the dark at room temperature. Sodium nitrite was used to generate a standard curve (10 μM,
20 μM, 40 μM, 60 μM, 80 μM and 100 μM). Absorbance was measured at 540 nm using a microplate
reader (FLUOstar Omega microplate reader, BMG Labtech, Offenburg, Germany). Each treatment was
measured in quintuplicate.
2.6.2. Inflammatory Cytokine Determination
Seeding of RAW264.7 cells (500,000 cells/well) was conducted in a 6-well plate and incubated
for 24 h. After confluency was reached, the RAW264.7 cells were treated with 25 μg/mL, 50 μg/mL,
100 μg/mL, 250 μg/mL RB phenolic extracts and DMSO (control) for 6 h. Inflammation was induced
with the addition of LPS (1 μg/mL) and the cells were incubated for an additional 24 h, after which,
the supernatant was collected by centrifugation (3000 × g, 10 min, 4 ◦C) and stored at −20 ◦C before
analysis. The anti-inflammatory effect of RB phenolic extracts on inflammatory cytokines (IL-6, MCP-1,
IL-10, TNF-α, IL-12p70, and IFN-γ) was determined using a BD™ Cytometric Bead Array Mouse
Inflammation Kit (BD Biosciences: 552364). Briefly, 50 μL of the diluted samples (1:40) and standards
were combined with 50 μL of the mixed capture beads and 50 μL of the mouse inflammation PE
detection reagent. This was then incubated for 2 h in the dark at room temperature. After which, 1 mL
of wash buffer was added to each assay tube and centrifuged (200 × g, 5 min). Following centrifugation,
the supernatant was discarded, and the bead pellet was suspended in 300 μL of fresh wash buffer.
Each sample was vortexed for 3–5 s and immediately inspected using a GalliosTM Flow Cytometer
(Beckman Coulter, CA, USA). Kaluza Flow Cytometry Analysis Software (Beckman Coulter, CA, USA)
was used for conducting the data analysis. Each treatment was measured in quintuplicate.
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2.7. Statistical Analysis
GraphPad Prism 7 software (GraphPad Software Inc., San Diego, California, USA) was utilized for
statistical analysis by one-way analysis of variance (ANOVA), followed by post-hoc Tukey’s multiple
comparisons test. Data were considered statistically significant when p< 0.05. Any significant statistical
interactions were included in the analysis where applicable. The results are reported as mean ±
standard deviation (SD).
3. Results
3.1. Cytotoxicity of RB Phenolic Extracts on RAW264.7 Cells
A time-course study was conducted on a range of incubation periods varying from 2–24 h
(data not shown) from which a 6 h incubation period was selected as the optimal time point associated
with cell viability. It was observed that RAW264.7 cells, post-exposure to RB phenolic extracts for 6 h,
did not display any toxic effects at any of the doses tested (25–1000 μg/mL) when compared to the
DMSO control. Therefore, the optimal and physiologically attainable concentrations of RB phenolic
extract selected for further examinations were between 25 and 250 μg/mL (Figure 1).
Figure 1. Cytotoxicity of RAW264.7 cells post-exposure to various doses of RB phenolic extracts (6 h
treatment). The RB phenolic extracts did not display any cytotoxic effect on the RAW264.7 cells at the
concentrations (25–1000 μg/mL) tested (n = 5). Data are presented as mean ± SD. Rice bran, RB.
3.2. Antioxidant Properties of RB Phenolic Extract
3.2.1. Malondialdehyde Concentration
MDA concentrations (nmol/mL) were significantly reduced in oxidative stress-induced RAW264.7
cells after treatment with 25 μg/mL (p < 0.05), 50 μg/mL (p < 0.05) and 100 μg/mL (p < 0.01) of RB
phenolic extract compared to the H2O2 control (Figure 2). However, the treatment with 250 μg/mL RB
phenolic extract did not reduce the MDA levels.
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Figure 2. The impact of the RB phenolic extract treatment on oxidative stress-induced RAW264.7
macrophage cells. A significant reduction in the MDA concentration (nmol/mL) is observed after
treatment with the different concentrations (25–100 μg/mL) of RB phenolic extracts compared to the
control (n = 5). The level of significance is indicated by the asterisks, whereby * p < 0.05, ** p < 0.01.
Data are presented as mean ± SD. Mouse macrophage cell, RAW264.7; hydrogen peroxide, H2O2;
rice bran, RB.
3.2.2. Intracellular Reactive Oxygen Species Generation
RAW264.7 cells induced with H2O2 showed a significant reduction in the generation of intracellular
reactive oxygen species after treatment with 25–250 μg/mL (p < 0.0001) of RB phenolic extract when
compared to the control (Figure 3).
Figure 3. The effect of RB phenolic extracts on intracellular reactive oxygen species generation in
oxidative stress-stimulated RAW264.7 cells. A significant reduction in intracellular reactive oxygen
species generation, as indicated by the differences in the fluorescence intensity, is observed after
treatment with the different concentrations (25–250 μg/mL) of RB phenolic extracts compared to the
control (n = 8). The level of significance is indicated by the asterisks, whereby **** p < 0.0001. Data are
presented as mean ± SD. Hydrogen peroxide, H2O2; rice bran, RB.
3.3. Anti-Inflammatory Effect of RB Phenolic Extract
3.3.1. Nitric Oxide Determination
RB phenolic extracts at all concentrations (25–250 μg/mL) reduced the expression of nitric oxide
levels in LPS-stimulated RAW264.7 cells (Figure 4).
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Figure 4. Effect of RB phenolic extract on nitric oxide levels in RAW264.7 cells induced with
LPS. A significant reduction in the nitric oxide levels is observed after treatment with the different
concentrations (25–250 μg/mL) of RB phenolic extracts compared to the control (n = 5). The level of
significance is indicated by the asterisks, whereby ** p < 0.01, *** p < 0.001, **** p < 0.0001. Data are
presented as mean ± SD. Lipopolysaccharide, LPS; rice bran, RB.
3.3.2. Inflammatory Cytokine Determination
It was observed that treatment with 250 μg/mL (p < 0.01) of RB phenolic extract reduced the
expression of IL-12p70 and IL-6 under a pro-inflammatory environment. Furthermore, the RB phenolic
extract at 100 μg/mL (p < 0.05) and 250 μg/mL (p < 0.01) concentrations reduced IFN-γ compared to
the LPS control (Figure 5). No significant differences in the regulation of the other cytokines tested
were observed (data not shown for IL-10, MCP-1, and TNF-α).
Figure 5. The effect of RB phenolic extracts in modulating pro-inflammatory cytokines. A significant
reduction in IL-12p70 and IL-6 cytokines is observed after treatment with 250 μg/mL (p < 0.01).
Furthermore, the pre-treatment with 100 μg/mL (p < 0.05) and 250 μg/mL (p < 0.01) of the RB phenolic
extract is observed to have resulted in a significant reduction in the IFN-γ cytokine compared to the
control (n = 5). The level of significance is indicated by the asterisks, whereby * p < 0.05, ** p < 0.01.
Data are presented as mean ± SD. Lipopolysaccharide, LPS; rice bran, RB.
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4. Discussion
Both oxidative stress and inflammation are known to be precursor risk factors that play a central
role in the development of chronic conditions such as cardiovascular disease [2]. Studies have proposed
that polyphenols possess anti-inflammatory properties by virtue of their free radical scavenging,
enzyme and cell signalling pathway modulating effects [19]. The current study has demonstrated that
phenolic extracts present in RB have significant antioxidant and anti-inflammatory properties under
oxidative stress-induced/inflammatory environment in macrophage cells. The drum-dried RB sample
used in this study was previously characterized and some of the bioactive compounds identified in
the extract were caffeic acid, ethyl vanillate, ferulic acid, feruloyl glycoside, p-coumaric acid, shikimic
acid, sinapic acid, syringic acid, tricin and vanillic acid. Among which, ferulic acid and its isomers
were identified to be the predominant compound in the extract with tricin having the most antioxidant
activity. Furthermore, the examination of the total phenolic content and antioxidant activity revealed
that the drum-dried RB extract had a total free phenolic content of 362.17 ± 34.16 GAE/100 g of RB
with an antioxidant activity of 975.33 ± 20.24 Fe2+/100 g of RB and a total bound phenolic content
of 160.65 ± 5.52 GAE/100 g of RB with an antioxidant activity of 551.91 ± 8.82 Fe2+/100 g of RB. It is
believed that the antioxidant and anti-inflammatory effects observed in this study could be due to the
synergistic action of the antioxidant-rich phenolic compounds identified in the extract [20].
An increase in free radicals results in the overproduction of MDA and reactive oxygen species levels
in the body. Hence, they serve as an accurate biomarker for the detection of oxidative stress and overall
antioxidant status [4]. In this study, RAW264.7 cells stimulated with H2O2 resulted in a significant
reduction in MDA concentration (nmol/mL) after treatment with 25, 50 and 100 μg/mL of RB phenolic
extract (Figure 2). Furthermore, it was observed that all RB extract concentrations (25–250 μg/mL)
reduced the intracellular reactive oxygen species levels under a H2O2-stimulated oxidative stress
environment (Figure 3). Other studies have also demonstrated that plant-derived bioactive compounds
can alleviate free radical production in vitro under oxidative stress conditions [22–24]. Curcumin
has been shown to decrease MDA and reactive oxygen species levels in macrophage cells that were
induced with oxidative stress conditions. The authors have highlighted curcumin to have increased the
activity of antioxidant enzymes and activated the Nrf2-Keap1 pathway [22]. In addition, pigeon pea
extracts rich in cyanidin-3-monoglucoside were also observed to prevent the reduction of antioxidant
enzyme activity and decrease MDA production in oxidative stress-induced macrophage cells [23].
By reducing hydrogen peroxidase, reactive oxygen species generation has been shown to increase free
metal ion production, consequently producing highly reactive hydroxyl radicals. Polyphenols, due to
their thermodynamically lower redox potential, reduce these oxidizing free radicals via their metal
chelating ability [19]. The results observed in this study are a clear demonstration of the ability of RB
polyphenols to reduce the highly oxidizing free radicals produced in an oxidative stress environment.
In summary, it is believed that the antioxidant potential of polyphenols is correlated to their capacity
to suppress reactive oxygen species formation, the inhibition of free radical-producing enzymes and/or
the upregulation of antioxidant defences. The structure of functional groups in polyphenols also plays
an important role in their antioxidant capacity. We believe that the synergistic action of polyphenols,
including the phenolic acids present in the RB extracts by virtue of the mechanisms listed above, is
blunting MDA and reactive oxygen species generation in an oxidative stress environment in vitro.
During inflammation, the activation of macrophage occurs as a result of a cascade of events
that are mediated by the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB)
and mitogen-activated protein kinase (MAPK) pathways [25,26]. Macrophages stimulated with
LPS result in the release of NF-κB protein, which acts as a transcription factor that promotes
inflammation [25]. Similarly, activated MAPKs contribute to the phosphorylation of downstream targets,
including protein kinases and transcription factors, which subsequently facilitates the transcription of
MAPK-regulated genes. This process results in the production of mediators such as pro-inflammatory
cytokines and nitric oxide in stimulated macrophage cells [26]. Since pro-inflammatory cytokines are
recognized to play a vital role in cell signalling and systemic inflammation, the excessive production
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of pro-inflammatory cytokines may result in tissue destruction and the development of several
pro-inflammatory processes [27].
In the present study, the stimulation of RAW264.7 cells with LPS was observed to up-regulate
several inflammatory markers which were subsequently suppressed by pre-treatment with
the RB phenolic extract. This included a significant decrease in the nitric oxide levels and
pro-inflammatory cytokine (IL-6, IL-12p70, and IFN-γ) production in RAW264.7 cells stimulated
with LPS (Figures 4 and 5). However, no significant differences were observed in the IL-10, MCP-1,
and the TNF-α production post-treatment with RB phenolic extracts (data not shown). Previous studies
have also revealed that nitric oxide levels in LPS-induced RAW264.7 macrophages can be suppressed
via treatment with extracts that have a high polyphenol content [28]. Rheosmin, a naturally occurring
phenolic compound, was noted to dose-dependently suppress nitric oxide production by inhibiting the
activity of NF-κB [29]. Moreover, it is also believed that nitric oxide inhibition by phenolic compounds
may be achieved as a result of the substitution of the hydroxyl functional group [28]. Polyphenols
are known to favourably modulate the activity of arachidonic acid metabolizing enzymes such as
cyclooxygenase (COX), lipoxygenase (LOX) and nitric oxide synthase (NOS) [19]. The observed effect
on the alleviation of the nitric oxide levels could be a direct impact of the synergistic action of RB
polyphenols in inhibiting the key inflammation-mediating enzymes.
The results observed in this study demonstrate that RB phenolic compounds effectively
down-regulated the expression of IL-6, IL-12p70, and IFN-γ production in LPS-stimulated RAW264.7
cells. IL-12 is a heterodimeric interleukin that plays an important role in defence against intracellular
pathogens [30]. It is characterized by the high-level secretion of both IFN-γ and TNF-α [30]. IL-12p70
is one of the first pro-inflammatory cytokines released after antigens from the foreign agents, apparent
in the microenvironment, and the secretion of IL-12p70 cytokine is critical for the initiation and
polarization of the appropriate immune response [31]. IFN-γ is a cytokine that is critical for both
innate and adaptive immunity and is widely recognized for its pro-inflammatory capability against
infectious agents [32]. Furthermore, it is predominantly produced by natural killer cells and is known
to inhibit viral replication directly [33]. An essential mediator of the inflammatory signalling pathway
induced by LPS is a transcription factor known as a signal transducer and an activator of transcription 3
(STAT3) [34]. Activated STAT3 is recognized to translocate to the nucleus and regulate the transcription
of inflammation-related genes. Upon LPS stimulation, the activation of STAT3 through the IL-6
signalling pathway can be observed to result in increased IL-6 production [34]. Polyphenols have
been known to modulate the aforementioned pro-inflammatory products by inhibiting the enzymes
associated with pro-inflammatory effects (COX-2, LOX and NOS); MAPK, protein kinase-C and
activated protein-1 activation; and NFkB inhibition [19]. It is believed that RB polyphenols, by virtue
of their structure-activity relationship and free radical scavenging attributes, might potentially target
the mechanisms detailed above. Further studies are warranted to understand the role of RB phenolic
extracts on specific molecular mechanisms associated with inflammation.
In the body, phytochemicals are processed as xenobiotics. This is because the human body is only
capable of distinguishing between nutrients and constituents that are not nutrients, and is unable to
differentiate between beneficial, neutral and toxic compounds. However, many of these phytochemicals
are known to activate the adaptive cellular response pathways to oxidative stress by acting as low-dose
stressors or pro-oxidants [35]. In the present study, treatment with lower doses of the RB phenolic
extract (25 μg/mL) was observed to have resulted in a more pronounced inhibitory effect to certain
markers compared to the higher doses (Figures 2–4). This occurs through a phenomenon known
as hormesis, a biphasic dose-response with stimulation in low-doses and inhibition in higher doses
(lesser activity) of the phytochemicals present in the RB extracts [36]. Furthermore, it is believed that
the oversaturation of phenolic compounds, though excreted via the portal circulation in vivo, could
result in the unfavourable activation of cellular signalling molecules . In addition, bioavailability is
another factor that needs to be considered, as the effect of any dietary compound is mainly influenced
by its bioavailability, or the proportion of the substance that actually enters the circulation when
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introduced into the body. Due to the remarkable diversity in the human population influenced by
genetics and/or medications, the appropriate bioavailable dosage may be significantly different [35].
Furthermore, future studies that compare the in vitro effect of crude RB phenolic extracts against
antioxidant/anti-inflammatory synthetic/therapeutic agents are warranted. This would also help
provide novel insights into potential mechanisms associated with the mode of action of natural
polyphenols in the pro-inflammatory process. Although the current study highlights the antioxidant
and anti-inflammatory properties of RB at physiologically attainable concentrations in vitro, it is
important to demonstrate similar effects in vivo due to the potential variation in the bioavailability of
polyphenol sub-classes and individual predisposition. Well controlled human dietary intervention
trials are warranted to confirm the thus observed in vitro impact of RB phenolic compounds.
5. Conclusions
This study highlights that RB phenolic extracts play a significant role in modulating the biomarkers
of oxidative stress and inflammation in an oxidative stress/inflammatory environment in vitro. It is
believed that the RB phenolic compounds, via their synergistic action, target pathways of inflammation
and oxidative stress through their free radical scavenging potential, and modulate pro-inflammatory
cytokine expression. The outcomes of this study suggest that RB phenolic extracts may potentially
be used as a functional food alternative and could have preventive or therapeutic implications in
chronic oxidative stress and inflammatory conditions. Further in vivo investigations that evaluate the
bioactivity of RB phenolic extracts in pro-inflammatory populations are warranted.
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ANOVA Analysis of variance
COX Cyclooxygenase
DMSO Dimethyl sulfoxide









MAPK Mitogen-activated protein kinase
MCP-1 Monocyte chemoattractant protein 1
NOS Nitric oxide synthase
NF-κB Nuclear factor kappa-light-chain-enhancer of activated B cells
RB Rice bran
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STAT3 Signal transducer and activator of transcription 3
SD Standard deviation
TBA Thiobarbituric acid
TNF-α Tumor necrosis factor-α
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Abstract: Extraction, isolation and characterization of Andrographis paniculata (A.p.) products
were developed. Three natural diterpenes compounds were obtained and one was used for
chemical modifications. Evaluation of their inhibition of TNFα induced NFκB transcriptional activity.
A rapid analytical method for the determination and quantitation of three diterpenoid lactones
(andrographolide 1, didehydroandrographolide 2, neoandrographiside 3) found in A. paniculata
extracts was investigated. After some optimizations on column type and injection solvent,
the separation was achieved in 9 min on a monolithic Chromolith Performance RP18e column
(100 mm × 4.6 mm ID, 2 μm), with a gradient solvent system of water and methanol, UV detection at
220 nm and ELSD detection. The method was proved to be suitable for the quantitation of these three
diterpenes in four different commercial Andrographis dietary supplements. The anti-inflammatory
activities of a mixture of known composition have been evaluated showing differences in activity
depending on the relative ratio of various diterpenes and also a possible synergic activity for some
of them.
Keywords: andrographolide; reversed-phase liquid chromatography; quantitative analysis; method
validation; anti-inflammatory activity
1. Introduction
Andrographis paniculata (Acanthaceae) (A.p.) is widely used as medicinal herb in traditional
medicine [1–3]. Diterpenoid lactones isolated from these extracts have been the subject of
intensive investigations and are reported to exhibit a wide spectrum of biological activities,
including antibacterial [4], anti-inflammatory [5–8], hepatoprotective [9–11], neuroprotective [12],
cardioprotective [13,14] and anticancer properties [15,16]. Andrographolide 1 (Figure 1) has been
reported to be the main active compound in the plant [17,18]. Its structure and stereochemistry have
been determined over many years using chemical and spectroscopic techniques [19], and its crystal
structure was characterized [20]. Other minor diterpenoid lactones also have been isolated from the
plant, and their structures have been investigated [21] but their activities are not well studied. Studies
about the pharmacological mechanism of its known anti-inflammatory actions have shown in 2004
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that andrographolide attenuates inflammation by inhibition of NFκB activation through a covalent
modification of reduced cysteine [22].
Figure 1. Structure of natural the compounds.
Considering the numerous biological applications of these compounds, commercial sources of
preparations based on different parts of the plant have been available for a few years. However, the box
does report if the given contents concern the major Compound 1 or the whole family of diterpenes,
and the method of preparation. It is well-known that the composition could change depending on
the origin and the season of gathering and on the part of plant studied (roots, leaves, stem, etc.).
Nevertheless, a variation in the ratio of Compound 1 as well as related compounds had not been
investigated and could lead to a change in therapeutic values. Considering that the composition of
these dietary supplements is unclear and in order to control their quality, it appeared to be important
for us to be able to quantify the composition of such commercial preparations, in order to connect their
chemical composition with the anti-inflammatory activities generated by these commercially available
preparations (Figure 2).
Figure 2. Composition of dietary supplements of natural compounds and pharmacomodulation.
HPLC is the most frequently used chromatographic technique in the laboratory setting.
Some qualitative HPLC analyses have been reported in literature for these compounds [23,24].
HPTLC assays of A.p. extracts based on the quantification from spot UV visualizations have been
described by Srivastava [25]; however, the extraction solvent influences the amount and nature of
the extracted compounds and methanol leads to better extraction yields than chloroform or ethyl
acetate. In addition, these methods often take long times and/or specific instrumentation. A few
years ago, some groups developed a new rapid method for the determination of andrographolide
in mixtures [24,26–28]. To complement these methods, we have developed a rapid and simple
method for the separation and quantitation of andrographolide 1, didehydroandrographolide 2 and
neoandrographiside 3. Based on the literature [23], using an Altima RP C18 column, an optimization
of the elution gradient allowed us to obtain a better separation of the compounds present in the plant.
Then we used a column dedicated to fast analysis of samples, the Chromolith Performance RP-18e
column. This type of column allows to work at higher flow rates than with conventional columns
of the same diameter without loss of efficiency or excessive increase in pressure. To assess to this
work, the developed method was applied to four commercial preparations containing between 4% and
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10% of andrographolides according to the labeling. Finally, the NFκB inhibition of these preparations
was evaluated.
2. Materials and Methods
2.1. Chemicals and Reagents
Methanol from SDS Carlo Erba (Val de Reuil, France) and water purified (resistance < 18 MΩ)
from ultra-pure water using an Elgastar UHQ II system (Elga, Antony, France) were used for the HPLC
mobile phase and to prepare the stock solutions of analytes. Methanol from Sigma Aldrich (Steinheim,
Germany) was used for the extraction and purification of crude extracts. Chloroform from SDS Carlo
Erba (Val de Reuil, France) was used for purification of crude extracts.
2.2. Instrumentation and Conditions
An Agilent HP 1100 system (Waldbronn, Germany) with a 20 μL loop, coupled to a Kontron
Ultra-Violet (UV) detector (Zurich, Switzerland) and piloted by EZchrome Elite workstation
software was used. LC separation was performed on a Chromolith Performance RP-18e column
(100 mm × 4.6 mm ID, 2 μm) provided by Merck (Darmstadt, Germany), with a gradient system
containing water as solvent A and Methanol as solvent B, using solvent B from 40% to 51% over 9 min,
at 3 mL·min−1. To avoid any peak tailing and samples precipitation, they were injected in a mixture
of water:methanol of 80:20. Detection was done by UV at 220 nm, and by ELSD giving the profile
shown in Figure 3 where we can see the detection of the three main compounds present in the plant:
andrographolide 1, didehydroandrographolide 2 and neoandrographiside 3.
Figure 3. Chromatogram of the crude extract of Andrographis from sample A. Chromolith Performance
RP-18e (100 × 4.6 mm ID, 2 μm); solvent A: water; solvent B: MeOH; gradient conditions: solvent B
from 40% to 51% over 9 min, at 3 mL min, room temperature. (a) UV at λ = 220 nm, (b) ELSD.
2.3. Extraction Procedure
Commercial Andrographis products, all in the form of tablets, were obtained from online dietary
supplements shops. To protect the manufacturer’s identity, the samples were labeled with letters A–D.
Extraction of diterpenoid lactones from tablets A–D was performed with a methanol ratio 15 mg·mL−1,
and the sample was sonicated at room temperature for 60 min. The mixture was filtered through
filter paper (Whatman #1) and the residue was returned to the sample vial. The above extraction
procedure was repeated two more times. The combined methanol extracts were evaporated under
reduced pressure to give a green powder as the crude extract.
2.4. Preparation of Pure Compounds
External standards were obtained after purification of crude extracts from sample A by flash
chromatography over silica gel (Geduran® Si 60, Merck), with an elution gradient of methanol from 3%
to 15% in chloroform [29]. Maximal absorbance wavelengths were 250 nm and 224 nm for Compounds
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1 and 2, respectively, whereas Compound 3 absorbed up to 220 nm. The purity of the compounds was
determined by HPLC with an Altima RP C18 column and gradient system containing water as solvent
A and MeOH as solvent B, using solvent B from 20% to 100% over 45 min, at 1 mL·min−1. Using UV
and ELSD detection and washing the column for 10 min with MeOH, purity of each compound has
been estimated to be superior to 99%. Further identification by NMR spectroscopy (1H, 13C, 1D,
2D) and LC-ESI-MS ([M + H]+, [M − H]−) were necessary to confirm the structures, and the results
are in agreement with the literature and listed in the Results and Discussion section (Section 3.4).
Semi-synthetic compounds from 4 to 7 (Figure 4) were obtained by treatment of 1 according to the
procedure described in the literature [30] (Scheme 1).
 
Figure 4. Structures of chemically modified derivatives.
 
Scheme 1. Modification of andrographolide.
Compound 7 came from the standard isomerization of Compound 5 and the semi-synthetic
Compounds 8 and 9 were obtained after treatment of 1 with MeONa in MeOH [31] at room temperature
(Scheme 2) according to the mechanism proposed in Scheme 3.
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Scheme 2. Opening of the lactone.
Scheme 3. Proposed mechanism for formation of Compounds 8 and 9.
2.5. Standard and Sample Preparation
Stock solutions of each compound were prepared by dissolving them in methanol to obtain
a 1 mg·mL−1 solution. Five calibration solutions were prepared by mixing the stock solution in a
suitable proportion of water and methanol to have a final composition of injection solvent equal to a
water:methanol of 20:80. The five concentrations were 50, 100, 125, 150 and 200 μg·mL−1 for Compound
1, 50, 75, 100, 150 and 200 μg·mL−1 for Compound 2, and 5, 10, 20, 40 and 50 μg·mL−1 for Compound 3.
Sample preparations were made according to the following procedure: About 1 mg of crude extract
was accurately weighted and methanol was added to obtain a 1 mg·mL−1 solution. This solution was
diluted with a water:methanol ratio of 20:80 to a final concentration of 0.5 mg·mL−1.
2.6. NFκB-Dependent Luciferase Activity Assay
A549/NFκB-luc cells were obtained by co-transfection of A549 cells (ATCC P/N CCL-185) with
pNFκB-luc (Panomics P/N LR0051) and pHyg followed by hygromycin selection. These cells were
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obtained from Panomics and they maintain a chromosomal integration of a luciferase reporter gene
regulated by multiple copies of NFκB response elements. They were cultured in DMEM medium
supplemented with 10% FBS in presence of 100 μg/mL of hygromycin, 100 units/mL of penicillin and
100 μg/mL of penicillin and streptomycin, respectively. The NFκB-promoter luciferase reporter was
used to assay the activity of NFκB activation. Stock solutions of samples were prepared in dimethyl
sulfoxide (DMSO) with a concentration of 10 mg/mL. A549/NFκB-luc cells were incubated in with
samples or its solvent and stimulated with TNFα (10 ng/mL, Sigma, Saint Quentin Fallavier Cedex,
France) in 1 mL culture medium. After 24 h, the luciferase level was measured by luminescence.
Cells were washed with PBS and centrifuged (7 min, 1500 rpm). After elimination of the supernatant,
the homogenization buffer (0.2 mL of 8 mM MgCl2, 1 mM dithiotreitol, 1 mM Ethylenediaminetetraacetic
acid (EDTA), 15% glycetol, 1% Triton X-100, 25 mM Tris-phosphate buffer pH 7.8) was poured into each
well. The tissue culture plates were shaken and kept at 20 ◦C for 10 min. The solution was recovered
and centrifuged (10 min, 3000 rpm). ATP (95 μL of a 2 mM solution of homogenization buffer without
Triton-X100) was added to 60 μL of supernatant and vigorously mixed. Luminescence was recorded
for 4 s using a luminometer (LUMAT LB 9501, Berthold, Wildbach, Germany) upon addition of 0.15 mL
of 167 mM luciferin solution in water. The relative luciferase activity can be given to evaluate the
inhibition of NFκB.
2.7. Assay Validation, Linearity of Calibration and Limit of Quantification (LOQ)
Calibration standards were prepared at five concentration levels from 50 to 200 μg·mL−1 for 1 and
2, and from 5 to 50 μg·mL−1 for 3. Every calibration standard was injected in triples, on three different
days. The nine replicates were then pooled. The linearity of the response was evaluated by plotting
calculated against theoretical concentrations to represent the linearity of the method; slopes appeared
to be near to 1, and the intercept near to 0; R2 for 1, 2 and 3 were evaluated at 0.9991, 0.9997 and 0.999,
respectively. The calibration curves were estimated to be linear using this model, and the area of the
peak corresponding to one compound was proportional to its concentration. The LOQ was defined as
the lowest concentration on the calibration curve with a standard deviation in the tolerance domain of
5% for precision and accuracy. A LOQ of 1, 2 and 3 was 10, 32 and 5 μg·mL−1, respectively.
2.8. Assay Validation—Precision
Intra-day precision was determined by assaying three replications of samples at five different
concentrations levels. The results were used to construct the calibration curves. Inter-day precisions
were assessed by assaying three standard mixtures freshly prepared once a day over three days (J1,
J2, J4). The precision of the method was calculated as the relative standard deviation (RSD) of the
concentration determined in all replicates. Intra-day and inter-day precision (RSD) were 0.16% and
0.24% for andrographolide (25 μg/mL), 0.85% and 0.68% for didehydroandrographolide (100 μg/mL)
and 0.76% and 0.68% for neoandrographiside (20 μg/mL).
2.9. Assay Validation—Accuracy
Accuracy was determined by analyzing three replicates at 125, 100 and 20 μg/mL for 1, 2 and 3,
respectively, once a day over three days. A fresh mixture was prepared each day. The accuracies were
assessed by comparing the determined concentrations with the nominal concentrations. We found that
the repeatability of the method was below 2% RSD and the accuracy of the method was 99.9%–101.5%,
reliable with a tolerant deviation of 5%.
3. Results and Discussion
3.1. Effects of Isolated and Modified Compounds on TNFα Induced NFκB Transcriptional Activation
Activation of A549 with TNFα increased NFκB transactivation luciferase activity and denoted as
(T+). No activation by DMSO was reported as (T−). The samples were tested with a concentration of
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25 μg/mL. The nine pure compounds and their inhibitory effects are shown in Figure 5. Inhibitory effects
are in purple for the natural compounds (Figure 1), and in green for semisynthetic derivatives (Figure 4,
Compounds 4 to 9).
Figure 5. Relative NFκB-luciferase activity of pure compounds from 1 to 9, 25 μg/mL.
The results obtained for Compounds 4 and 7 showed that a modification of the diol present on
the starting andrographolide did not change the anti-inflammatory activity. While, for Compounds
5, 6, 8 and 9, results showed that the modification of the lactone (5-membered ring) could lead to a
radical change in the anti-inflammatory activity. Indeed, Compound 8 did not significantly inhibit
NFκB transcriptional activity, aldehyde 6 showed the same activity than neoandrographiside and
Compound 5 showed the best inhibition of these nine derivatives.
In fact, previous experiments have shown that modification of the compound at the lactone level
(5-membered ring system) can modify the anti-inflammatory activity of andrographolide. In order
to understand the mechanism of inhibition of NFκB by andrographolide, andrographolide 1 was
treated with NHBoc-L-cysteine methyl ester. A Modification of NFκB by site-directed mutagenesis [22]
has shown that a cysteine residue would be involved in the formation of a covalent bond with
andrographolide. We therefore put andrographolide in the presence of a cysteine residue, in a buffered
medium approaching the biological environment, and we were able to isolate Compound 10, resulting
from the addition of cysteine on andrographolide, at 40% yield.
Compound 10 as shown in Figure 6 was isolated and tested for its biological effect. The results
showed that this compound did not inhibit NFκB transcriptional activity yet. This means that
andrographolide acts as a Michael acceptor in the inhibition of NFκB and that in Compound 10 the lack
of inhibition was due either to the absence of the acceptor, or to the steric hindrance of the compound









Figure 6. Structure of Compound 10 and relative NFκB-luciferase activity.
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This last result could explain why Analogue 6 kept a significant inhibition. In this compound,
addition of thiol is possible on carbonyl. Analogue 5 appeared to be the best Michael acceptor for the
inhibition of NFκB transcriptional activity.
3.2. Quantitation of Commercial Preparations
As it has been shown that Andrographis extracts could have a better immunostimulant activity than
andrographolide alone [32], we were interested in the difference of activity for mixtures with different
ratios in andrographolide derivatives. Consequently, the quantification method was applied to four
commercial preparations. The commercial samples were first extracted with methanol, as described in
the Materials and Methods section. The extraction yields of dry substance were 44%, 40%, 17% and 33%
for samples A to D, respectively. The four chromatograms were similar to those presented in Figure 3.
Concentrations determined by external standard quantitation method were presented in Table 1.
Table 1. Quantitation of three diterpenes in commercial preparations. Concentrations given in μg·mL−1
± SD.
Diterpene A B C D
1 176.7 ± 12 138.8 ± 0.2 82.0 ± 0.1 127.3 ± 0.3
2 95.5 ± 0.7 136.9 ± 3.6 96.1 ± 2.1 51.3 ± 0.3
3 18.3 ± 0.7 13.4 ± 0.4 26.4 ± 0.4 9.8 ± 0.3
As expected, the analysis proved that the compositions of the commercial preparations are not
the same. The dietary supplements B and C were reported to contain 10% Andrographis and it clearly
appeared that both samples did not contain the same quantity neither in 1 nor in the rest of the
compounds of the diterpenes family. Actually, B contains 10% andrographolide 1, and C contains 10%
of the three andrographolide derivatives 1, 2 and 3. Moreover, for the sample C, 1 is not the major
compound. This analysis showed that there is a real difference in the labeling information of dietary
supplements and the relative properties will not be the same.
3.3. Effects of the Extracts of Known Concentrations on TNFα Induced NFκB Transcriptional Activation
Using the quantitation of diterpenes in mixtures, we investigated the activity of herbal preparations
incubating the same quantity of andrographolide, and we standardized the final concentration of
andrographolide at 17 μg/mL. The results could show if there is a synergic or complementary effect of
several compounds in the extracts for the inhibition of NFκB. The results are presented in Figure 7 and
show that if the mixtures contain 1 as the major compound and only low amounts of 2 and 3 (as in A
and D), the inhibitory activity follows the activity of Compound 1. Nevertheless, for mixtures such as
B and C where the quantity of 2 is not negligible, the inhibitory activity increases.
Figure 7. Relative NFκB-luciferase activity of A, B, C and D with 17 μg/mL andrographolide.
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These results could explain those reported in the literature [31], showing that there were other
compounds than andrographolide in A. paniculata extracts that act as an immunostimulant, and we
proved herein that there was a complementary activity of 2 at the studied concentrations.
3.4. Characterization of Products 1, 2 and 3
Extracted compounds were characterized by standard spectral methods, NMR, mass Spectroscopy
(ESIMS) and high resolution mass spectroscopy (HRMS), and conform to already-described data [33].
1: 1H NMR (DMSO, 400 MHz) δ 6.62 (1H, dt, J11,12 = 7.0 Hz, J12,14 1.5 Hz, H12), 5.71 (1H, d, J14,OH
6.0 Hz, OH14), 5.05 (1H, d, J3,OH 5.0 Hz, OH-3), 4.91 (1H, t, J14,15 6.0 Hz, H14), 4.81 (1H, s, H17A),
4.62 (1H, s, 17B), 4.39 (1H, dd, J15A,15B 10Hz, J14,15A 6.0 Hz, H15A), 4.13 (1H, dd, J19B,OH 7.5 Hz,
J19A,OH 2.5 Hz, OH-19), 4.03 (1H, dd, J15A,15B 10.0 Hz, J14,15B 2.0 Hz, H15B), 3.84 (1H, dd, J19A,19B
11.0 Hz, J19A,OH 2.5 Hz, H19A), 3.29–3.20 (2H, m, H3, H19B), 2.46 (1H, m, H11A), 2.32 (1H, br d,
J7A,7B 13.0 Hz, H7A), 1.6–1.84 (2H, m, H7B, H11B), 1.75–1.61 (5H, m, H1A, H2, H6A, H9), 1.35 (1H,
dq, J6A,6B J6B,7B 13.0 Hz, J6B,7A 4.0 Hz, H6B), 1.23–1.17 (2H, H1B, H5), 1.08 (3H, s, H18), 0.66 (3H, s,
H20). 13C NMR (DMSO, 100 MHz) δ 170.8 (C16), 148.5 (C8), 147.2 (C12), 129.9 (C13), 109.2 (C17),
79.3 (C3), 75.2 (C15), 65.4 (C14), 63.6 (C19), 56.4 (C9), 55.3 (C5), 43.1 (C10), 39.5 (C4), 38.4 (C7),
38.1 (C11), 37.4 (C1), 28.8 (C2), 24.8 (C6), 24.0 (C18), 15.6 (C20). ESIMS (negative mode) m/z
331 [M-H2O]−, 349 [M-H]−, 395 [M-H+HCOOH]−, (positive mode) 351 [M+H]+, 373 [M+Na]+.
HRMS: calcd for C20H31O5 [M+H]+ 351.2167, found 351.2166.
2: 1H NMR (DMSO, 400 MHz) δ 7.65 (1H, brs, H14), 6.74 (1H, dd, J11,12 15.5 Hz, J9,11 10.0 Hz, H11),
6.12 (1H, d, J11,12 15.5 Hz, H12), 5.03 (1H, d, J3,OH 5.0 Hz, OH-3), 4,89 (2H, brs, H15), 4.73 (1H,
s, H17A), 4.42 (1H, s, H17B), 4.12 (1H, t, JOH,19B 6.5 Hz, OH-19), 3.84 (1H, dd, J19A,19B 13.0 Hz,
J19A,OH 5.0 Hz, H19A), 3.28–3.16 (2H, m, H3, 19B), 2.36–2.32 (2H, m, H9, H7A), 1.97 (1H, m, H7B),
1.72 (1H, m, H2A), 1.58–1.54 (2H, m, H2, H6A), 1.40 (1H, dd, J6A,6B 13.0 Hz, J6B,7B 4.0 Hz, H6B),
1.28–1.12 (2H, m, H1), 1.07 (3H, s, H18), 0.76 (3H, s, H20). 13C NMR (DMSO, 100 MHz) δ 172.9
(C16), 149.5 (C8), 147.2 (C14), 134.7 (C11), 127.5 (C13), 121.6 (C12), 108.5 (C17), 79.1 (C3), 63.1 (C19),
61.0 (C9), 54.2 (C5), 42.8 (C4), 38.4 (C1), 36.7 (C7), 29.4 (C10), 28.1 (C2), 23.6 (C6), 23.4 (C18),
15.9 (C20). ESIMS (negative mode) m/z 331 [M-H]−, 377 [M-H+HCOOH]−, (positive mode) 355
[M+Na]+. HRMS: calcd for C20H28O4 [M+Na]+ 355.2035, found 355.2036.
3: 1H NMR (DMSO, 400 MHz) δ7.46 (1H, s, H14), 4.86–4.78 (6H, 3OH, H15, H17A), 4.59 (1H, s,
H17B), 4.38 (1H, t, J6′,OH 6.0 Hz, OH-6’), 4.02 (1H, d, J1′,2′ 8.0 Hz, 3.88 (1H, d, J19A,19B 10.0 Hz,
H19A), 3.63 (1H, dd, J6′A,6′B 10.5 Hz, J5′,6′A 6.0 Hz, H6A), 3.43 (1H, dd, J6′A,6′B 10.5 Hz, J5′,6′B 5.0
Hz, H6B), 3.17–3.04 (3H, m, H3’, H4’, H5’), 2.92 (1H, m, H2′), 2.36–0.90 (16H, m, H1, H2, H3, H5,
H6, H7, H9, H11, H12), 0.95 (3H, s, H18), 0.61 (3H, s, H20). 13C NMR (DMSO, 100 MHz) δ 174.6
(C16), 148.1 (C8), 147.4 (C14), 132.6 (C13), 107.0 (C17), 104.0 (C1’), 77.3, 77.1, 70.6 (C3’, C4’, C5’),
74.0 (C2’), 71.2 (C15), 70.9 (C19), 61.5 (C6’), 56.1 (C9), 55.8 (C5), 38.8, 38.4, 36.1, 21.9, 19.0 (C1, C2,
C3, C6, C7, C11, C12), 38.3 (C4), 28.0 (C18), 24.4 (C10), 15.6 (C20). ESIMS (negative mode) m/z
479 [M-H]−, 525 [M-H+HCOOH]−, (positive mode) 503 [M+Na]+. HRMS: calcd for C26H41O8
[M+H]+ 481.2795, found 481.2796.
4. Conclusions
The isolation of natural andrographolide derivatives allowed to modify their structure and to
study the inhibition of NFκB transcriptional activity of pure analogues. Compound 5 highlighted the
best anti-inflammatory activity from the nine tested derivatives. The HPLC quantitation method has
been developed in order to quantify three major diterpenes in A. paniculata extracts. This method was
applied for the quantitation of four commercial herbal preparations. The composition was compared
to the inhibitory activity of NFκB of such preparations and showed that even if andrographolide 1 is
the major and more potent active compound in the plant, the amount of didehydroandrographolide 2
is not negligible.
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Abstract: This study was investigated to evaluate the antioxidant activity, the angiotensin I-converting
enzyme (ACE) inhibition effect, and the α-amylase and α-glucosidase inhibition activities of hot
pepper water extracts both before and after their fermentation. The fermented pepper water extract
(FP) showed significantly higher total phenol content, 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical
inhibition effect, metal chelating activity and ACE inhibition activity compared to the non-fermented
raw pepper water extract (RP) (p < 0.05). Meanwhile, the FP showed lower α-amylase and higher
α-glucosidase inhibitory activities, but the RP showed similar levels of α-amylase and α-glucosidase
inhibitory activities. Taken together, these results suggested that fermented pepper extract using water
should be expected to have potentially inhibitory effects against both hyperglycemia and hypertension.
Keywords: pepper; fermentation; hyperglycemia; angiotensin I-converting enzyme (ACE) inhibition;
antioxidant
1. Introduction
Hypertension is a condition of oxidative stress, therefore a decline in the antioxidant system can
be fatal in hypertension patients, which can cause atherosclerosis and other hypertension-induced
organ injuries [1]. Several researchers have reported the side effects of artificial antioxidants such
as potential health hazards, for example, carcinogens [2,3]. Additionally, concerns about synthetic
products have caused increasing interest in natural antioxidants made from food or other bioresources.
Recently, there has been active interest in the research-based development of natural antioxidants such
as vitamin E and ascorbic acid [3–5].
Meanwhile, angiotensin I is activated by renin secreted from the kidney; and angiotensin
I-converting enzyme (ACE) changes angiotensin I to angiotensin II [6]. Angiotensin II leads to
cardiovascular disease and vasoconstriction [7]. There are two kinds of prescription for treating
hypertension—angiotensin converting enzyme inhibitor (ACEI) and angiotensin receptor blocker
(ARB). Mostly, ACEI is used first with patients, because ACEI significantly reduces all-cause mortality
at a rate greater than that of ARB [8,9]. Lee et al. [7] reported that general ACEI—such as captopril,
quinapril, enalapril, lisinopril—has side effects such as cough, hypotension, and inflammatory
response [10]. Therefore, the development of treatments having no side effect is needed, and much
research along these lines has been reported [11,12].
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α-amylase and α-glucosidase are related to the hydrolysis of dietary carbohydrates and the
absorbance of glucose from the small intestine to the blood, respectively [13,14]. Control of these
enzymes can play a key role in treating patients with diabetes mellitus [6,13]. Several inhibitors of these
enzymes—such as acarbose, trestatin, and amylostatin—have recently shown adverse effects such
as abdominal distention and meteorism [15]. This occurs because of the fermentation of undigested
carbohydrates by anaerobic bacteria in the colon [13,16,17]. Thus, comparatively riskless inhibitors
should be developed.
Pepper is currently being widely used for cooking in both traditionally and contemporary cuisine,
and it contains a variety of phytochemicals such as capsaicin and ascorbate [18]. Capsaicin has an
anti-obesity effect [19], can be used as an analgesic [20], and is an antioxidant [21]. However, due to its
pungency, it is difficult to use it as a food additive in the food industry. In our previous studies, pepper
fermented by Bacillus licheniformis showed significantly decreased capsaicin content, and pungency
was decreased also, and this microorganism can utilize capsaicin as an energy source [22–24].
This study was performed to evaluate the antioxidant activity and the key enzyme inhibition
effects related with hypertension and diabetes mellitus using fermented pepper, for the purpose of
developing new functional food ingredients.
2. Materials and Methods
2.1. Materials
The pepper was obtained from a local market (Hwayang-dong, Seoul, Korea). All reagents were
obtained from Sigma-Aldrich (St. Louis, MO, USA).
The pepper was blended and freeze dried. To prepare fermented pepper, 40 g of powdered pepper
was mixed with 1 L of distilled water. After sterilization, the sample was inoculated with 5% of Bacillus
licheniformis SK1230. It was then incubated for 11 days at 37 ◦C in a shaking incubator (Jisico, J-SIL-R,
Seoul, Korea). After fermentation, the fermented pepper was freeze dried. For the raw pepper, the
same amount of sterilized (inactive) Luria–Bertani (LB) broth (NaCl 10 g/L, tryptone 10 g/L, and yeast
extract 5 g/L) was added (to substitute for the presence of microorganism), then freeze dried. Powdered
raw pepper and fermented pepper were stored at −20 ◦C before use and were used as samples in this
experiment. According to previously reported capsaicin analysis method [22], the amount of capsaicin
in raw hot pepper was 1.31 mg/g and that of fermented pepper was significantly decreased to 1.20 mg/g
(p < 0.05).
To prepare the ACE solution, 1 g of commercial rabbit lung acetone powder (Sigma-Aldrich,
St. Louis, MO, USA) in 10 mL buffer (0.05 M Na2B4O7 : 0.2 M H3BO3 = 135 : 165, pH 8.3) was stirred at
4 ◦C for 24 h in dark room. Then, it was centrifuged at 12,000 rpm for 30 min. The supernatant was
used as the ACE solution [25].
Dinitrosalicylic acid (DNS) reagent was prepared by mixing 1 g of DNS with 50 mL of distilled
water. Then, 30 g of sodium potassium tartrate tetrahydrate was slowly added. 20 mL of 2 N NaOH
was also added to the mixture, and distilled water was added until the mixture totaled 100 mL [26].
2.2. Extraction
The extract was prepared by means of a modified method published by Kwon et al. [13]. Of the
sample 0.4 g was extracted with 10 mL of distilled water, over a period of 3 h. After centrifuging at
9300× g for 10 min, the supernatant was filtered using Whatman filter paper No. 2, and it was used for
experimentation. (The “raw pepper water extract” and the “fermented pepper water extract” were
expressed as RP and FP in this study, respectively.)
2.3. Total Phenol Compounds Content
The total content of the phenol compounds was determined according to literature [27]. Of the
extract 30 μL was mixed with the same amount of 95% ethanol, 150 μL of distilled water, and 15 μL
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of 1 N Folin–Ciocalteu reagent. This mixture was allowed to react for 5 min, after which time 5%
Na2CO3 30 μL was added. After 1 h, absorbance was measured at 725 nm. Gallic acid was used to
establish a standard curve, and results were expressed as mg of gallic acid equivalents per gram of
dried sample weight.
2.4. 1,1-Diphenyl-2-Picrylhydrazyl (DPPH) Radical Scavenging Activity
DPPH (1,1-diphenyl-2-picrylhydrazyl) radical scavenging activity by Blois [28] were performed
to evaluate antioxidant activity of the extract. Of the extract, 20 μL was reacted with 180 μL of 0.1 mM
DPPH in a 96 well plate. The absorbance was recorded at 517 nm after 30 min in a dark room. Ethanol,
instead of extract, was used for the control. DPPH radical inhibition was calculated by:
Inhibition (%) = (1 − A517(extract)/A517(control)) × 100 (1)
2.5. Metal Chelating Activity
Another antioxidant activity of extract was performed by metal chelating activity [29]. Of the
extract, 100 μL was mixed with 50 μL of 2 mM ferrous chloride, and the reaction was started by adding
0.2 mL of 5 mM ferrozine. Then, absorbance was recorded at 562 nm after 10 min in a dark room.
Distilled water, instead of extract, was used for the control. Metal chelating activity was calculated by:
Inhibition (%) = (1 − A562(extract)/A562(control)) × 100 (2)
2.6. Angiotensin I-Converting Enzyme (ACE) Inhibition Effect
The ACE inhibition effect was performed by Chushman et al.’s method [25]. An extract of 40 μL,
12.5 mM of hippuryl-histidyl-leucine in an 80 μL buffer (0.05 M Na2B4O7 : 0.2 M H3BO3 = 135 : 165,
0.4 M NaCl, pH 8.3) and an ACE solution of 80 μL was reacted for 30 min in a 37 ◦C water bath. Then,
200 μL 1 N HCl was added to stop the reaction. Ethylacetate (1.2 mL) was added, and the mixture
was vortexed for 5 min. After centrifugation at 3000 rpm for 15 min, the supernatant of 0.8 mL was
allowed to stand at 90 ◦C for removal of ethylacetate. After that, the residue was mixed with 2.4 mL of
distilled water, and the absorbance was recorded at 228 nm (OPTIZEN 2120UV, Mecasys Co. Ltd.,
Daejeon, Korea). The blank contained HCl from the beginning to prevent the reaction of substrate and
enzyme. Distilled water, instead of extract, was used for the control. The ACE inhibition activity was
calculated as below:
Inhibition (%) = (1 − (A228(extract) − A228(extract blank))/(A228(control) − A228(control
blank))) × 100 (3)
2.7. α-Amylase Inhibition Effect
The α-amylase inhibition effect was evaluated by a modification of the assay described by the
Worthington Enzyme Manual [26]. Of the extract, 30 μL and 0.02 M of sodium phosphate buffer (pH 6.9)
containing 400 U/mL of α-amylase was mixed and pre-incubated at 25 ◦C for 10 min. After adding
30 μL of 1% starch solution in 0.02 M sodium phosphate buffer (pH 6.9) to the mixture, it was stored at
25 ◦C for 10 min. To stop the reaction, 60 μL of DNS color reagent was added. Then, it was allowed
to stand in a boiling water bath for 5 min, prior to cooling to room temperature. After dilution with
distilled water in the amount of 0.4 mL, absorbance was read at 540 nm. Only 0.02 M sodium phosphate
buffer (pH 6.9), instead of buffer containing α-amylase and extract, was used for the blank and the
control, respectively. Percentage of inhibition was calculated as follows:
Inhibition (%) = (1 − (A540(extract) − A540(blank))/A540(control)) × 100 (4)
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2.8. α-Glucosidase Inhibitory Activity
The α-glucosidase inhibitory activity was measured by the modified method of Ranilla et al. [6].
Of the extract, 50 μL and 0.1 M potassium phosphate buffer (pH 6.9) containing 1 U/mL of
α-glucosidase, was mixed and pre-incubated at 25 ◦C for 10 min. After adding 50 μL of 5 mM
p-nitro-phenyl-α-D-glucopyranoside in a 0.1 M potassium phosphate buffer (pH 6.9) to the mixture,
absorbance was measured at 405 nm. Then, after incubating the mixture at 25 ◦C for 5 min, absorbance
was read at 405 nm. Potassium phosphate buffer (0.1 M, pH 6.9), in the place of extract, was used for
control. Inhibitory activity was calculated as below:
Inhibition (%) = (1 − (ΔA405(extract))/ΔA405(control)) × 100 (5)
2.9. Statistical Analysis
All results were stated as mean ± standard error of mean (SEM) and, analyzed by t-test using
SPSS 18.0 (SPSS Inc., Chicago, IL, USA). The experiments were performed in triplicates. Significant
difference was evaluated by p < 0.05.
3. Results
3.1. Amount of Total Phenol Contents
Total phenol contents in extracts from raw and fermented peppers varied from 150 to 250 μg/mL
(Table 1), and it was similar to the range reported by Kwon et al. [18]. The total phenol content of FP
was 40% higher than that of the raw pepper extract significantly (p < 0.05).




(gallic acid μg/mL) 156.47 ± 2.12 b 224.55 ± 2.51
a
RP, raw pepper extract prepared using water. FP, fermented pepper extract prepared using water. a,b Superscripts
with different letters indicate significant difference (p < 0.05).
3.2. Antioxidant Activity
Antioxidant activities were determined by both DPPH radical inhibition assay and metal chelating
assay (Table 2). The FP showed significantly higher radical inhibition activity and chelating activity
than did those of the RP (p < 0.05). Meanwhile, metal chelating activity was significantly higher than
DPPH radical inhibition activity in both RP and FP (p < 0.05).
Table 2. Antioxidant activities of raw and fermented pepper extracts.
RP FP
DPPH radical inhibition (%) 52.00 ± 0.28 b B 66.12 ± 0.72 a B
Metal chelating activity (%) 67.32 ± 0.75 b A 71.99 ± 0.82 a A
RP, raw pepper extract prepared using water. FP, fermented pepper extract prepared using water. DPPH:
1,1-diphenyl-2-picrylhydrazyl. a,b Superscripts with different letters indicate significant difference between RP and
FP (p < 0.05). A,B Superscripts with different letters indicate significant difference between DPPH radical inhibition
and metal chelating activity (p < 0.05).
3.3. ACE Inhibition Effect
The inhibition rate of angiotensin I-converting enzyme is exhibited in Table 3. The water extract
of fermented pepper showed a significantly higher inhibition rate as compared to that of raw pepper
extract (p < 0.05).
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Table 3. Angiotensin I-converting enzyme (ACE) inhibition effects of raw and fermented water-prepared
pepper extracts.
RP FP
ACE inhibition (%) 54.29 ± 0.71 b 71.04 ± 0.58 a
RP, raw pepper extract prepared using water. FP, fermented pepper extract prepared using water. ACE: angiotensin
I-converting enzyme. a,b Superscripts with different letters indicate significant difference (p < 0.05).
3.4. α-Amylase Inhibition and α-Glucosidase Inhibitory Activity
α-amylase and α-glucosidase inhibition activity were seen in the RP and FP (Table 4). Fermented
pepper extract exhibited significantly lower α-amylase and α-glucosidase inhibition rates than the RP
(p < 0.05). Meanwhile, α-amylase and α-glucosidase inhibition activity in RP were similar each other
(p > 0.05), but in FP, low α-amylase and high α-glucosidase inhibition activity were shown significantly
(p < 0.05).
Table 4. Inhibition rates of α-amylase in raw pepper water extract (RP) and fermented pepper water
extract (FP).
RP FP
α-amylase inhibition (%) 25.15 ± 0.27 a NS 8.26 ± 0.16 b B
α-glucosidase inhibition (%) 24.32 ± 0.86 a 14.47 ± 0.67 b A
RP, raw pepper extract prepared using water. FP, fermented pepper extract prepared using water. a,b Superscripts
with different letters indicate significant difference between RP and FP (p < 0.05). A,B Superscripts with different
letters indicate significant difference between amylase and glucosidase inhibition (p < 0.05). NS Not significant
between amylase and glucosidase inhibition (p > 0.05).
4. Discussion
Consistent with this study, Sim and Han [30] reported that the amount of phenolic compounds
derived from red pepper seed on Kimchi significantly increased during fermentation (p < 0.05).
Generally, phenolics exist as conjugated forms together with sugars or other moieties. Glucosidase
is related to the hydrolysis of glycosidic linkages, and it leads to the release of free phenolics [31].
In this study, glucosidase inhibition activity of FP decreased significantly as compared to that of the RP
(Table 4, p < 0.05). This means that the FP had higher glucosidase activity than the RP. Therefore, it
suggested that it resulted in the release of free phenolics with increasing glucosidase activity during
fermentation of the pepper.
Meanwhile, antioxidant activity generally correlates with the amount of phenolic compounds.
Vattem et al. [31] reported that total phenolics and antioxidant activity correlated positively with
glucosidase activity. Accordingly, significantly higher DPPH radical inhibition effect in the FP was
suggested due to a higher total phenolics level and a lower glucosidase inhibition rate in comparison
to the RP (Tables 1 and 4, p < 0.05). There were several ways to protect oxidation. Elimination of over
produced free radicals which can react with biomolecules and cause chronic diseases [32] and heavy
metals by chelating agent from fermented pepper extract would be the way for antioxidation.
There have been several reports about ACE inhibition activities by fermented milk peptides [33],
flavanol-rich foods [34], and various fermented foods such as soy sauce, fish sauce, natto, and
cheese [35]. Actis-Goretta et al. [34] referenced that the ACE inhibition effect was related to amounts of
phenolics and flavanols. Meanwhile, Okamoto et al. [35] implied, on the basis of their research, that an
ACE inhibitor would be produced during fermentation. For example, cottage cheese—which has no
maturing step in the manufacturing process—did not show ACE inhibition activity. By contrast, red
cheddar, blue, and camembert cheese—all of which have a maturing process—showed ACE inhibition
effect. In this study, pepper exhibited a significantly higher amount of total phenolics after fermentation
(p < 0.05). A relationship with higher ACE inhibition activity than before fermentation has been
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suggested. Higher ACE inhibition means lower conversion of angiotensin I to angiotensin II, a potent
vasoconstrictor, and it seems to be a strategic treatment to protect against hypertension—which is a
representative complication of diabetes [6].
Ranilla et al. [6] recently reported that high phenolic-linked plants showed a high α-glucosidase
inhibition rate with a low activity of α-amylase. Consistent with this result, FP—having a higher
total phenol contents than the RP—had higher α-glucosidase inhibition activity with lower α-amylase
inhibition significantly (p < 0.05). Martin and Montgomery [36] referenced a finding that such a result
could have functionality regarding the potential controlling of glucose absorption and of adverse
effects from high α-amylase inhibition activity.
In this study, we fermented pepper for 11 days with the intention of “capsaicin decrease” not
“no capsaicin” in pepper for adjustable pungency. If the effect of fermented pepper is higher than
that of raw hot pepper, it is thought to be resulted from the degradation of the ingredient of capsaicin
or other fermentation by-product even if capsaicin remains in the fermented pepper. Indeed, the
chromatogram of fermented pepper showed a greater area in some peaks compared to that of raw hot
pepper (blue square in Figure 1) and what this compound is and whether it has functionality will be
studied in future.
Figure 1. The chromatogram of raw hot pepper and fermented pepper.
5. Conclusions
Fermented pepper extract using water was evaluated about antioxidant activity, ACE and enzymes
relevant for hyperglycemia inhibition effects. Results showed significantly higher total phenol contents,
DPPH radical inhibition activity, metal chelating activity, and ACE inhibition effect than those of RP
(p < 0.05). Furthermore, lower α-amylase and higher α-glucosidase inhibition effects in FP could have
inhibitory potential in diabetes. Therefore, it is suggested that water extract of fermented pepper
might be appropriate for a functional prevention ingredient of hypertension and hyperglycemia as a
natural resource.
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Abstract: Nature has generously offered a wide range of herbs (e.g., thyme, oregano, rosemary,
sage, mint, basil) rich in many polyphenols and other phenolic compounds with strong antioxidant
and biochemical properties. This paper focuses on several natural occurring phenolic acids (caffeic,
carnosic, ferulic, gallic, p-coumaric, rosmarinic, vanillic) and first gives an overview of their most
common natural plant sources. A summary of the recently reported antioxidant activities of the
phenolic acids in o/w emulsions is also provided as an in vitro lipid-based model system. Exploring the
interfacial activity of phenolic acids could help to further elucidate their potential health properties
against oxidative stress conditions of biological membranes (such as lipoproteins). Finally, this review
reports on the latest literature evidence concerning specific biochemical properties of the examined
phenolic acids.
Keywords: phenolic acids; emulsions; antioxidants; health properties
1. Introduction and Target of This Review
By “plant phenolics”, we refer to a wide range of natural compounds (e.g., anthocyanins,
flavonoids, phenolic acids etc.) with varying structural characteristics that modulate their antioxidant
activity and their subsequent health and biological effects [1,2].
The phenolic acids, in particular, offer an important group of powerful natural compounds
that having substantial lipid and water solubility can inhibit oxidative deterioration when added as
functional ingredients in emulsion model systems [3]. Research studies in this field have focused
on the free radical scavenging capacity of phenolic acids and more specifically on radical quenching
that can be validly measured through kinetic parameters [4]. Over the last decade, the food industry
has increasingly considered the use of natural phenolic antioxidants as an efficient strategy to retard
oxidative deterioration in food-based systems and thereby maintain their sensory characteristics [5,6].
In emulsified foods, (e.g., dressings, sauces, soups, and desserts) lipid oxidation can occur rapidly
due to their large surface area [7,8] with mechanisms that are more complex and not fully understood
compared to bulk oils [9,10]. Furthermore, the antioxidant activity in interfaces can be crucial not only
for developing novel food applications but also for further exploring their potential health properties
against oxidative stress [11]. Emulsion systems generally mimic the amphiphilic nature and the basic
structural characteristics of important biological membranes (e.g., lipoproteins) that are prone to
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oxidative degradation when attacked by singlet oxygen and free radicals [12]. A typical example of a
“bio-interfacial system” is offered by plasma lipoproteins, which are complex aggregates of lipids and
proteins that render the hydrophobic lipids accessible by the aqueous environment of body fluids and
thereby by reactive oxygen species potentially present [13]. The initiation of these harmful biochemical
processes leads to in vivo oxidative damage of biomolecules and ultimately the development of serious
human health conditions such as aging, carcinogenesis, and cardiovascular diseases [14,15].
This paper first examines in Section 2 the most common naturally occurring phenolic acids that can
be extracted from various plant sources, including edible herbs and well-known botanicals. In addition,
the authors provide a summary of the available research findings concerning the antioxidant activity
of each examined phenolic acid in o/w emulsion systems. Overall, in vitro research on the oxidative
stability and antioxidant effects of phenolic acids in model emulsions could provide useful background
knowledge and information of nutritional interest to support in vivo clinical trials.
In the last few years, an increasing body of clinical research has focused on the potential effects of
phenolic acids against the development of cancer, cardiovascular diseases, and other health disorders
(such as skin problems, inflammations, bacterial infections etc.). The main target of this publication
is to provide in Section 3 an overview of the most recent literature evidence concerning the health
beneficial effects of the examined phenolic acids.
2. Natural Sources and Antioxidant Activities of Phenolic Acids in Food Emulsions
This section provides a summary of the most important natural sources for a few common—in
nature and food—phenolic acids that are listed along with their chemical structure in Table 1. In parallel,
the authors have performed a literature search on the in vitro antioxidant activities of each examined
phenolic acid against the oxidation of oil-based emulsion systems.
2.1. Caffeic Cid (CA)
CA is a hydroxycinnamic acid structurally composed of both phenolic and acrylic functional
groups, the derivatives of which are trans in nature [16,17]. It is found at high levels in some herbs,
especially in the South American herb yerba mate (1.5 g/kg) [18], and thyme (1.7 mg/kg), [19]. In fruits
(such as berries, apples, and pears) CA was quantified in high amounts, representing together with
p-coumaric acid 75–100% of the total hydroxycinnamic acids [20]. Also, CA can be found in the bark
of Eucalyptus globulus [21] and was identified as the main phenolic constituent in coffee and coffee
oil [22]. Boke et al. (2019) [23] analysed samples of Cephalaria species using high-performance liquid
chromatography coupled with tandem mass spectrometry (HPLC-MS/MS) and determined CA as
major phenolic acid.
A few researchers have reported a clear antioxidant effect of CA in various Tween-based emulsions
prepared with linoleic acid [4] or other vegetable oils such as corn, flaxseed, and sunflower oils [24].
Sorensen et al. (2017) [25] observed that CA presents a clear antioxidant activity in Citrem-and
Tween-stabilised emulsions in the presence of endogenous tocopherols but acted as a prooxidant
in the absence of tocopherols. The authors suggested that the observed differences in antioxidant
efficiency with different emulsifiers (and with or without endogenous tocopherols) were caused due to
emulsifier–antioxidant interactions and antioxidant–antioxidant interactions in the emulsions.
2.2. Gallic Acid (GA)
GA (also known as 3,4,5-trihydroxybenzoic acid) is the main phenolic acid in tea [26] but also
found in high amounts in chestnuts and several berries [19]. It is encountered in a number of land
plants, such as the parasitic plant Cynomorium coccineum, the aquatic plant Myriophyllum spicatum,
and the blue-green alga Microcystis aeruginosa [27,28]. Very recently, Souza et al. (2020) [29] has isolated
gallic acid from black tea extract at a concentration around 0.8 mg/kg.
There is some contradictory evidence in the literature about the effect of GA against the oxidative
deterioration of emulsions. Bou et al. (2011) [30] did not see any statistically remarkable effect of
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GA following its addition in Tween-based sunflower o/w emulsions. Alavi Rafiee et al. (2018) [31]
reported that GA exerted a high antioxidant action in the bulk oils but showed lower activity in o/w
emulsions, highlighting the critical role of the carboxyl group and the effect of the degree of lipid
unsaturation in GA antioxidant activity. Di Mattia et al. (2009) [32] reported that GA contributed
to the colloidal stabilisation of the o/w emulsion systems, whilst exhibited a low activity towards
secondary oxidation. Zhu et al. (2019) [33], however, observed clear antioxidant effects—in terms of
peroxide values and hexanal content- of GA and its alkyl esters in o/w emulsions in the following
order of activity: propyl gallate > lauryl gallate > octyl gallate > gallic acid > stearyl gallate. In a
study by Wang et al. (2019) [34] GA or its alkyl esters were added in combination with α-tocopherol
in o/w emulsions. The results showed that all the tested gallate esters (propyl, octyl and dodecyl
gallate) exerted antioxidant activities combined with α-tocopherol, and propyl gallate, with the shortest
alkyl chain length, possessed the highest synergistic action. Other researchers have also observed
an enhancement of antioxidant activity of esterified GA derivatives in double emulsions by use of
encapsulation [35].
2.3. Rosmarinic Acid (RA)
RA is an ester of caffeic acid, present as the main phenolic component in several members of
the Lamiaceae family including among others: Rosmarinus officinalis, Origanum spp., Perilla spp.,
and Salvia officinialis [36,37]. A few researchers reported RA as the main phenolic acid of various
culinary herbs (oregano, thyme sage, and rosemary) in concentrations varying between 0.05 and 26
g/kg dry weight [38,39]. Additionally, the results of Tsimogiannis et al. [40] indicate an amount of
19.5 g/kg in the leaves of pink savory (Satureja thymbra L.).
A body of research has reported antioxidant activities of RA (in terms of both hydroperoxides and
volatiles formation) in o/w emulsions based on (i) corn oil and stabilised by various emulsifiers [41];
(ii) Tween-based emulsions prepared with linoleic acid [14] or soybean oil [42]. Bakota et al. (2015) [43]
incorporated both pure RA and RA-rich extract (from Salvia officinalis leaves), at a concentration
of ~30 mg/g, into o/w emulsions and observed that both treatments were effective in suppressing
lipid oxidation.
2.4. Carnosic Acid (CarA)
CarA is a labdane-type diterpene present in plant species of the Lamiaceae family, such as rosemary
and common salvia species [44]. CarA is commonly found in the dried leaves of sage in 1.5 to 2.5%
concentration [45]. CarA is used as a preservative in food and non-food products, e.g., toothpaste,
mouthwash, and chewing gum, since it is endowed with antioxidative and antimicrobial properties [46].
Through the pioneer work of Frankel et al. (1996) [47], CarA was reported to exhibit an antioxidant
activity in emulsions that was enhanced at pH 4–5. The following years, several studies used
extracts from rosemary and other Lamiaceae family herbs in emulsions and attributed the antioxidant
activity mainly to CarA and carnosol [48,49]. Very recently, Lei et al. (2019) [50] have developed a
α-tocopherol-based microemulsion aiming to improving the antioxidant stability of CarA and thereby
set up a model system for potential applications in bioactive components.
Overall, although this lipid-soluble compound is recognised for its high antioxidative capacities,
(which led to many industrial applications in foods and beverages), its mode of action against the
oxidation of emulsions have not been yet fully elucidated [51].
2.5. Ferulic Acid (FA)
FA is a phenolic acid commonly found in the seeds of coffee, apple, artichoke, peanut,
and orange [52]. Flaxseed has been reported as the richest natural source of FA glucoside
(4.1 ± 0.2 g/kg) [53]. According to various researchers [54,55], black beans contain FA at an average
concentration of 0.8 g/kg. In addition, FA can be found in Brassica vegetables and tomatoes [20].
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There is a certain body of literature evidence claiming clear antioxidant effects of FA in various
o/w systems including: (i) corn oil-based emulsions stabilised with the use of various emulsifiers [56];
(ii) Tween-linoleic acid-based emulsions [14] (iii) in Tween-menhaden o/w emulsions [57]. More recently,
Shin et al. (2019) [58] reported that 4-vinylguaiacol (4-VG), (product of FA decarboxylation), exerted a
strong antioxidant activity when added at 200 ppm in a 10% o/w emulsion for 50 days. Permin et al.
(2019) [59], however, reported that FA showed no antioxidant activity in o/w emulsions rich in ω-3
fatty acids and stabilised by whey proteins.
2.6. p-Coumaric Acid (p-CA)
A large number of natural plants sources have been reported to be rich in p-CA such as fungi,
peanuts, navy beans, tomatoes, carrots, basil, and garlic [60]. The substance p-CA is abundant in most
fruits (especially pears and berries) and cereals [20,61], as well as in honey at a concentration range
1.7–4.7 mg/kg [62]. Kannan et al. (2013) [63], by using HPLC analysis, reported that the extracts of
Halodule pinifolia and Clytra rotundata are rich in p-CA, a fact that may account for their high biological
activity. The same authors observed that p-CA is present in high amounts in a few mushroom species.
In addition, a few researchers noted that p-CA is present in extracts derived from Amaranth leaves
and stem at a concentration range of 28–44 mg/kg [64,65]. Oh et al. (2015) [66] identified p-CA as the
main phenolic constituent present in the aqueous extracts of hulled barley (Hoerdeum vulgare L.).
In addition, a recent body of research evidence has focused on antioxidant activities of p-CA [67]
along with its identification in various natural sources [68]. Very recently, Park et al. (2019) [69]
conducted HPLC and NMR analysis of aqueous and ethanolic extracts of roasted rice hulls and
identified p-CA, VA, and FA as the dominant phenolic compounds. The authors reported that added
roasted rice hull extracts, particular rich in p-CA, protected against the oxidative deterioration of o/w
emulsions, at 60 ◦C.
2.7. Vanillic Acid (VA)
VA is a dihydroxybenzoic acid derivative commonly used as a flavoring agent. It is found in
several fruits, olives, and cereal grains (e.g., whole wheat), as well as in wine, beer, and cider [70,71].
Kim et al. (2019) [72] performed an identification of the main phenolic constituents in potatoes samples
(Solanum tuberosum L.) and quantified VA at a concentration between 0.02 and 0.04 g/kg. Espinosa et al.
(2015) [73] analysed an extract of red propolis and reported VA as being the major phenolic constituent.
VA was also found in fruit extract of the açaí palm plant (Euterpe oleracea) [74] and was identified by
Zhao et al. [75] in the root of Angelica sinensis (an herb indigenous to China) at concentrations between
1.1 and 1.3 g/kg. Furthermore, Radmanesh et al. (2017) [76] reported that VA is present in various
botanical sources including Juglans regia L., Chenopodiastrum murale, orchard grass, and Melilotus
messanensis.
Keller et al. (2016) [77] observed a strong antioxidant character of VA during autoxidation of
Tween 40-based o/w systems, at pH 3.5. Furthermore, Vishnu et al. (2017) [78] evaluated the antioxidant
activity of VA grafted chitosan (Va-g-Ch) during the microencapsulation of polyunsaturated fatty
acid-rich sardine oil in o/w emulsions. After four weeks of storage, a decrease of peroxide values
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3. Health and Biochemical Properties of Phenolic Acids and Their Natural Extracts
3.1. General Health Aspects of Phenolic Acids
Section 2 of the manuscript provided an overview of several natural sources of the phenolic acids
while also reported on a number of research findings most of which revealed their clear antioxidant
character against the lipid oxidation of o/w emulsions. As also discussed in the introduction of the
manuscript, the emulsions could offer useful in vitro model systems as a basis for further investigation
of the phenolic activity in interfacial biological systems.
This section focuses on the main target of this review, which is to provide an overview of the latest
literature concerning the health properties of the examined phenolic acids. The authors have reviewed
a large number of studies investigating into individual phenolic acids and/or their mixtures extracted
from natural plant sources. A body of research evidence focuses on the activity of various phenolic acids
against cancer and the main mechanisms by which they may exert their effects such as: scavenging of
free radicals, induction of enzymes, DNA damage repair, cell proliferation, and apoptosis [82].
Rosa et al. (2016) [83] supported that phenolic acids have been a prime source for the treatment
of various forms of cancer, with focus on colon cancer in human colon adenocarcinoma cells.
Vinayagam et al. (2016) [84] reviewed the properties of phenolic acids to improve glucose and lipid
profiles linked pathologic conditions (diabetes, cardiovascular diseases etc.). A diet rich in phenolic
acids has been also reported to protect against certain allergies and slow down the development of
Alzheimer’s disease [85].
Table 2 provides an overview of recent in vitro and in vivo clinical studies on the health/biochemical
properties of the examined phenolic acids. More specific information per phenolic acid is presented in
the following paragraphs.
3.2. Caffeic Acid (CA) and its Esters
CA presents a remarkable antioxidant potential and also demonstrates in vitro antimicrobial
properties [86]. Further to its well-established antioxidant and anti-aging activities, CA has
been reported to own strong antimicrobial properties and protect against dermal diseases [87].
De Oliveira et al. (2012) [88] designed a drug delivery system based on o/w emulsions with CA
containing microparticles, developed in order to ensure a prolonged CA release in the target cells
and thereby treat the folliculitis skin disease. Similarly, Paulo and Santos (2019) [89] examined
how incorporation of caffeic–ethyl cellulose microparticles in skin care products can offer anti-aging
protection. Furthermore, a body of recent research evidence has demonstrated that caffeic acid phenyl
ester (CAPE) is a natural compound with anticancer activities. The chemical structure of CA (presence
of free phenolic hydroxyls) is believed to strongly account for its antioxidant capacities that, in turn,
link to certain anti-carcinogenic properties [90]. Dietary supplementation of rats, with CA and CAPE
(5 mg/kg body wt subcutaneous or 20 mg/kg oral), was shown to inhibit tumor growth in HCC cells
(HepG2) and reduce the tumor invasion at a liver metastatic site [91]. Another clinical study [92] has
reported a clear chemoprotective effect of CAPE and its analogs (20 mg/kg body wt) against lipid
peroxidation and subsequent cell proliferation of hepatic tumors (HCC) in rats.
Guan et al. (2019) [93] used sucrose fatty acid ester to nano-encapsulate CAPE in aqueous
propylene glycol with a temperature-cycle method and reported that nano-encapsulation enhanced
cytotoxicity of CAPE against colon cancer HCT-116, and breast cancer MCF-7 cells. Another recent
medical study [94] reported clear inhibitory effects of CAPE derivatives against acetylcholinesterase,
an enzyme linked with the development of Alzheimer’s disease. CA and its derivatives, such as
CAPE, have been reported to act against colon cancer through their cytotoxic to tumors but not to
normal cells [95]. In addition, Zhang et al. 2017 [96] examined the action of CA (100 mg/kg) on
structural changes caused by HCC in the rat microbiota. The authors concluded that this phenolic
compound reduces certain biomarkers that indicate liver injury (among other alanine, transaminase,
aspartate aminotransferase, alkaline phosphatase, total bile acid and total cholesterol).
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3.3. Carnosic Acid (CarA)
Since its first extraction from various natural sources (e.g., Salvia and Rosmarinus species) and
given its well reported functional and antioxidant properties, CarA has been used in a range of cosmetic
and pharmaceutical applications [50,51].
Several researchers have focused on the liver protective effect of CarA. In an interesting placebo
clinical trial [97] a male ob/ob mice (model for NAFLD (non-alcoholic fat liver disease)) followed a diet
with CarA for 5 weeks and compared to placebo experienced weight loss and reduced visceral adiposity.
The authors concluded that CarA could be considered for the development of new drugs against the
NAFLD liver syndrome. Dickmann et al. (2012) [98] explored the hepatotoxicity potential of CarA
(at varying concentrations of 4–10 μM) in primary human hepatocytes and microsomes. While CarA
did not exhibit any significant time-dependent enzyme inhibition at 4 mM, it even increased enzyme
activity at 10 μM, compared with Phenobarbital and Rifampicin drugs. According to the authors,
the results indicate potential CarA interaction with drugs, thereby a need for its appropriate safety
assessment before its further use as a weight loss supplement.
Bahri et al., 2016 [99] noted that CarA can have a protective effect against chronic neurodegenerative
conditions, like Parkinson’s disease, via a mechanism that links to the transcriptional activation of
antioxidant Nrf2/ARE pathway.
Einbond et al. (2012) [100], after in vitro experiments in human breast cancer cells, have observed
that treatment with CarA at 20 μg/mL resulted in the prevention of ER-negative breast cancer via an
activation of expression of antioxidant and apoptosis genes. A more recent study by Solomonov et al.
(2018) [101] demonstrated a significant anti-inflammatory effect of CarA combined with astaxanthin
and a lycopene-rich tomato extract in a nutrient supplementation.
However, Raes et al. (2015) [45] did not report any effect of CarA, against lipid and protein
oxidation in an in vitro simulated gastric digestion model.
3.4. Gallic Acid
Over the last few years, a body of research evidence had reported cardioprotective, neuroprotective,
and anticancer properties of GA and gallates that are mostly attributed to their antioxidative properties
against the reactive oxygen species (ROS) signaling networks [102]. Sourani et al. (2016) [103]
reported that GA inhibits proliferation and induces apoptosis in lymphoblastic leukemia cell line.
In a very recent study [104] the ability of GA to potentiate the anti-cancer effects of chemotherapeutic
drugs (e.g., Paclitaxel, Carboplatin) was examined in human HeLa cells. The authors reported
that a Paclitaxel/GA combination could represent a promising alternative with lower side effects
for Paclitaxel/Carboplatin combinations in treatment of cervical cancer. Recent pharmacokinetic
human and animal clinical studies were based on Chinese GA-based patented medicines but further
investigation is needed on the GA kinetic profile after dietary supplementation before drawing any
conclusion for its efficacy against pathological conditions [105]. Paolini et al. (2015) [106] performed
a study to explore the potential of GA as a promising new anticancer drug. The authors treated
T98G human glioblastoma cell lines for 24 h with increasing concentrations of GA (ranging from 1 to
100 μg/mL). According to the results, GA exerts a protective or an anti-proliferative effect on glioma
T98G cells via dose-dependent epigenetic regulation mediated by miRNAs.
Yu et al. (2018) [107] contacted a clinical study on myocardial infarcted rats with an oral
administration of GA monohydrate at a dose of 50 and 100 mg/kg body wt. The authors observed
that myocardial infarction could modify the pharmacokinetic process of GA and thereby determine its
potential activity. Similarly, Nwokocha et al. [108] concluded that GA can present negative chronotropic
and inotropic effects in isoproterenol induced myocardial damage.
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3.5. Ferulic Acid (FA)
Over the last few years, a number of clinical studies have demonstrated that FA can exert in vivo
antioxidant effects by scavenging free radicals and enhancing the cell stress response through the
upregulation of cytoprotective systems [80,109]. Based on its antioxidant and anti-inflammation
functions, FA is widely considered as a phenolic compound with well documented protective actions
against many pathologic conditions (e.g., types of cancer, cardiovascular diseases, diabetes mellitus
and skin problems) [110]. Sgarbossa et al. (2015) [79] reviewed the health benefits of FA and noted
its protective role against neurotoxicity based on a number of in vitro and in vivo animal clinical
studies. Sung et al. (2014) [111] treated Dawley rats (male, 210–230 g) with FA (100 mg/kg body wt)
and reported a clear neuroprotective role. The above-indicated findings recommend the use of FA for
drugs development against neurodegenerative diseases, although a few questions are still open before
its clinical development and application in patients.
Chowdhury et al. (2016) [112] performed a clinical study that involved oral administration of
diabetic rats with FA (at a dose of 50 mg/kg body wt, orally for eight weeks). The authors concluded a
protective role of FA against streptozotocin-induced cellular stress in the cardiac tissues. Baeza et al.
(2017) [113] reported a strong inhibitory effect of dihydroferulic acid against in vitro platelet activation.
Ambothi et al. (2014) [114] concluded that FA (in the concentration range 10–40 μg/mL) can
prevent the ultraviolet-B radiation (290–320 nm) induced oxidative DNA damage in human dermal
fibroblasts. The same researchers conducted another clinical study [115] reporting that FA protected
against carcinogenesis and tumor formation induced via chronic UVB exposure (180 mJ/cm2 for
30 weeks) in the skin of Swiss albino mice. Russo et al. (2017) [116] conducted a population-based
case-control study in South Italy to examine any association between dietary phenolic acid consumption
and prostate cancer. From a sample of 2044 individuals, 118 histopathological-verified prostate cancer
cases were collected, and multivariate logistic regression showed that both CA and FA were associated
with reduced risk of this cancer type.
3.6. p-Coumaric Acid (p-CA)
p-CA has been reported to decrease the peroxidation of low-density lipoproteins (LDL) and exert
anti-mutagenesis, anti-genotoxicity, and anti-microbial activities [117]. Very recently, Ferreira et al.
(2019) [118] gave a literature overview of certain biochemical properties of CA (including radical
scavenging and tumor suppression activities) that link to its claimed pharmacological effects.
Boo (2019) [119] has highlighted the anti-melanogenic effects of p-CA by focusing on its inhibitory
action against melanin synthesis as observed in human epidermal melanocytes. Neog and Rasool
(2018) [120] supported that dietary p-CA could intervene in the osteoclast formation and thereby
alleviate the effect of rheumatoid arthritis, a finding also supported by Trisha (2016) [60].
Pei et al. (2015) [61] focused on p-CA and its conjugates reviewing their dietary sources,
and biological activities. The authors concluded that future studies should focus on pharmacokinetic
properties of p-CA in order to further promote its use in the food and cosmetic applications.
Janicke et al. (2011) [121] treated Caco-2 cells with 150 μM p-CA for 24 h and noticed a protective
effect against the development of colon cancer by retarding the cell cycle progression. In addition,
Sharma et al. (2017) [122] conducted a study to evaluate the chemo-preventive potential of p-CA in
rats challenged with the colon-specific procarcinogen DMH. According to the results, p-CA presented
a concentration-dependent anti-carcinogenic effect since it acted more efficiently at a dose of 100 mg/kg
body wt, compared to 50 mg/kg body wt. Amalan et al. (2016) [123] reported that p-CA inhibited
the development of oxidative stress by increasing the endogenous antioxidant capacity (level of
glutathione-GSH) in the livers of diabetic rats. In addition, Vauzour et al. (2010) [124] compared the
neuroprotection capacities of various phenolic compounds in primary cultures of mice cortical neuron.
The authors concluded a stronger protective effect of p-CA at 1 mM concentration than those of CA
and GA. Very recently, Sunitha et al. (2018) [125] reported that p-CA mediated the protection of H9c2
cells from Doxorubicin-induced cardiotoxicity.
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3.7. Rosmarinic Acid (RA)
Yang et al. (2013) [126] reported the health protective effects of RA on high mobility group
box1 (HMGB1) protein-induced inflammation that mediates responses to infection and injury cases.
Similarly, Tsung et al. (2013) [127] observed that RA can suppresses Propionibacterium acnes–induced
inflammatory responses. Concerning the anti-inflammatory mechanism, Ku et al. (2013) [128] observed
that RA down-regulates endothelial protein C receptor shedding, in vitro and in vivo. Braidy et al.
(2016) [129] investigated whether RA (0.01–0.1 mg/mL) can protect against CTX-mediated toxicity
in primary human neurons. According to the results pre-treatment with RA at 0.01 mg/mL (but not
higher) exerted a neuroprotective effect, generating significant decrease in CTX-mediated extracellular
LDH activity, NAD decline, and DNA damage, compared to CTX treated cells alone.
Nunes et al. (2017) [130] noted that RA displays several health beneficial effects (including
antimicrobial and anti-carcionogenic properties) the magnitude of which depends greatly on both
its intake and bioavailability. Hossan et al. (2014) [131] have more specifically focused on the
anticarcinogenic properties of RA proposing various mechanisms of anticancer activity including
antioxidant actions along with proliferation and apoptosis of cancer cells.
Stansbury (2014) [37] summarised the clinical trials that have demonstrated RA activities against
allergic immunoglobulin and inflammatory responses of polymorphonuclear leukocytes, thereby being
effective in the treatment of allergic disorders. Alagawany et al. (2019) [132] have also reviewed the
mode of action, and health benefits of RA.
Domitrović et al. (2013) [133] reported that RA can protect against acute liver damage in intoxicated
mice by exerting certain antioxidant, anti-inflammatory, and anti-apoptotic activities. More recently,
De Oliveira et al. (2019) [134] examined the protective effects of RA against ethanol-induced DNA
damage in mice and reported a clear antigenotoxic capacity in a concentration of 100 mg/kg body
wt by using the comet assay. Luno et al. (2014) [135] concluded that RA at 105 μM concentration
improves function and in vitro fertilising ability of boar sperm, by inhibiting oxidative stress during
cryopreservation. Furthermore, Venkatachalam et al. (2016) [136] investigated the mode and molecular
mechanisms that govern the chemoprotective action of RA against colon cancer in rats. The authors
reported that supplementation with RA (5–20 mg/kg body wt) protected treated rats from the deleterious
effects caused by the colon carcinogenic 1,2-dimethylhydrazine.
3.8. Vanillic Acid (VA)
VA has been reported to confer certain health beneficial effects, via antioxidative, anti-mutagenic,
anti-cancer, anti-inflammatory, and neuroprotective activities [137,138]. In a recent study [76], male rats
(separated in groups of 10) were supplemented with varying concentrations of VA (0–10 mg/kg body
wt) for a period of 10 days. The results have shown a clear effect of VA against the risk of myocardial
dysfunction. Similarly, Dianat et al. (2014) [139] demonstrated the effectiveness of VA against lipid
peroxidation, indicated by malondialdehyde (MDA) reduction, and endogenous antioxidant enzymes
improvement, in isolated rat hearts exposed to ischemia-reperfusion. Kim et al. (2010) [140] following
a clinical trial in rats reported beneficial effects of VA in the treatment of ulcerative colitis. Erdem et al.
(2012) [141] examined the potential effect of VA against mitomycin C-induced genomic damage in
human lymphocytes in vitro. Interestingly, VA (at 1 μg/mL) significantly reduced DNA damage
cells but at a higher concentration (2 μg/mL) exerted a genotoxic effect on DNA. On the contrary,
Krga et al. [142] (2018) reported that VA at 2 μM did not significantly decrease biomarkers of platelet
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In a clinical trial by Chellammal et al. (2015) [143], five groups of mice were treated as control or
active groups supplemented with VA in the concentration range 5–100 mg/kg for 28 days. The results
showed that VA at 50 and 100 mg/kg dose significantly (p < 0.001) improved the habituation
memory, decreased the AChE, corticosterone, and increased the antioxidant capacity of the mice.
Furthemore, Yemis et al. (2011) [144] reported a pH-dependent antimicrobial effect of VA that was
found to inhibit the growth and heat resistance of Cronobacter bacterial species, a conclusion that
could lead to the use of VA for new food storage applications.
3.9. Natural Extracts as Mixtures of Phenolic Acids
Nature has generously offered a wide range of herbs (e.g., thyme, oregano, rosemary, sage, mint)
that are rich in many phenolic compounds with strong antioxidant biochemical and anti-inflammatory
properties [145,146] including protection of DNA from oxidative damage [147]. More specifically,
bael (Aegle marmelos) flower (rich in p-CA, CA, and VA) and tulsi (Ocimum tenuiflorum) seeds
(rich in GA and p-CA) have been reported to present a strong antioxidant character again DNA
damage [148,149].
Findings from recent nutritional intervention studies with natural extracts rich in phenolic
acids suggest that they can exert a clear cardio-protective effect through modulations of platelet
function [150]. Padmanabhan and Geetha (2015) [151] reported a clear hypo-lipidemic and anti-obesity
effect of hydro-alcoholic fruit extract of avocado (particularly rich in GA and VA) in rats fed with high
fat diet (co-administered with 100 mg/kg body wt of HFEA for 14 weeks).
Extensive research has been conducted in the last decade about rosemary extracts that are
particularly rich in RA and CarA. Chkhikvishvili et al. (2013) [152] demonstrated that a rosemary
extract (RE) can protect Jurkat cells from oxidative stress induced by hydrogen peroxide. Very recently,
Pérez-Sánchez et al. (2019) [153] investigated the antitumor activity of RE obtained by using supercritical
fluid extraction, through its capacity to inhibit various signatures of cancer progression and metastasis.
Ulbricht et al. (2010) [154] has published an evidence-based systematic review on RE by examining
various aspects of their health properties including also information on their adverse effects and
toxicology. In a recent study, Sánchez Salcedo et al. (2015) [155] demonstrated that RE can exert
an in vivo anti-tumor action through a reactive oxygen species-initiated cell death. Andrade et al.
(2018) [156] reported a clear protective role of RE in preventing colds, rheumatism, and pain of muscles
and joints.
De Oliveira et al. (2019) [134] reviewed the in vivo and in vitro studies of R. officinalis highlighting
the therapeutic and prophylactic effects of RE on some physiological disorders caused by various
biochemical agents. Moore et al. (2016) [157] reviewed the phytochemical biological activities and
anti-carginogenic properties of R. officinalis.
Moreover, p-CA rich methanolic extracts of Amaranthus spinosus and of Amaranthus caudatus L. were
shown to possess significant central and peripheral anti-nociceptive potential and anti-inflammatory
activity, in mouse model [36]. Jeong et al. (2017) [158] observed clear therapeutic effects of
polyphenolic mixtures (containing among others GA, p-CA and ellagic acid) against cell lung cancer.
Hydroxycinnamic acid derivatives of mulberry fruits were reported to increase the production of
reactive oxygen species production by acting as pro-oxidants and hence killing the cancer cells [159].
Hilbig et al. (2017) [160] reported that an aqueous extract from pecan nut (particularly rich in GA,
CA and VA) showed clear inhibitory effects against breast cancer cell line MCF-7, as well as against
tumor growth in Balb-C mice. Simin et al. (2019) [161] provided an overview of the beneficial biological
activities of less known wild onions (A. sect. Codonoprasum), which are particularly rich in the common
phenolic acids. The same group [162] has concluded that a methanolic extract of small yellow onion
(Allium flavum), particularly rich in FA, p-CA, CA, and VA, can exert selective inhibitory action towards
cervix epithelioid carcinoma and colon adenocarcinoma cells.
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4. Conclusions and Future Challenges
Based on the analysis of this manuscript on in vitro and in vivo biochemical activities of phenolic
acids, the authors have drawn the following conclusions along with a few recommendations for future
investigation in this field:
4.1. Activities of Phenolic Acids in O/W Emulsions
Over the last few years, an increasing number of researchers have reported well documented
antioxidant activities of naturally occurring phenolic acids in o/w model systems. The findings of the
recent studies on phenolic acids antioxidant activity in emulsion formulations could offer a basis for
innovative insights in a wide range of food and cosmetic relevant products.
Controlling the interfacial concentrations of antioxidants in o/w emulsions could be regarded as a
reasonable approach to monitor more systematically their activity against lipid oxidation Further work
in this field could focus on estimating distribution constants of the phenolic acids in emulsions as a
factor that would further elucidate and monitor their antioxidant efficiencies in interfacial systems.
Future challenges may include the development of nano-based emulsion systems to enable the
delivery of functional bio-constituents (e.g., phenolic acids) and thereby promote their applications in
innovative dietary supplements or even drug formulations.
4.2. Health Biochemical Properties of Phenolic Acids
This analysis presented a summary of the most recent clinical (mainly animal) studies on phenolic
acids. The findings overall offer sufficient evidence to support that each of the examined phenolic
acids, through their dietary supplementation, could exert health protective effects against a wide
range of pathogenic conditions including cancer, bacterial infections, cardiovascular, inflammatory,
and neurodegenerative diseases.
Mixtures of phenolic acids (most commonly present in a wide range of botanical extracts) have
been reported by latest research evidence to possess a number of beneficial health properties. The strong
antioxidant and biochemical potential of these natural plant preparations may more specifically link to
the synergistic effect of their individual phenolic compounds.
Although a few phenolic acids are well-known as efficient bioactive dietary ingredients,
their pharmacokinetics and metabolic properties are not fully elucidated yet. This is a factor that limits
their current use and therapeutic potential and requires further clinical investigations to support and
optimise their future use in nutritional and pharmaceutical applications.
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Aura, A.-M. Factors affecting intake, metabolism and health benefits of phenolic acids: Do we understand
individual variability? Eur. J. Nutr. 2019, 1–19. [CrossRef]
21. Dezsi, S.; Bădărău, A.-S.; Bischin, C.; Vodna, D.-C.; Dumitrescu, R.-S.; Gheldiu, A.-M.; Mocan, A.; Laurian, V.
Antimicrobial and antioxidant activities and phenolic profile of Eucalyptus globulus. Molecules 2015, 20,
4720–4734. [CrossRef] [PubMed]
22. Deotale, S.M.; Dutta, S.; Moses, J.A.; Anandharamakrishnan, C. Coffee oil as a natural surfactant. Food Chem.
2019, 295, 180–188. [CrossRef] [PubMed]
23. Boke, S.; Goren, A.C.; Kirmizigul, S. Simultaneous determination of several flavonoids and phenolic
compounds in nineteen different Cephalaria species by HPLC-MS/MS. J. Pharm. Biomed. Anal. 2019, 173,
120–125. [CrossRef] [PubMed]
24. Conde, E.; Gordon, M.-H.; Moure, A.; Dominguez, H. Effects of caffeic acid and bovine serum albumin
in reducing the rate of development of rancidity in oil-in-water and water-in-oil emulsions. Food Chem.
2011, 129, 1652–1659. [CrossRef]
25. Sørensen, A.D.; Villeneuve, P.; Jacobsen, C. Alkyl caffeates as antioxidants in O/W emulsions: Impact of
emulsifier type and endogenous tocopherols. Eur. J. Lipid Sci. Technol. 2017, 119, 6. [CrossRef]
163
Foods 2020, 9, 534
26. Pandurangan, A.-K.; Mohebali, N.; Norhaizan, M.-E.; Looi, C.-Y. Gallic acid attenuates dextran sulfate
sodium-induced experimental colitis in BALB/c mice”. Drug Des. Dev. Ther. 2015, 9, 3923–3934. [CrossRef]
27. Liu, Y.; A Carver, J.; Calabrese, A.N.; Pukala, T.L. Gallic acid interacts with α-synuclein to prevent the
structural collapse necessary for its aggregation. Biochim. Biophys. Acta (BBA) Proteins Proteom. 2014, 1844,
1481–1485. [CrossRef]
28. Zucca, P.; Antonella, R.; Tuberoso, C.; Piras, A.; Rinaldi, A.; Sanjust, E.; Dessì, M.; Rescigno, A. Evaluation of
Antioxidant Potential of “Maltese Mushroom” (Cynomorium coccineum) by means of multiple chemical
and biological assays”. Nutrients 2013, 5, 149–161. [CrossRef]
29. Souza, M.-C.; Santos, M.-P.; Sumere, B.-P.; Silva, L.-C.; Cunha, D.-T.; Martínez, J.; Barbero, F.-G.;
Rostagno, M.-A. Isolation of gallic acid, caffeine and flavonols from black tea by on-line coupling of
pressurized liquid extraction with an adsorbent for the production of functional bakery products. LWT Food
Sci. Technol. 2020, 117, 108661. [CrossRef]
30. Bou, R.; Boo, C.; Kwek, A.; Hidalgo, D.; Decke, E.A. Effect of different antioxidants on lycopene degradation
in oil-in-water emulsions. Eur. J. Lipid Sci. Technol. 2011, 113, 724–729. [CrossRef]
31. Alavi Rafiee, S.; Farhoosh, R.; Sharif, A. Antioxidant activity of gallic acid as affected by an extra carboxyl
group than pyrogallol in various oxidative environments. Eur. J. Lipid Sci. Technol. 2018, 120, 1800319.
[CrossRef]
32. Di Mattia, C.; Sacchetti, G.; Pittia, P.; Mastrocola, D. Effect of phenolic antioxidants on the dispersion state
and chemical stability of olive oil O/W emulsions. Food Res. Int. 2009, 42, 1163–1170. [CrossRef]
33. Zhu, M.; Wu, C.; Chen, Y.; Xie, M. Antioxidant effects of different polar gallic acid and its alkyl esters in
oil-in-water emulsions. J. Chin. Inst. Food Sci. Technol. 2019, 19, 13–22.
34. Wang, Y.; Wu, C.; Zhou, X.; Zhang, M.; Chen, Y.; Nie, S.; Xie, M. Combined application of gallate ester and
α-tocopherol in oil-in-water emulsion: Their distribution and antioxidant efficiency. J. Dispers. Sci. Technol.
2019, 1–9. [CrossRef]
35. Evageliou, V.; Panagopoulou, E.; Mandala, I. Encapsulation of EGCG and esterified EGCG derivatives in
double emulsions containing whey protein isolate, bacterial cellulose and salt. Food Chem. 2019, 281, 171–177.
[CrossRef]
36. Oreopoulou, A.; Papavassilopoulou, E.; Bardouki, H.; Vamvakias, M.; Bimpilas, A.; Oreopoulou, V.
Antioxidant recovery from hydrodistillation residues of selected Lamiaceae species by alkaline extraction.
J. Appl. Res. Med. Aromat. Plants 2018, 8, 83–89. [CrossRef]
37. Stansbury, J. Rosmarinic acid as a novel agent in the treatment of allergies and asthma. J. Restor. Med. 2014,
3, 121. [CrossRef]
38. Vallverdú-Queralt, A.-L.; Rejueiro, J.; Martínez-Huélamo, M.; Alvarenga, J.-F.; Leal, L.-N.;
Lamuela-Raventos, R.-M. A comprehensive study on the phenolic profile of widely used culinary herbs and
spices: Rosemary, thyme, oregano, cinnamon, cumin and bay. Food Chem. 2014, 154, 299–307. [CrossRef]
39. Yashin, A.; Yashin, Y.; Xia, X.; Nemzer, B. Antioxidant activity of spices and their impact on human health: A
review. Antioxidants 2017, 6, 70. [CrossRef]
40. Tsimogiannis, D.; Choulitoudi, E.; Bimpilas, A.; Mitropoulou, G.; Kourkoutas, Y.; Oreopoulou, V. Exploitation
of the biological potential of Satureja thymbra essential oil and distillation by-products. J. Appl. Res. Med.
Aromat Plants 2016, 4, 12–20. [CrossRef]
41. Alamed, J.; Chaiyasit, W.; McClements, D.-J.; Decker, E.-A. Relationships between free radical scavenging
and antioxidant activity in foods. J. Agric. Food Chem. 2009, 57, 2969–2976. [CrossRef] [PubMed]
42. Panya, A.; Kittipongpittaya, K.; Laguerre, M.; Bayrasy, C.; Lecomte, J.; Villeneuve, P.; Decker, E.-A.
Interactions between α-tocopherol and rosmarinic acid and its alkyl esters in emulsions: Synergistic, additive,
or antagonistic effect? J. Agric. Food Chem. 2012, 60, 10320–10330. [CrossRef] [PubMed]
43. Bakota, E.-L.; Winkler-Moser, J.-K.; Berhow, M.-A.; Eller, F.-J.; Vaughn, S.-F. Antioxidant activity and sensory
evaluation of a rosmarinic acid-enriched extract of Salvia officinalis. J. Food Sci. 2015, 80, 711–717. [CrossRef]
[PubMed]
44. Loussouarn, M.; Krieger-Liszkay, A.; Svilar, L.; Bily, A.; Birtić, S.; Havaux, M. Carnosic acid and carnosol,
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Abstract: The genus Berberis includes about 500 different species and commonly grown in Europe,
the United States, South Asia, and some northern areas of Iran and Pakistan. Leaves and fruits can be
prepared as food flavorings, juices, and teas. Phytochemical analysis of these species has reported
alkaloids, tannins, phenolic compounds and oleanolic acid, among others. Moreover, p-cymene,
limonene and ocimene as major compounds in essential oils were found by gas chromatography.
Berberis is an important group of the plants having enormous potential in the food and pharmaceutical
industry, since they possess several properties, including antioxidant, antimicrobial, anticancer
activities. Here we would like to review the biological properties of the phytoconstituents of this
genus. We emphasize the cultivation control in order to obtain the main bioactive compounds,
the antioxidant and antimicrobial properties in order to apply them for food preservation and for
treating several diseases, such as cancer, diabetes or Alzheimer. However, further study is needed to
confirm the biological efficacy as well as, the toxicity.
Keywords: Berberis; food preservative; alkaloid; antioxidant; human health
1. Introduction
Berberis spp. are shrubs in the family Berberidaceae, native to central and southern Europe, western
Asia, as well as northwest Africa [1]. About 500 species of these plants are found in most areas of central
and southern Europe, the north-eastern region of United States, and Asia (including the northern area
of Pakistan [2] and Iran [3]). The genus Berberis consists of spiny deciduous evergreen shrubs which
are characterized by yellow wood and flowers [2], dimorphic long and short shoots (1–2 mm). Some
Berberis fruits are small oblong berries 7–10 mm long and 3–5 mm broad and turn blue or red upon
ripening during the late summer or autumn [1].
Berberis species are mainly consumed fresh, dried and used in juice production [4]. The fruits
are very popular, known as zereshk in Iran where they are commonly used for cooking and in jam
production, thus, encouraging the production of fresh edible seedless barberries fruits reaching about
22,000 tons per annum [5]. The fruits are also processed into beverages, drinks, syrups, candy and
other confectionary products which are popular Iran. Furthermore, the leaves and fruits have also
found applications in the production of food flavorings and teas. Berberis are popular due to their
nutritional importance; however, they have found most usefulness in folk and traditional medicine
where various parts, including roots, bark, leaves and fruits serve as major ingredients of herbal
remedies in Ayurvedic, Iranian and Chinese medicine dating back at least 3000 years [6]. Currently,
this species flower is popularly used amongst Tibetan speaking population in areas, such as Litang,
China [7].
The effect of cold-pressed filtered oil of Berberis spp. seeds in delaying soybean oil oxidation
in comparison to commercial antioxidants were carried out, and the study reported that Berberis oil
contributed to oxidative stability of soybean oil comparably to commercial antioxidants [8]. Antioxidant
and antibacterial activity of water extract of barberry has suggested their possible application as
preservatives in food industries [9].
Isoquinoline alkaloids are the major bioactive constituents in Berberis [10]. Protoberberines and
bisbenzyl-isoquinoline alkaloids, such as berbamine, tetrandrine and chondocurine, which have
been known for their anti-inflammatory and immunosuppressive properties, have been detected by
phytochemical analysis of the root and stem back extracts of B. vulgaris. Berberine (an isoquinoline
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alkaloid) and berbamine are the most abundant phytochemicals of Berberis species [2]. The fruits
contain a high amount of alkaloids, tannins, phenolic compounds and oleanolic acid [3,11], gum, pectin,
oleoresins, organic acids, anthocyanins and carotenoids. In addition, palmitine [10], stigmasterol and
its glycoside [12] have all been detected in various species of the Berberis plant.
Some Berberis fruits have been employed in the treatment of guts [13] kidney stones [14] and
liver [15] and gall bladder [10] conditions. The root bark and stem of the Berberis have found usage as
a diuretic, febrifuge, cathartic and antiseptic. Furthermore, preparations of the stem and root bark
have been used to treat mouth and stomach ulcers [16]. Several parts of the plant have been reported
to possess astringent and antiseptic properties, while the stem bark and flowers were found to be
anti-rheumatic [17]. The alkaloid rich root bark of the plant has also been used as purgative and
treatment for both diarrhea and rheumatism [18]. The berberine-rich rhizomes of Berberis species
possess marked antibacterial and antitumor properties, with reported efficacies in treatment of various
eye conditions [10,19]. Furthermore, the anti-inflammatory activity of berberine has been extensively
studied amongst other pharmacological actions [10,20].
Berberine sulphate which is an alkaloid extracted from the roots and bark of various Berberis
spp. Have been reported to possess antibacterial, antifungal and antiprotozoal activities. Reported
the bacteriostatic activity of berberine against streptococci, and that the sub-minimum inhibitory
concentrations (MICs) of the compound blocked the adherence of streptococci to host cells, immobilized
fibronectin, and hexadecane in epithelial cells [21]. Furthermore, blood glucose and lipid regulatory
properties of Berberis have been demonstrated [3,22–24]; and this was due to berberine-induced
improvement in insulin sensitivity through regulation of adipokine secretion [25–27]. Effectiveness of
Berberis species in the maintenance of heart health has been demonstrated in their ability to improve
hypertension, ischemic heart disease, cardiac arrhythmias and cardiomyopathy [2,28].
The health-promoting effect of Berberis spp. cannot be overemphasized, as well as its popularity;
however, this is restricted to central and southern Europe, western Asia, as well as northwest Africa.
Hence, efforts should be geared towards making the Berberis plant also available to other regions of the
world. Furthermore, most studies on Berberis spp. have been on berberine; therefore, efforts should be
made towards researching possible therapeutic benefits of all other important phytoconstituents of the
plant. Furthermore, the synergistic or additive effect of these phytoconstituents should be studied
so as to elucidate the complex molecular interaction amongst various phytochemicals leading to the
observed therapeutic properties. In addition, the modulatory effect of the plant/plant materials on
gene expression should be prioritized.
The aim of this review is to provide a detailed overview to the cultivation of Berberis species,
in-depth insight on the biological properties of the phytoconstituents of this genus, regarding its food
preservative applications, antimicrobial, antioxidant and anticancer effects, and lastly, special emphasis
to its clinical effectiveness in humans. The present work was performed by consulting the database
of PubMed, Web of Science, Embase, and Google Scholar (as a search engine) to retrieve the most
updated articles on the topic under investigation (phytochemicals and biological activities of Berberis
species). The strategy of the search included the use of the following keywords: “Berberis” or “barberry”
and “cultivation” or “essential oil” or “antimicrobial” or “food preservative” or “antioxidant” or
“anticancer”. Authors carefully examined articles and for the review, prioritizing the articles published
from 2013 to 2018 [29]. Only English articles having full text were considered.
2. Cultivation of Berberis Plants
The genus Berberis include about 500 different species and commonly grown in Europe, United
States, South Asia and some northern areas of Iran and Pakistan (Figure 1) [11,30]. In Pakistan, majority
of Berberis species are found in high mountains (1400 m–3500 m above sea level). In Iran, five Berberis
species are present, including two important species, i.e., B. orthobotrys and B. khorassanica, which are
grown in eastern, northern and southern regions of Iran [31]. Other important local species zereshk is
also widely cultivated in the South-Khorasan province of Iran [32]. In Iran, 11,000 hectares of area is
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under cultivation of common barberry (B. vulgaris) species, and one of the most leading producers
of barberry fruit in the world. Annually, Iran produces more than 10,000 tons of dried barberry
fruits, while maximum production comes from the Southern Khorasan. More than 97% of the area
located near Ghaenat County and Southern Khorasan province is cultivated with common barberry
that produces 95% of fruit in Iran [33]. B. vulgaris is gathered from the wild in Eastern Europe in
countries like Poland [34,35]. In addition, it is known as K’otsakhuri in Georgia, where it is grown and
collected from the southeast forests of the country [36]. The yield-related important traits of many
Berberis species are significantly affected by environmental factors, biotic stresses, seasonal variations,
the climatic condition of an area, planting and harvesting date or methods, irrigation source, fruit
processing and storage methods, etc.
 
Figure 1. The areas where the Berberis plants are commonly grown (shown in red).
The fruit remains a vital part, producing many important secondary metabolites and used in
pharmaceutical and food industries. In this section, we have highlighted the cultivation of different
Berberis species, its status and various factors affecting its cultivation. Common barberry is a native
plant in Asia’s western and middle mountains and non-native to North America [37]. The hybrid
species Berberis × ottawaensis are widely cultivated in Europe and North America [38]. The European
settlers introduced common barberry to New England, and used it as a source of medicine, food,
and for other aesthetic purposes [37,39]. The colonists of New England determined its cultivation
spread Puccinia graminis fungus, causing wheat rust and important reduction of its crop [40].
The seedless type (B. vulgaris var. asperma) is commonly cultivated in the southern parts of the
Khorasan province of Iran for domestic purposes [41]. B. lyceum represents a native species of Nepal
and distributed in the temperate and subtropical regions of the world, including some part of Australia.
It is distributed from Kashmir to Uttaranchal North-western Himalayas [42]. Sixteen species, and some
varieties of barberry, were found in the Boaxing country, situated on the Eastern side of Hengduan
Mountains in Sichuan Province, Southwest China [43]. The Japanese barberry is invasive in twenty
different states of the world and five other provinces of Canada [44]. According to Reference [45]
there are 21 Berberis species in Nepal, including two new species Berberis pendryi Bh. Adhikari and
Berberis karnaliensis Bh. Adhikari. Berberis crataegina DC. is commonly grown in Turkey, Asia and
European regions. The fruit are locally known as “karamuk” and “kadıntuzluğu” in Turkey and used
as traditional medicine [46].
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In Pakistan, twenty species and six subspecies of Berberis have been reported, and the majority
of these is growing in northern parts of the country [47]. The other dominant species of Berberis is
B. aristata, grown in Nepal, Pakistan and India. In Pakistan, it mainly cultivated in the Hazara division
of Khyber Pakhtunkhwa (KP), and Azad Jamu and Kashmir (AJK) regions. In AJK it is locally named
sumbal and commonly known as daruharidra [48]. B. lyceum is another key species, highly distributed in
different Asian countries, including, Afghanistan, Pakistan, Nepal, India and Bangladesh. In Pakistan,
it grows in different areas of KP, Punjab and Baluchistan [49]. The fruit part locally called kashmal,
is used as a source of food, and for preparing the sauce in Himalayan regions of Jammu and Kashmir,
and Himachal Pradesh [50,51].
The yield of barberry plants depends on various factors like managing operations, size and age of
shrub and date and method of harvesting [52,53]. Proper harvesting method at a suitable time is one of
the key steps in berry yield production because the shrubs include maximum spines in shoot part and
also the fruit peel is so thin. The harvesting date plays a vital role to gain maximum yield with high
quality. The local farmers set some useful sensory parameters for starting the harvest of the crop. These
parameters include change of fruit color from bright red to dark red, tissue softening, the concentration
of contents, and reducing sourness in fruit, etc. [11]. The optimum time for barberry harvesting in
the autumn cold season, when the berries ripen. In this stage, the fruit gains dark red color due to
the presence of high anthocyanin content, sweetness increases, while the berberine and sourness are
reduced [53–57]. In different regions of North America and Western Europe, the common Barberry
ripens in the month of August or September [58,59]. While the seeds can be mature in October [60].
The berries of common barberry remain with the stem through winter [61]. However, the delay in
harvesting from 10 September to 13 November increases the anthocyanin content about 2.5 times [53].
It may also increase the yield and quality, but too much delaying may lead to early autumn chilling
injury to plant. For Iranian seedless barberry 170 days after the flowering is an optimum date for
harvesting [56]. Fruit maturation and development vary in different geographic regions. So, it is
important to optimize a suitable harvesting date for each region.
3. Berberis Plants Essential Oils and Phytochemical Composition
Essential oils (EO) are volatile, complex natural compounds, which formed in aromatic plants as
secondary metabolites. They are used in pharmaceutical, agricultural, and food industries, as well as
are associated with antibacterial, anti-inflammatory, antioxidant, and insecticidal potential [62–64].
The gas chromatography coupled to mass spectrometry (GC-MS) analysis of various parts of
B. vulgaris revealed that benzaldehyde, benzyl alcohol, 1-hexanol and I-2-hexenal [65] were major
compounds of the EOs from fruit, while p-cymene, limonene and ocimene were identified as major
compounds of the EOs (Figure 2) from leaves and flowers [66].
  
 
(a) (b) (c) 
Figure 2. Major compounds of the essential oils (EOs) of Berberis vulgaris leaves and flowers.
(a) p-cymene; (b) limonene; (c) ocimene.
Turkish B. crataegina fruit berry has 22 volatile compounds which are aldehydes had the highest
concentration (5382 μg/kg), followed by alcohols (2487 μg/kg) and lactone (2422 μg/kg).
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Major volatile compounds of the B. crataegina fruit are γ-butyrolactone, 3-hexanal and
2,6-dimethylphenol. Moreover, the olfactometric analysis of dry B. crataegina resulted eight aroma
active compounds [67].
EOs of the roots of B. integerrima were analyzed by using modified microwave-assisted
hydrodistillation (MAHD). Chemical diversity of 10 and 18 compounds were obtained from MAHD,
MAHD with modified anyl, and with modified phenyl magnetic nanoparticles, the yields of the EOs
were 0.16, 0.61 and 0.71 w/w %, respectively. Hexadecanoic acid was identified as a major compound
for MAHD and modified MAHD methods [68].
Moreover, the GC/MS study on hexane extracts of the B. aetnensis and B. libanotica roots was
showed that B. aetnensis have twenty-six and B. libanotica have thirty-seven non-polar compounds.
Stigmasterol (Figure 3) is the major compound of both species [69].
 
Figure 3. Stigmasterol.
On the other hand, alkaloids (Table 1) represent the main compounds in Berberis species, and many
of them have been identified by different spectroscopic techniques previously mentioned. The most
known are berberine, berbamine, palmitine, jatrorrhizine, and isotetrandrine. They are located mainly
in the cortical tissues of the roots and stems and have important biological activities. In fact, in vitro and
in vivo anti-proliferative and anti-metastatic effects on various types of cancers have been reported for
different alkaloids. These compounds, such as vinblastine, have already used as anticancer drugs [3].
Table 1. Alkaloids from Berberis species.




Foods 2019, 8, 522
Table 1. Cont.









Foods 2019, 8, 522
Table 1. Cont.








Foods 2019, 8, 522
Table 1. Cont.




4. Food Preservative Applications of Berberis Plants
Food preservation is the most vital issue in food industries to ensure food safety for a longer
period. Basically, the process of food preservation depends on the growth inhibition of undesirable
microorganisms. Use of chemical agents with antimicrobial activity is commonly used a traditional
method for food preservation [70]. However, antimicrobial agents also gain momentum, due to their
fewer side effects and compatibility with the human body. Further, synthetic antimicrobials and
their toxicological safety as food additives needed to be ensured by regulatory authorities. Moreover,
processed foods with natural preservatives have great demand and considered safer and beneficial for
public health [71]. The naturally occurring compounds demonstrated antimicrobial activity in foods as
natural ingredients and can be used as additives to other foods.
Berberis is an important plants having enormous potential in the food industry. However, only a
few reports are available on the direct application of these plants in food products. For example,
seed oil and fruit extracts of B. crataegina were supplementing into chitosan matrix for preparation
of a chitosan-based edible film. The films produced have been analyzed for the physiochemical and
biological activities. Results showed that chitosan-fruit extract film exhibited higher thermal stability,
antimicrobial, antioxidant, and anti-quorum sensing activity as compared to other films. Furthermore,
the addition of B. crataegina seed oil and fruit extract into the chitosan film create a mark reduction in the
UV-vis transmittance but improve the tensile strength. Likewise, hydrophobicity of the chitosan-seed
oil film was found to be higher than chitosan-control film, while chitosan-fruit extract film displayed
slightly lower hydrophobicity than chitosan film. These results indicated that chitosan-fruit extract
film of B. crataegina fruit extract could be used as an effective ingredient for the production of the edible
film with increased physicochemical and biological properties [72].
A list of the antimicrobial potential of the Berberis species evaluated across the globe is provided
which support the use of Berberis species in food preservation (Table 2).
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5. Antioxidant Activities of Berberis Plants (In Vitro and In Vivo)
Free radicals ubiquitous in the environment affect human health by oxidative stress-induced
damage. Finding exogenous sources with antioxidant activity is necessary in order to support the
organism against the actions of free radicals. The fruits of most plants from Berberidaceae family
have a sour taste which is due mainly to the presence of ascorbic acid or vitamin C. The vitamins and
antioxidant compounds in barberry plant might be useful for treating diseases [109].
The antioxidant effect of B. vulgaris on oxidative systems, such as liver cells oxidation,
red blood cells haemolysis, and haemoglobin non-enzymatic glycosylation was demonstrated,
and the highest inhibitory effect was exerted on glycosylation. The extracts of B. vulgaris was
the most promising as antioxidants, as well as anti-inflammatory and acetylcholinesterase (AChE)
inhibitors. The capacity of B. vulgaris for scavenging 1,1-diphenyl-2-picrylhydrazyl (DPPH) and
2,2′-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS), the inhibitions of lipoxygenase and
AChE are mainly due to the phenol and flavonoid contents [110].
B. vulgaris root extract was evaluated for the alleviation of oxidative stress by using female
Japanese quails. Moreover, B. vulgaris root extract exerted antioxidant effects through inhibiting NF-kB,
which was activated and suppressed in the heat stress environment [111]. The antioxidant potential of
50% aqueous ethanolic root extract of B. aristata was examined on antioxidant enzymes of the liver in
diabetic rats, along with its safety parameters. The root extract of B. aristata has strong potential to
decrease oxidative stress [112].
Significant antioxidant effects, mainly on ABTS, hydroxyl radicals and DPPH, have been reported
to berberine hydrochloride. The relationship among diabetes mellitus and the increase of formation of
free radicals and a decrease in antioxidant potential is well known. Since berberine hydrochloride
has significant radicals scavenging and protective effects against β-cell damage and antioxidant of the
pancreas in diabetes mellitus, it seems reasonable that antioxidants can play an important role in the
improvement of diabetes and in screening the novel treatment drug of diabetes mellitus [113].
The extracts from the inner stem bark of B. vulgaris exhibited high antioxidant activity, and most
of the identified compounds were isoquinoline alkaloids. The values were higher than the standard
antioxidant compounds (vitamin C and butylated hydroxytoluene (BHT)) [114].
It was widely investigated the composition of the major anthocyanins and the antioxidant activities
of the fruit of B. heteropoda. The high anthocyanins content indicated that this fruit could be considered
as an excellent source of natural colorants and a functional food that benefits human health [115].
Regarding the alkaloid extract of B. aetnensis roots, it is also possessed antioxidant properties, and all
results are in agreement with other reports on the alkaloids from the roots of Berberis species [116].
The findings suggested that B. vulgaris fruits have an important potential for their antioxidant
activities depends on the content of phenolic compounds and organic acids [117].
6. Anticancer Activities of Berberis Plants (In Vitro and In Vivo)
Cancer is the third leading cause of death worldwide, preceded by cardiovascular and infectious
diseases. In medical science, there is need for effective and acceptable cancer therapeutics agents that
are non-toxic, highly efficacious against multiple cancers, cost effective, and acceptable by human
population [118]. The interest in natural products has increased because they are less toxic to normal
cells, and they reduce side effects and drug resistance observed in synthetic drugs.
In India, medicinal plants have been used for treating disease since ancient times. Many of these
belong to the genus Berberis. The fruit of B. vulgaris is rich in polyphenols, vitamins, proteins, ascorbic
acid, and anthocyanin, which are important for human health. Moreover, they are rich in alkaloids
which promote anticancer activity. In particular in hepatic cancer cell (Hepg2) ethanol extract of the
fruit of B. vulgaris reduces cell vitality and promotes the selective increase of protein expression like
alkaline phosphatase (ALP), a hepatic enzyme important in the diagnosis of disease [119]. Anticancer
activity of fruit extract of B. vulgaris was also demonstrated on human breast cancer cells (MCF-7).
The extract reduces cell proliferation in time and dose-dependent manner. It has also been evidenced
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the importance of the solvent for the extraction processes, because as it is reported in several studies,
ethanol extract is more active than water extract, probably due to its capacity to extract more compounds
responsible for anticancer activity like alkaloids [120]. B. vulgaris ethanol extract reduces viability in
the breast, colon, hepatic and cervix cancer cell lines in a dose-dependent manner after incubation at
24, 48 and 72 h. The ethanol extract has a similar activity of berberine chloride [121]. This was also
confirmed by El Khalki et al. [122], who studied cytotoxicity on human breast adenocarcinoma cell
(MCF-7) of B. vulgaris and berberine.
The antioxidant activity might play a major role in increasing efficiency of such extracts to
kill cancer cells and protect normal cells, besides the inhibition of cell growth. Choi et al. [123]
demonstrated that treatment with berberine reduces p53 expression in the human prostate cancer cell.
In fact, berberine promotes translocation of p53 in nuclei and arrest of the cell cycle in G0/G1. This was
also confirmed in in vivo studies. In this sense, the intraperitoneal administration of berberine at
10 mg/kg caused a substantial decline in tumor volume and weight of prostate cancer. The effect is
more evident in cancer expressing p53 (LNCaP) both in vivo and in vitro [123].
Berberine and curcumin have been tested on different types of cancer cell line models as A549
(lung cancer cell line), Hep-G2 (liver cancer cell line), MCF-7 (breast cancer cell line), Jurkat (leukemia
cancer cell line) and K562 (kidney cancer cell line) by Balakrishna et al. [124]. This work can reveal
the synergetic activity of these compounds. The anticancer effects in these cells are mediated by
inducing apoptosis [124]. The synergistic effect of two different compounds was also evidenced by
Ren et al. [125]. They showed as galangine and berberine together demonstrated an anticancer activity
stronger than that showed when used singularly, on esophageal carcinoma cells. In fact, they induce
apoptosis, promote cell cycle arrest in the G2/M phase and increase reactive oxygen species (ROS) in
cancer cells [125]. The anticancer activity of B. aristata roots was also evaluated on human osteosarcoma
cells [126].
B. libanotica root extract showed potential anti-inflammatory and anticancer activity, mostly due
to alkaloids and other compounds. This effect was demonstrated on human colon cancer cells [127] in
which berberine inhibits COX-2 transcriptional activity. B. libanotica extract reduced the viability of
CD4 T-cells infected by the retrovirus HTLV1, a kind of cell characteristic of an aggressive form of
leukaemia [128]. Moreover, root extract showed anticancer activity on different cell lines of prostate
cancer; it reduces cell viability and promotes cell cycle arrest in G0/G1 [129]. Subsequent studies on
human erythroleukemia cell lines investigated molecular pathways responsible for the anticancer
activity. The extract induced apoptosis of cells through the modulation of Akt/NF-Kb/COX-2 signal
transduction pathways [130]. B. libanotica extract showed a dominant effect on K562 cells by the
activation of the late markers of apoptosis with caspase-3 activation, Poly (ADP-ribose) polymerase
(PARP) cleavage and DNA fragmentation. The study demonstrated that treatment with the extract
induces apoptosis in erythroleukemia cell line expressing COX-2 (HEL cells) or not (K562), especially
at a dose of 300 μg/mL after 48h of treatment. In particular, B. libanotica extract induced activation of
caspase-3 and -9, correlated with PARP cleavage and DNA fragmentation. In this process, the extract is
more effective than berberine tested at a dose of 40 μg/mL. Moreover, the extract reduced significantly
the expression of COX-2, which prevent apoptosis in cancer cells through the activation of Akt and
NF-kB. A similar mechanism was shown for 4-chlorobenzoyl berbamine; and a synthetic compound
derived from berbamine. It induces apoptosis in lymphoma cell lines and G2/M cell cycle arrest
through PI3K/Akt and NF-kB signaling pathways [131]. Changes as esterification, etherification or
sulfonylation on the structure of berbamine allowed to obtaining new molecules capable of solving
the problem of resistant in many types of tumor [132]. Many synthetic derivatives of berbamine also
demonstrated antineoplastic activity. Among these, BBMD3 was shown to be the most potent as an
anticancer agent on human melanoma cells. It inhibits JAK/STA3 pathways reducing pro-apoptotic
gene expression [133]. This was also confirmed in osteosarcoma and glioblastoma cell lines where
BBMD3 induced inhibition of Jak2/STAT3 signaling pathway and activation of the stress response
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JNK pathway. Moreover, it increases the expression of miR-4284 involved in tumorigenesis and
apoptosis [134,135].
Berbamine, which is contained in B. amurensis, has activity also tested on solid tumor. In fact,
it arrests growth and migration in vitro and ex vivo of human lung cancer A549 cell line at low
concentration trough down-regulation of anti-apoptotic protein Bcl-2 and up-regulation of the
pro-apoptotic protein Bax [136]. B. amurensis extract arrests proliferation of Hepg2 and MCF-7
cells; extraction technique influences the presence of the active compound and consequently the extract
activity [137].
B. orthobotrys is another species of this genus mainly grow in Iran. Roots bark leaves are used in
traditional medicine in easy problem like menstrual pains, kidney stones, but the species have also
demonstrated anticancer activity in HeLa cell line. As reported by Bavand et al. [138], ethanol root
extract induces morphological change and apoptosis in HeLa cells then 72 h of treatment. In particular
treatment of cells with 1.25 mg/mL of extract, reduced the cell viability, inhibited the cell growth,
changed cell adhesion to the substrate, pigmented the cells and formed apoptotic bodies [138].
Treatment with a low concentration of the extract also presents anticancer activity on other types of
cancer cell line. Engel et al. [139] reported that the reduction of cell vitality of 60% caused by treatment
with different doses ranged from 100 to 1 μg/mL of root extract of B. orthobotrys. They also studied
the possible molecular mechanism responsible for cell death. Microscopic analysis of cells showed
the accumulation of lysosome, which starts programmed cell death trough liberation of ROS and
hydrolytic enzymes, granularization and formation of Golgi vesicles, as well as the diffuse distribution
of neutral lipids. This is pronounced at 100 μg/mL, but also lower doses causes a slight formation of
lysosome vesicles [139].
In addition to alkaloids there are other secondary metabolites with anticancer activity, for example,
the triterpenoids the main active constituent of the trunk of B. koreana. They have been identified
through mass spectrometry and nuclear magnetic resonance and tested in different cancer cell lines
(A549, SK-OV-3, SK-MEL-2 and HCT-15) where they reduce cell proliferation [140,141].
7. Clinical Studies of Berberis Plants in Human
Currently available clinical trials regarding this group of plants point on their effects in various
conditions related to cardiovascular diseases and associated risk factors, neurodegenerative diseases
and inflammation.
One group of clinical trials conducting by Guiseppe Derosa et al. [142–145] had a specific interest
in a fixed combination that included B. aristata and Silybum marianum (Berberol®). The reason for this
combination lies in low bioavailability of B. aristata, while S. marianum is there to improve its intestinal
absorption. A 52-week double-blind placebo-controlled study in 136 obese patients with type-2
diabetes mellitus (T2DM) and metabolic syndrome analyzed various parameters, including: Fasting
blood glucose, insulin, total cholesterol, HDL, LDL, triglycerides, and body mass index (BMI). [146].
All of these parameters have been significantly improved in the treatment group compering with the
baseline and in order to control group. Previously, comparing same fixed combination vs. B. aristata
monotherapy in clinical trial conducting by Di Pierro et al. [147] with T2DM subjects, shown that
combination is more effective in decreasing of HbA1c indicated that positive effects are partly due to S.
marianum. In another study with the same combination of extracts in 102 dyslipidemia subjects after
three months, it has been shown reducing of total cholesterol, triglycerides and LDL, with increasing
of HDL from randomization and compared to the placebo group. The same result on lipid profile
has been observed in a double-blind, randomized placebo-controlled trial that included 106 patients
with metabolic syndrome treated with B. vulgaris [148]. Another two double-blind, randomized,
placebo-controlled, 6-months clinical studies with Berberol® conducting by Derosa et al. [142,143],
followed dyslipidaemic subjects intolerant to statins at high dosages. In both studies were included
patients tolerant to a half dose of statins. The lipid profile of included patients did not significantly
change in the active treatment group after reduction of statins dosage and the introduction of
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Barberol®. Meanwhile, in placebo group lipid profile was worsened compared to baseline and with
active treatment.
The clinical trial with type 1 diabetes mellitus (T1DM) subjects treated with the same
fixed combination (Berberol®) showed decreasing of insulin dose necessary to reach adequate
glycemic control [144]. The clinical trial with subjects at low cardiovascular risk also confirmed
hypocholesterolemia effects of a fixed combination of Berberol® [145].
Berberin has been shown to inhibit CYP3A4 in in vitro and animal models, as well as in humans,
and that inhibition should increase blood levels of statins, cyclosporine, and calcium channel blockers,
similar to the action of grapefruit [149]. The inhibition of enzyme CYP3A4 activity in humans has been
observed in a two-phase randomized-crossover clinical study in healthy male subjects after two weeks
of berberine administration (300 mg, p.o.) [150]. In a randomized double-blind placebo-controlled
clinical trial, patients suffering from irritable bowel syndrome received berberine hydrochloride twice
daily for two months [151]. The benefits from the treatment were observed as better IBS symptom and
depression/anxiety scores.
One of the clinical trials examined the effect of aqueous extract of dried barberry taken orally as
an anti-acne agent [152]. The results obtained from teenagers in this placebo-containing trial show the
effectiveness of using barberry in the treatment of acne vulgaris, despite the treatment and control
groups were small.
In all of these trials, no patients had serious adverse events. The limitations were the relatively
small size of the sample, and relatively short follow-up period. However, the side effects of berberine
have been reported in some in vitro and in vivo animal models, and observed effects were related to its
neurotoxicity [153,154]. Despite that, in animal models of Alzheimer’s disease neuroprotective effects
of berberine have been illustrated [155]. The published results in a review article from 2015 indicated
that on web page www.clinicaltrials.gov there was 17 clinical trials on the efficacy of berberine [156],
and currently there are 51 clinical trials which showing us increasing interest in beneficial effects of this
compound [data obtained searching web page dated 24 May 2018].
8. Conclusions
Berberis is an important genus of wild plants with a multitude of uses in pharmacology and
food industry. These species are the abundant source of important natural compounds, i.e., vitamins,
minerals, alkaloids and antioxidants, which can be used in a wide array of pharmaceutical and
nutraceutical products. Some of the species of the genus like B. vulgaris are also cultivated in Iran and
other countries, but information regarding its cultivation, diseases and production technology is sparse.
The present study has been carried out to report on the adaptation of different Berberis species, suitable
agro-climatic conditions for the higher yield, its production technology, diseases and harvesting
methods. However, further studies should be conducted to evaluate genetic diversity in the cultivated
species for selection of high yielding genotypes, development of new varieties, yield enhancement
through appropriate cultivation practices and integrated pest management (IPM) techniques.
Regarding food and pharmacological applications, Berberis is an important group of the plants
having enormous potential in the food industry, and several reports of their antimicrobial activity
have been found in the literature. Several phytochemicals found in fruits, leaves, stems and root
have demonstrated biological activities. Phytochemicals present in EOs confer antimicrobial and
antioxidant properties that make them useful as food preservatives. On the other hand, alkaloids
present pharmacological properties, such as anticancer activities reported. However, not much
information is available on the direct application of these plants in food products. On the other
hand, the extracts of B. vulgaris were the most promising as antioxidants as well as inflammatory
and neurological disorders protective. In addition, positive effects related to cancer targets have been
reported to reduce cell proliferation without affecting a normal human cell. For this reason, Berberis
spp. maybe considered an alternative for cancer treatment, but it is necessary to confirm their efficacy
in vivo, especially investigating the toxicity during drug therapy.
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Abstract: Diabetes mellitus is one of the biggest public health concerns worldwide, which includes
type 1 diabetes mellitus, type 2 diabetes mellitus, gestational diabetes mellitus, and other rare
forms of diabetes mellitus. Accumulating evidence has revealed that intestinal microbiota is closely
associated with the initiation and progression of diabetes mellitus. In addition, various dietary
natural products and their bioactive components have exhibited anti-diabetic activity by modulating
intestinal microbiota. This review addresses the relationship between gut microbiota and diabetes
mellitus, and discusses the effects of natural products on diabetes mellitus and its complications
by modulating gut microbiota, with special attention paid to the mechanisms of action. It is hoped
that this review paper can be helpful for better understanding of the relationships among natural
products, gut microbiota, and diabetes mellitus.
Keywords: gut microbiota; natural products; diabetes mellitus; complications; mechanisms
1. Introduction
Over the past 20 years, the prevalence of diabetes mellitus (DM) and its complications has rapidly
increased across the world, which poses a serious threat to global health [1–3]. The international
diabetes federation (IDF) estimated that one in eleven adults aged 20 to 79 (415 million) have DM
globally in 2015, and predicts that the number can rise to 642 million by 2040 [4]. DM is a complex
metabolic disorder characterized with the functional impairment or a lack of insulin-producing β-cells,
alone or in combination with insulin resistance [5]. DM has several types, including type 1 diabetes
mellitus (T1DM), type 2 diabetes mellitus (T2DM), gestational diabetes mellitus (GDM), and other
rare forms of diabetes mellitus [6,7]. T1DM is an autoimmune disease that is associated with the
aberrant immune responses to specific β-cell autoantigens, which causes the reduction of insulin [8–11].
T2DM is due to insulin resistance in the target tissue and a relative lack of insulin secreted by islet
β-cells, and is mainly affected by the combination of genetic susceptibility and lifestyle factors [12–15].
GDM is a kind of diabetes during pregnancy due to the increased severity of insulin resistance and an
impairment of the compensatory increase in insulin secretion [16–18]. Other rare forms of diabetes
mellitus, such as maturity-onset of diabetes of the young (MODY) resulted from mutations in a single
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gene. In addition, maternally inherited diabetes with deafness (MIDD) is caused by mitochondrial
mutations, and rare forms resulted from insulin gene mutations [19,20]. In this review paper, only
T2DM and T1DM will be discussed, because T2DM and T1DM are the main types of diabetes mellitus,
accounting for 90%–95% and 5%–10%, respectively [4,21,22]. In addition, T2DM can induce various
complications, which contributes to high morbidity and mortality, such as diabetic cardiovascular
diseases, nephropathy, retinopathy, neuropathy, and erectile dysfunctions [23,24]. Furthermore, many
studies have shown that some natural products and their bioactive components could prevent and
manage diabetes mellitus and its complications by several possible mechanisms, such as enhancing
insulin action, ameliorating insulin resistance, activating insulin signaling pathway, protecting islet
β-cells, scavenging free radicals, decreasing inflammation, and modulating gut microbiota [25–29]. In
recent years, the role of gut microbiota in the prevention and management of diabetes mellitus and its
complications has been a hot topic in research [14,30–32]. Special attention will be paid to the role of
gut microbiota in this paper.
Gut microbiota has been recently reported to be involved in the pathogenesis of several diseases,
such as obesity [33–37], liver diseases [38–41], cardiovascular diseases [42–44], cancer [45,46], and
DM [47–50]. The alteration of intestinal microbiota and the production of metabolites have been
demonstrated to play a critical role in the initiation and development of DM [51–54]. Some bacteria like
Saccharomyces boulardii Biocodex, Bifidobacterium animalis subsp. lactis 420, Lactobacillus casei CCFM419,
and Clostridium butyricum CGMCC0313.1 have been shown to ameliorate DM [55–59]. However, it
was reported that some bacteria, like Bacteroides and Candida albicans, promoted the incidence and
progression of T2DM in animal studies [60,61]. On the other hand, natural products have attracted
wide attention in recent years due to their diverse bioactivities, such as cardiovascular protective,
hepatoprotective, anti-cancer, anti-obesity, and anti-diabetic effects [25,36,62–71]. Furthermore, natural
products are also important factors in regulating gut microbiota [72–74]. A variety of dietary natural
products and their bioactive components have shown anti-diabetic effects by regulating gut microbiota
composition and abundance, the change of gut permeability, the production of short-chain fatty acids
(SCFAs), the decrease of lipopolysaccharides (LPS), and the inhibition of inflammation [58,75–80]. In
addition, natural products can be effective adjuvant agents in the therapy of T2DM with lower cost and
less side effects [81,82]. In this review paper, we first address the relationship between gut microbiota
and T1DM as well as T2DM based on animal and epidemiological studies, and then discuss the effects
of natural products on T2DM and its complications via modulation of gut microbiota, based on the
literature from animal and clinical studies in the last five years (2015–2019).
2. The Association Between Gut Microbiota and DM Based on Animal and
Epidemiological Studies
Many animal studies have revealed that the gut microbiota plays an important role in the incidence
and development of T1DM as well as T2DM [54,75,83,84]. In addition, increasing investigations have
found that gut microbiota is closely associated with T1DM and T2DM patients [85–87], and they will
be discussed in detail below.
2.1. The Association between Gut Microbiota and T1DM
The animal studies have shown that T1DM has been associated with the composition of the gut
microbiota [88]. For example, the abundance of Proteobacteria showed a more marked change than
that of the predominant phyla, such as Firmicutes and Bacteroidetes compared with the healthy control
in the rat model of T1DM induced by streptozotocin [89]. In another study, the gut microbiota from
non-obese diabetic (NOD) mice without myeloid differentiation primary response gene 88 (MyD88)
was transferred to wild-type NOD mice, which reduced the intensity of insulitis and delayed the onset
of autoimmune diabetes in recipients, by decreasing the amount of Lactobacillaceae and increasing the
number of Lachnospiraceae and Clostridiaceae [59]. Moreover, the deficiency of TIR-domain-containing
adapter-inducing interferon-β in NOD mice could prevent diabetes via the change in the gut microbiota,
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such as the proportion of Sutterella, Rikenella, and Turicibacter species [90]. In addition, the mouse
β-defensin 14 (mBD14) in pancreatic endocrine cells in NOD mice could prevent autoimmune diabetes,
while the microbiota dysbiosis could induce the deficiency of the pancreatic expression of mBD14,
which results in the higher incidence of T1DM [91].
The relationship between gut microbiota and T1DM has been summarized in a review paper
published in 2015 [54]. In addition, the epidemiological studies have reported that some intestinal
microbiota like phylum Bacteroidetes, genus Clostridium, Bacteroides, and Veillonella as well as Candida
albicans increased in T1DM patients, while some other gut microbiota like phylum Actinobacteria and
Firmicutes, genus Lactobacillus, Bifidobacterium, and Faecalibacterium as well as the ratio of Firmicutes to
Bacteroidetes decreased in T1DM patients [92–96].
2.2. The Association between Gut Microbiota and T2DM
The animal studies have found that there have been prominent differences in the composition
of gut microbiota between T2DM animal models and control subjects. For example, an in vivo
study found that the diabetic db/db mice had higher abundance of phyla Firmicutes, Proteobacteria,
and Fibrobacteres [97]. Additionally, the streptozotocin-induced T2DM mice showed an increase in
Brevibacterium, Corynebacterium, and Facklamia compared with wild type mice [98]. A decrease in
the diversity of gut microbiota and a lack of butyrate-producing bacteria were observed in T2DM
cats [99]. The level of serum fructosamine was inversely associated with the abundance of Prevotellaceae,
and was positively associated with the abundance of Enterobacteriaceae. In addition, the transfer of
Lachnospiraceae (strain AJ110941) from the feces of hyperglycemic obese mice to germ-free ob/ob mice
contributed to the development of T2DM in ob/ob mice. The colonization of Lachnospiraceae could
induce an increase in the level of fasting blood glucose (FBG) and a decrease in the level of plasma
insulin as well as homeostasis model assessment-β (HOMA-β). The decrease in HOMA-β values
indicated the dysfunction of pancreatic β-cells [100].
The epidemiological studies have also investigated the relationship between gut microbiota and
T2DM patients [101–104]. For example, a case-control study has shown that the proportions of phylum
Firmicutes and class Clostridia as well as the ratio of Firmicutes to Bacteroidetes decreased, whereas the
abundance of class Betaproteobacteria increased in T2DM patients [101]. In addition, the concentration of
Faecalibacterium prausnitzii and the abundance of genus Blautia was reduced in T2DM patients [102,103].
Moreover, a case-control study demonstrated that T2DM and obese patients had a lower quantity of
Lactobacillus, especially its subgroups (L. acidophilus, L. plantarum, and L. reuteri) in comparison with
controls [104].
Overall, several animal studies have revealed that the intestinal microbiota play an important
role in T1DM and T2DM. In addition, many epidemiological investigations have demonstrated the
closed association between gut microbiota and T2DM (Table 1). Furthermore, there are few prospective
studies on the relationship between gut microbiota and DM, which should be further investigated in
the future.
201
Foods 2019, 8, 440
Table 1. The epidemiological studies on the association between gut microbiota and T2DM.
Study Types Participants
Alterations in Gut Microbiota
Composition
Reference
Case-control study Adults with T2DM (n = 18)Healthy male adults (n = 18)
↓ The proportions of phylum
Firmicutes and class Clostridia,
and the ratios of Firmicutes to
Bacteroidetes
↑ The proportion of
betaproteobacteria
[101]
Case-control study Patients with T2DM (n = 18)Healthy individuals (n = 18)
↓ The concentration of
Faecalibacterium prausnitzii [102]
Case-control study Patients with T2DM (n = 10)Healthy individuals (n = 12)
↓ The abundance of genus
Blautia [103]
Case-control study Patients with T2DM (n = 100)Healthy individuals (n = 100)
↓ The counts of Lactobacillus sp.
(L. acidophilus, L. plantarum, and
L. reuteri) and Bifidobacterium
[104]
Abbreviations: T2DM, Type 2 diabetes mellitus. ↓, Decrease. ↑, Increase.
3. The Relationships among Natural Products, Gut Microbiota, and T2DM as well as T1DM
Based on Animal Studies
Some natural products, such as vegetables, fruits, dietary fibers, and medicinal plants, have
shown potential preventive effects against T2DM and T1DM as well as diabetic complications with
mechanisms of action, at least partly, via the modulation of gut microbiota [80,105–108].
3.1. Diabetes Mellitus
The extracts of vegetables and their bioactive components have been demonstrated to alleviate
T2DM by modulating the gut microbiota [75,79,80]. Capsaicin could improve the glucose homeostasis
and insulin tolerance in obese diabetic ob/ob mice by increasing the production of SCFAs and modulating
gut microbiota. It could increase the ratio of Firmicutes to Bacteroidetes and the quantity of Roseburia,
and reduce the quantities of Bacteroides and Parabacteroides at the genus level, which could decrease
the levels of pro-inflammatory cytokines, such as TNF-α and IL-6 [79]. Additionally, pumpkin
polysaccharide alleviated the T2DM in mice fed with a high-fat diet (HFD). Its antidiabetic effects
were also related to the increase in SCFAs production and selective enhancement of some bacteria,
such as Bacteroidetes, Prevotella, and Deltaproteobacteria [75]. Moreover, the carrot juice fermented with
Lactobacillus rhamnosus GG was demonstrated to ameliorate T2DM in rats via the increase in SCFAs in
the cecum and the change in the composition and abundance of gut microbiota, such as Oscillibacter
and Akkermansia [80]. In addition, the anti-diabetic activity of Momordica charantia (bitter melon) was
enhanced by the fermentation of Lactobacillus, which could induce an increase in the abundance of
Bacteroides caecigallinarwn, Bacteroides thetaiotaomicron, Prevotella loescheii, Prevotella oralis, and Prevotella
melaninogenica as well as the level of SCFAs [109].
It has also been reported that the extracts of several fruits and their bioactive components could
improve T2DM via gut microbiota [105,110,111]. The phlorizin in many fruits could competitively
inhibit the sodium-glucose symporters and regulate the level of blood glucose by decreasing the
level of serum LPS and insulin resistance, and increasing the level of SCFAs, especially butyric acid.
It could also increase the quantity of Akkermansia muciniphila and Prevotella, which modulates the
gut microbial community structure [110]. In addition, polysaccharides from the mulberry fruit have
shown protective effects against T2DM via gut microbiota in db/db mice, and the treatment with
polysaccharides could enrich the functional bacteria, such as Bacteroidales, Lactobacillus, Allobaculum,
Bacteroides, and Akkermansia [105]. The extracts from cinnamon bark were reported to improve glucose
tolerance and insulin resistance by reducing the abundance of genus Peptococcus, and the extracts from
grape pomace could reduce Desulfovibrio and Lactococcus, and increase Allobaculum and Roseburia in
diabetic mice [111].
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The inulin was also found to alleviate different stages of T2DM in diabetic mice by modulating
gut microbiota. It increased the relative abundance of Cyanobacteria and Bacteroides, and reduced the
relative abundance of Deferribacteres and Tenericutes [112]. In another study, the oral administration
with inulin-type fructan could reduce the FBG level, increase the glucagon-like peptide-1 (GLP-1)
level, and alleviate glucose intolerance as well as blood lipid in T2DM rats induced by HFD and
streptozotocin [108]. The treatment with inulin also increased the level of GLP-1 and improved the
gut microbiota dysbiosis by enriching probiotic bacteria Lactobacillus and SCFAs-producing bacteria
Lachnospiraceae, Phascolarctobacterium, and Bacteroides. Furthermore, the supplementation of the
long-chain inulin-type fructan fibers from chicory root to female NOD mice could delay the progression
of T1DM via the modulation of gut microbiota. This fiber could increase the ratio of Firmicutes to
Bacteroidetes and the abundance of Ruminococcaceae and Lactobacilli, which might contribute to the
increase in the expression of tight junction proteins occludin and claudin-2 and an antidiabetogenic
effect [106].
Some traditional Chinese medicine have been found to be effective in preventing and treating
T2DM. The administration of ethanol extract of Atractylodis macrocephalae rhizoma improved the
glucose metabolism by regulating the gut microbiota in diabetic db/db mice, and it could increase the
abundance of Bacteroides thetaiotaomicron and Methanobrevibacter smithii [113]. In addition, the extract
of Alpinia oxyphylla Miq. had protective effects against diabetes in T2DM db/db mice. It decreased
the blood glucose levels by modulating the intestinal microbiota composition, which increased the
abundance of Akkermansia and decreased Helicobacter [114]. The water extract of Potentilla discolor Bunge
could alleviate diabetes, which might be related to the change in the gut microbiota. The treatment
reduced the relative abundance of Proteobacteria in T2DM mice induced by HFD and streptozotocin [77].
It was related to an increase in levels of fecal acetic acid, butyric acid, and their specific receptors
including the expression of G-protein-coupled receptor 41 (GPR41) and G-protein-coupled receptor 43
(GPR43), which increased the insulin sensitivity and decreased the fat accumulation. Additionally, the
expressions of toll-like receptor-4 (TLR4), MyD88, nuclear factor-kappa B (NF-κB), and gut mucosal tight
junction proteins (caudin-3 and occludin) were decreased, which could reduce the gut permeability and
inflammation. In addition, the oral administration of total saponins and polysaccharides in Polygonatum
kingianum could prevent T2DM by regulating the gut microbiota [115]. The treatment improved
micro-ecology in the gut by reducing the abundance of Bacteroidetes and Proteobacteria, and increasing
Firmicutes. Furthermore, the baicalein showed anti-diabetic effects on diabetic rats, which reduced the
levels of blood glucose, LPS, and insulin resistance. The treatment of baicalein could regulate the gut
microbiota by increasing the relative abundance of Bacteroides and Bacteroidales S24-7 [78]. It could also
increase the production of SCFAs as well as the thickness of the gut mucus layer.
Overall, many studies have focused on the effects of different natural products, such as vegetables,
fruits, dietary fibers, and medicinal plants, on T2DM by regulating gut microbiota and improving
microecology in the gut. On the other hand, there are few studies about the effect of natural products on
T1DM by modulating gut microbiota. In the future, more studies are needed to investigate the effects of
different natural products and bioactive components on T1DM via gut microbiota-related mechanisms.
3.2. Diabetic Complications
Long-term diabetes increases the likelihood of its complications like diabetic erectile dysfunctions,
nephropathy, cardiovascular diseases, retinopathy, and neuropathy [116,117]. The gut microbiota has
also been found to have a close relationship with the development of the diabetic complications. In the
rat models with T2DM erectile dysfunction, there was a reduction in the relative abundance of beneficial
bacteria like Allobaculum, Bifidobacterium, Eubacterium, and Anaerotruncus. In addition, the relative
abundance of opportunistic pathogens increased, such as Enterococcus, Corynebacterium, Aerococcus,
and Facklamia [118]. Some natural products have been reported to have protective effects on diabetic
nephropathy or kidney injury in diabetic mice by modulating the gut microbiota balance [107,119]. For
example, the polyphenolic extract of Dendrobium loddigesii could improve the symptoms of diabetes
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and complications in diabetic db/db mice. These effects were likely related to the improvement of
the intestinal flora balance, with an increase in the relative abundance of Prevotella and Akkermansia,
and the reduction in the relative abundance of S24-7/Rikenella/Escherichia coli [119]. Additionally, the
treatment with the water-ethanolic extract of green macroalgae Enteromorpha prolifera reduced the
inflammation in the liver and kidney by significantly increasing the abundance of Lachnospiraceae and
Alisties as well as regulating the insulin signaling pathway in T2DM mice induced by HFD and high
sucrose diet (HSD) and streptozotocin [107].
To sum up, several studies have demonstrated that the gut microbiota has a tight association
with diabetic complications. The increase or decrease in different types of gut microbiota could exert
different effects on the progression of diabetic complications. Moreover, several natural products have
showed potential efficacy on the prevention and management against diabetic complications, and these
effects were mainly associated with the modulation of gut microbiota composition and abundance,
regulation of the insulin signaling pathway, and inhibition of inflammation.
Lastly, the relationship among gut microbiota, T2DM, and its complications is shown in Figure 1,
and the association among natural products, gut microbiota, T2DM, and its complications is given in
Table 2 and Figure 2.
Figure 1. The association among gut microbiota, T2DM, and its complications. The changes of gut
microbiota caused the increase in LPS, which could cause inflammation and insulin resistance. It
indicates that gut microbiota would play an important role in the initiation and development of T2DM
and its complications. Abbreviations: LPS, lipopolysaccharides; T2DM, type 2 diabetes mellitus.
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Figure 2. The relationship among natural products, gut microbiota, T2DM, and its complications. Some
natural products and their bioactive components alleviate T2DM by changing the composition and
abundance of gut microbiota. It decreases the permeability of gut and the level of LPS, increases the
production of SCFAs, and inhibits the inflammation. The arrows out of the box indicates the direction of
action, and the up arrows in the box mean the upregulation or activation, and the down arrows in the box
mean the downregulation or inhibition. Abbreviations: LPS, lipopolysaccharides. SCFAs, short-chain
fatty acids. T2DM, type 2 diabetes mellitus. GPR41/43, G-protein-coupled receptor41/43. TLR4, toll-like
receptor-4. GLP-1, glucagon-like peptide-1. PYY, peptide YY. MyD88, myeloid differentiation primary
response gene 88. PI3K, phosphatidylinositol-3-kinase. NF-κB, nuclear factor-kappa B. IL-6, interleukin
6. IL-8, interleukin 8. TNF-α, tumor necrosis factor-α.
4. The Relationships among Natural Products, Gut Microbiota, and T2DM Based on
Clinical Studies
Several clinical trials have evaluated the protective effects of natural products on T2DM via gut
microbiota [120,121]. A double-blind, randomized, controlled clinical trial (RCT) involving 60 patients
with T2DM found that the supplementation of 10 g/day inulin powder promoted the gut health by
increasing the proportion of Akkermansia muciniphila [120]. Moreover, an RCT study found that the
fiber-rich macrobiotic Ma-Pi 2 diet could regulate gut microbiome dysbiosis in obese T2DM patients by
increasing the gut microbiota ecosystem diversity, recovering the SCFAs-producing bacteria community,
such as Roseburia, Lachnospira, Faecalibacterium, Bacteroides, and Akkermansia, and inhibiting the increase
of the pro-inflammatory group, such as Collinsella and Streptococcus [122]. Furthermore, an RCT study
including 100 patients with T2DM reported that a Chinese herbal formula could ameliorate T2DM and
improved the glucose and lipid homeostasis by increasing the abundance of Faecalibacterium spp. [116].
Another RCT study observed that the treatment with Gegen Qinlian decoction, which is a type of
Chinese herbal formula, at the moderate and high doses, significantly reduced the mean alterations in
adjusted FBG and glycated hemoglobin A1c (HbA1c) levels by enriching the beneficial bacteria, such
as Faecalibacterium prausnitzii [121].
To sum up, several clinical trials demonstrate that natural products can ameliorate T2DM by
regulating gut microbiota (Table 3). Some natural products, such as inulin and medicine plants, are able
to enrich certain beneficial bacteria in T2DM patients, such as Akkermansia muciniphila, Faecalibacterium,
and Lachnospira.
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5. Conclusions
In conclusion, the relationship among diabetes mellitus (including T1DM and T2DM), gut
microbiota, and natural products has been summarized and discussed. Animal and epidemiological
studies found significant differences in intestinal microbiota composition and abundance between
diabetic patients and healthy controls. The abundance of Bifidobacterium and Lactobacillus as well as the
ratio of Firmicutes to Bacteroidetes decreased, while the abundance of Bacteroidetes and Proteobacteria
increased in T1DM and T2DM patients. However, the consequences were not always consistent
due to other factors like types of diets and progression of diseases. In addition, animal studies
have demonstrated that gut microbiota is one of the most important factors for diabetes initiation
and development. Several natural products possessing prebiotic effects like fruits, vegetables, and
medicinal plants, have been found to ameliorate T2DM by modulating gut microbiota composition and
abundance, reducing the gut permeability, increasing the production of SCFAs, decreasing the level of
LPS, and inhibiting the inflammation. Moreover, clinical trials have further confirmed that several
natural products are effective in preventing and treating T2DM, with regulation of gut microbiota as
one of the potential mechanisms. In the future, it is necessary to explore the effects of more natural
products and their bioactive components on DM via gut microbiota-related mechanisms. In addition,
more well-designed clinical trials on natural products and their various bioactive compounds should
be carried out to verify their effects on T2DM and its complications by regulating gut microbiota.
Furthermore, functional foods based on natural products can be researched and developed by targeting
gut microbiota for the prevention and management of T2DM. On the other hand, present studies
mainly focus on modulating the action of natural products and their bioactive components on gut
microbiota for preventing and managing T2DM. However, seldom studies have been carried out about
the metabolism of natural products and their bioactive components by gut microbiota, even though
the metabolites could directly play a role in the prevention and management of DM or, in return, could
modulate gut microbiota. Thus, metabolisms of natural products and their bioactive components by
gut microbiota should be widely studied in the future for the prevention and management of DM.
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